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Abstract
A wide range of synthetic chemicals and their metabolites present in the envi-
ronment can antagonise the receptor activity of androgen hormones present in wildlife
and humans. With increasing global production of new synthetic chemicals, little is
known about their environmental fate, health consequences and end-points.  This study
was conducted to identify and characterise chemicals with anti-androgenic activity pre-
sent in wastewater influent and effluent. This study was undertaken by applying a com-
bination of biological and analytical chemistry techniques involving Solid Phase Extrac-
tion (SPE), High Performance Liquid Chromatography (HPLC) and an in vitro steroid
receptor assay for profiling and characterising extracts of grab influent and effluent
wastewater samples using a toxicity identification and evaluation (TIE) procedure.
Initial work revealed variable recoveries of anti-androgenic activity from SPE of
wastewaters. Therefore SPE methodology to screen wastewater samples was developed
using a mixture of selected compounds which possess a range of polarities (log Kow).
Their recoveries from SPE were measured by HPLC protocol and ranged from 95-
100%. The mean±SD and % RSD values of the analysed wastewater replicates were
3.20±0.03 mgFeq/L and 0.78% for influent and 0.22±0.01 mgFeq/L and 3.80% for ef-
fluent samples. The recoveries of wastewater extracts after fractionation were between
78.6% and 99.6%. Fractions containing anti-androgenic activity were analysed by Gas
Chromatography Mass Spectrometry (GC-MS). A number of household chemicals were
detected in both influent and effluent wastewater fractions that contained anti-
androgenic activity. These included the anti-bacterial agents- triclosan, chlorophene,
dichlorophene, chloroxylenol, the musk fragrance galaxolide, the flame retardants-
tris(1-chloro-2-propyl)phosphate (TCPP) and tris(2-butoxyethyl)phosphate (TBEP),
polymer plasticizer n-butylbenzenesulfonamide (NBBSA) and bisphenol A (BPA)
which is a chemical associated with the polycarbonate usage. The anti-androgenic po-
iii
tency of pure contaminants compared with that of flutamide ranged from 0.04 (TCPP)
to 13.40 (chlorophene). Anti-androgenic activity of 1.69 and 2.00% was recovered from
the fractions of the effluent and influent samples respectively indicating that AA of
about 98% are yet to be recovered.
This work reveals for the first time that over 12 contaminants contribute to the
total anti-androgenic activity present in wastewater effluent and that a number of com-
pounds commonly used in household products (such as chlorophene, triclosan and
NBBSA) are predominant anti-androgens in wastewater effluents.
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1Literature Review
1.0 Background
Chemical communication is the fundamental process by which all living
organisms exchange vital information within their internal systemic components, with
other organisms and with their immediate environment (Cheek et al., 1998; Fox, 2004).
This process is basically accomplished through three major communication
mechanisms: endocrine, immune and nervous systems. Although their modes of action
are dissimilar, the endocrine and immune communication systems are co-ordinated
through the blood (Pardridge, 1981). The presence of some man-made chemicals and
their by-products in the global environment can pose a serious risk to public health
when they interfere with any of these communication mechanisms (Arcand-Hoy and
Benson, 2001). Given that the endocrine communication system is responsible for the
regulation of metabolic processes, homeostasis, reproduction and basic developmental
mechanisms (Kime, 1998), it is thus possible for some chemicals that possess hormone-
like behaviours to disrupt its normal regulatory activities. Within the progressive
attempts aimed at meeting the rising challenges and burden of the human needs (health,
social, food and economic demands), production and use of consumer products such as
pharmaceuticals, cosmetic products, laundry and washing detergents, agronomic and
synthetic foodstuffs and other human consumables have increased, and their potential
for environmental contamination has also heightened. As a consequence, exposure to
cycles of potentially harmful chemicals can bring about endocrine modulation and
genetic alterations, which may lead to dangerous health effects in humans, mammals
and other living organisms. This revelation has added to the speculation that
environmental chemicals may contribute to the growing cases of certain global health
problems.
1.1 Endocrine System
The endocrine system is responsible for co-ordinating a wide range of complex
biological processes in the body. It controls the physiological activities of the body by
secreting hormones through the collection of endocrine glands and non-endocrine
organs in the body. Some of these hormone-secreting bodies include the hypothalamus
(which is situated above the brainstem and under the cerebrum), the pituitary glands
(that are attached to the underside of the brain by stem stalks) and the various other
2organs such as thyroid, kidney, pancreas, ovary and testis (Figure 1.0). Hormones are
chemical messengers that communicate useful coded information to the target sites
where chemical ‘messages’ are utilised to bring about necessary changes. For example,
hormones such as gonadotropin-releasing hormones (GnRH), thyrotropin-releasing
hormones (TRH) and corticotropin-releasing hormones (CRH) are secreted by the
neurons in the hypothalamus and transported via the blood to encourage the pituitary
glands to secrete some endocrine regulatory hormones. Hormones such as thyroid-
stimulating hormone (TSH), follicle-stimulating hormone (FSH), luteinising hormone
(LH), adrenocorticotropic hormone (ACTH), prolactin (PRL) and growth hormone are
secreted by the anterior pituitary while antidiuretic hormone (ADH) and oxytocin
(OXY) are produced by the posterior pituitary. At the particular target site where
exchange of chemical messages are required, a number of functional receptors are
situated either on the surface of the target cells on the plasma membrane or at the
nuclear region. These facilitate the binding of hormones to the specific receptors
through which chemical signalling takes place. Action of chemical communication via
hormones could occur in a localised area of the body (autocrine and paracrine effects)
and, sometimes, it extends to all over the body (endocrine effect) (Bigsby et al., 1999).
3Figure 1.0: The diagram of human endocrine system showing the locations of various
internal organs associated with hormone secretion in the body. Adapted from
Endocrinology Medicine website, www.endoatsoim.com
1.2 Steroidal and Non-steroidal Hormones
Hormones occur as steroidal and nonsteroidal molecules with different structural
forms which accounts for their diverse molecular weight. Their occurrence in different
molecular weight as lipophilic or lipophobic compounds will explain why the activity of
some hormones are localised to a particular region of the body. Generally, steroids are
found in nature as fat-soluble, sparingly water-soluble, organic compounds (lipids)
which have evolved as plant and animal hormones (Bishop and Koncz, 2002). Steroidal
hormones are broadly classified into five subdivisions based on their physiological
behaviours, which are: mineralocorticoids (which influence sodium retention through
renal tubules), glucocorticoids (which regulate carbohydrate metabolism and inhibit the
absorption of calcium in the intestine) and the three sex steroid hormones (estrogens,
androgens and progestins) (Miller, 1988).
Non-steroidal hormones constitute the majority of hormone population in a
category comprising proteins, peptides, amino acids and fatty acid derivatives (Hinuma
4et al., 1998). Peptide hormones are water-soluble, relatively moderate molecular weight
molecules (in comparison with protein) which are formed by varying chain-lengths of
linear and/or ring amino acids (Neal, 2001). Some hybrid non-steroidal hormones,
formed as a linkage between peptide hormones and carbohydrates, have also been
identified. This class of hormones are known as glycoproteins (ibid.). Few common
examples of glycoproteins are luteinising hormone (LH), follicle stimulating hormone
(FSH), human chorionic gonadotropin (β-hcG) and thyroid-stimulating hormone (TSH)
(ibid.). In this section, the functions of some steroid hormones especially sex steroid
hormones and non-steroid hormones like GnRH, CRH and TRH are discussed.
1.2.1 Sex Steroid Hormones
The sex steroid hormones are synthesised by the endocrine system of most
animal species and are responsible for the regulation of critical stages in the animals’
life cycle which include gametogenesis, fertilisation, sexual development and
reproduction (Gross et al., 2003). They can be divided into three major classes; namely:
estrogens, androgens and progestins (or progestagens). Generally, steroid hormones
have chemical structures composed of a three-dimensionally arranged four, fused
carbon rings in a 6-6-6-5 ring structure with a ketonic, aldehydic or alcoholic functional
group and terpenoid appendages in rare instances (Xu et al., 2003; Ying et al., 2002).
This core nuclear arrangement has been described as cyclopentan-o-
perhydrophenanthrene ring system, having 17 carbon atoms in total (Shen and Lin,
2006; Wynn, 1965; Ying et al., 2002). The ring nature varies from one steroid to
another. Whereas the first six-carbon ring may be saturated (cyclohexane) or partly
saturated in one structure, yet in another it would be fully unsaturated (benzene ring).
The fourth ring is a cyclopentane, a saturated five-carbon ring (Xu et al., 2003) (see
Figure 1.1).
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Figure 1.1: Chemical structures of common endogenous steroid hormones in the
vertebrate endocrine system.
1.2.1.1 Estrogens
Estrogens are a group of steroid sex hormones which are responsible for the
maintenance and regulation of growth, development, differentiation and function of
reproductive organs, sexual characteristics and other reproductive processes in both
mature wildlife and humans (Ciana et al., 2003). In addition, they control some
important body organs such as the bones, brain and cardiovascular system (ibid.).
Although, these hormones are found largely in females, they are present in male animals
in trace amounts. In male animals, estrogen may regulate the commencement process of
Progesterone Cortisol
Estrone
6spermatogenesis by facilitating spermatogonia multiplication and by enhancing the role
of follicle stimulating hormone (FSH) in activating spermatogenesis (Ebling et al.,
2000; Kula, 1988; Kula et al., 2001; Walczak-Jedrzejowsksa et al., 2005). They are
composed of estrone, estradiol and estriol which are produced by the ovaries, adrenal
glands and the fatty tissues. The first two hormones are formed in the ovaries while the
last is produced in one of the reproductive tissues during luteal phase in the corpus
luteum (Barlow and Logan, 1966). Estriol can also be formed through aromatisation of
16-OH-dehydroepiandrosterone sulphate (a DHEA derivative formed in the liver)
during pregnancy in the placenta (Ryan, 1959).
1.2.1.2 Androgens
Androgens are a class of sex steroid hormones which are produced by both
mature male and female animals. They control the development and maintenance of
masculine characteristics, sperm induction and sexual differentiation as well as enhance
virility and libido; in addition, they regulate water (through the synthesis of aldosterone
hormone which is produced by adrenal cortex of the adrenal gland situated above the
kidney) (Shigeoka et al., 1985; Milledge et al., 1983), nitrogen retention (Urban et al.,
1995; Brodsky et al., 1996) and activate skeletal growth (Quigley et al., 1995). This
class of hormones include androsterone, testosterone and dihydrotostesterone and they
are secreted by the testis, ovaries, adrenal glands and placenta. Androgens are produced
from enzymatic metabolism of cholesterol and steroid intermediates as shown in Figure
1.2.
7Figure 1.2: Biosynthetic pathways of some androgen hormones and their enzyme-
mediated conversion products. The blue enzymes catalyse the formation and
metabolism of androgen hormones including the aromatase. The red enzymes act on the
pro-androgen hormone precursors and metabolites produced during steroidogenesis
(adapted from, http://www.conf.ncku.edu.tw).
1.2.1.3 Progestins
Progestins are a class of steroid hormones derived from both natural and
synthetic origins. They are used to sustain pregnancy to maturity (reduce preterm
delivery), inhibit ovulation and menstrual cycle control, reduce the endometrial wall and
stem the growth of prostate cancer (Sitruk-Ware 2004). The natural progestins (such as
progesterone) are manufactured and secreted in the corpus luteum (ovary), the placenta
and the adrenal cortex of female humans (Schindler et al., 2003). In the male humans,
this hormone is secreted by the testes and the adrenal cortex (Simpkins et al., 2005).
Comparatively, the level of progesterone in female humans is higher than that in male
counterpart but this drops to the level found in the male during the follicular stage of the
menstrual cycle (Chrousos et al., 2001). Apart from the natural progestins, a wide range
of progestins are being manufactured on an industrial scale today for therapeutic use
(e.g. manufacturing of contraceptives) (Falconer, 2006). The presence of
8polychlorinated biphenyls (PCBs) in the body could facilitate the breakdown of
progesterone in the liver (Colborn et al., 1997). For example, it has been documented
that women who experience incessant miscarriages possess relatively higher level of
PCBs in their bodies compared to those carrying normal pregnancies (Leoni et al., 1989;
Saxena et al., 1981). The presence of PCBs could possibly lead to drastic reduction or
non-availability of progesterone in the body system (ibid.). While the occurrence of
PCBs may be correlated to the incessant miscarriages in pregnant women, it has not yet
been proven that they are responsible for the phenomenon.
1.2.2 Non-steroidal Hormones
1.2.2.1 Gonadotropin-Releasing Hormone (GnRH)
Gonadotropin-releasing hormone (GnRH) is a decapeptide produced by the cell
bodies of hypothalamic neurons present in the brain. It is released into the portal blood
system and transported to the anterior pituitary to stimulate gonadotropin production.
The gonadotropin FSH and LH are heteromeric glycoproteins which stimulate gonadal
synthesis of sex steroid hormones (testosterone, estrogen and progesterone), which are
required for spermatogenesis and oogenesis (Dalken et al., 2001). Both FSH and LH
hormones have a similar α-subunit and a distinctive β-subunit (Conn, 1994). The
secretion of GnRH occurs during the outset of puberty. Although the function of GnRH
in the gonads (the testis, the ovary), the uterus (the placenta), the breast and the central
nervous system is unknown, it has been detected in these organs (Grossman, 1998).
1.2.2.2 Corticotropin-Releasing Hormone (CRH)
Corticotropin-releasing hormone is a 41-amino acid peptide produced by the
parvocellular neurons situated in the hypothalamic paraventricular nucleus (Vale et al.,
1981). In addition to their presence in the hypothalamus, the CRH-secreting neurons are
distributed across the central nervous system as well as the adrenal cortex, the spinal
cord and the limbic regions (Brady et al., 1990; Merchenthaler et al., 1984; Swanson et
al., 1983; Thompson et al., 1987). It influences the synthesis of adenocorticotropic
hormone (ACTH) by activating the anterior pituitary cells. The ACTH secreted acts on
the adrenal cortex and facilitates secretion of glucocorticoids (e.g. corticol in human and
corticosterone in rat), the hormones which act in response to stress. The ACTH is
directly responsible for regulating the effect of stress on immune system or
inflammatory system (Berridge and Dunn, 1987). Although CRH is a widely known
9moderator of endocrine and immune responses to stress, it is also responsible for a wide
range of behaviour such as reproduction, arousal and feeding (De Souza, 1995; Dunn
and Berridge, 1990). It is a key regulatory element required during human pregnancy
and parturition (ibid.). As the period of gestation advances, the concentration of the
CRH peptide in placenta increases correspondingly as that in the maternal plasma
(Sasaki et al., 1987; Riley et al., 1991).
1.2.2.3 Thyrotropin-Releasing Hormone (TRH)
Thyrotropin-releasing hormone is another tropic tripeptide hormone which is
produced by the paraventricular nucleus of the hypothalamic neurons. It is released at
the median eminence to facilitate the secretion of thyrotrophic-stimulating hormone
(TSH) at the anterior pituitary which regulates the release of triiodothyronine (T3) and
thyroxine (T4) from the thyroid gland (Ghamari-Langroudi et al., 2010). The thyroid
hormones (T3 and T4) secreted can also act as the negative feedback mechanism by
controlling the activity of TRH-secreting neurons in the hypothalamus (ibid.).
1.2.3. Intracellular and Extracellular Hormone Receptors
Hormones are biological change agents that bind with specific hormone
receptors to regulate some essential biological activities (such as growth, metabolism,
puberty and reproduction) in the body. Extracellular messages carried by the hormones
are converted to intracellular signals after forming a complex with the hormone
receptors of the target cell. The nature of the receptors involved in such binding depends
on the chemical structure of the hormone. Based on their cellular localisation, hormone
receptors are broadly classified into two main categories, namely extracellular receptors
otherwise known as cell-surface receptors (CRs) and intracellular receptors (IRs). In
addition to the two major receptors, there are some receptors whose activating ligands
are not known. This class of receptors is referred to as orphan receptors. CRs are
glycoprotein structures located in the phospholipid bilayer of the cell membrane which
explains the reason why they are referred to as cell-surface receptors. Structurally, they
transverse the hydrophilic outer cell surface, the hydrophobic plasma membrane and
hydrophilic inner framework of the cell cytoplasm. CRs are remarkably sensitive to
different extracellular signalling molecules especially high molecular mass peptides that
cannot diffuse naturally into the cell through the plasma. The commonly known
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examples of CRs are G-protein coupled receptors (GPCRs), receptor tyrosine kinases
(RTK), integrins and toll-like receptors.
Intracellular receptors are hormone receptors using hormone-binding to induce
intracellular signals in a cellular system. Unlike the CRs, they are localised in either the
inner cytoplasm or the nucleus of the cell. This class of hormone receptors has affinity
for low molecular mass hormones which can easily diffuse through the plasma
membrane to initiate binding in the cell. Examples of intracellular receptors include
androgen receptor (AR), estrogen receptor (ER), progesterone receptor (PR), thyroid
hormone receptor (THR), retinoic acid receptor (RAR), retinoid X receptor (RXR) and
vitamin D receptor (VDR). Interestingly, some intracellular receptors can also bind and
activate certain CRs. A member of the GPCRs family (GPR30) has recently been
identified to demonstrate high binding affinity to estrogen in contrast to binding to the
known cellular estrogen receptor (e.g. ERα and ERβ) (Revankar et al., 2005; Thomas et
al., 2005). It was also discovered that the GPR30 binding produces multiple
intracellular responses that are associated with growth, proliferation and differentiation
(Filardo et al., 2000; Kanda et al., 2003; Kanda et al., 2004). This new finding is
regarded as a possible significant step towards treating tumours which are not
dependent on estrogen receptor agonism.
1.2.4 Mechanisms of Hormone Action
Hormones modulate gene expression via genomic and non-genomic signalling.
While a genomic signalling is initiated by influencing the RNA and certain protein
synthesis through receptor complex interaction with the hormone response element of
the DNA, a non-genomic pathway bypasses these components by recruiting other
signalling pathways (Vincent et al., 2008). Some non-steroid hormones, such as insulin,
oxytocin and vasopressin, are known to elicit cellular expressions via non-genomic
signalling but steroid hormones (e.g. estrogen, progesterone and androgen) can regulate
cellular expressions via both genomic and non-genomic mechanisms (Losel et al., 2003;
Simoncini and Genazzani, 2003; Vincent et al., 2008). In this Section, both
transcriptional and non-transcriptional mechanisms of steroid and non-steroid hormone
actions are briefly described.
When steroid hormones are released into the blood stream after secretion, they
are transported to the target cells where the process of biological changes is set to occur.
At these cells, they locate and bind to the functional intracellular receptors, known as
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steroid receptors, which are present either in the cytoplasm (cytosol), when in free state
or in the nucleus, when they occur as complex (see Figure 1.3; Ing and O’Malley, 1995;
Jacobson et al., 1995; Kemppainen et al., 1992; Waller et al., 2000). Steroid hormone
receptors are biological co-change agents with hormones which can facilitate internal
communication and transformation. Steroid hormone receptors are made up of amino-
and carboxyl-terminus, the DNA and ligand binding domains (LBD) (Beato, 1989).
Generally, they exist in the cytoplasm as a monomer with perinuclear distribution as
well as homodimers or heterodimers (Jacobson et al., 1995; Kemppainen et al., 1992;
Waller et al., 2000). After the formation of steroid receptor complexes, the heat shock
proteins (HSP) detached from the receptors while the receptor complexes formed
diffuse through the cytoplasm and the nuclear pores as they translocate into the nucleus
(Keller et al., 1996). In the nucleus, the receptor complexes bind to the human response
elements (HREs) on the DNA. Prior to the binding, the receptor complexes undergo a
series of conformational changes which modify them into a form that will interact with
the hormone response elements (HREs) (see Figure 1.3; Beato et al., 1987; Beato, 1989;
Mckenna et al., 1999; Mckenna and O’Malley, 2002). To initiate transactivation, the
HREs attract coactivators or corepressors which induce the transcription of downstream
DNA to messenger RNA. The necessary gene expressions are stimulated in the target
cells by the protein formed through the RNA transcription (Ing and O’Malley, 1995).
The choice of either coactivators or corepressors is determined by the nature of the
ligand that bounds to the receptor. An agonist signalling could sometimes recruit
coactivators which will lead to increased expression of one or more genes and the
proteins which they encode. The process is referred to as gene up-regulation. For
instance, increase in concentration of testosterone in the bloodstream induces
production of more androgen receptor and hence activates gene up-regulation that
would bring about skeletal muscle development in animals (e.g. cattle) (Squires, 2003).
Conversely, decrease in certain gene expression and their encoding protein are induced
when an agonist signalling occurs by recruiting corepressors. The phenomenon is
known as gene down-regulation. The build-up of progesterone concentration in the
uterine and endometrial regions leads to the reduction of progesterone receptors and
hence causes gene down-regulation (Bazer, 1998). While some knowledge of the
genetic behaviour of agonist signalling exists, little is known about genetic behaviour of
antagonist signalling.
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corepressor
Figure 1.3: Structural configuration and nature of a typical nuclear (e.g. androgen)
receptor: showing the location of nuclear receptor (NR) in the cytosol in absence of
ligand, the dissociation of heat shock proteins (HSP), dimerization and  nuclear
translocation of activated receptor as well as the coactivator (or corepressor)
recruitment, the DNA binding of the translocated receptor and the translation of
downstream DNA to RNA which would effect change in the cell function (adapted from
Wikimedia Commons, http://www.commons.wikimedia.org and reconstructed).
The mechanisms by which non-steroid hormones carry out their actions are
somewhat complex compared to the modalities involved in steroid hormones. Given the
relatively large size of their molecules, it is difficult for non-steroid hormones to diffuse
through the cell wall in order to bind intracellular receptors. Rather, they interact with
membrane receptors on the surface of the cell to form a complex which generates signal
that alters the conformation of the receptor. G-protein coupled receptors (GPCRs) are
just one example of a number of protein hormone receptors present in animal tissues.
The receptor in such modified configuration facilitates coupling to the G-protein to
form hormone-receptor-G protein complex (Birnbaumer and Birnbaumer, 1995). Non-
activated G proteins are heterotrimeric guanine nucleotide-binding protein which has
three subunits (Gα, Gβ and Gγ subunits) and the guanosine diphosphate (GDP) moiety
(Chedrese, 2009). The direct binding of the receptor complex to the Gα-subunit of the
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G-protein leads to the activation of G-protein and causes the dissociation of G protein
into Gα and Gβγ subunits (Neer, 1995; Surya et al., 1998; Strader et al., 1994). Hitherto
activation, the Gα of the G-protein is bound to the GDP as Gα-GDP but upon activation,
it becomes Gα-GTP. The activation of G-protein is presumed to facilitate the exchange
of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) (Neer, 1995; Surya
et al., 1998). The activated G protein dissociates from the receptor to modulate the
activity of the effector protein, which could be an ion channel or an enzyme (e.g.
adenylyl cyclase, phospholipase C and guanylyl cyclase), to produce certain levels of
second messengers (e.g. cyclic adenosine monophosphate (cAMP), diacylglycerol
(DAG) and Inositol triphosphate (IP3)) and transduction of signals (Chedrese, 2009).
However, given that Gα subunits carry some G-protein signalling modulating
proteins, referred to as GTPase activating protein, GTP can be hydrolysed to GDP
(Melmed and Conn, 2005). This same GTPase activating property is possessed by some
effector proteins such as adenylyl cyclase (Melmed and Conn, 2005). Upon activation,
these effector proteins will interact with Gα–GTP and convert it to Gα-GDP thus
making the Gα inactive (Chedrese, 2009; Melmed and Conn, 2005). The Gα
reassociates with Gβγ subunits of the G protein, fully ready to repeat the cycle
(Chedrese, 2009). Hormones associated with these cell surface receptors (and second
messengers) include TSH and catecholamine. As hitherto indicated (Section 1.2.3), CR
signalling can also be modulated via other molecular mechanisms such as ligand-gated
ion exchange (e.g. nicotinic acetylcholine receptors), receptor serine/threonine kinases
(e.g. receptors of activins and inhibins), receptor tyrosine kinases (RTK), receptor
guanylate cyclase (e.g. atrial natriuretic factor receptor), integrins and toll-like receptors
beside using G-protein coupled receptors (Kronenberg et al., 2008).
1.3 Endocrine Communication Pathways, Feedback Mechanism and Reproduction
End-points.
Endocrine communication involves concerted contributions and collaboration of
the central nervous system, the hypothalamus, the pituitary and the target tissues. The
central nervous system is a major division of the nervous system that controls and co-
ordinates dissemination of information useful for regulating biological processes of the
whole body. Given that the brain and the spinal cord constitute the central nervous
system, it directly supervises the activities of the hypothalamus and the pituitary gland
which co-ordinate and regulate the production of endocrine hormones. The
14
hypothalamus, the pituitary glands and the effector organ or tissue are frequently,
conveniently addressed as a single entity because they work in co-operation to produce
the desired effects. Thus, many triangular communication partnerships between the
hypothalamus, the pituitary gland and any of the different effector organs and tissues in
the body have been recognised but this study will be limited to three major ones
associated with reproduction, immune system and growth. These are the hypothalamic-
pituitary-gonadal (HPG), the hypothalamus-pituitary-adrenal (HPA) and the
hypothalamus-pituitary-thyroidal (HPT) axes. It is widely held that for the reproductive
system to function normally the activities of the HPG, the HPA and the HPT axes must
be balanced out (Simon and Polan, 1994). The HPG axis constitutes one of the major
endocrine signalling pathways in which the endocrine hormones are deployed for
specific localised actions on the body’s reproductive processes (see Figure 1.4). The
activities of the hypothalamus, the pituitary and the endocrine effector organs/tissues are
complementary. The preoptic region of the hypothalamus is composed of gonadotropin-
releasing hormone (GnRH) neurons, which induces the secretion of both luteinizing
hormone (LH) and follicle-stimulating hormone (FSH). They work in concert to
provide both positive and negative feedbacks to the hypothalamus and the pituitary
gland (Conn and Crowley, 1994; Shupnik, 1996). In females, both the FSH and LH
function essentially to stimulate the ovaries to produce estrogen and inhibin (Finkelstein
et al., 1991; Billiar et al., 2003). They are also responsible for regulating the menstrual
and ovarian cycles. While estrogen is known to contribute effectively to the negative
feedback mechanism leading to inhibition of GnRH production in the hypothalamus, the
inhibin is responsible for constraining activin which induces the production of GnRH
producing cells (Holdcraft and Braun, 2004; Drummond and Findlay, 1999). In males,
the LH controls the production of testosterone by activating the interstitial cells situated
in the testis and the FSH contributes to spermatogenesis (Luconi et al., 2002). As in
female, gonadal androgens can regulate cell growth, sensitivity to GnRH and level of
expression of the gonadotropins by feeding back directly on the pituitary gonadotropes
(Melmed and Conn, 2005). Generally, feedbacks on the hypothalamus and pituitary
sites are activated by the gonadal hormones at high concentrations in order to regulate
the secretion and release of gonadotropin (Melmed and Conn, 2005) (See Figure 1.4).
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Figure 1.4: A diagram showing the transition of activity and feedback network (cross-
talks) between the brain and hypothalamus-pituitary-gonad (HPG) axis during
endocrine hormone regulatory activity in the body. In Figure 1.4(a), the + and –
symbols in the diagram stand for and trace the positive and negative feedback pathways
respectively in the male body. Figure 1.4(b) shows similar progression of activity and
feedback mechanism in the female body (both diagrams were adapted from National
Institute of Alcohol Abuse and Alcoholism publications,
http://pubs.niaaa.nih.gov/publications). The feedback pathways are indicated by the
upward arrows. In the two diagrams, the activin and inhibin are secreted by the gonads
to regulate the feedback mechanism. The transition occurs via the action of luteinising
hormone releasing hormone (LHRH) on the anterior pituitary through to the gonads.
The regulatory ability of the HPG axis could be influenced by the other two axes
identified in this study. The HPA axis is a control pathway which links the hormone
system and the central nervous system. It has also demonstrated the ability to influence
the activity of HPG axis. Stress serves as a major mechanism by which the HPA axis is
activated. Some HPA components via which such activation is induced include CRH,
corticotropin, β-endorphin and glucocorticoid (Weinstock, 1997). CRH and GnRH are
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two peptide hormones that are secreted in the hypothalamus which are indirectly
responsible for adrenal and gonadal activities respectively (Rivest and Riviest, 1995).
Moreover, a direct neural linkage between the two hormones has been reported (ibid.).
In addition to HPA regulation, CRH has also been shown to regulate
proopiomelanocortin-derived peptides, such as β-endorphin, which inhibit the secretion
of GnRH in the hypothalamus (Chrousos et al., 1998).  This leads to non-secretion of
LH and FSH which are responsible for gonadal reproductive activity (Chen et al.,
1992). Likewise, the adrenal glucocorticoid can influence the HPG axis via positive and
negative feedback mechanisms at the level of the hypothalamus, pituitary, gonad and
other tissues (Chatterjee and Chatterjee, 2009; Dubey and Plant, 1985). It has been
reported that long-term elevation of glucocorticoid concentration can lead to the
suppression of HPG functions and the immune system (Melmed and Conn, 2005).
Glucocorticoids can feedback on the gonads to suppress gonadotropin synthesis (ibid.)
The HPT axis constitutes another vital feedback mechanism which can influence
the HPG axis. The process (described schematically in Figure 1.5 and Section 1.2.2.3)
leads to the formation of thyroid hormones (thyroxine, T4 and triiodothyronine, T3) and
regulation of hormone equilibrium in the body. The thyroid hormones are secreted to
regulate development, reproduction, metabolism, behaviour and growth in vertebrate
animals (Gorbman et al., 1983). The thyroid hormones influence the ovaries indirectly
by reducing the gonadotropin-releasing hormones (GnRH) in anestrous ewe (Clark,
1988). It is also likely responsible for the seasonal reproductive patterns in Bos indicus
cattle and Welsh Mountain ewe including development of refractoriness at the end of
the reproductive season (De Moraes et al., 1998; Follet and Potts, 1990). When thyroid
hormones are in excess of requirement during regulatory activities, they form a negative
feedback network which will influence the collective processes that facilitate their
secretion in the thyroid glands (Figure 1.5). Such a negative feedback mechanism will
down-regulate the activities of the hypothalamus and the pituitary, and in turn, affect the
activities along the HPG axis. For example, the relationship of the HPT with
reproductive activities in some vertebrate fish species has been established. Cyr and
Eales (1996) showed, over some specific phases in the reproductive cycle of some
teleosts, that there exists temporal relationship between the thyroidal and the gonadal
states. It was widely reported from studies on a wide variety of teleost species that the
increased thyroidal activity observed during early gonadal development is usually
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sustained during reproduction (ibid.). Conversely, the activity in both the thyroid and
gonad reduces during the spawning and post-spawning stages (ibid.).
Figure 1.5: A diagram illustrating the positive and negative feedback mechanisms of
the hypothalamus-pituitary-thyroid (HPT) axis between the brain, pituitary and thyroid
organs of the body (by courtesy Zoe).
1.4 Endocrine Disrupting Chemicals
A wide variety of anthropogenic chemicals, and some exogenous natural
chemicals, can influence the course of endocrine communication processes in humans
and wildlife. This class of bioactive chemicals are referred to as endocrine disrupting
chemicals, or simply as endocrine disruptors. An endocrine disruptor is broadly defined
as any exogenous agent that interferes with the normal processes of production,
secretion, transportation and receptor activation of natural hormones which are
responsible for the maintenance of homeostasis, growth, reproduction, and other
internal activities (Kavlock et al., 1996; USEPA, 1998). Endocrine disrupting chemicals
are mostly lipophilic in nature, bioaccumulative and environmentally persistent while
some are characterised with low vapour pressure (Colborn et al., 1995). At low
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concentrations, endocrine chemicals have potentials of inducing biological effects. The
likely reason for this is associated with the ability of these endocrine disrupting
compounds to act via multiple mechanisms. The effects of endocrine disrupting
chemicals and their biological end-points in living organisms may be irreversible.
Therefore, there are possibilities that these biological end-points may be expressed
during developmental and reproductive stages (Rhind, 2002). Controlled laboratory
exposure of fetal rodents to p,p’-DDT has resulted in reproductive defects such as
reduced and impaired fertility, decreased viability of the offspring, variation in
hormonal level and sexual behaviour of adult males and occurrence of some
developmental abnormalities such as cryptorchidism, hypospadias, disruption in the
network of intercellular bridges conjoining the germ cells in the testes and anomalies in
the acrosome, the nucleus and the shape of the sperms in these adults (Veeramachaneni,
2008). Effects such as increased anogenital distance (AGD), vagina agenesis,
masculinisation of female offsprings and induced male-like accessory tissues have also
been reported in female rats exposed in utero to β-trenbolone (Hotchkiss et al., 2007a;
Wilson et al., 2002). It has also been reported that most environmental chemicals
exhibiting endocrine disrupting characteristics have dissimilar chemical structures
(ibid.).
1.4.1. Behavioural and Structural Diversity of Endocrine Disrupting Chemicals
Although most disrupting activities of environmental chemicals are presumed to
occur via steroid receptor activation, it is also possible for these chemicals to alter the
synthesis, transport and metabolism pathways of hormones. The steroid hormone
production process is largely controlled by receptor-based feedback mechanisms and
consists of networked pathways of precursors, enzymes and products. In addition to
steroidogenesis (steroid hormone synthesis), endocrine chemicals can also alter the level
of hormone excretion and steroid biotransformation mechanisms. In gastropod mollusks
(e.g. dogwhelk, Nucella lapillus), tributyltin (TBT) can obstruct the formation of
sulphate conjugates of testosterone and its related metabolites regarded as less potent
and easily excreted forms of testosterone (Nelson et al., 1996; Ohno et al., 2005; Ohhira
et al., 2006). TBT can also inhibit aromatase cytochrome P450 enzymes involved in
biotransformation of androgens to estrogens. In most cases, environmental chemicals
having endocrine disrupting ability are different in structure when compared to the
structures of endogenous hormones modulating similar effects (McLachlan, 2001;
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Mantovani, 2002). While ethynylestradiol (EE2) and estrogen possess structural
similarities that could be receptor active, compounds such as nonylphenol (NP) and
dibutylphthalate (DBP) possess structures that are relatively different from that of
estrogen and yet are estrogen receptor(ER)-active (Sonnenschein and Soto, 1998). In
addition, chiral compounds may exhibit different biological activities based on their
enantiomeric forms (Garrison et al., 2000; Puttmann et al., 1989; Rodman et al., 1991;
Ulrich et al., 2001; Shen et al., 2006). Studies of induction of ethoxyresorufin-O-
deethylase (EROD) and benzphetamine Ndemethylase (BPDM), the cytochrome P450-
dependent enzymes, by 2,2',3,4,6-pentachlorobiphenyl (PeCB), 2,2',3,4,4',6-
hexachlorobiphenyl (HeCB), and 2,2',3,3',4,4',6,6'-octachlorobiphenyl (OCB) showed
that their (-)-enantiomers are more potent than the (+)-enantiomers except for HeCB
where the reverse is the case (Rodman et al., 1991). Therefore, it may be practically
difficult to design models for predicting the steroid receptor activity of compounds
based on their structures. Some of the diverse chemical structures are highlighted in
Figure 1.6.
1.4.2: Mechanisms of Endocrine Disruption Action
There is a wide range of means by which bioactive xenobiotics could disrupt the
normal endocrine activities. However, this review will be restricted to cellular-based
endocrine disrupting mechanisms which may or may not involve steroid hormone-
receptor sites and these include ligand receptor agonism, ligand receptor antagonism,
biosynthetic interruption, hormone transport interference and hormone metabolism.
1.4.2.1 Steroid Hormone-Receptor Agonism and Antagonism
Hormones produce effect-directed responses after successfully binding to the
targeted hormone receptor site. Hormone receptor sites are generally made of flexible,
broad domains with unique size and structure where interactions with a wide range of
hormone-like chemicals can take place. This tolerance behaviour of steroid hormone
receptors (Cooper and Kavlok, 1997) explains why xenobiotics would be able to disrupt
the activities of the endocrine system. Steroid hormone-receptor interaction can be
classified broadly into four categories based on the nature and type of ligand, and the
eventual hormone-receptor complexes formed: direct-acting agonists, direct-acting
antagonists, indirect-acting agonists and indirect-acting antagonists (Cooper and
Kavlock, 1997). Akin to endocrine hormones, bioactive xenobiotics can activate the
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hormone receptor sites to produce similar effects caused by endogenous hormones. The
principle associated with the receptor binding of endogenous hormone is the same as
that involving a direct-acting agonism except for the biochemical response. The level of
response induced corresponds to the potency of such compounds and the effectiveness
(success) of such binding. It must be stated that binding effectiveness accomplished by
a xenobiotic is determined by how closely fit in size and shape the ligand is to the
receptor in the ligand-receptor complex. Xenobiotics with higher potency are expected
to produce stronger physiological response than endogenous hormones of the same
concentration. Examples of xenobiotics known to possess hormone receptor agonism
include estrogen agonists diethylstilbestrol (DES), nonylphenol (NP), octylphenol (OP),
nonylphenol polyethoxylates (NPE), genistein, bisphenol-A (BPA), paraben and
tamoxifen (Fisher et al., 1999; Gray et al., 2001a; Snyder et al., 1999) and androgen
agonists 17α-and 17β-trenbolone, PCB-169, androstenedione and androstadienedione
(Ankley et al., 2003; Denton et al., 1985; Gray et al., 1999; Hewitt et al., 2000;
Hotchkiss et al., 2007a,b). The structures of some estrogen agonists, estrogen
antagonists and mixed agonist-antagonist are shown in Figure 1.6.
However, some receptor binding will not elicit response. This receptor-binding
effect is referred to as direct-acting antagonism and can be via competitive or non-
competitive antagonism. In the former, the hormone antagonists compete with agonists
for hormone binding sites. If the antagonist-receptor binding was successful, it will be
practically impossible for the binding to transform to signal. Chemical compounds that
can exhibit this form of behaviour are tamoxifen (a breast cancer drug), linuron,
cyproterone acetate, vinclozolin, dibutylphthalates (DBP), diethylhexylphthalate
(DEHP) and nafoxidine (Baker, 2001; Clark et al., 1973; Mantovani, 2002). In non-
competitive antagonist binding, the hormone antagonist can work in two possible ways:
inhibition of structural alteration at the receptor site which will cause ligand binding to
occur or inhibition of post-binding interactions with the HRE of the DNA that would
normally produce a response to the ligand. Vinclozolin derivatives (M1 and M2) have
been reported to demonstrate the potentials of impeding androgen-dependent gene
expression activation by effectively blocking androgen-induced steroid-steroid receptor
complexes (AR) binding to the HRE on the DNA (Kelce et al., 1994; Wong et al.,
1995). Some synthetic chemicals can express dual behavioural responses in different
biochemical environments. Such chemicals can be classified into partial agonist-partial
antagonist and mixed agonist-antagonist. The action of the latter produces different
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binding competence in different environmental conditions but sometimes the former can
act under such different environmental conditions too. The former acts as a partial
agonist by binding to the target receptors as a surrogate ligand in absence of the
endogenous hormone. Most often, such binding occurs at concentrations comparatively
lower than the effective concentrations of the endogenous ligand and the biological
responses produced are usually very weak (De Castro et al., 1991). However, as partial
antagonist, the exogenous ligand competitively binds the receptors at elevated
concentrations compared to that required for binding when it was acting as partial
agonist as well as that required by endogenous ligand (Ayd, 2000). When the
endogenous hormone is involved, the binding interaction mostly favours the exogenous
ligand due to its comparative advantage (i.e. high concentration). The biological
response induced in the process falls below that produced if endogenous ligands were to
act alone. In succinct description, partial agonist-partial antagonist compounds usually
produce agonistic response that increases as the concentration of the compound
increases at the receptor until it reaches a plateau where further increase in
concentration will no longer raise the level of the response (De Castro et al., 1999). Any
further increase in concentration will only elicit antagonistic response at that same
receptor (ibid.). Sometimes, the responses displayed by compounds having partial
agonist-partial antagonist characteristics are induced by the ionic strength of the
environment they operate in. Common examples of compounds acting relative to this
environmental condition are olanzapine and clozapine (Bymaster and Falcone, 2000).
Mixed agonist-antagonist phenomenon is expressed by tamoxifen which acts as anti-
estrogen in the breast tissues but also exhibits agonist behaviour in the bone and uterine
environments (Lewis-Wambi and Jordan, 2005; Fawell et al., 1990; Figure 1.6).
Raloxifene is another mixed agonist-antagonist compound which is highly effective as
an antagonist in the reproductive tissues as well as an agonist in the bone (Draper et al.,
1996; Gustafsson, 1998; Jordan, 1998). An example of a partial agonist-partial
antagonist is 2-arylpyrazolo[4,3-c] quinolin-3-ones, a derivative  of benzenediazepines
(Yokoyama et al., 1982).
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Figure 1.6: Structures of some endocrine disrupting chemicals behaving as estrogen
receptor-binding agonist (diethylstilboestrol, enterodiol and coumestrol) and estrogen
antagonist (equol). Tamoxifen acts as estrogen agonist and antagonist (or estrogen
mixed agonist-antagonist).
1.4.2.2 Disruption of Steroidogenesis
Hormone biosynthesis and metabolism are significant molecular processes
relevant to regulation and maintenance of cellular activities. With cholesterol as the
starting materials, a wide array of hormones can be produced by the action of enzymes
either directly on cholesterol or indirectly via other intermediates of steroid hormone
biosynthesis (see Figure 1.2). It is possible for xenobiotics to interfere with any of these
vital enzymatic pathways to induce endocrine-related health problems (Sanderson et al.,
2006). The broad range of enzymes involved in steroidogenesis is classified into four
Diethylstilbestrol
O
OH
OH
Equol
OH
OH
OH
OH
Enterodiol CH3
O N
CH3
CH3
O O
OH
OH
O
OH CH3
CH3 OH
Tamoxifen
Coumestrol
23
basic categories: aromatase, demolases, hydroxylases and hydroxysteroid
dehydrogenases. The biosynthetic pathways in Figure 1.2 reveal the many potential
disruption points where enzymatic functions may be altered during steroidogenesis. A
known enzymatic disruption pathway that has been reported in wildlife occurred in
dogwhelk (Bettin et al., 1996; Oehlmann et al., 1996). Bettin and colleagues (1996)
showed that TBT can inhibit P450 aromatase enzyme (known to be responsible for the
conversion of testosterone to estradiol) in dogwhelks when exposed to it. The study
also indicated that the aromatase inhibition by TBT must have led to the accumulation
of testosterone which is responsible for the formation of penis (imposex) in female
dogwhelks (ibid.). Ketoconazole, an antifungal antibiotic, is another compound that can
inhibit certain mammalian cytochrome P450-dependent enzyme such as C17,20-lyase and
17-hydroxylase (which are responsible for biosynthesis of androgens in the animal) at
elevated concentration (Vanden Bossche et al., 1987). It can also inhibit the production
of cortisol in the human adrenal glands (Engelhardt et al., 1985; Mantovani, 2002).
1.4.2.3 Interference with Hormone Transport
Steroid hormones are lipophilic biological molecules which account for why
they are sparingly soluble in water. They are transported in free or bound state to their
binding destination via the blood plasma. Special hormone carrier proteins such as
albumins and globulins are manufactured in the liver and the steroids are transported in
conjugated form as glucoronides and sulphates or as the lipid-soluble hormones
themselves. These globulin proteins occur as steroid hormone-binding globulin (SHBG)
or testosterone-estrogen-binding globulin (TEBG) and they may bind to either
testosterone or estrogen (Pertschuk et al., 1980; Roy et al., 2008). Since hormones are
transported in small concentrations, any slight increase in globulin concentration is
expected to reduce the chances of hormone availability for binding. Steroid hormones
are temporarily stored in the blood carrier proteins where they are shielded from
enzymatic activities which may lead to metabolism (ibid.). The carrier protein may
release these hormones, from time-to-time whenever there is a short-fall in free-state
concentration present in the blood. The role of the blood carrier proteins is to shield the
hormones from enzymatic action (e.g. deactivating activity of the liver) and this
contributes to why they are able to persist longer in the body. When hormones occur
below the receptor binding concentration, there is a possibility that they may be less
effective and hence have a shorter half-life in vivo. With the presence of circulating
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xenobiotics in the body, the transport protein binding sites are subjected to competition
with other chemicals and so may reduce binding of endogenous hormones to the carrier
protein and disrupt the transport of the hormone. The implication of disrupting the
hormone transportation mechanism is that the biological process of hormone complex
formation which induces gene expression could be significantly impaired or affected.
This may lead to serious health problem.
1.5 Endocrine Disruption Phenomena in the Environment
Every living organism requires the functionality of an effective chemical
communication mechanism to regulate and facilitate its complex internal arrays of
activities (MacLachlan 2001). These complex networks of biological activities include
cellular growth, sexual differentiation, reproduction and biological development. In
addition to normal intracellular regulation, the activities of organs and some specialised
systems are also co-ordinated. In recent times, environmental agents of both natural and
synthetic origins have come under intense investigation, especially concerning their role
in disrupting chemical signalling and inducing adverse health effects in wildlife and
humans. Interdisciplinary studies conducted to date have increasingly linked the
growing endocrine-related health cases in wildlife to this chemical disruption
phenomenon.
1.5.1 Evidence of Endocrine Disruption in Invertebrates.
A wide range of biological effects associated with the exposure of some species
of invertebrate phyla to endocrine disrupting chemicals has been identified. The most
comprehensive account of these environmental disturbances is summarised in the
exposure of oyster (Crassostrea gigas), female marine gastropods (molluscs) and dog-
whelk snail (Nucella lapillus) to organotin compounds (TBT). These compounds were
used as biocides in marine antifouling paints for ship hulls, boats and aquaculture pen
nets but also used in wood preservatives, agricultural pesticides, textiles and as UV
stabilizers in some plastics (Oehlmann et al., 1998). A wide spread occurrence of
imposex phenomenon, also known as pseudohermaphroditism, has been reported
globally in marine gastropod species. Molluscs account for the majority of marine
invertebrates found to be sensitive to TBT exposure. The term imposex defines the
reproductive defect where the male reproductive organs (penis and vas deferens) are
superimposed on the female marine species (Bryan et al., 1986; Horiguchi, 2006).
25
Additional effects linked to imposex include increased concentration of testosterone in
the tissue of marine snail (Spooner et al., 1991). About 150 species of gonochoristic
prosobranch gastropods worldwide are found to exhibit this reproductive abnormality
(ibid.; Matthiessen and Gibbs, 1998). At low concentration (1-2ng/l), female dogwhelk
exposed to TBT developed a blockage of oviduct, otherwise known as sterility (Bryan
et al., 1986). Further elevation in concentration (3-8ng/l) led to diminished juvenile
recruitment, induced masculinisation, reproductive difficulties, population reduction
and extinction (Matthiessen and 1998; Fox, 1992). These morphological abnormalities
are thought to be the consequence of inhibiting the aromatase (enzyme), which is
responsible for the conversion of testosterone to 17β-estradiol (Oehlmann et al., 1996).
The increased concentrations of testosterone induced biological effects which resulted
in this masculinisation phenomenon (Matthiessen and Gibbs, 1998). With competing
arguments suggesting a wide range of other possible modes of action of TBT such as its
action as a retinoid X receptor agonist (Nishikawa et al., 2004), interruption of
neuropeptide signaling pathways and modification of testosterone metabolism, the most
likely mechanism of action based on causal-effect evidence comes from aromatase
(CYP19) inhibition of testosterone metabolism. In oyster (Crassostrea gigas), the
consequences of TBT include shell deformation and decimation of adult population as
reproductive failure increased. Following worldwide confirmation of the long-term
toxicological implication associated with continued use of TBT, the International
Maritime Organisation (IMO) treaty in 2001 ratified the imposition of a partial and total
worldwide ban on its use on boats and ships which indeed took effect from 2003 and
2008 respectively (Antizar-Ladislao, 2008).
Similar to TBT, triphenyltin, a compound used in similar capacity as TBT in the
production of certain antifouling paint, has shown the potential of inducing imposex
phenomenon in some species of marine snail. It is significant to state that triphenyltin
(TPT) usage is not restricted to the production of antifouling paint alone (Crompton,
1998). In the 1960s, TPT was the main constituent of triphenyltinhydroxide and
triphenyltinacetate used as fungicides to treat potato blight, leaf spot and powdery
mildew (Keijzer and Loch, 1995). Schulte et al. (2000) reported imposex in female
freshwater ramshorn snail (Marisa cornuarietis), an ampillariidae-mesogatropod,
exposed to TPT. Some male sexual abnormalities associated with TPT have been
reported to include azoospermia (spermatogenesis impairment) and partial infertility.
These experimental discoveries underscore the endocrine disrupting impact of TPT
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across both sexes of freshwater ramshorn snail (Marisa cornuarietis) (ibid.). While no
significant negative effects were recorded in female netted whelk (Hinia reticulate),
dogwhelk (Nucella lapillus) showed abnormal sexual features highlighting impairment
of oogenesis and spermatogenesis when exposed to TPT.
Another biological effect of endocrine disruption in invertebrates is
intersexuality. Intersex reproductive abnormality was reported as the phenotypic
interference of sex determining organs occurring between the gonad and genital tracts
(Oehlmann et al., 1994; Bauer et al., 1995). Intersex males and females retained
phenotypic identity but are differentiated by the presence of additional reproductive
features specific to their opposite sex (Ford et al., 2004). While the female intersexed
species possess one or two penis or vas deferens (genitalia), the male species carry
rudimentary oostegites, the female brood plates (ibid.). It is reported that periwinkles
(Littorina littorea) developed intersexuality effects when exposed to TBT, a
phenomenon that contrast with the outcome of the previous exposures (Matthiessen et
al, 1995). Intersex phenomenon has been reported in crustaceans (harpacticoid
copepods) exposed to sewage effluents along the east coast of Edinburgh, Scotland
(Moore and Stevenson, 1994). Although the mechanisms surrounding the phenomenon
is unclear, factors responsible for intersex vary and may include age and the species (De
Bock and Greco, 2010), parasitism (Ford et al., 2004), temperature (Vazquez et al.,
2004), bacterial infection (Rigaud and Juchault, 1998), genetic control (Lebederf, 1939),
environmental sex determination (Dunn et al., 1996; Dunn et al., 2005), protandrous
hermaphroditism (Yaldwyn, 1966), exogenous chemicals (Olmstead and Leblanc, 2007)
and pollution (Moore and Stevenson, 1991; Ford et al., 2004a). The following copepods
were discovered to exhibit intersexuality: Paramphiascella hyperborea and Stenhelia
gibba and it was also evident in two species of Halectinosoma (Similidistinctum and
finmarchicum). Intersex contrasts with imposex in their reproductive morphology.
While imposex phenomenon can be described as complete superimposition of the
female reproductive organs with the penis or the vas deferens (the male reproductive
organs), intersex phenomenon is characterised with deepening development of abnormal
pallial oviduct by the female reproductive organs.
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1.5.2 Evidence of Endocrine Disruption in Vertebrates.
1.5.2.1 Reptiles:
Accidental spillage of a mixture of chemicals containing diclofol, DDT, DDE
and sulphuric acid, into Lake Apopka in Florida induced a wide range of reproductive
and developmental abnormalities in juvenile alligators (Alligator mississippiensis)
living in the lake (USEPA, 1979). In addition to the spill, the lake is known to receive
agricultural wastewaters which have further caused the level of its contamination over
time to be complicated (Guillette et al., 1994). Three years post-spillage review of the
alligator densities in the lake showed 90% reduction in the population of juvenile
alligators in the lake (Guillette et al., 1995; Jenning et al., 1988). This noticeable decline
in the alligator population has been attributed to reproductive failure modulated by DDT
and its metabolites, DDE and DDD. Woodward et al. (1993) reported reduced hatching
success from 80% to about 20% of the eggs taken from alligators harvested from Lake
Apopka. The juvenile male alligators that matured from these hatchlings were
discovered to have developed small penis size. High mortality rate of hatchlings (about
50%) occurred after 14 days when the concentration of bioaccumulated pesticides and
their metabolites recorded in the eggs doubled (ibid.). Abnormal morphological effects
attributed to these endocrine disrupting chemicals in both adult male and female
alligators include demasculinisation of male alligator (where increased length of
testicular phalluses was developed), malformation of cell structures in seminiferous
tubules, ovarian defects in the female alligators (ibid.). Plasma hormone concentration
studies of the gonad region have reportedly confirmed elevation of estradiol-
testosterone ratio (E2/T2) by a factor of 2 in female alligators and quadrupled factor
from 0.5 in the male reptiles under the influence of DDT and their metabolites stressing
the biological implication of xenoestrogens in vivo (Milnes et al., 2002; Guillette et al.,
1994). Laboratory studies revealed that o, p’-DDE which is suspected to be responsible
for most hormonal effects (estradiol) in alligator could effect sex differentiation when
eggs coated with chemical was incubated in the hatchery (Hileman, 1994). At normal
male hatching temperature, DDE coated eggs produced a mixture of male, female and
intersex in ratio 2:1:2 against 100% male recorded by DDE-free eggs (ibid.).
Another known example of environmental occurrence of endocrine induced
chemical effects detected in Lake Apopka occurred in red-eared slider turtle (Trachemys
scripta) population. Investigation conducted on the eggs, juvenile and adults of this
turtle species in Lake Apopka revealed some developmental and reproductive
28
abnormalities which have been attributed to exposure to chemical contaminants in the
lake. Seven years review of the turtle densities after the spillage revealed an alteration in
the hormonal balance and the trend of androgen synthesis. Most male sexed turtles are
progressively demasculinised while hatchlings either result in abnormal male or intersex
according to histopathological studies (Guillette et al., 1994). Studies have shown that
two hydroxylated PCB(2’,4’,6’-trichloro-4-biphenylol and 2’,3’,4’,5’-tetra-4-
biphenylol), which may be detected as metabolites of PCBs in the marine environment,
could activate estrogenic characteristics in eggs of red-eared male turtles that are pre-
dosed (coated) with these compounds when incubated at male-producing temperature
(Bergeron et al., 1994). Their endocrine disrupting characteristic could induce sex
reversal in male but the end-results in female turtles are unknown (ibid.).
1.5.2.2 Amphibians:
The declining profile of amphibians in the wild has raised questions about the
role of endocrine disrupting chemicals in the reduction of their population. Currently,
the available evidence implicating xenobiotic chemicals for the extinction of some
wildlife species is so far limited. Exposure of some amphibian species {e.g. northern
leopard frogs (Rana pipiens), green frogs (Rana clamitans) and mink frogs (Rana
septentironalis)} to agricultural chemicals has resulted in some developmental
deformities in addition to some physiological and immunological abnormalities and
propensities such as alteration in developmental hormones, increased susceptibility to
diseases, missing or supernumerary limbs, bony limb-like projections, digit and muscle
defects as well as those associated with central nervous system (Ankley and Giesy,
1998). Chemical-induced developmental and reproductive malformations have further
suggested that chemical exposure may be responsible for the decline of some amphibian
populations. Metamorphosis is a crucial developmental process by which eggs of a
wildlife species are transformed to the adult wildlife. Each of these stages is mediated
by the endocrine system through the endogenous hormones. Although the role of
endogenous hormones on the formation and transformation of larvae is not known, it is
suspected that sex steroid hormones can hinder larval development in some amphibian
species (Gray and Janssens, 1990; Hayes, 1997; Richards and Nace, 1978). Long-term
exposure of amphibians to estrogen and estrogen-like chemicals can modulate sex
differentiation during metamorphosis (Bevan et al., 2003; Christensen et al., 2005; Goto
et al., 2006; Mackenzie et al., 2003). Studies of cricket frog (Acris crepitans) taken from
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a PCBs- and polychlorinated dibenzofuran (PCDF)-contaminated site in Illinois, USA
revealed that male frog species showed sex ratio alteration. The additional reproductive
abnormalities reported include formation of testicular oocytes, incomplete
metamorphosis, and feminisation. Common morphological abnormalities documented
in female frogs comprise female-biased sex ratio and gonadal malformation (Jofre and
Karasov, 2007). Similar malformations have been reported in Northern leopard frogs
(Rana pipiens) captured in Ontario, USA.
1.5.2.3 Aves (Birds):
The best known examples of endocrine disrupting effects of environmental
chemicals in wild birds pertain to egg shell thinning, supernormal clutches and sex
differentiation. Widespread DDT and DDE pollution across the Pacific coast of the
United States of America between the 1950s and 1970s has been linked with some
developmental and reproductive abnormalities. Roughly 2 million kilograms of
industrial DDT and its metabolites were released into the coastline via the sewers
leading to bioaccumulation and bioconcentration of their particulates in the tissues of
fish, sea birds and sea lions. The effect-based ecological response to these contaminants
led to breeding failure in double-crested cormorants (Phalacrocorax auritus), brown
Pelicans (Pelecanus occidentalis) of Anacapa Island, common egrets (Casmerodius
albus) in California, sparrowhawks (Accipiter nisus) of South Scotland, fish-eating
Caspian and Foster’s terns (Stern caspia and Stern forsteri), white-tailed eagles
(Haliaeetus albicilla) of Schleswig Hostein, herring gulls (Larus argentatus) of Lake
Ontario and shoreline-nesting bald eagles (Haliaeetus leucocephalus) in the Great Lake
Basin. These and some other chlorinated pesticides were linked to the general decline in
the population of wild birds (Fry and Toone, 1981; Palmiter and Mulvhill, 1978). The
step-wise formation process of medullary bone (which is recognised as the primary
source of calcium during formation of eggs and eggshells) and calcium metabolism are
regulated by the sex steroid hormone, estrogen. It is possible for bioaccumulated DDT
and its metabolites in the tissues to act against the transportation of calcium across
eggshell gland mucosa given that some chlorinated pesticides have been reported to
have estrogenic characteristic. This calcium transportation inhibition leads to eggshell
thinning in predatory and non-predatory birds (Taylor and Harrison, 1999; Risebrough
et al., 1968). In addition to eggshell thinning, seen to be the prevalent symptom in most
exposed bird species, sex differentiation (skewed sex ratios) such as feminisation and
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intersexuality, have been reported to occur in some breeding populations of some wild
birds. Such bird species include Japanese quails (Bryan et al., 1989), Western gulls and
Herring gulls (Fry et al., 1981). Further long-term effects of morphological
abnormalities reported in wild birds include development of malformed ovarian tissues
and oviducts in male embryos (Fry et al., 1981), hematology (Bryan et al., 1989),
developmental abnormalities, such as feather malformation and growth retardation, and
mortality (Safe et al., 2000).
Another illustrative evidence of endocrine disruption reported in wild birds is
the incidence of supernormal clutches, where the average number per clutch (nest) rose
from three to between four and six (Dawson, 2000; Kovacs and Ryder, 1985; Ryder and
Somppi, 1979). Due to biased sex ratio in the population density (which resulted in the
shortage of male population density), it is observed that two female members could
come together (in what has been termed female-female pairing effect) to lay eggs in
common nest and share the responsibility of rotational incubation which was usually
undertaken with the male (Hunt and Hunt, 1977; Kovacs and Ryder, 1985). This
phenomenon was triggered by the high level of o, p’-DDT contaminants which induced
feminisation of male Western gull embryos found in the heavily contaminated Santa
Barbara Island (Fry and Toone, 1981). Supernormal clutches in member birds was
caused by skewed sex ratio in the population. Another explanation tenable for this
behaviour, which has not been investigated, is the masculinisation of female Western
gulls’ behaviour. The effect was no longer noticed after a worldwide ban was imposed
on the production and use of DDT as pesticide.
1.5.2.4 Pisces (Fish):
Among the five classes of vertebrate animals, fish ranks as one of the most
widely studied to illustrate endocrine disrupting effects of environmental chemicals.
This is because the aquatic environment, which is their natural habitat, is regarded as
“the ultimate sink” for natural and anthropogenic chemicals (Sumpter, 1998). Studies
have also shown that wastewater effluents are one of the major sources of chemical
contaminants of the aquatic environment (Desbrow et al., 1998; Snyder et al., 1999;
Baronti et al., 2000). There is a general view that severe endocrine disrupting
consequences, which could threaten the reproductive health and population
sustainability of fish, would not only spell their extinction but could also have adverse
consequences on the population and health of humans, predatory animals and other
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living organisms. Studies of the physiology and morphology of fish species caught
downstream of some wastewater-receiving rivers and lagoons and some laboratory
exposures showed diverse degrees of abnormalities (Kime, 1998; Tyler et al., 1998).
Gonad analysis of caged and wild male roach (Rutilus rutilus) exposed to wastewater
effluents during sexual differentiation revealed the induction of protein egg-yolk,
known as vitellogenin, a phospholipoprotein manufactured in the liver of egg-laying
female vertebrates (Folmar et al., 1996; Larsson et al., 1999; Purdom et al., 1994;
Rodgers-Gray et al., 2000, 2001). This egg-yolk formation has been defined as
feminisation of the male fish. Similarly, formation of vitellogenin has been reported in
juvenile male rainbow trout (Oncorhynchus mykiss), Japanese medaka (Oryzias latipes),
fathead minnows (Pimaphales promelas), zebrafish (Danio rerio) and cyprinid fish
species exposed to laboratory dosage of estrone (E1), 17β-estradiol (E2) and 17α-
ethinylestradiol (EE2) (Brion et al., 2001; Harries et al., 2000; Orn et al., 2006; Purdon
et al., 1994; Routledge et al., 1998; Thorpe et al., 2000, 2003). The presence of
nonylphenol, a metabolite of nonylphenol ethoxylate surfactants, in wastewater
effluents induces the egg yolk formation and inhibits testicular growth (Harries et al.,
1995). However, other variables such as water temperature, the migratory habits of fish,
the nature and dosage of EDC exposed to (including the diverse past EDCs exposure
which can leverage the fresh exposure threshold) can also contribute to the level of
vitellogenic response (Purdom et al., 1994; Kirby et al., 2004; Pait and Nelson, 2003;
Panter et al., 2002).
In addition to feminisation effect in male fish, formation of cysteine-rich
glycoprotein called spiggin in female fish species, as yet another reproductive
abnormality, has been reported. At the biochemical level during the breeding period, the
male stickleback fish develops kidney hypertrophy under the influence of androgen
thereby causing the epithelial cells of the kidney to produce hydrophobic protein named
spiggin (Jakobsson et al., 1999; Sanchez et al., 2008). This 230kDa protein is released
into the urinary bladder where it is constituted as a structural thread (or glue) that is
used for the purpose of nest-building preparatory to the egg-laying process by female
fish (Jakobsson et al., 1999). Conventionally, kidneys of female sticklebacks are not
known to produce spiggin until recently when the spiggin-forming genes in female
stickleback were found in dormant (latent) form (Sanchez et al., 2008). As in male
stickleback, these dormant genes in the female can be induced by androgen receptor
agonists to produce spiggins. It is realised that spiggin formation via androgen induction
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in young and immature female stickleback fish could serve as a reliable end-point which
can be used to screen (xeno)-androgens and anti-androgens in the laboratory and the
field (Allen et al., 2002; Bjorkblom et al., 2007; Katsiadaki et al., 2002, 2006; Jones et
al., 2001) .
In Florida, USA, female mosquito fish (Gambusia affinis) harvested in rivers
downstream of pulp and paper mills were observed to exhibit masculinisation
phenomenon which affected its behavioural pattern too (Howell et al., 1980). In
addition, the female mosquito fish was reported to develop elongated anal fins which
are a replica of male gonopodium (ibid.). The males caught in the same rivers were also
reported to show hypermasculinisation which makes them develop a more
hyperaggressive mating behaviour than the normal males (ibid.). Other abnormalities
identified include reduced sex hormone level, delayed sexual maturity, reduced and
abnormal sexual organs, reproductive difficulties, reduced fecundity and intersexuality
(Gray et al., 1999; Hirai et al., 2006; Lange et al., 2001; Robinson et al., 2007).
Although, the environmental chemicals responsible for these reproductive effects were
not immediately known as studies indicated that such chemicals have hormonal
characteristics similar to endogenous androgens.
A wide range of scientific studies undertaken have identified some of the
xenobiotic chemicals involved in some of these reproductive endpoint abnormalities to
include PCBs (mostly components or metabolites of known pesticides e.g. DDT, DDE
and chlordane), natural estrogens (e.g. 17β-estradiol, phytoestrogen) and other unknown
chemicals (Allen et al., 1999; Sumpter and Jobling, 1995). Significantly, laboratory
studies have further advanced the knowledge on endocrine disrupting effects of
environmental chemicals as most of the observed effects have been replicated.
Incidences of vitellogenin production and gonadosomatic index development in juvenile
Atlantic cod (Gadus morhua) and flounder (Platichthys flesus) have been demonstrated
in the laboratory (Allen et al., 1997; Ilylland et al., 1997).
1.5.2.5 Mammals:
A spectrum of well-established evidences of endocrine disrupting chemicals in
mammals has been reported. Most examples documented were based on the
reproductive endpoints and population reduction in terrestrial and aquatic mammals. For
instance, Florida panthers (Felis concolor coryi), grey seal (Halichoerus grypus),
common seal (Phoca vitulina), Baltic ringed seal (Phoca hispicla botnica), bottlenose
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dolphin (Tursiops truncatus), striped dolphins (Stenella coeruleoalba) and beluga
whales (Delphinapterus leucas) exhibit a wide range of developmental abnormalities
and reproductive dysfunction. Following progressive declines in their populations,
investigation revealed that a high level of organochlorines was found in the tissues of
the Florida panthers (Facemire et al., 1995). The organochlorines detected are suspected
to originate from raccoon (Procyon lotor) food items contaminated by mercury and
pesticides during production (ibid.). Florida panthers (Felis concolor coryi) have also
shown reproductive and morphological abnormalities such as low ejaculation volume,
diminished sperm concentration, sperm characterised with high morphological anomaly,
cryptorchidism and male infertility (Facemire et al., 1995; Roelke, 1990). Declining
trends of grey and ringed seals’ population in the Baltic Sea has likewise been linked to
endocrine disruptive effects of environmental chemicals (Taylor and Harrison, 1999).
Increased concentration of PCBs, DDT and its metabolites in the tissues of seals has
also been detected, some of which have developed abnormalities such as testicular
steroidogenetic defects, immune dysfunction and infertility linked with these endocrine
disrupting chemicals. Similar abnormalities occurred when seals harvested in the
heavily polluted Wadden Sea were analysed (ibid.). Additional evidences documented
from this experimental analysis include high incidence of fatality and reduced
concentrations of estradiol resulting in imbalances in this endogenous hormone. For
example, polar bears (Ursus maritimus) in Svalbard, Norway recorded a drastic decline
in female population following chemically-induced hormonal imbalance that nearly
wiped out the female bear population from age sixteen upward (Derocher et al., 2003).
Occurrence of pseudo-hermaphrodites, a phenomenon synonymous to females
developing small penis in front of their vagina, has been documented in female polar
bears (Wiig et al., 1998). The elevated PCB concentration in polar bears may be the
potential causal agent responsible for dwindling younger polar bear population in
Svalbard although there is no enough evidence yet to suggest that these are the key
agents (ibid.).
1.5.2.6 Evidence of Endocrine Disrupting Phenomena in Human.
The best known evidence of endocrine disruption in human beings involved use
of diethylstilbestrol (DES).  DES is a popular anabolic agent widely used in the USA to
improve the economic values of livestock. However, DES was administered to pregnant
women between late 1940s and early 1970s to prevent spontaneous abortion and this led
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to a myriad of irreversible reproductive abnormalities, many of which affected the
unborn baby directly (Marselos and Tomatis, 1992). The outcome of long-term in utero
studies of DES exposure, which has widened through meat and dairy-related products,
has been characterised. Similar to laboratory animals, risks of human exposure to DES
include suppression of lactation, testicular malformation, underdevelopment or absence
of vas deferens, gynecomastia (development of abnormally large breast tissue in men),
retention of Mullerian ducts, deteriorated sperm quality and formation of epididymal
cysts in matured male progeny (McLachlan et al., 2001; Steinberger and Lloyd, 1985).
Structural malformations such as cryptorchidism, hypoplastic testis and penis and
meatal stenosis (narrowing urethra tube leading to the penis opening) have been
similarly reported in children male born after their parents’ exposure to DES (Gill et al.,
1977; Bibbo et al., 1977; Gill et al., 1979; Stillman et al., 1982). Female children that
emerged after in utero exposure in their parents’ womb have been shown to develop
reproductive and developmental malformations. Some of such effects include
subfertility and virilisation (Kunz et al., 2004), vaginal adenocarcinoma, premature
birth, pseudo precocious puberty (Felner and White, 2000), vaginal adenosis, elevated
serum testosterone, structural abnormalities in the uterus, ectopic pregnancy, hood and
polyps of cervical and vaginal organs, anatomical masculinisation and malformation of
cervical canal, reduced libido, sexual impotence and tumours of reproductive organs in
adult women (Steinberger and Lloyd, 1985; Newbold, 1995; Grajewski et al., 1996;
Whelan et al., 1996).
1.5.3 Environmental Sources of Exposure to Endocrine Disruptors
A wide range of synthetic and natural chemicals which are capable of
modulating endocrine-related reproductive and developmental health problems have
been detected in the environment. Synthetic chemicals find their way into the
environment via accidental and deliberate human and non-human activities from several
point and non-point sources. Some of these sources identified include agricultural,
industrial, commercial and residential outlets. For instance, pesticide applications (to
improve crop yields in plantations), industrial by-products discharges, landfill leachates,
combustion process, sewage sludge and domestic wastes discharges are commonly
known means of chemical sources in the environment. The fact that endocrine
disruptors possess a wide range of physicochemical properties will suggest the
possibility of exhibiting different modes of behaviour in the environment. For instance,
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most EDCs are known to be lipophilic but have variable chemical and biological
transformation pathways in the environment which are dependent on their structures and
other chemical properties. Moreover, catabolic processes such as chemical degradation
often are altered by environmental factors (e.g. aerobic and anaerobic conditions,
elevated temperature and photocatalysis, and hydrolysis) to change the form and,
sometimes, the state of these chemical compounds. However, some of these compounds
are relatively stable as they do not undergo any degradation. For this reason, they tend
to bioaccumulate in the environment, maintain a high shelf-life and long enduring
transportation away from their sources. These are expected to impact on the general
mechanism of distribution. Human and wildlife exposure to endocrine disrupting
chemicals can take place through contact with food, water, air, personal care products
(consumer products), soil and aquatic sediments. These exposure sources are broadly
classified into two:  indoor and outdoor sources. Generally, endocrine disruptors enter
into the blood streams of human and wildlife through ingestion, inhalation and direct
access across the cell membrane via skin and gill contacts.
1.5.4 Anti-androgens in the Environment.
The word ‘anti-androgen’ can be defined, in a short phrase, as “action taken
against androgen”. Androgens are useful hormones secreted by the gonads in
conjunction with the pituitary glands to induce chains of biochemical processes in the
body of vertebrate animals for the purpose of reproduction and reproductive activities.
The word ‘androgen’ originated from the combination of two Greek words, “andros”
(man) and “genein” (to produce). Androgens mediate biological responses through
interaction with androgen receptor (AR) as described in Section 1.4.2. Anti-androgenic
chemicals simply act by blocking the biological process of complex formation and/or
transcription, which are strategic for activating biological responses. Exogenous anti-
androgens are also referred to as xenoanti-androgens and they describe the endocrine
disrupting chemicals that are responsible for interrupting these internal biologically
strategic processes.
Therefore, broadly expressed, anti-androgens are any group of androgen
(receptor) antagonists, hormone synthesis inhibitors, hormone metabolism interrupters
or hormone transport modulators capable of obstructing partially or totally the
biological responsibilities of any natural or synthetic chemical compounds (androgens),
which act on appropriate target cells in the body system to promote and activate the
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production, development and maintenance of masculine sex organs and sundry
secondary sexual characteristics in vertebrates.
Anti-androgens existing in the environment originate generally from natural and
synthetic sources as steroid and non-steroid compounds. Most known naturally
occurring anti-androgens are derived from plant sources and are substantially non-
steroid in form (Section 1.5.4.1). The knowledge of natural steroid and non-steroid anti-
androgens from animal sources is currently not available. A wide range of exogenous
anti-androgens, occurring in steroidal and non-steroidal forms, have been reported
among the myriads of anthropogenic chemicals found in the environment. Presently, the
only known synthetic anti-androgenic compound having steroidal property is
cyproterone acetate (CPA)(Figure 1.9). From this analysis, it may be appropriate to say
that most synthetic anti-androgens known are non-steroidal.
Nonsteroidal synthetic anti-androgens (NSA) are synthesised for myriads of
human and non-human use, many of which cut across agriculture, medicine,
environment, industries and domestic life.
1.5.4.1. Plant and Fungal Anti-androgens
Anti-androgens that occur in nature are limited and most of those reported so far
originate from plant sources. Some of the exogenous anti-androgenic compounds
reported in nature include permixon (an extract derived from an American dwarf palm
tree, Serenoa repens B) (Wilt et al., 1998), a non-steroidal CpdA [2-(4-acetoxyphenyl)-
2-chloro-N methylethylammonium chloride -a stable derivative of the African
shrub, Salsola tuberculatiformis Botsch, prepared from less stable hydroxyphenyl
aziridine] (Tanner et al., 2003) and isolates of three leaves -beech, oak and reed extracts
(Hermelink et al., 2010) (see Figure 1.7).  Also, estrogenic effects sometime reported in
poultry and livestock have been linked with feeds contaminated with Zearalenone, a
fungal mycotoxin produced by the action of Fusarium sp on carbohydrate feeds
(Manfred, 2001; Meronuck et al., 1970; Roine et al., 1971). Studies have shown that
zearalenone and its metabolites (zearalanone, zearalanol and zearalenol) have anti-
androgenic potency almost equivalent to flutamide (Paris et al., 2005). This discovery
has shown that some estrogens can act as also anti-androgens at receptor level.
Although, the AR binding mechanism is currently poorly understood, zearalenone has
been reported to demonstrate hepatic ER binding (Powell-Jones et al., 1981). There are
in vivo data indicating that in utero exposure could lead to sex differentiation and
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serious disruption of reproductive competence (ibid.). Equol (7-hydroxy-3[4’-
hydroxyphenyl]-chroman) [see Figure 1.6] has also been investigated as a biologically
active compound with anti-androgenic property (Lund et al., 2004). Equol is a chief
component of daidzein, a phytoestrogenic derivative of soyabeans. It is found that equol
has poor AR affinity but bind selectively, with high affinity, to 5α-dihydrotestosterone
(DHT) to deny DHT from AR binding opportunity (ibid.). Binding affinity of equol to
DHT is partly accountable for lean epididymal and prostate weight after exposure
(ibid.).
Figure 1.7: The chemical structures of 2-(4-acetoxyphenyl)-2-chloro-N-methyl-
ethylammonium chloride (CpdA) and Zearalenone.
1.5.4.2 Agricultural Anti-androgens
A wide range of chemicals that are associated with agricultural practices have
been reported to possess anti-androgenic properties. Effect-based studies of the anti-
androgenic activities of some of these agro-allied chemicals under in vivo and in vitro
experimental conditions have been conducted. Gray and co-workers (1994) discovered
that, at cell receptor level, some pesticides possess anti-androgenic characteristics in
vitro or ex vitro and, in some, with a high degree of potency. The majority of these
pesticides have been discovered in the environment in their original or metabolised
form and their mechanism of anti-androgenic action is expressed via aromatase
inhibition. For most environmental compounds that modulate anti-androgenic effects,
aromatase induction clears away the competitive binding hurdles posed by the
endogenous androgen hormones at the target receptors and makes passage to the
receptors free for the chemical anti-androgens to bind to. Classical examples of anti-
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androgens in the environment include insecticides DDT and its metabolite-DDE (Kelce
et al., 1995a,b), fenitrothoin, chlorpyrifos-methyl (CPM) (Kang et al., 2004), toxaphene
and metachlor (its metabolite, HPTE), fungicide vinclozolin and metabolites M1 and
M2, procymidone (Kelce et al, 1994; Ostby et al., 1999; Gray et al., 2001), prochloraz
(Gray et al., 2001) and herbicide linuron (Lambright et al., 2000; McIntyre et al., 2000;
Vinggaard et al., 2005) (Figure 1.8). In utero exposure of some male terrestrial
mammals (e.g. rat, dog, sheep and pig) to vinclozolin and p, p’-DDE induces reduced
anitogenital distance (AGD), reduced weight of sex accessory glands, hypospadias,
ectopic and undescended testes, vaginal pouch and retained nipples (Gray et al., 2001;
Wolf et al., 1999; Kelce et al., 1995a, b). No knowledge of phenotypic effect has so far
been reported in the females of all the laboratory animals exposed to procymidone, p,p’-
DDE and vinclozolin. Identified effects of developmental exposure to each of the three
compounds include testicular cancer (Shakkebaek, 1972), erectile dysfunction and
infertility in rats (Brien et al., 2000). Given that anti-androgenic response of vinclozolin
is very weak relative to its metabolites (M1 and M2), the potency is comparatively low.
Although, linuron and methoxychlor also exhibit AR antagonism in vivo and in vitro,
and induce reproductive-based effects similar to vinclozolin, procymidone and p,p’-
DDE, the fact that their bioactive concentration are higher implies low potency.
Most of these agricultural anti-androgens have been detected in the environment
either in their original or metabolised form. Due to their non-persistence in nature,
residues of a wide range of pesticides have been discovered in water, air, soil and food
samples. Organochlorine chemicals such as DDT, linuron, procymidone, metachlor,
vinclozolin and methoxychlor are widely used on agricultural farmlands to control
broad range of pests. Although DDT is either completely banned or restricted in some
countries across the globe, its residues are still being recovered in previously exposed
soil layers years afterward. For instance, DDT detected in Tianjin soil samples analysed
in China occurred in the range of 628.1-2840.5ng/g decades after its application was
banned (Gong et al., 2002). In Argentina where DDT usage has been restricted, traces of
it at levels of 0.0204-2.123ppm have been reported in dairy by-products such as butter
(Lenardon et al., 1994). Similar investigation in Spain has also confirmed the
occurrence of DDT in trace quantity in pasteurised milk (Martinez et al., 1997).
Investigation carried out in Ayeduasi, KNUST and K-Poly in Kumasi, Ghana has also
reported the occurrence of DDT in yoghurt at concentrations of 8.96µg/kg, 4.09µg/kg
and 7.52µg/kg respectively (Darko and Acquaah, 2008). In addition, studies further
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indicate that traces of DDT were detected in fresh milk at a concentration of 12.53µg/kg
in KNUST samples and in cheese sampled from Aboabo, Tafo and Asawasi at
concentrations of 14.02µg/kg, 298.57µg/kg and 42.17µg/kg respectively (Darko and
Acquaah, 2008). In an experimental study undertaken thirty-days after procymidone
application to four supervised leek fields in China, an average range of 0.033-
0.17mg/kg and 0.020-1.75mg/kg of its residues, corresponding to 74.9-100% and 82.5-
92.5%, were detected in leeks and soil samples respectively (Chen et al., 2010).
Procymidone residues have been discovered in wine grapes and vegetables harvested
from exposed farmlands (Urruty et al., 1997; Rodriguez et al., 2002). Linuron is a
herbicide that is used extensively for cultivating tuber and vegetative crops such as
onions, carrots and potatoes (Sanchez-Camazano et al., 2000). About 70% of linuron
was reported to leach into the soil when four natural soil samples taken from the
Province of Salamanca, Spain were investigated (ibid.). There was a significant
variation in the result outcome when the organic content of the soil samples was
modified indicating that the level of linuron retention in the soil changes with different
soil profiles (ibid.). Prochloraz is a fungicide for controlling eyespot disease and
powdery mildew in cereals and fungal diseases in vegetables and fruits (Birchmore et
al., 1977; Lafuente and Tadeo, 1985; Kapteyn et al., 1992). A multiresidue analysis
carried out on pesticide-contaminated soil samples taken from Sao Paolo state, Brazil
reported a recovery range of 54-73% of prochloraz between 55-730C temperatures.
During the analysis, recoveries of linuron and vinclozolin were also measured at the
respective range of 55-70% and 69-73% under the same temperature conditions (Risatto
et al., 2005). Prochloraz-formylurea and prochloraz-urea are two metabolites of
prochloraz that have been detected at different concentrations of various subsoil layers
(Hollrigl-Rosta et al., 1999).  The level of prochloraz degradation is a function of the
texture, pH and the temperature of the soil (ibid.).
Analytical studies of horticultural soil samples taken in five different locations
in northern Portugal showed the occurrence of chlorpyrifos (a derivative of
chlorpyrifos-methyl) in 33.8µg/kg respectively (Goncalves and Alpendurada, 2005).
While chlorpyrifos-methyl has been shown to possess anti-androgenic activity, the
biological activity of chlorpyrifos is yet to be known. In Saudi Arabia, residues of
toxaphene were detected in subsoil samples of contaminated farmlands (30-60cm) at
concentration between 0.006-0.162mg/kg (Al-Wabel et al., 2011). Another commonly
known anti-androgenic organochlorine pesticide is methoxychlor. It is used in isolation
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or in combination with other chemicals to control cereal and fruit pests especially
during storage and planting seasons (ATSDR, 1994). It is also used on agricultural
fields planted with vegetable, soyabeans and nuts to control insect pests (ibid.). Its mode
of action is known to be similar to that of DDT. Traces of methoxychlor residue have
been detected in food stuff, water and soil. Due to its less persistence, methoxychlor is
rarely found in the environment but could be detected near the disposal, dispensal or the
manufacturing premises. In soil, methoxychlor has an anaerobic half-life of 30 days and
an aerobic half-life over 100 days (Muir and Yarechewski, 1984). Fenitrothion is a
non-persistent organophosphorus insecticide that has been identified to exhibit anti-
androgenic property. It is commonly used to control insects associated with cereals,
vegetables, stored grains and cotton on agricultural fields (Tamura et al., 2001). It
undergoes biodegradation under aerobic condition to produce toxic nitrophenolic
metabolites in soil and water (Mikami et al., 1985). One major metabolite generated
during its aerobic biodegradation, which only occur via artificial means, is 3-methyl-4-
nitrophenol (MNP) (Keith and Telliard, 1979). Due to the possibility of producing
myriads of toxic metabolites aerobically, extensive use of fenitrothion has become the
likely channel that could constitute environmental health concerns in humans and
wildlife (Tago et al., 2006). The structures of these agricultural anti-androgenic
compounds are provided in Figure 1.8.
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Figure 1.8: A diagram showing examples of agricultural anti-androgens found in the
environment.
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1.5.4.3 Clinical Anti-androgens
In utero administration of DES to pregnant women, as estrogenic supplement,
for three decades in the USA led to a wide range of phenotypic end-points that indicated
compromise in health conditions. Cases of cryptorchidism, hypospadias, and diminished
volume and quality of sperm in adult laboratory animals have been reported (Imperato-
McGinley et al., 1992; van der Schoot, 1992; Silversides et al., 1995; Sharpe et al.,
2000). For the fact that an estrogen could induce all the effects highlighted above
strongly suggests that it can exercise the ability to block the androgen receptor.
Investigation later confirmed similar reproductive effects when anti-androgen exposure
was carried out. This highlights the fact that while the mechanisms through which these
compounds operate in any vertebrate system are dissimilar, yet the endpoints are same.
DES can be reported, on that basis, to exhibit anti-androgenic activity.
Hydroprogesterone and cyproterone acetate (CPA), its synthetic derivative, are reported
to demonstrate both anti-androgenic and progestational activities (Huang et al., 1985;
Brinkmann et al., 1983). In vivo exposure of CPA, progesterone and anti-progestin
RU486 has been shown to induce nuclear transport, AR DNA binding and
transcriptional activity due to competitive AR inhibition binding (Kemppainen et al.,
1992). Cyproterone acetate belongs to the dydrogesterone (17-OH progesterone) class
of anti-androgenic progestin family (Sitruk-Ware, 2008). Cyproterone acetate exerts its
anti-androgenic activity by either engaging in competitive inhibition with AR or by
disrupting the conversion agent (enzyme) of testosterone to dihydrotestosterone (DHT)
(Sitruk-Ware, 2008). Other clinical anti-androgens in regular use today consist of
flutamide, finasteride, nilutamide, spironolactone, hydroxyflutamide, valproate,
osaterone acetate, danazol and ketoconazole (Imperato-McGinley et al., 1992; Death et
al., 2005; Gunes and Fetil, 2000; Minato et al., 2005; Terouanne et al., 2002; Korner et
al., 2004; Xu et al., 2006; Schurmeyer and Nieschlag, 1984) (Figure 1.9). Flutamide,
nilutamide and bicalutamide are another category of clinical anti-androgens which
operate in similar manner as CPA. Despite their regular use, their concentrations in the
environment are not reported.
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Figure 1.9: Structures of some clinical anti-androgens
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1.5.4.4 Industrial Anti-androgens
Anti-androgenic effects of industrial chemicals are increasingly being reported.
This surge is due, in part, to the growing production of nonsteroidal chemicals, many of
which have not been characterised. Examples of chemicals identified with anti-
androgenic activity include a range of phthalates such as dibutyphthalate (DBP),
diethylhexylphthalate (DEHP) and butylbenzylphthalate (BBP) (Wilson et al., 2004)
and polybrominated diphenyl ethers (PBDEs) such as   DE-71 and DE-100 (Stoker et
al., 2005). Phthalates are ubiquitous environmental contaminants many of which have
been reported to possess anti-androgenic activity in vitro. Although, in vivo studies
indicate that phthalates are non-bioaccummulative, in this instance the parent
compounds are metabolised into active hydrolytic monoesters (or oxidative metabolites
via enzymatic oxidation of the alkyl chain when high molecular weight phthalates are
involved) which may induce abnormal reproductive disorders (Silva et al., 2003; Gray
et al., 1999; McIntyre et al., 2001; Mylchreest et al., 1998; Mylchreest et al., 1999).
Male offsprings of pregnant animals exposed to DBP and DEHP were reported to
induce cryptorchidism, hypospadias and testicular weight loss (Mylchreest et al., 1998).
Similarly, exposure of laboratory animals to PBDEs have produced abnormal
reproductive health effects some of which are delayed puberty in both sexes of rodents,
weight loss during pregnancy, decreased sperm concentration, alteration in the ovary
cells, decreased testicular size, exhibition of gender-specific sexual-related behaviours
and some birth defects (Akutsu et al., 2008; Chao et al., 2007; Lilienthal et al., 2006;
Meeker et al., 2009; Schreder et al., 2006; Stoker et al., 2005; Yang et al., 2009). Other
anti-androgenic industrial chemicals detected in the environment or identified through
laboratory analysis include bisphenol A (Sohoni and Sumpter, 1998), bisphenol F
(Satoh et al., 2004), TCDD, polychlorinated biphenyls (PCBs), ethane-1,2-dimethane
sulphonate (EDS) (Wolf et al., 1999; Gray et al., 2001), some polyhalogenated aromatic
hydrocarbons (Calle et al., 2002; Sharpe and Irvine, 2004) and polycyclic musks (e.g.
tonalide, phantolide, celestolide) and UV filters (e.g. homosalate, 3-benzylidene
camphor, benzophenone-3 and 4-methylbenzylidene camphor) (Ma et al., 2003;
Schreurs et al., 2005) (Figure 1.10).
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Figure 1.10: Diagrams of some industrial anti-androgens identified in the environment.
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1.6. Anti-androgens in Wastewater Effluents as Potential Causal Agents of
Intersex in Fish Living in UK Rivers and Lagoons.
Anthropogenic chemicals present in aquatic environments can interfere with the
endocrine system of the living organisms dwelling in them to the extent of modulating
biological responses that could result in irreversible physiological and reproductive
abnormalities. In the late 1970s and early 1980s, anglers in the United Kingdom
observed the preponderance of abnormal incidence of intersexuality (i.e. simultaneous
occurrence of male and female gonads) in roach (Rutilus rutilus), a gonochoristic fish,
caught in the River Lee downstream of a sewage treatment plant. Studies have also
shown that it is possible for some fish species to develop intersexuality, among other
reproductive abnormalities, when exposed to chemicals in wastewater effluents via
water samples from aquatic environments (Jobling et al., 1998; Allen et al., 1999b;
Harshbarger et al., 2000; Hashimoto et al., 2000; Vigano et al., 2001; van Aerle et al.,
2001; Sole et al., 2003). Some of such chemicals identified in wastewater effluents
possess estrogenic properties and they include ethynylestradiol, an active compound in
birth control pills, bisphenol-A, octylphenol, alkylphenol ethoxylates (APEs) and
nonylphenol (Korner et al., 2000). The identities of many other compounds in
wastewater effluents are still yet unknown (ibid.). It has been discovered that some
estrogenic compounds can induce vitellogenin at low concentrations and intersexuality
at high concentrations. Some studies have shown that exposure of young medaka to
17β-estradiol at concentration range of 0.01-1.66µg/L for a month would lead to sex
reversal while exposure of its eggs and fry hatchlings to a concentration as high as
15µg/L of 17β-estradiol could result in the formation of ovo-testis (Nimrod and Benson,
1998; Koger et al, 2000). Similarly, laboratory exposure of some juvenile fish species to
androgens at a range of concentrations can result in the formation of vitellogenin just as
its long-term exposure can also lead to the formation of intersex. Laboratory exposure
of juvenile zebrafish at concentrations less than 1µg/L 17-methyltestosterone can lead to
formation of intersexuality. The modality, by androgens, for inducing intersex in fish
has been associated with its (androgens) aromatisation to estrogen in the course of
which the concentration of estrogen in the fish builds up to a trigger threshold. For pulp
and mill wastewater effluents, aromatisation of androgenic chemicals can lead to
induction of vitellogenin in juvenile zebrafish, just as it can also induce intersex (Orn et
al., 2006). It is not yet clear whether environmental estrogens are solely responsible for
inducing intersex in fish. Laboratory studies have shown that anti-androgens can also
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induce intersexuality as estrogens would (Urbatzka et al., 2007). Exposure of some fish
species to anti-androgens (e.g.nonylphenol) could also lead to the formation of ovo-
testis. Exposure of Japanese medaka (Oryzias latipes) to nonylphenol can induce
intersex (Gray et al., 2007). Although, nonylphenol has estrogenic effect, it has also
been shown to possess anti-androgenic property which underscores the assertion that
some estrogens are equally anti-androgens (Sohoni and Sumpter, 1998).
1.7. Wastewater Treatment Plants as Potential Sources of Environmental Anti-
androgenic xenobiotics.
Wastewater Treatment Plants (WwTPs) are collection and treatment centres for
a wide range of environmental chemicals entering into the aquatic environments.
Wastewater contributions from households, industries and commercial settlements are
reported to contain high concentrations of chemicals which are hazardous to the well-
being of the living environmental organisms. In order to prevent (or minimise) the
potential risks that would be posed by their presence, wastewaters are made to undergo
physical, chemical and biological treatment processes (Svenson et al., 2003). During
these stepwise mechanical treatment processes (classified into primary, secondary and
tertiary) (Figure 1.11), various chemicals present in the waste samples are either totally
or partially removed (Svenson et al., 2003). The first process involves the use of coarse
grits to remove objects which are greater than 3mm in diameter. Further removal of
particulates is carried out with sand traps before running the filtrate into pre-settling
basins where aeration is applied, and solid organic materials and nutrients are removed.
Through the process of adsorption, a wide range of lipophilic compounds are also
removed. This complete removal mechanism described above is referred to as primary
treatment.
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Figure 1.11: A diagram showing the primary, secondary and tertiary stages of
wastewater treatment plants.
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treatment chamber where the mixture of bacteria and other sewage suspended matters
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may proceed in more than one step. Using the activated sludge alone or in combination
with trickling filters (or biobeds) and biological nitrogen removal means, bacteria,
nitrogen and anoxic substances are removed. The tertiary stage requires the use of
chemicals to remove phosphorus, particulates and other dissolved organic matter
through the process known as coagulation or chemical precipitation. The coagulants are
precipitated and discharged as sludge. The settling of the coagulants may be facilitated
using polyelectrolytes which fused the small coagulant units into heavier ones.
Commonly used precipitating chemicals include aluminium sulphate, lime and ferric
chloride (Svenson et al., 2003). Sometimes a direct precipitation of these contaminants
with chemicals may be undertaken after the first and second filtration (ibid.).  In which
case, the total microbial removal may be partly compromised. During this removal
process, the sludge (which represents the waste substances removed) is treated and may
be used as agricultural fertiliser. Otherwise, the sludge may be digested either
anaerobically or aerobically or converted to compost manure.
Generally, a series of physical, chemical and biological activities are discovered
to occur at the WwTPs during treatment processes through which chemicals and other
unwanted components are removed. These, in summary, include flocculation (Kim et
al., 2002; Ternes et al., 2002), sedimentation (Zhang and Emary, 1999; Strenn et al.,
2003), coagulation (Adams et al., 2002), precipitation (Strenn et al., 2003),
biofilteration (Shon et al., 2006), sorption or adsorption into sludge (Petrović et al,
2001), vaporisation or volatilisation (Meakins et al., 1994; Birkett and Lester, 2003),
photolysis (Gray and Sedlak, 2003; Liu et al., 2003; Mansell et al., 2004),
biotransformation or microbial metabolism (biodegradation, aerobic and anaerobic
degradation) (Holbrook et al., 2002; Johnson and Sumpter, 2001; Semple et al., 1999)
and chemical transformation (chemical hydrolysis by oxidation and reduction,
enolisation and isomerisation) (Huang et al., 2001; Sedlak and Pinkson, 2001).
Studies have shown overtime that the final effluents which are released into
receiving rivers and lagoons contain a complex mixture of chemicals indicating that
some compounds are not completely eliminated during the treatment process. Published
studies indicate that a wide range of some compounds found in effluent wastewaters
possess estrogenic, anti-estrogenic and androgenic activities. A few of such reports have
also indicated the occurrence of compounds having anti-androgenic activities. The
diversity of the wastewaters treated is better appreciated based on the nature of the
community from where supplies originate. By the same relationship, the nature of
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compounds present in wastewater effluents is largely dependent on the origin of their
sources. It is expected that a more industrialised community will produce wastewaters
with higher industrial contribution than less industrial communities. However, due to
the pathway of this research, focus will be directed to wastewaters with minimal
industrial contribution and mainly domestic input.
1.8 Bioassays for Screening Endocrine Disruption Chemicals in Environmental
Samples.
Bioassays are biomolecular preparations or mixture of cellular formulations that
can be used to activate and evaluate effect-based measureable end-points. Through
formation of a new biomolecule, activation or inhibition of chemical reactions,
induction of immunological responses or any variable parameter, screening of bioactive
chemicals in environmental samples are achieved. The relevance of these biological
assays includes detection, measurement and evaluation of biological activity, potency
and toxicity of chemical compounds being considered for pharmaceuticals, or those
derived from effluent wastes, contaminated soil and sediments. Two main categories of
bioassays predominantly used are in vitro and in vivo bioassays.
1.8.1 In vivo Bioassays
Although in vitro bioassays are the most frequently used means of screening the
endocrine chemicals especially due to the relative ease of use, cost effectiveness,
reproducibility, sensitivity and accuracy, in vivo bioassays is still considered as the best
evaluation approach. Tests of chemicals for endocrine effects are carried out in the
system of living animals where true reaction of such an animals to the activity can be
effectively measured. Common in vivo assays used are Hershberger, three-spined
stickleback kidney cell culture assay and Tier 1 screening assay (Gray, 1998; Jolly et
al., 2006; Katsiadaki et al., 2002, 2006). Given that the volume of environmental
samples prepared for analysis at any specific time could be enormous, it is practically
uneconomical to adopt in vivo method. For that reason, discussion on bioassays will be
limited to in vitro bioanalysis.
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1.8.2 In vitro Bioassays
In vitro bioassays are a broad range of rapid, cost-effective bioanalytical
techniques developed based on high sensitivity, specificity and optimally throughput
biological scheme and used to identify, quantify and screen for the biological effects of
endocrine disruptors from various environmental samples (Fertuck, 2002; Zacharewski,
1997). Three major in vitro bioassays are currently used to screen androgen and anti-
androgens. They include: receptor competitive binding assays (or transcription
activation assays), cell proliferation Screen Assays and Reporter Gene Assays. Receptor
binding bioassays are test standards developed to bind to a specific receptor sites of
target compounds. The non-radiolabelled ligand (the test compound) engaged in
competitive binding with the established radiolabelled ligand (hormone) for androgen
receptor site (Lambright et al., 2000) situated on the cellular or nuclear region of the
target cell or tissue during incubation (Lambright et al., 2000; Wong et al., 1995). The
problem associated with this type of assay is its failure to distinguish between
androgenic and anti-androgenic activity of test compounds which explains why it is
poorly selective. Androgen cell proliferation screen assay explores the ability of
endogenous androgen to stimulate cell proliferation and induce hypertrophy in male
secondary sex organs (Sonnenschein and Soto, 1998). The proliferation process is
activated when cell lines interact with the test compounds. During the interaction, the
test samples replace receptor binding on the labelled hormone conjugate leading to the
occurrence of bioactivity. For anti-androgenic compounds, the cell proliferation process
is inhibited (Sonnenschein and Soto, 1998). A wide range of cell lines is readily
available for this type of assay, which includes mammalian cells. Examples of this assay
are MCF-7 and A-SCREEN. The major drawback is the inter-laboratory (and intra-
laboratory) variability but can be employed productively, efficiently and effectively to
distinguish androgenic and anti-androgenic activity due to its selectivity.
Endocrine disruptors have also been successfully evaluated with receptor gene
bioassays where yeast or cell lines are used to measure the degree of transcriptional
activity generated in response to hormone stimulation. The yeast or cell lines which are
developed from either mammalian cell lines (e.g. MCF-7, COS-1, CHO, AR-CALUX,
HEH293) or yeast strains (e.g. Saccharomyces cerevisiae) are transfected with plasmids
encoding the hormone receptor and the androgen-dependent receptor gene (Figure
1.12). The receptor gene is coupled with a promoter (e.g. β-galactosidase or luciferase)
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which consists of hormone response elements (HREs) via which the receptor activation
process is facilitated (Sohoni and Sumpter, 1998; Roy et al., 2004).
Figure 1.12: Diagram showing the (i) typical structural configuration of a genetically
modified yeast strain in anti-androgen yeast screen (AYAS) assay, (ii) anti-androgenic
binding pathways (1-3) and the (iii) activation of gene expression (4-5). The human
androgen receptor (hAR) gene is incorporated into the yeast genome and expresses
cytosolic hAR. In the presence of an androgen ligand such as DHT, it binds to an
androgen receptor element (1) occurring within the promoter on the inserted plasmid.
The anti-androgen complex (3) formed between the anti-androgen molecule and the
human receptor gene (2) inhibits DHT, the natural steroid agonist, and the generation
and expression of Lac-Z, (4) the reporter gene through which enzyme β–galactosidase is
produced. Non-secretion of β–galactosidase into the medium containing the anti-
androgen will cause a chromogenic response from red to yellow colour to occur.
Sample-receptor complex is produced from the active binding brought about by
chemical interaction of the potential androgen sample and the receptor present on the
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yeast strains. The HRE of the reporter gene is activated when the sample-receptor
complex binds to it following which the enzymes such as luciferace, β-galactosidase
and chloramphenicol acetate transferase, which are suitably measured with luminometry
or spectrophotometry, are produced (Sohoni and Sumpter, 1998; Roy et al., 2004).
Generally, reporter gene bioassays are easy to culture and manipulate genetically. In
addition, they possess the ability to metabolise the test samples. They produce non-
uniform permeability when yeast cell walls are exposed to test compounds which cause
them to have different set of AR co-regulators better than the mammalian cells. They
have been used for screening of androgens and lately anti-androgens (ibid.).
1.9 Aims and Objectives.
The aims of this research work are to investigate, identify and quantify
anthropogenic chemicals that can induce androgen-receptor antagonism, and to measure
the relative potency of these compounds in predominantly domestic wastewater
influents and effluents sourced from Horsham Wastewater Treatment Plant, South East
of England. This investigation encompasses the following objectives:
1. To investigate the profiles of androgen-receptor antagonists in a domestic
wastewater (from Horsham wastewater treatment works) using the in vitro
androgen recombinant receptor transcription yeast screen (AYAS).
2. To identify the structures of androgen receptor antagonist chemicals present in
effluent and influent samples from Horsham wastewater treatment works using
Toxicity and Identification Evaluation (TIE) techniques.
3. To measure the relative potency of anti-androgens identified in the wastewater
samples.
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Literature Review 
1.0 Background 
Chemical communication is the fundamental process by which all living 
organisms exchange vital information within their internal systemic components, with 
other organisms and with their immediate environment (Cheek et al., 1998; Fox, 2004). 
This process is basically accomplished through three major communication 
mechanisms: endocrine, immune and nervous systems. Although their modes of action 
are dissimilar, the endocrine and immune communication systems are co-ordinated 
through the blood (Pardridge, 1981). The presence of some man-made chemicals and 
their by-products in the global environment can pose a serious risk to public health 
when they interfere with any of these communication mechanisms (Arcand-Hoy and 
Benson, 2001). Given that the endocrine communication system is responsible for the 
regulation of metabolic processes, homeostasis, reproduction and basic developmental 
mechanisms (Kime, 1998), it is thus possible for some chemicals that possess hormone-
like behaviours to disrupt its normal regulatory activities. Within the progressive 
attempts aimed at meeting the rising challenges and burden of the human needs (health, 
social, food and economic demands), production and use of consumer products such as 
pharmaceuticals, cosmetic products, laundry and washing detergents, agronomic and 
synthetic foodstuffs and other human consumables have increased, and their potential 
for environmental contamination has also heightened. As a consequence, exposure to 
cycles of potentially harmful chemicals can bring about endocrine modulation and 
genetic alterations, which may lead to dangerous health effects in humans, mammals 
and other living organisms. This revelation has added to the speculation that 
environmental chemicals may contribute to the growing cases of certain global health 
problems. 
 
1.1 Endocrine System  
The endocrine system is responsible for co-ordinating a wide range of complex 
biological processes in the body. It controls the physiological activities of the body by 
secreting hormones through the collection of endocrine glands and non-endocrine 
organs in the body. Some of these hormone-secreting bodies include the hypothalamus 
(which is situated above the brainstem and under the cerebrum), the pituitary glands 
(that are attached to the underside of the brain by stem stalks) and the various other 
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organs such as thyroid, kidney, pancreas, ovary and testis (Figure 1.0). Hormones are 
chemical messengers that communicate useful coded information to the target sites 
where chemical ‘messages’ are utilised to bring about necessary changes. For example, 
hormones such as gonadotropin-releasing hormones (GnRH), thyrotropin-releasing 
hormones (TRH) and corticotropin-releasing hormones (CRH) are secreted by the 
neurons in the hypothalamus and transported via the blood to encourage the pituitary 
glands to secrete some endocrine regulatory hormones. Hormones such as thyroid-
stimulating hormone (TSH), follicle-stimulating hormone (FSH), luteinising hormone 
(LH), adrenocorticotropic hormone (ACTH), prolactin (PRL) and growth hormone are 
secreted by the anterior pituitary while antidiuretic hormone (ADH) and oxytocin 
(OXY) are produced by the posterior pituitary. At the particular target site where 
exchange of chemical messages are required, a number of functional receptors are 
situated either on the surface of the target cells on the plasma membrane or at the 
nuclear region. These facilitate the binding of hormones to the specific receptors 
through which chemical signalling takes place. Action of chemical communication via 
hormones could occur in a localised area of the body (autocrine and paracrine effects) 
and, sometimes, it extends to all over the body (endocrine effect) (Bigsby et al., 1999).  
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Figure 1.0: The diagram of human endocrine system showing the locations of various 
internal organs associated with hormone secretion in the body. Adapted from 
Endocrinology Medicine website, www.endoatsoim.com 
   
1.2 Steroidal and Non-steroidal Hormones 
Hormones occur as steroidal and nonsteroidal molecules with different structural 
forms which accounts for their diverse molecular weight. Their occurrence in different 
molecular weight as lipophilic or lipophobic compounds will explain why the activity of 
some hormones are localised to a particular region of the body. Generally, steroids are 
found in nature as fat-soluble, sparingly water-soluble, organic compounds (lipids) 
which have evolved as plant and animal hormones (Bishop and Koncz, 2002). Steroidal 
hormones are broadly classified into five subdivisions based on their physiological 
behaviours, which are: mineralocorticoids (which influence sodium retention through 
renal tubules), glucocorticoids (which regulate carbohydrate metabolism and inhibit the 
absorption of calcium in the intestine) and the three sex steroid hormones (estrogens, 
androgens and progestins) (Miller, 1988).  
Non-steroidal hormones constitute the majority of hormone population in a 
category comprising proteins, peptides, amino acids and fatty acid derivatives (Hinuma 
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et al., 1998). Peptide hormones are water-soluble, relatively moderate molecular weight 
molecules (in comparison with protein) which are formed by varying chain-lengths of 
linear and/or ring amino acids (Neal, 2001). Some hybrid non-steroidal hormones, 
formed as a linkage between peptide hormones and carbohydrates, have also been 
identified. This class of hormones are known as glycoproteins (ibid.). Few common 
examples of glycoproteins are luteinising hormone (LH), follicle stimulating hormone 
(FSH), human chorionic gonadotropin (β-hcG) and thyroid-stimulating hormone (TSH) 
(ibid.). In this section, the functions of some steroid hormones especially sex steroid 
hormones and non-steroid hormones like GnRH, CRH and TRH are discussed.  
 
1.2.1 Sex Steroid Hormones 
The sex steroid hormones are synthesised by the endocrine system of most 
animal species and are responsible for the regulation of critical stages in the animals’ 
life cycle which include gametogenesis, fertilisation, sexual development and 
reproduction (Gross et al., 2003). They can be divided into three major classes; namely: 
estrogens, androgens and progestins (or progestagens).  Generally, steroid hormones 
have chemical structures composed of a three-dimensionally arranged four, fused 
carbon rings in a 6-6-6-5 ring structure with a ketonic, aldehydic or alcoholic functional 
group and terpenoid appendages in rare instances (Xu et al., 2003; Ying et al., 2002). 
This core nuclear arrangement has been described as cyclopentan-o-
perhydrophenanthrene ring system, having 17 carbon atoms in total (Shen and Lin, 
2006; Wynn, 1965; Ying et al., 2002). The ring nature varies from one steroid to 
another. Whereas the first six-carbon ring may be saturated (cyclohexane) or partly 
saturated in one structure, yet in another it would be fully unsaturated (benzene ring). 
The fourth ring is a cyclopentane, a saturated five-carbon ring (Xu et al., 2003) (see 
Figure 1.1).  
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Figure 1.1: Chemical structures of common endogenous steroid hormones in the 
vertebrate endocrine system. 
 
1.2.1.1 Estrogens 
Estrogens are a group of steroid sex hormones which are responsible for the 
maintenance and regulation of growth, development, differentiation and function of 
reproductive organs, sexual characteristics and other reproductive processes in both 
mature wildlife and humans (Ciana et al., 2003). In addition, they control some 
important body organs such as the bones, brain and cardiovascular system (ibid.). 
Although, these hormones are found largely in females, they are present in male animals 
in trace amounts. In male animals, estrogen may regulate the commencement process of 
Progesterone Cortisol 
Estrone 
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spermatogenesis by facilitating spermatogonia multiplication and by enhancing the role 
of follicle stimulating hormone (FSH) in activating spermatogenesis (Ebling et al., 
2000; Kula, 1988; Kula et al., 2001; Walczak-Jedrzejowsksa et al., 2005). They are 
composed of estrone, estradiol and estriol which are produced by the ovaries, adrenal 
glands and the fatty tissues. The first two hormones are formed in the ovaries while the 
last is produced in one of the reproductive tissues during luteal phase in the corpus 
luteum (Barlow and Logan, 1966). Estriol can also be formed through aromatisation of 
16-OH-dehydroepiandrosterone sulphate (a DHEA derivative formed in the liver) 
during pregnancy in the placenta (Ryan, 1959).  
 
1.2.1.2 Androgens 
Androgens are a class of sex steroid hormones which are produced by both 
mature male and female animals. They control the development and maintenance of 
masculine characteristics, sperm induction and sexual differentiation as well as enhance 
virility and libido; in addition, they regulate water (through the synthesis of aldosterone 
hormone which is produced by adrenal cortex of the adrenal gland situated above the 
kidney) (Shigeoka et al., 1985; Milledge et al., 1983), nitrogen retention (Urban et al., 
1995; Brodsky et al., 1996) and activate skeletal growth (Quigley et al., 1995). This 
class of hormones include androsterone, testosterone and dihydrotostesterone and they 
are secreted by the testis, ovaries, adrenal glands and placenta. Androgens are produced 
from enzymatic metabolism of cholesterol and steroid intermediates as shown in Figure 
1.2. 
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Figure 1.2: Biosynthetic pathways of some androgen hormones and their enzyme-
mediated conversion products. The blue enzymes catalyse the formation and 
metabolism of androgen hormones including the aromatase. The red enzymes act on the 
pro-androgen hormone precursors and metabolites produced during steroidogenesis 
(adapted from, http://www.conf.ncku.edu.tw). 
 
1.2.1.3 Progestins 
Progestins are a class of steroid hormones derived from both natural and 
synthetic origins. They are used to sustain pregnancy to maturity (reduce preterm 
delivery), inhibit ovulation and menstrual cycle control, reduce the endometrial wall and 
stem the growth of prostate cancer (Sitruk-Ware 2004). The natural progestins (such as 
progesterone) are manufactured and secreted in the corpus luteum (ovary), the placenta 
and the adrenal cortex of female humans (Schindler et al., 2003). In the male humans, 
this hormone is secreted by the testes and the adrenal cortex (Simpkins et al., 2005). 
Comparatively, the level of progesterone in female humans is higher than that in male 
counterpart but this drops to the level found in the male during the follicular stage of the 
menstrual cycle (Chrousos et al., 2001). Apart from the natural progestins, a wide range 
of progestins are being manufactured on an industrial scale today for therapeutic use 
(e.g. manufacturing of contraceptives) (Falconer, 2006). The presence of 
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polychlorinated biphenyls (PCBs) in the body could facilitate the breakdown of 
progesterone in the liver (Colborn et al., 1997). For example, it has been documented 
that women who experience incessant miscarriages possess relatively higher level of 
PCBs in their bodies compared to those carrying normal pregnancies (Leoni et al., 1989; 
Saxena et al., 1981). The presence of PCBs could possibly lead to drastic reduction or 
non-availability of progesterone in the body system (ibid.). While the occurrence of 
PCBs may be correlated to the incessant miscarriages in pregnant women, it has not yet 
been proven that they are responsible for the phenomenon. 
 
1.2.2 Non-steroidal Hormones 
1.2.2.1 Gonadotropin-Releasing Hormone (GnRH) 
Gonadotropin-releasing hormone (GnRH) is a decapeptide produced by the cell 
bodies of hypothalamic neurons present in the brain. It is released into the portal blood 
system and transported to the anterior pituitary to stimulate gonadotropin production. 
The gonadotropin FSH and LH are heteromeric glycoproteins which stimulate gonadal 
synthesis of sex steroid hormones (testosterone, estrogen and progesterone), which are 
required for spermatogenesis and oogenesis (Dalken et al., 2001). Both FSH and LH 
hormones have a similar α-subunit and a distinctive β-subunit (Conn, 1994). The 
secretion of GnRH occurs during the outset of puberty. Although the function of GnRH 
in the gonads (the testis, the ovary), the uterus (the placenta), the breast and the central 
nervous system is unknown, it has been detected in these organs (Grossman, 1998).   
     
1.2.2.2 Corticotropin-Releasing Hormone (CRH) 
Corticotropin-releasing hormone is a 41-amino acid peptide produced by the 
parvocellular neurons situated in the hypothalamic paraventricular nucleus (Vale et al., 
1981). In addition to their presence in the hypothalamus, the CRH-secreting neurons are 
distributed across the central nervous system as well as the adrenal cortex, the spinal 
cord and the limbic regions (Brady et al., 1990; Merchenthaler et al., 1984; Swanson et 
al., 1983; Thompson et al., 1987).  It influences the synthesis of adenocorticotropic 
hormone (ACTH) by activating the anterior pituitary cells. The ACTH secreted acts on 
the adrenal cortex and facilitates secretion of glucocorticoids (e.g. corticol in human and 
corticosterone in rat), the hormones which act in response to stress. The ACTH is 
directly responsible for regulating the effect of stress on immune system or 
inflammatory system (Berridge and Dunn, 1987). Although CRH is a widely known 
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moderator of endocrine and immune responses to stress, it is also responsible for a wide 
range of behaviour such as reproduction, arousal and feeding (De Souza, 1995; Dunn 
and Berridge, 1990).  It is a key regulatory element required during human pregnancy 
and parturition (ibid.). As the period of gestation advances, the concentration of the 
CRH peptide in placenta increases correspondingly as that in the maternal plasma 
(Sasaki et al., 1987; Riley et al., 1991). 
 
1.2.2.3 Thyrotropin-Releasing Hormone (TRH) 
Thyrotropin-releasing hormone is another tropic tripeptide hormone which is 
produced by the paraventricular nucleus of the hypothalamic neurons. It is released at 
the median eminence to facilitate the secretion of thyrotrophic-stimulating hormone 
(TSH) at the anterior pituitary which regulates the release of triiodothyronine (T3) and 
thyroxine (T4) from the thyroid gland (Ghamari-Langroudi et al., 2010). The thyroid 
hormones (T3 and T4) secreted can also act as the negative feedback mechanism by 
controlling the activity of TRH-secreting neurons in the hypothalamus (ibid.).   
 
1.2.3. Intracellular and Extracellular Hormone Receptors 
 Hormones are biological change agents that bind with specific hormone 
receptors to regulate some essential biological activities (such as growth, metabolism, 
puberty and reproduction) in the body. Extracellular messages carried by the hormones 
are converted to intracellular signals after forming a complex with the hormone 
receptors of the target cell. The nature of the receptors involved in such binding depends 
on the chemical structure of the hormone. Based on their cellular localisation, hormone 
receptors are broadly classified into two main categories, namely extracellular receptors 
otherwise known as cell-surface receptors (CRs) and intracellular receptors (IRs). In 
addition to the two major receptors, there are some receptors whose activating ligands 
are not known. This class of receptors is referred to as orphan receptors. CRs are 
glycoprotein structures located in the phospholipid bilayer of the cell membrane which 
explains the reason why they are referred to as cell-surface receptors. Structurally, they 
transverse the hydrophilic outer cell surface, the hydrophobic plasma membrane and 
hydrophilic inner framework of the cell cytoplasm. CRs are remarkably sensitive to 
different extracellular signalling molecules especially high molecular mass peptides that 
cannot diffuse naturally into the cell through the plasma. The commonly known 
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examples of CRs are G-protein coupled receptors (GPCRs), receptor tyrosine kinases 
(RTK), integrins and toll-like receptors.  
 Intracellular receptors are hormone receptors using hormone-binding to induce 
intracellular signals in a cellular system. Unlike the CRs, they are localised in either the 
inner cytoplasm or the nucleus of the cell. This class of hormone receptors has affinity 
for low molecular mass hormones which can easily diffuse through the plasma 
membrane to initiate binding in the cell. Examples of intracellular receptors include 
androgen receptor (AR), estrogen receptor (ER), progesterone receptor (PR), thyroid 
hormone receptor (THR), retinoic acid receptor (RAR), retinoid X receptor (RXR) and 
vitamin D receptor (VDR).  Interestingly, some intracellular receptors can also bind and 
activate certain CRs. A member of the GPCRs family (GPR30) has recently been 
identified to demonstrate high binding affinity to estrogen in contrast to binding to the 
known cellular estrogen receptor (e.g. ERα and ERβ) (Revankar et al., 2005; Thomas et 
al., 2005).  It was also discovered that the GPR30 binding produces multiple 
intracellular responses that are associated with growth, proliferation and differentiation 
(Filardo et al., 2000; Kanda et al., 2003; Kanda et al., 2004). This new finding is 
regarded as a possible significant step towards treating tumours which are not 
dependent on estrogen receptor agonism.  
 
 1.2.4 Mechanisms of Hormone Action  
Hormones modulate gene expression via genomic and non-genomic signalling. 
While a genomic signalling is initiated by influencing the RNA and certain protein 
synthesis through receptor complex interaction with the hormone response element of 
the DNA, a non-genomic pathway bypasses these components by recruiting other 
signalling pathways (Vincent et al., 2008).  Some non-steroid hormones, such as insulin, 
oxytocin and vasopressin, are known to elicit cellular expressions via non-genomic 
signalling but steroid hormones (e.g. estrogen, progesterone and androgen) can regulate 
cellular expressions via both genomic and non-genomic mechanisms (Losel et al., 2003; 
Simoncini and Genazzani, 2003; Vincent et al., 2008). In this Section, both 
transcriptional and non-transcriptional mechanisms of steroid and non-steroid hormone 
actions are briefly described.  
When steroid hormones are released into the blood stream after secretion, they 
are transported to the target cells where the process of biological changes is set to occur. 
At these cells, they locate and bind to the functional intracellular receptors, known as 
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steroid receptors, which are present either in the cytoplasm (cytosol), when in free state 
or in the nucleus, when they occur as complex (see Figure 1.3; Ing and O’Malley, 1995; 
Jacobson et al., 1995; Kemppainen et al., 1992; Waller et al., 2000). Steroid hormone 
receptors are biological co-change agents with hormones which can facilitate internal 
communication and transformation. Steroid hormone receptors are made up of amino- 
and carboxyl-terminus, the DNA and ligand binding domains (LBD) (Beato, 1989). 
Generally, they exist in the cytoplasm as a monomer with perinuclear distribution as 
well as homodimers or heterodimers (Jacobson et al., 1995; Kemppainen et al., 1992; 
Waller et al., 2000). After the formation of steroid receptor complexes, the heat shock 
proteins (HSP) detached from the receptors while the receptor complexes formed 
diffuse through the cytoplasm and the nuclear pores as they translocate into the nucleus 
(Keller et al., 1996). In the nucleus, the receptor complexes bind to the human response 
elements (HREs) on the DNA. Prior to the binding, the receptor complexes undergo a 
series of conformational changes which modify them into a form that will interact with 
the hormone response elements (HREs) (see Figure 1.3; Beato et al., 1987; Beato, 1989; 
Mckenna et al., 1999; Mckenna and O’Malley, 2002). To initiate transactivation, the 
HREs attract coactivators or corepressors which induce the transcription of downstream 
DNA to messenger RNA. The necessary gene expressions are stimulated in the target 
cells by the protein formed through the RNA transcription (Ing and O’Malley, 1995). 
The choice of either coactivators or corepressors is determined by the nature of the 
ligand that bounds to the receptor. An agonist signalling could sometimes recruit 
coactivators which will lead to increased expression of one or more genes and the 
proteins which they encode. The process is referred to as gene up-regulation. For 
instance, increase in concentration of testosterone in the bloodstream induces 
production of more androgen receptor and hence activates gene up-regulation that 
would bring about skeletal muscle development in animals (e.g. cattle) (Squires, 2003). 
Conversely, decrease in certain gene expression and their encoding protein are induced 
when an agonist signalling occurs by recruiting corepressors. The phenomenon is 
known as gene down-regulation. The build-up of progesterone concentration in the 
uterine and endometrial regions leads to the reduction of progesterone receptors and 
hence causes gene down-regulation (Bazer, 1998). While some knowledge of the 
genetic behaviour of agonist signalling exists, little is known about genetic behaviour of 
antagonist signalling. 
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Figure 1.3: Structural configuration and nature of a typical nuclear (e.g. androgen) 
receptor: showing the location of nuclear receptor (NR) in the cytosol in absence of 
ligand, the dissociation of heat shock proteins (HSP), dimerization and  nuclear 
translocation of activated receptor as well as the coactivator (or corepressor) 
recruitment, the DNA binding of the translocated receptor and the translation of 
downstream DNA to RNA which would effect change in the cell function (adapted from 
Wikimedia Commons, http://www.commons.wikimedia.org and reconstructed).   
 
 The mechanisms by which non-steroid hormones carry out their actions are 
somewhat complex compared to the modalities involved in steroid hormones. Given the 
relatively large size of their molecules, it is difficult for non-steroid hormones to diffuse 
through the cell wall in order to bind intracellular receptors. Rather, they interact with 
membrane receptors on the surface of the cell to form a complex which generates signal 
that alters the conformation of the receptor. G-protein coupled receptors (GPCRs) are 
just one example of a number of protein hormone receptors present in animal tissues. 
The receptor in such modified configuration facilitates coupling to the G-protein to 
form hormone-receptor-G protein complex (Birnbaumer and Birnbaumer, 1995). Non-
activated G proteins are heterotrimeric guanine nucleotide-binding protein which has 
three subunits (Gα, Gβ and Gγ subunits) and the guanosine diphosphate (GDP) moiety 
(Chedrese, 2009). The direct binding of the receptor complex to the Gα-subunit of the 
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G-protein leads to the activation of G-protein and causes the dissociation of G protein 
into Gα and Gβγ subunits (Neer, 1995; Surya et al., 1998; Strader et al., 1994). Hitherto 
activation, the Gα of the G-protein is bound to the GDP as Gα-GDP but upon activation, 
it becomes Gα-GTP. The activation of G-protein is presumed to facilitate the exchange 
of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) (Neer, 1995; Surya 
et al., 1998).  The activated G protein dissociates from the receptor to modulate the 
activity of the effector protein, which could be an ion channel or an enzyme (e.g. 
adenylyl cyclase, phospholipase C and guanylyl cyclase), to produce certain levels of 
second messengers (e.g. cyclic adenosine monophosphate (cAMP), diacylglycerol 
(DAG) and Inositol triphosphate (IP3)) and transduction of signals (Chedrese, 2009).  
However, given that Gα subunits carry some G-protein signalling modulating 
proteins, referred to as GTPase activating protein, GTP can be hydrolysed to GDP 
(Melmed and Conn, 2005).  This same GTPase activating property is possessed by some 
effector proteins such as adenylyl cyclase (Melmed and Conn, 2005). Upon activation, 
these effector proteins will interact with Gα–GTP and convert it to Gα-GDP thus 
making the Gα inactive (Chedrese, 2009; Melmed and Conn, 2005). The Gα 
reassociates with Gβγ subunits of the G protein, fully ready to repeat the cycle 
(Chedrese, 2009). Hormones associated with these cell surface receptors (and second 
messengers) include TSH and catecholamine. As hitherto indicated (Section 1.2.3), CR 
signalling can also be modulated via other molecular mechanisms such as ligand-gated 
ion exchange (e.g. nicotinic acetylcholine receptors), receptor serine/threonine kinases 
(e.g. receptors of activins and inhibins), receptor tyrosine kinases (RTK), receptor 
guanylate cyclase (e.g. atrial natriuretic factor receptor), integrins and toll-like receptors 
beside using G-protein coupled receptors (Kronenberg et al., 2008). 
 
1.3 Endocrine Communication Pathways, Feedback Mechanism and Reproduction 
End-points. 
Endocrine communication involves concerted contributions and collaboration of 
the central nervous system, the hypothalamus, the pituitary and the target tissues. The 
central nervous system is a major division of the nervous system that controls and co-
ordinates dissemination of information useful for regulating biological processes of the 
whole body. Given that the brain and the spinal cord constitute the central nervous 
system, it directly supervises the activities of the hypothalamus and the pituitary gland 
which co-ordinate and regulate the production of endocrine hormones. The 
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hypothalamus, the pituitary glands and the effector organ or tissue are frequently, 
conveniently addressed as a single entity because they work in co-operation to produce 
the desired effects. Thus, many triangular communication partnerships between the 
hypothalamus, the pituitary gland and any of the different effector organs and tissues in 
the body have been recognised but this study will be limited to three major ones 
associated with reproduction, immune system and growth. These are the hypothalamic-
pituitary-gonadal (HPG), the hypothalamus-pituitary-adrenal (HPA) and the 
hypothalamus-pituitary-thyroidal (HPT) axes. It is widely held that for the reproductive 
system to function normally the activities of the HPG, the HPA and the HPT axes must 
be balanced out (Simon and Polan, 1994). The HPG axis constitutes one of the major 
endocrine signalling pathways in which the endocrine hormones are deployed for 
specific localised actions on the body’s reproductive processes (see Figure 1.4). The 
activities of the hypothalamus, the pituitary and the endocrine effector organs/tissues are 
complementary. The preoptic region of the hypothalamus is composed of gonadotropin-
releasing hormone (GnRH) neurons, which induces the secretion of both luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH).  They work in concert to 
provide both positive and negative feedbacks to the hypothalamus and the pituitary 
gland (Conn and Crowley, 1994; Shupnik, 1996). In females, both the FSH and LH 
function essentially to stimulate the ovaries to produce estrogen and inhibin (Finkelstein 
et al., 1991; Billiar et al., 2003). They are also responsible for regulating the menstrual 
and ovarian cycles. While estrogen is known to contribute effectively to the negative 
feedback mechanism leading to inhibition of GnRH production in the hypothalamus, the 
inhibin is responsible for constraining activin which induces the production of GnRH 
producing cells (Holdcraft and Braun, 2004; Drummond and Findlay, 1999). In males, 
the LH controls the production of testosterone by activating the interstitial cells situated 
in the testis and the FSH contributes to spermatogenesis (Luconi et al., 2002).  As in 
female, gonadal androgens can regulate cell growth, sensitivity to GnRH and level of 
expression of the gonadotropins by feeding back directly on the pituitary gonadotropes 
(Melmed and Conn, 2005). Generally, feedbacks on the hypothalamus and pituitary 
sites are activated by the gonadal hormones at high concentrations in order to regulate 
the secretion and release of gonadotropin (Melmed and Conn, 2005) (See Figure 1.4).  
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Figure 1.4: A diagram showing the transition of activity and feedback network (cross-
talks) between the brain and hypothalamus-pituitary-gonad (HPG) axis during 
endocrine hormone regulatory activity in the body. In Figure 1.4(a), the + and – 
symbols in the diagram stand for and trace the positive and negative feedback pathways 
respectively in the male body. Figure 1.4(b) shows similar progression of activity and 
feedback mechanism in the female body (both diagrams were adapted from National 
Institute of Alcohol Abuse and Alcoholism publications, 
http://pubs.niaaa.nih.gov/publications). The feedback pathways are indicated by the 
upward arrows. In the two diagrams, the activin and inhibin are secreted by the gonads 
to regulate the feedback mechanism. The transition occurs via the action of luteinising 
hormone releasing hormone (LHRH) on the anterior pituitary through to the gonads.  
 
The regulatory ability of the HPG axis could be influenced by the other two axes 
identified in this study. The HPA axis is a control pathway which links the hormone 
system and the central nervous system. It has also demonstrated the ability to influence 
the activity of HPG axis. Stress serves as a major mechanism by which the HPA axis is 
activated. Some HPA components via which such activation is induced include CRH, 
corticotropin, β-endorphin and glucocorticoid (Weinstock, 1997). CRH and GnRH are 
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two peptide hormones that are secreted in the hypothalamus which are indirectly 
responsible for adrenal and gonadal activities respectively (Rivest and Riviest, 1995). 
Moreover, a direct neural linkage between the two hormones has been reported (ibid.). 
In addition to HPA regulation, CRH has also been shown to regulate 
proopiomelanocortin-derived peptides, such as β-endorphin, which inhibit the secretion 
of GnRH in the hypothalamus (Chrousos et al., 1998).  This leads to non-secretion of 
LH and FSH which are responsible for gonadal reproductive activity (Chen et al., 
1992). Likewise, the adrenal glucocorticoid can influence the HPG axis via positive and 
negative feedback mechanisms at the level of the hypothalamus, pituitary, gonad and 
other tissues (Chatterjee and Chatterjee, 2009; Dubey and Plant, 1985). It has been 
reported that long-term elevation of glucocorticoid concentration can lead to the 
suppression of HPG functions and the immune system (Melmed and Conn, 2005). 
Glucocorticoids can feedback on the gonads to suppress gonadotropin synthesis (ibid.)  
The HPT axis constitutes another vital feedback mechanism which can influence 
the HPG axis. The process (described schematically in Figure 1.5 and Section 1.2.2.3) 
leads to the formation of thyroid hormones (thyroxine, T4 and triiodothyronine, T3) and 
regulation of hormone equilibrium in the body. The thyroid hormones are secreted to 
regulate development, reproduction, metabolism, behaviour and growth in vertebrate 
animals (Gorbman et al., 1983). The thyroid hormones influence the ovaries indirectly 
by reducing the gonadotropin-releasing hormones (GnRH) in anestrous ewe (Clark, 
1988). It is also likely responsible for the seasonal reproductive patterns in Bos indicus 
cattle and Welsh Mountain ewe including development of refractoriness at the end of 
the reproductive season (De Moraes et al., 1998; Follet and Potts, 1990).  When thyroid 
hormones are in excess of requirement during regulatory activities, they form a negative 
feedback network which will influence the collective processes that facilitate their 
secretion in the thyroid glands (Figure 1.5). Such a negative feedback mechanism will 
down-regulate the activities of the hypothalamus and the pituitary, and in turn, affect the 
activities along the HPG axis. For example, the relationship of the HPT with 
reproductive activities in some vertebrate fish species has been established. Cyr and 
Eales (1996) showed, over some specific phases in the reproductive cycle of some 
teleosts, that there exists temporal relationship between the thyroidal and the gonadal 
states. It was widely reported from studies on a wide variety of teleost species that the 
increased thyroidal activity observed during early gonadal development is usually 
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sustained during reproduction (ibid.). Conversely, the activity in both the thyroid and 
gonad reduces during the spawning and post-spawning stages (ibid.).  
 
 
 
Figure 1.5: A diagram illustrating the positive and negative feedback mechanisms of 
the hypothalamus-pituitary-thyroid (HPT) axis between the brain, pituitary and thyroid 
organs of the body. 
 
1.4 Endocrine Disrupting Chemicals  
A wide variety of anthropogenic chemicals, and some exogenous natural 
chemicals, can influence the course of endocrine communication processes in humans 
and wildlife. This class of bioactive chemicals are referred to as endocrine disrupting 
chemicals, or simply as endocrine disruptors. An endocrine disruptor is broadly defined 
as any exogenous agent that interferes with the normal processes of production, 
secretion, transportation and receptor activation of natural hormones which are 
responsible for the maintenance of homeostasis, growth, reproduction, and other 
internal activities (Kavlock et al., 1996; USEPA, 1998). Endocrine disrupting chemicals 
are mostly lipophilic in nature, bioaccumulative and environmentally persistent while 
some are characterised with low vapour pressure (Colborn et al., 1995). At low 
 
 
 
 
 
 
 
The diagram removed on this page is available in the bound copy 
of this thesis and also in its soft copy archived in the electronic 
library of the University of Sussex.  
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concentrations, endocrine chemicals have potentials of inducing biological effects. The 
likely reason for this is associated with the ability of these endocrine disrupting 
compounds to act via multiple mechanisms.  The effects of endocrine disrupting 
chemicals and their biological end-points in living organisms may be irreversible. 
Therefore, there are possibilities that these biological end-points may be expressed 
during developmental and reproductive stages (Rhind, 2002).  Controlled laboratory 
exposure of fetal rodents to p,p’-DDT has resulted in reproductive defects such as 
reduced and impaired fertility, decreased viability of the offspring, variation in 
hormonal level and sexual behaviour of adult males and occurrence of some 
developmental abnormalities such as cryptorchidism, hypospadias, disruption in the 
network of intercellular bridges conjoining the germ cells in the testes and anomalies in 
the acrosome, the nucleus and the shape of the sperms in these adults (Veeramachaneni, 
2008). Effects such as increased anogenital distance (AGD), vagina agenesis, 
masculinisation of female offsprings and induced male-like accessory tissues have also 
been reported in female rats exposed in utero to β-trenbolone (Hotchkiss et al., 2007a; 
Wilson et al., 2002). It has also been reported that most environmental chemicals 
exhibiting endocrine disrupting characteristics have dissimilar chemical structures 
(ibid.). 
   
1.4.1. Behavioural and Structural Diversity of Endocrine Disrupting Chemicals 
Although most disrupting activities of environmental chemicals are presumed to 
occur via steroid receptor activation, it is also possible for these chemicals to alter the 
synthesis, transport and metabolism pathways of hormones.  The steroid hormone 
production process is largely controlled by receptor-based feedback mechanisms and 
consists of networked pathways of precursors, enzymes and products. In addition to 
steroidogenesis (steroid hormone synthesis), endocrine chemicals can also alter the level 
of hormone excretion and steroid biotransformation mechanisms. In gastropod mollusks 
(e.g. dogwhelk, Nucella lapillus), tributyltin (TBT) can obstruct the formation of 
sulphate conjugates of testosterone and its related metabolites regarded as less potent 
and easily excreted forms of testosterone (Nelson et al., 1996; Ohno et al., 2005; Ohhira 
et al., 2006). TBT can also inhibit aromatase cytochrome P450 enzymes involved in 
biotransformation of androgens to estrogens. In most cases, environmental chemicals 
having endocrine disrupting ability are different in structure when compared to the 
structures of endogenous hormones modulating similar effects (McLachlan, 2001; 
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Mantovani, 2002). While ethynylestradiol (EE2) and estrogen possess structural 
similarities that could be receptor active, compounds such as nonylphenol (NP) and 
dibutylphthalate (DBP) possess structures that are relatively different from that of 
estrogen and yet are estrogen receptor(ER)-active (Sonnenschein and Soto, 1998). In 
addition, chiral compounds may exhibit different biological activities based on their 
enantiomeric forms (Garrison et al., 2000; Puttmann et al., 1989; Rodman et al., 1991; 
Ulrich et al., 2001; Shen et al., 2006). Studies of induction of ethoxyresorufin-O-
deethylase (EROD) and benzphetamine Ndemethylase (BPDM), the cytochrome P450-
dependent enzymes, by 2,2',3,4,6-pentachlorobiphenyl (PeCB), 2,2',3,4,4',6-
hexachlorobiphenyl (HeCB), and 2,2',3,3',4,4',6,6'-octachlorobiphenyl (OCB) showed 
that their (-)-enantiomers are more potent than the (+)-enantiomers except for HeCB 
where the reverse is the case (Rodman et al., 1991). Therefore, it may be practically 
difficult to design models for predicting the steroid receptor activity of compounds 
based on their structures. Some of the diverse chemical structures are highlighted in 
Figure 1.6.  
 
1.4.2: Mechanisms of Endocrine Disruption Action 
There is a wide range of means by which bioactive xenobiotics could disrupt the 
normal endocrine activities. However, this review will be restricted to cellular-based 
endocrine disrupting mechanisms which may or may not involve steroid hormone-
receptor sites and these include ligand receptor agonism, ligand receptor antagonism, 
biosynthetic interruption, hormone transport interference and hormone metabolism.  
 
1.4.2.1 Steroid Hormone-Receptor Agonism and Antagonism 
Hormones produce effect-directed responses after successfully binding to the 
targeted hormone receptor site. Hormone receptor sites are generally made of flexible, 
broad domains with unique size and structure where interactions with a wide range of 
hormone-like chemicals can take place. This tolerance behaviour of steroid hormone 
receptors (Cooper and Kavlok, 1997) explains why xenobiotics would be able to disrupt 
the activities of the endocrine system. Steroid hormone-receptor interaction can be 
classified broadly into four categories based on the nature and type of ligand, and the 
eventual hormone-receptor complexes formed: direct-acting agonists, direct-acting 
antagonists, indirect-acting agonists and indirect-acting antagonists (Cooper and 
Kavlock, 1997). Akin to endocrine hormones, bioactive xenobiotics can activate the 
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hormone receptor sites to produce similar effects caused by endogenous hormones. The 
principle associated with the receptor binding of endogenous hormone is the same as 
that involving a direct-acting agonism except for the biochemical response. The level of 
response induced corresponds to the potency of such compounds and the effectiveness 
(success) of such binding. It must be stated that binding effectiveness accomplished by 
a xenobiotic is determined by how closely fit in size and shape the ligand is to the 
receptor in the ligand-receptor complex. Xenobiotics with higher potency are expected 
to produce stronger physiological response than endogenous hormones of the same 
concentration. Examples of xenobiotics known to possess hormone receptor agonism 
include estrogen agonists diethylstilbestrol (DES), nonylphenol (NP), octylphenol (OP), 
nonylphenol polyethoxylates (NPE), genistein, bisphenol-A (BPA), paraben and 
tamoxifen (Fisher et al., 1999; Gray et al., 2001a; Snyder et al., 1999) and androgen 
agonists 17α-and 17β-trenbolone, PCB-169, androstenedione and androstadienedione 
(Ankley et al., 2003; Denton et al., 1985; Gray et al., 1999; Hewitt et al., 2000; 
Hotchkiss et al., 2007a,b). The structures of some estrogen agonists, estrogen 
antagonists and mixed agonist-antagonist are shown in Figure 1.6.   
However, some receptor binding will not elicit response. This receptor-binding 
effect is referred to as direct-acting antagonism and can be via competitive or non-
competitive antagonism. In the former, the hormone antagonists compete with agonists 
for hormone binding sites. If the antagonist-receptor binding was successful, it will be 
practically impossible for the binding to transform to signal. Chemical compounds that 
can exhibit this form of behaviour are tamoxifen (a breast cancer drug), linuron, 
cyproterone acetate, vinclozolin, dibutylphthalates (DBP), diethylhexylphthalate 
(DEHP) and nafoxidine (Baker, 2001; Clark et al., 1973; Mantovani, 2002). In non-
competitive antagonist binding, the hormone antagonist can work in two possible ways: 
inhibition of structural alteration at the receptor site which will cause ligand binding to 
occur or inhibition of post-binding interactions with the HRE of the DNA that would 
normally produce a response to the ligand. Vinclozolin derivatives (M1 and M2) have 
been reported to demonstrate the potentials of impeding androgen-dependent gene 
expression activation by effectively blocking androgen-induced steroid-steroid receptor 
complexes (AR) binding to the HRE on the DNA (Kelce et al., 1994; Wong et al., 
1995). Some synthetic chemicals can express dual behavioural responses in different 
biochemical environments. Such chemicals can be classified into partial agonist-partial 
antagonist and mixed agonist-antagonist. The action of the latter produces different 
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binding competence in different environmental conditions but sometimes the former can 
act under such different environmental conditions too. The former acts as a partial 
agonist by binding to the target receptors as a surrogate ligand in absence of the 
endogenous hormone. Most often, such binding occurs at concentrations comparatively 
lower than the effective concentrations of the endogenous ligand and the biological 
responses produced are usually very weak (De Castro et al., 1991).  However, as partial 
antagonist, the exogenous ligand competitively binds the receptors at elevated 
concentrations compared to that required for binding when it was acting as partial 
agonist as well as that required by endogenous ligand (Ayd, 2000). When the 
endogenous hormone is involved, the binding interaction mostly favours the exogenous 
ligand due to its comparative advantage (i.e. high concentration). The biological 
response induced in the process falls below that produced if endogenous ligands were to 
act alone. In succinct description, partial agonist-partial antagonist compounds usually 
produce agonistic response that increases as the concentration of the compound 
increases at the receptor until it reaches a plateau where further increase in 
concentration will no longer raise the level of the response (De Castro et al., 1999). Any 
further increase in concentration will only elicit antagonistic response at that same 
receptor (ibid.). Sometimes, the responses displayed by compounds having partial 
agonist-partial antagonist characteristics are induced by the ionic strength of the 
environment they operate in. Common examples of compounds acting relative to this 
environmental condition are olanzapine and clozapine (Bymaster and Falcone, 2000). 
Mixed agonist-antagonist phenomenon is expressed by tamoxifen which acts as anti-
estrogen in the breast tissues but also exhibits agonist behaviour in the bone and uterine 
environments (Lewis-Wambi and Jordan, 2005; Fawell et al., 1990; Figure 1.6). 
Raloxifene is another mixed agonist-antagonist compound which is highly effective as 
an antagonist in the reproductive tissues as well as an agonist in the bone (Draper et al., 
1996; Gustafsson, 1998; Jordan, 1998). An example of a partial agonist-partial 
antagonist is 2-arylpyrazolo[4,3-c] quinolin-3-ones, a derivative  of benzenediazepines 
(Yokoyama et al., 1982).  
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Figure 1.6:  Structures of some endocrine disrupting chemicals behaving as estrogen 
receptor-binding agonist (diethylstilboestrol, enterodiol and coumestrol) and estrogen 
antagonist (equol). Tamoxifen acts as estrogen agonist and antagonist (or estrogen 
mixed agonist-antagonist).  
 
     1.4.2.2 Disruption of Steroidogenesis 
Hormone biosynthesis and metabolism are significant molecular processes 
relevant to regulation and maintenance of cellular activities. With cholesterol as the 
starting materials, a wide array of hormones can be produced by the action of enzymes 
either directly on cholesterol or indirectly via other intermediates of steroid hormone 
biosynthesis (see Figure 1.2). It is possible for xenobiotics to interfere with any of these 
vital enzymatic pathways to induce endocrine-related health problems (Sanderson et al., 
2006). The broad range of enzymes involved in steroidogenesis is classified into four 
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basic categories: aromatase, demolases, hydroxylases and hydroxysteroid 
dehydrogenases. The biosynthetic pathways in Figure 1.2 reveal the many potential 
disruption points where enzymatic functions may be altered during steroidogenesis. A 
known enzymatic disruption pathway that has been reported in wildlife occurred in 
dogwhelk (Bettin et al., 1996; Oehlmann et al., 1996). Bettin and colleagues (1996) 
showed that TBT can inhibit P450 aromatase enzyme (known to be responsible for the 
conversion of testosterone to estradiol) in dogwhelks when exposed to it.  The study 
also indicated that the aromatase inhibition by TBT must have led to the accumulation 
of testosterone which is responsible for the formation of penis (imposex) in female 
dogwhelks (ibid.).  Ketoconazole, an antifungal antibiotic, is another compound that can 
inhibit certain mammalian cytochrome P450-dependent enzyme such as C17,20-lyase and 
17-hydroxylase (which are responsible for biosynthesis of androgens in the animal) at 
elevated concentration (Vanden Bossche et al., 1987).  It can also inhibit the production 
of cortisol in the human adrenal glands (Engelhardt et al., 1985; Mantovani, 2002).  
 
1.4.2.3 Interference with Hormone Transport  
Steroid hormones are lipophilic biological molecules which account for why 
they are sparingly soluble in water.  They are transported in free or bound state to their 
binding destination via the blood plasma. Special hormone carrier proteins such as 
albumins and globulins are manufactured in the liver and the steroids are transported in 
conjugated form as glucoronides and sulphates or as the lipid-soluble hormones 
themselves. These globulin proteins occur as steroid hormone-binding globulin (SHBG) 
or testosterone-estrogen-binding globulin (TEBG) and they may bind to either 
testosterone or estrogen (Pertschuk et al., 1980; Roy et al., 2008). Since hormones are 
transported in small concentrations, any slight increase in globulin concentration is 
expected to reduce the chances of hormone availability for binding.  Steroid hormones 
are temporarily stored in the blood carrier proteins where they are shielded from 
enzymatic activities which may lead to metabolism (ibid.). The carrier protein may 
release these hormones, from time-to-time whenever there is a short-fall in free-state 
concentration present in the blood. The role of the blood carrier proteins is to shield the 
hormones from enzymatic action (e.g. deactivating activity of the liver) and this 
contributes to why they are able to persist longer in the body. When hormones occur 
below the receptor binding concentration, there is a possibility that they may be less 
effective and hence have a shorter half-life in vivo. With the presence of circulating 
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xenobiotics in the body, the transport protein binding sites are subjected to competition 
with other chemicals and so may reduce binding of endogenous hormones to the carrier 
protein and disrupt the transport of the hormone. The implication of disrupting the 
hormone transportation mechanism is that the biological process of hormone complex 
formation which induces gene expression could be significantly impaired or affected. 
This may lead to serious health problem.  
 
1.5 Endocrine Disruption Phenomena in the Environment 
Every living organism requires the functionality of an effective chemical 
communication mechanism to regulate and facilitate its complex internal arrays of 
activities (MacLachlan 2001). These complex networks of biological activities include 
cellular growth, sexual differentiation, reproduction and biological development. In 
addition to normal intracellular regulation, the activities of organs and some specialised 
systems are also co-ordinated. In recent times, environmental agents of both natural and 
synthetic origins have come under intense investigation, especially concerning their role 
in disrupting chemical signalling and inducing adverse health effects in wildlife and 
humans. Interdisciplinary studies conducted to date have increasingly linked the 
growing endocrine-related health cases in wildlife to this chemical disruption 
phenomenon. 
 
1.5.1 Evidence of Endocrine Disruption in Invertebrates. 
A wide range of biological effects associated with the exposure of some species 
of invertebrate phyla to endocrine disrupting chemicals has been identified. The most 
comprehensive account of these environmental disturbances is summarised in the 
exposure of oyster (Crassostrea gigas), female marine gastropods (molluscs) and dog-
whelk snail (Nucella lapillus) to organotin compounds (TBT). These compounds were 
used as biocides in marine antifouling paints for ship hulls, boats and aquaculture pen 
nets but also used in wood preservatives, agricultural pesticides, textiles and as UV 
stabilizers in some plastics (Oehlmann et al., 1998). A wide spread occurrence of 
imposex phenomenon, also known as pseudohermaphroditism, has been reported 
globally in marine gastropod species. Molluscs account for the majority of marine 
invertebrates found to be sensitive to TBT exposure. The term imposex defines the 
reproductive defect where the male reproductive organs (penis and vas deferens) are 
superimposed on the female marine species (Bryan et al., 1986; Horiguchi, 2006). 
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Additional effects linked to imposex include increased concentration of testosterone in 
the tissue of marine snail (Spooner et al., 1991). About 150 species of gonochoristic 
prosobranch gastropods worldwide are found to exhibit this reproductive abnormality 
(ibid.; Matthiessen and Gibbs, 1998). At low concentration (1-2ng/l), female dogwhelk 
exposed to TBT developed a blockage of oviduct, otherwise known as sterility (Bryan 
et al., 1986). Further elevation in concentration (3-8ng/l) led to diminished juvenile 
recruitment, induced masculinisation, reproductive difficulties, population reduction 
and extinction (Matthiessen and 1998; Fox, 1992).  These morphological abnormalities 
are thought to be the consequence of inhibiting the aromatase (enzyme), which is 
responsible for the conversion of testosterone to 17β-estradiol (Oehlmann et al., 1996). 
The increased concentrations of testosterone induced biological effects which resulted 
in this masculinisation phenomenon (Matthiessen and Gibbs, 1998). With competing 
arguments suggesting a wide range of other possible modes of action of TBT such as its 
action as a retinoid X receptor agonist (Nishikawa et al., 2004), interruption of 
neuropeptide signaling pathways and modification of testosterone metabolism, the most 
likely mechanism of action based on causal-effect evidence comes from aromatase 
(CYP19) inhibition of testosterone metabolism. In oyster (Crassostrea gigas), the 
consequences of TBT include shell deformation and decimation of adult population as 
reproductive failure increased. Following worldwide confirmation of the long-term 
toxicological implication associated with continued use of TBT, the International 
Maritime Organisation (IMO) treaty in 2001 ratified the imposition of a partial and total 
worldwide ban on its use on boats and ships which indeed took effect from 2003 and 
2008 respectively (Antizar-Ladislao, 2008).   
Similar to TBT, triphenyltin, a compound used in similar capacity as TBT in the 
production of certain antifouling paint, has shown the potential of inducing imposex 
phenomenon in some species of marine snail. It is significant to state that triphenyltin 
(TPT) usage is not restricted to the production of antifouling paint alone (Crompton, 
1998). In the 1960s, TPT was the main constituent of triphenyltinhydroxide and 
triphenyltinacetate used as fungicides to treat potato blight, leaf spot and powdery 
mildew (Keijzer and Loch, 1995). Schulte et al. (2000) reported imposex in female 
freshwater ramshorn snail (Marisa cornuarietis), an ampillariidae-mesogatropod, 
exposed to TPT. Some male sexual abnormalities associated with TPT have been 
reported to include azoospermia (spermatogenesis impairment) and partial infertility. 
These experimental discoveries underscore the endocrine disrupting impact of TPT 
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across both sexes of freshwater ramshorn snail (Marisa cornuarietis) (ibid.).  While no 
significant negative effects were recorded in female netted whelk (Hinia reticulate), 
dogwhelk (Nucella lapillus) showed abnormal sexual features highlighting impairment 
of oogenesis and spermatogenesis when exposed to TPT.   
 Another biological effect of endocrine disruption in invertebrates is 
intersexuality. Intersex reproductive abnormality was reported as the phenotypic 
interference of sex determining organs occurring between the gonad and genital tracts 
(Oehlmann et al., 1994; Bauer et al., 1995). Intersex males and females retained 
phenotypic identity but are differentiated by the presence of additional reproductive 
features specific to their opposite sex (Ford et al., 2004). While the female intersexed 
species possess one or two penis or vas deferens (genitalia), the male species carry 
rudimentary oostegites, the female brood plates (ibid.). It is reported that periwinkles 
(Littorina littorea) developed intersexuality effects when exposed to TBT, a 
phenomenon that contrast with the outcome of the previous exposures (Matthiessen et 
al, 1995). Intersex phenomenon has been reported in crustaceans (harpacticoid 
copepods) exposed to sewage effluents along the east coast of Edinburgh, Scotland 
(Moore and Stevenson, 1994). Although the mechanisms surrounding the phenomenon 
is unclear, factors responsible for intersex vary and may include age and the species (De 
Bock and Greco, 2010), parasitism (Ford et al., 2004), temperature (Vazquez et al., 
2004), bacterial infection (Rigaud and Juchault, 1998), genetic control (Lebederf, 1939), 
environmental sex determination (Dunn et al., 1996; Dunn et al., 2005), protandrous 
hermaphroditism (Yaldwyn, 1966), exogenous chemicals (Olmstead and Leblanc, 2007) 
and pollution (Moore and Stevenson, 1991; Ford et al., 2004a). The following copepods 
were discovered to exhibit intersexuality: Paramphiascella hyperborea and Stenhelia 
gibba and it was also evident in two species of Halectinosoma (Similidistinctum and 
finmarchicum). Intersex contrasts with imposex in their reproductive morphology. 
While imposex phenomenon can be described as complete superimposition of the 
female reproductive organs with the penis or the vas deferens (the male reproductive 
organs), intersex phenomenon is characterised with deepening development of abnormal 
pallial oviduct by the female reproductive organs.  
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1.5.2 Evidence of Endocrine Disruption in Vertebrates. 
1.5.2.1 Reptiles: 
Accidental spillage of a mixture of chemicals containing diclofol, DDT, DDE 
and sulphuric acid, into Lake Apopka in Florida induced a wide range of reproductive 
and developmental abnormalities in juvenile alligators (Alligator mississippiensis) 
living in the lake (USEPA, 1979). In addition to the spill, the lake is known to receive 
agricultural wastewaters which have further caused the level of its contamination over 
time to be complicated (Guillette et al., 1994). Three years post-spillage review of the 
alligator densities in the lake showed 90% reduction in the population of juvenile 
alligators in the lake (Guillette et al., 1995; Jenning et al., 1988). This noticeable decline 
in the alligator population has been attributed to reproductive failure modulated by DDT 
and its metabolites, DDE and DDD. Woodward et al. (1993) reported reduced hatching 
success from 80% to about 20% of the eggs taken from alligators harvested from Lake 
Apopka. The juvenile male alligators that matured from these hatchlings were 
discovered to have developed small penis size. High mortality rate of hatchlings (about 
50%) occurred after 14 days when the concentration of bioaccumulated pesticides and 
their metabolites recorded in the eggs doubled (ibid.).  Abnormal morphological effects 
attributed to these endocrine disrupting chemicals in both adult male and female 
alligators include demasculinisation of male alligator (where increased length of 
testicular phalluses was developed), malformation of cell structures in seminiferous 
tubules, ovarian defects in the female alligators (ibid.). Plasma hormone concentration 
studies of the gonad region have reportedly confirmed elevation of estradiol-
testosterone ratio (E2/T2) by a factor of 2 in female alligators and quadrupled factor 
from 0.5 in the male reptiles under the influence of DDT and their metabolites stressing 
the biological implication of xenoestrogens in vivo (Milnes et al., 2002; Guillette et al., 
1994). Laboratory studies revealed that o, p’-DDE which is suspected to be responsible 
for most hormonal effects (estradiol) in alligator could effect sex differentiation when 
eggs coated with chemical was incubated in the hatchery (Hileman, 1994). At normal 
male hatching temperature, DDE coated eggs produced a mixture of male, female and 
intersex in ratio 2:1:2 against 100% male recorded by DDE-free eggs (ibid.).   
Another known example of environmental occurrence of endocrine induced 
chemical effects detected in Lake Apopka occurred in red-eared slider turtle (Trachemys 
scripta) population. Investigation conducted on the eggs, juvenile and adults of this 
turtle species in Lake Apopka revealed some developmental and reproductive 
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abnormalities which have been attributed to exposure to chemical contaminants in the 
lake. Seven years review of the turtle densities after the spillage revealed an alteration in 
the hormonal balance and the trend of androgen synthesis. Most male sexed turtles are 
progressively demasculinised while hatchlings either result in abnormal male or intersex 
according to histopathological studies (Guillette et al., 1994). Studies have shown that 
two hydroxylated PCB(2’,4’,6’-trichloro-4-biphenylol and 2’,3’,4’,5’-tetra-4-
biphenylol), which may be detected as metabolites of PCBs in the marine environment, 
could activate estrogenic characteristics in eggs of red-eared male turtles that are pre-
dosed (coated) with these compounds when incubated at male-producing temperature 
(Bergeron et al., 1994). Their endocrine disrupting characteristic could induce sex 
reversal in male but the end-results in female turtles are unknown (ibid.). 
 
1.5.2.2 Amphibians: 
The declining profile of amphibians in the wild has raised questions about the 
role of endocrine disrupting chemicals in the reduction of their population. Currently, 
the available evidence implicating xenobiotic chemicals for the extinction of some 
wildlife species is so far limited. Exposure of some amphibian species {e.g. northern 
leopard frogs (Rana pipiens), green frogs (Rana clamitans) and mink frogs (Rana 
septentironalis)} to agricultural chemicals has resulted in some developmental 
deformities in addition to some physiological and immunological abnormalities and 
propensities such as alteration in developmental hormones, increased susceptibility to 
diseases, missing or supernumerary limbs, bony limb-like projections, digit and muscle 
defects as well as those associated with central nervous system (Ankley and Giesy, 
1998). Chemical-induced developmental and reproductive malformations have further 
suggested that chemical exposure may be responsible for the decline of some amphibian 
populations. Metamorphosis is a crucial developmental process by which eggs of a 
wildlife species are transformed to the adult wildlife. Each of these stages is mediated 
by the endocrine system through the endogenous hormones. Although the role of 
endogenous hormones on the formation and transformation of larvae is not known, it is 
suspected that sex steroid hormones can hinder larval development in some amphibian 
species (Gray and Janssens, 1990; Hayes, 1997; Richards and Nace, 1978). Long-term 
exposure of amphibians to estrogen and estrogen-like chemicals can modulate sex 
differentiation during metamorphosis (Bevan et al., 2003; Christensen et al., 2005; Goto 
et al., 2006; Mackenzie et al., 2003). Studies of cricket frog (Acris crepitans) taken from 
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a PCBs- and polychlorinated dibenzofuran (PCDF)-contaminated site in Illinois, USA 
revealed that male frog species showed sex ratio alteration. The additional reproductive 
abnormalities reported include formation of testicular oocytes, incomplete 
metamorphosis, and feminisation. Common morphological abnormalities documented 
in female frogs comprise female-biased sex ratio and gonadal malformation (Jofre and 
Karasov, 2007). Similar malformations have been reported in Northern leopard frogs 
(Rana pipiens) captured in Ontario, USA.       
 
1.5.2.3 Aves (Birds): 
The best known examples of endocrine disrupting effects of environmental 
chemicals in wild birds pertain to egg shell thinning, supernormal clutches and sex 
differentiation.  Widespread DDT and DDE pollution across the Pacific coast of the 
United States of America between the 1950s and 1970s has been linked with some 
developmental and reproductive abnormalities. Roughly 2 million kilograms of 
industrial DDT and its metabolites were released into the coastline via the sewers 
leading to bioaccumulation and bioconcentration of their particulates in the tissues of 
fish, sea birds and sea lions. The effect-based ecological response to these contaminants 
led to breeding failure in double-crested cormorants (Phalacrocorax auritus), brown 
Pelicans (Pelecanus occidentalis) of Anacapa Island, common egrets (Casmerodius 
albus) in California, sparrowhawks (Accipiter nisus) of South Scotland, fish-eating 
Caspian and Foster’s terns (Stern caspia and Stern forsteri), white-tailed eagles 
(Haliaeetus albicilla) of Schleswig Hostein, herring gulls (Larus argentatus) of Lake 
Ontario and shoreline-nesting bald eagles (Haliaeetus leucocephalus) in the Great Lake 
Basin. These and some other chlorinated pesticides were linked to the general decline in 
the population of wild birds (Fry and Toone, 1981; Palmiter and Mulvhill, 1978). The 
step-wise formation process of medullary bone (which is recognised as the primary 
source of calcium during formation of eggs and eggshells) and calcium metabolism are 
regulated by the sex steroid hormone, estrogen. It is possible for bioaccumulated DDT 
and its metabolites in the tissues to act against the transportation of calcium across 
eggshell gland mucosa given that some chlorinated pesticides have been reported to 
have estrogenic characteristic. This calcium transportation inhibition leads to eggshell 
thinning in predatory and non-predatory birds (Taylor and Harrison, 1999; Risebrough 
et al., 1968). In addition to eggshell thinning, seen to be the prevalent symptom in most 
exposed bird species, sex differentiation (skewed sex ratios) such as feminisation and 
30 
 
intersexuality, have been reported to occur in some breeding populations of some wild 
birds. Such bird species include Japanese quails (Bryan et al., 1989), Western gulls and 
Herring gulls (Fry et al., 1981).  Further long-term effects of morphological 
abnormalities reported in wild birds include development of malformed ovarian tissues 
and oviducts in male embryos (Fry et al., 1981), hematology (Bryan et al., 1989), 
developmental abnormalities, such as feather malformation and growth retardation, and 
mortality (Safe et al., 2000).     
 Another illustrative evidence of endocrine disruption reported in wild birds is 
the incidence of supernormal clutches, where the average number per clutch (nest) rose 
from three to between four and six (Dawson, 2000; Kovacs and Ryder, 1985; Ryder and 
Somppi, 1979). Due to biased sex ratio in the population density (which resulted in the 
shortage of male population density), it is observed that two female members could 
come together (in what has been termed female-female pairing effect) to lay eggs in 
common nest and share the responsibility of rotational incubation which was usually 
undertaken with the male (Hunt and Hunt, 1977; Kovacs and Ryder, 1985). This 
phenomenon was triggered by the high level of o, p’-DDT contaminants which induced 
feminisation of male Western gull embryos found in the heavily contaminated Santa 
Barbara Island (Fry and Toone, 1981). Supernormal clutches in member birds was 
caused by skewed sex ratio in the population. Another explanation tenable for this 
behaviour, which has not been investigated, is the masculinisation of female Western 
gulls’ behaviour. The effect was no longer noticed after a worldwide ban was imposed 
on the production and use of DDT as pesticide.  
   
1.5.2.4 Pisces (Fish): 
Among the five classes of vertebrate animals, fish ranks as one of the most 
widely studied to illustrate endocrine disrupting effects of environmental chemicals. 
This is because the aquatic environment, which is their natural habitat, is regarded as 
“the ultimate sink” for natural and anthropogenic chemicals (Sumpter, 1998). Studies 
have also shown that wastewater effluents are one of the major sources of chemical 
contaminants of the aquatic environment (Desbrow et al., 1998; Snyder et al., 1999; 
Baronti et al., 2000). There is a general view that severe endocrine disrupting 
consequences, which could threaten the reproductive health and population 
sustainability of fish, would not only spell their extinction but could also have adverse 
consequences on the population and health of humans, predatory animals and other 
31 
 
living organisms. Studies of the physiology and morphology of fish species caught 
downstream of some wastewater-receiving rivers and lagoons and some laboratory 
exposures showed diverse degrees of abnormalities (Kime, 1998; Tyler et al., 1998). 
Gonad analysis of caged and wild male roach (Rutilus rutilus) exposed to wastewater 
effluents during sexual differentiation revealed the induction of protein egg-yolk, 
known as vitellogenin, a phospholipoprotein manufactured in the liver of egg-laying 
female vertebrates (Folmar et al., 1996; Larsson et al., 1999; Purdom et al., 1994; 
Rodgers-Gray et al., 2000, 2001). This egg-yolk formation has been defined as 
feminisation of the male fish. Similarly, formation of vitellogenin has been reported in 
juvenile male rainbow trout (Oncorhynchus mykiss), Japanese medaka (Oryzias latipes), 
fathead minnows (Pimaphales promelas), zebrafish (Danio rerio) and cyprinid fish 
species exposed to laboratory dosage of estrone (E1), 17β-estradiol (E2) and 17α-
ethinylestradiol (EE2) (Brion et al., 2001; Harries et al., 2000; Orn et al., 2006; Purdon 
et al., 1994; Routledge et al., 1998; Thorpe et al., 2000, 2003). The presence of 
nonylphenol, a metabolite of nonylphenol ethoxylate surfactants, in wastewater 
effluents induces the egg yolk formation and inhibits testicular growth (Harries et al., 
1995). However, other variables such as water temperature, the migratory habits of fish, 
the nature and dosage of EDC exposed to (including the diverse past EDCs exposure 
which can leverage the fresh exposure threshold) can also contribute to the level of 
vitellogenic response (Purdom et al., 1994; Kirby et al., 2004; Pait and Nelson, 2003; 
Panter et al., 2002). 
In addition to feminisation effect in male fish, formation of cysteine-rich 
glycoprotein called spiggin in female fish species, as yet another reproductive 
abnormality, has been reported. At the biochemical level during the breeding period, the 
male stickleback fish develops kidney hypertrophy under the influence of androgen 
thereby causing the epithelial cells of the kidney to produce hydrophobic protein named 
spiggin (Jakobsson et al., 1999; Sanchez et al., 2008). This 230kDa protein is released 
into the urinary bladder where it is constituted as a structural thread (or glue) that is 
used for the purpose of nest-building preparatory to the egg-laying process by female 
fish (Jakobsson et al., 1999).  Conventionally, kidneys of female sticklebacks are not 
known to produce spiggin until recently when the spiggin-forming genes in female 
stickleback were found in dormant (latent) form (Sanchez et al., 2008).  As in male 
stickleback, these dormant genes in the female can be induced by androgen receptor 
agonists to produce spiggins. It is realised that spiggin formation via androgen induction 
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in young and immature female stickleback fish could serve as a reliable end-point which 
can be used to screen (xeno)-androgens and anti-androgens in the laboratory and the 
field (Allen et al., 2002; Bjorkblom et al., 2007; Katsiadaki et al., 2002, 2006; Jones et 
al., 2001) .  
In Florida, USA, female mosquito fish (Gambusia affinis) harvested in rivers 
downstream of pulp and paper mills were observed to exhibit masculinisation 
phenomenon which affected its behavioural pattern too (Howell et al., 1980). In 
addition, the female mosquito fish was reported to develop elongated anal fins which 
are a replica of male gonopodium (ibid.). The males caught in the same rivers were also 
reported to show hypermasculinisation which makes them develop a more 
hyperaggressive mating behaviour than the normal males (ibid.). Other abnormalities 
identified include reduced sex hormone level, delayed sexual maturity, reduced and 
abnormal sexual organs, reproductive difficulties, reduced fecundity and intersexuality 
(Gray et al., 1999; Hirai et al., 2006; Lange et al., 2001; Robinson et al., 2007). 
Although, the environmental chemicals responsible for these reproductive effects were 
not immediately known as studies indicated that such chemicals have hormonal 
characteristics similar to endogenous androgens.  
A wide range of scientific studies undertaken have identified some of the 
xenobiotic chemicals involved in some of these reproductive endpoint abnormalities to 
include PCBs (mostly components or metabolites of known pesticides e.g. DDT, DDE 
and chlordane), natural estrogens (e.g. 17β-estradiol, phytoestrogen) and other unknown 
chemicals (Allen et al., 1999; Sumpter and Jobling, 1995). Significantly, laboratory 
studies have further advanced the knowledge on endocrine disrupting effects of 
environmental chemicals as most of the observed effects have been replicated. 
Incidences of vitellogenin production and gonadosomatic index development in juvenile 
Atlantic cod (Gadus morhua) and flounder (Platichthys flesus) have been demonstrated 
in the laboratory (Allen et al., 1997; Ilylland et al., 1997). 
 
1.5.2.5 Mammals: 
A spectrum of well-established evidences of endocrine disrupting chemicals in 
mammals has been reported. Most examples documented were based on the 
reproductive endpoints and population reduction in terrestrial and aquatic mammals. For 
instance, Florida panthers (Felis concolor coryi), grey seal (Halichoerus grypus), 
common seal (Phoca vitulina), Baltic ringed seal (Phoca hispicla botnica), bottlenose 
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dolphin (Tursiops truncatus), striped dolphins (Stenella coeruleoalba) and beluga 
whales (Delphinapterus leucas) exhibit a wide range of developmental abnormalities 
and reproductive dysfunction. Following progressive declines in their populations, 
investigation revealed that a high level of organochlorines was found in the tissues of 
the Florida panthers (Facemire et al., 1995). The organochlorines detected are suspected 
to originate from raccoon (Procyon lotor) food items contaminated by mercury and 
pesticides during production (ibid.). Florida panthers (Felis concolor coryi) have also 
shown reproductive and morphological abnormalities such as low ejaculation volume, 
diminished sperm concentration, sperm characterised with high morphological anomaly, 
cryptorchidism and male infertility (Facemire et al., 1995; Roelke, 1990). Declining 
trends of grey and ringed seals’ population in the Baltic Sea has likewise been linked to 
endocrine disruptive effects of environmental chemicals (Taylor and Harrison, 1999).  
Increased concentration of PCBs, DDT and its metabolites in the tissues of seals has 
also been detected, some of which have developed abnormalities such as testicular 
steroidogenetic defects, immune dysfunction and infertility linked with these endocrine 
disrupting chemicals. Similar abnormalities occurred when seals harvested in the 
heavily polluted Wadden Sea were analysed (ibid.). Additional evidences documented 
from this experimental analysis include high incidence of fatality and reduced 
concentrations of estradiol resulting in imbalances in this endogenous hormone. For 
example, polar bears (Ursus maritimus) in Svalbard, Norway recorded a drastic decline 
in female population following chemically-induced hormonal imbalance that nearly 
wiped out the female bear population from age sixteen upward (Derocher et al., 2003). 
Occurrence of pseudo-hermaphrodites, a phenomenon synonymous to females 
developing small penis in front of their vagina, has been documented in female polar 
bears (Wiig et al., 1998). The elevated PCB concentration in polar bears may be the 
potential causal agent responsible for dwindling younger polar bear population in 
Svalbard although there is no enough evidence yet to suggest that these are the key 
agents (ibid.).    
 
1.5.2.6 Evidence of Endocrine Disrupting Phenomena in Human. 
The best known evidence of endocrine disruption in human beings involved use 
of diethylstilbestrol (DES).  DES is a popular anabolic agent widely used in the USA to 
improve the economic values of livestock. However, DES was administered to pregnant 
women between late 1940s and early 1970s to prevent spontaneous abortion and this led 
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to a myriad of irreversible reproductive abnormalities, many of which affected the 
unborn baby directly (Marselos and Tomatis, 1992). The outcome of long-term in utero 
studies of DES exposure, which has widened through meat and dairy-related products, 
has been characterised. Similar to laboratory animals, risks of human exposure to DES 
include suppression of lactation, testicular malformation, underdevelopment or absence 
of vas deferens, gynecomastia (development of abnormally large breast tissue in men), 
retention of Mullerian ducts, deteriorated sperm quality and formation of epididymal 
cysts in matured male progeny (McLachlan et al., 2001; Steinberger and Lloyd, 1985).  
Structural malformations such as cryptorchidism, hypoplastic testis and penis and 
meatal stenosis (narrowing urethra tube leading to the penis opening) have been 
similarly reported in children male born after their parents’ exposure to DES (Gill et al., 
1977; Bibbo et al., 1977; Gill et al., 1979; Stillman et al., 1982).  Female children that 
emerged after in utero exposure in their parents’ womb have been shown to develop 
reproductive and developmental malformations. Some of such effects include 
subfertility and virilisation (Kunz et al., 2004), vaginal adenocarcinoma, premature 
birth, pseudo precocious puberty (Felner and White, 2000), vaginal adenosis, elevated 
serum testosterone, structural abnormalities in the uterus, ectopic pregnancy, hood and 
polyps of cervical and vaginal organs, anatomical masculinisation and malformation of 
cervical canal, reduced libido, sexual impotence and tumours of reproductive organs in 
adult women (Steinberger and Lloyd, 1985; Newbold, 1995; Grajewski et al., 1996; 
Whelan et al., 1996).   
 
1.5.3 Environmental Sources of Exposure to Endocrine Disruptors   
A wide range of synthetic and natural chemicals which are capable of 
modulating endocrine-related reproductive and developmental health problems have 
been detected in the environment. Synthetic chemicals find their way into the 
environment via accidental and deliberate human and non-human activities from several 
point and non-point sources. Some of these sources identified include agricultural, 
industrial, commercial and residential outlets. For instance, pesticide applications (to 
improve crop yields in plantations), industrial by-products discharges, landfill leachates, 
combustion process, sewage sludge and domestic wastes discharges are commonly 
known means of chemical sources in the environment.  The fact that endocrine 
disruptors possess a wide range of physicochemical properties will suggest the 
possibility of exhibiting different modes of behaviour in the environment. For instance, 
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most EDCs are known to be lipophilic but have variable chemical and biological 
transformation pathways in the environment which are dependent on their structures and 
other chemical properties. Moreover, catabolic processes such as chemical degradation 
often are altered by environmental factors (e.g. aerobic and anaerobic conditions, 
elevated temperature and photocatalysis, and hydrolysis) to change the form and, 
sometimes, the state of these chemical compounds. However, some of these compounds 
are relatively stable as they do not undergo any degradation. For this reason, they tend 
to bioaccumulate in the environment, maintain a high shelf-life and long enduring 
transportation away from their sources. These are expected to impact on the general 
mechanism of distribution. Human and wildlife exposure to endocrine disrupting 
chemicals can take place through contact with food, water, air, personal care products 
(consumer products), soil and aquatic sediments. These exposure sources are broadly 
classified into two:  indoor and outdoor sources. Generally, endocrine disruptors enter 
into the blood streams of human and wildlife through ingestion, inhalation and direct 
access across the cell membrane via skin and gill contacts.                                                                                                       
 
1.5.4 Anti-androgens in the Environment. 
The word ‘anti-androgen’ can be defined, in a short phrase, as “action taken 
against androgen”. Androgens are useful hormones secreted by the gonads in 
conjunction with the pituitary glands to induce chains of biochemical processes in the 
body of vertebrate animals for the purpose of reproduction and reproductive activities. 
The word ‘androgen’ originated from the combination of two Greek words, “andros” 
(man) and “genein” (to produce).  Androgens mediate biological responses through 
interaction with androgen receptor (AR) as described in Section 1.4.2. Anti-androgenic 
chemicals simply act by blocking the biological process of complex formation and/or 
transcription, which are strategic for activating biological responses. Exogenous anti-
androgens are also referred to as xenoanti-androgens and they describe the endocrine 
disrupting chemicals that are responsible for interrupting these internal biologically 
strategic processes.  
   Therefore, broadly expressed, anti-androgens are any group of androgen 
(receptor) antagonists, hormone synthesis inhibitors, hormone metabolism interrupters 
or hormone transport modulators capable of obstructing partially or totally the 
biological responsibilities of any natural or synthetic chemical compounds (androgens), 
which act on appropriate target cells in the body system to promote and activate the 
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production, development and maintenance of masculine sex organs and sundry 
secondary sexual characteristics in vertebrates.  
Anti-androgens existing in the environment originate generally from natural and 
synthetic sources as steroid and non-steroid compounds. Most known naturally 
occurring anti-androgens are derived from plant sources and are substantially non-
steroid in form (Section 1.5.4.1). The knowledge of natural steroid and non-steroid anti-
androgens from animal sources is currently not available.  A wide range of exogenous 
anti-androgens, occurring in steroidal and non-steroidal forms, have been reported 
among the myriads of anthropogenic chemicals found in the environment. Presently, the 
only known synthetic anti-androgenic compound having steroidal property is 
cyproterone acetate (CPA)(Figure 1.9). From this analysis, it may be appropriate to say 
that most synthetic anti-androgens known are non-steroidal.  
Nonsteroidal synthetic anti-androgens (NSA) are synthesised for myriads of 
human and non-human use, many of which cut across agriculture, medicine, 
environment, industries and domestic life.   
 
1.5.4.1. Plant and Fungal Anti-androgens 
Anti-androgens that occur in nature are limited and most of those reported so far 
originate from plant sources. Some of the exogenous anti-androgenic compounds 
reported in nature include permixon (an extract derived from an American dwarf palm 
tree, Serenoa repens B) (Wilt et al., 1998), a non-steroidal CpdA [2-(4-acetoxyphenyl)-
2-chloro-N methylethylammonium chloride -a stable derivative of the African 
shrub, Salsola tuberculatiformis Botsch, prepared from less stable hydroxyphenyl 
aziridine] (Tanner et al., 2003) and isolates of three leaves -beech, oak and reed extracts 
(Hermelink et al., 2010) (see Figure 1.7).  Also, estrogenic effects sometime reported in 
poultry and livestock have been linked with feeds contaminated with Zearalenone, a 
fungal mycotoxin produced by the action of Fusarium sp on carbohydrate feeds 
(Manfred, 2001; Meronuck et al., 1970; Roine et al., 1971). Studies have shown that 
zearalenone and its metabolites (zearalanone, zearalanol and zearalenol) have anti-
androgenic potency almost equivalent to flutamide (Paris et al., 2005).  This discovery 
has shown that some estrogens can act as also anti-androgens at receptor level.  
Although, the AR binding mechanism is currently poorly understood, zearalenone has 
been reported to demonstrate hepatic ER binding (Powell-Jones et al., 1981). There are 
in vivo data indicating that in utero exposure could lead to sex differentiation and 
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serious disruption of reproductive competence (ibid.). Equol (7-hydroxy-3[4’-
hydroxyphenyl]-chroman) [see Figure 1.6] has also been investigated as a biologically 
active compound with anti-androgenic property (Lund et al., 2004). Equol is a chief 
component of daidzein, a phytoestrogenic derivative of soyabeans. It is found that equol 
has poor AR affinity but bind selectively, with high affinity, to 5α-dihydrotestosterone 
(DHT) to deny DHT from AR binding opportunity (ibid.). Binding affinity of equol to 
DHT is partly accountable for lean epididymal and prostate weight after exposure 
(ibid.).  
 
Figure 1.7: The chemical structures of 2-(4-acetoxyphenyl)-2-chloro-N-methyl-
ethylammonium chloride (CpdA) and Zearalenone. 
 
1.5.4.2 Agricultural Anti-androgens 
A wide range of chemicals that are associated with agricultural practices have 
been reported to possess anti-androgenic properties. Effect-based studies of the anti-
androgenic activities of some of these agro-allied chemicals under in vivo and in vitro 
experimental conditions have been conducted.  Gray and co-workers (1994) discovered 
that, at cell receptor level, some pesticides possess anti-androgenic characteristics in 
vitro or ex vitro and, in some, with a high degree of potency. The majority of these 
pesticides have been discovered in the environment in their original or metabolised 
form and their mechanism of anti-androgenic action is expressed via aromatase 
inhibition. For most environmental compounds that modulate anti-androgenic effects, 
aromatase induction clears away the competitive binding hurdles posed by the 
endogenous androgen hormones at the target receptors and makes passage to the 
receptors free for the chemical anti-androgens to bind to.  Classical examples of anti-
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androgens in the environment include insecticides DDT and its metabolite-DDE (Kelce 
et al., 1995a,b), fenitrothoin, chlorpyrifos-methyl (CPM) (Kang et al., 2004), toxaphene 
and metachlor (its metabolite, HPTE), fungicide vinclozolin and metabolites M1 and 
M2, procymidone (Kelce et al, 1994; Ostby et al., 1999; Gray et al., 2001), prochloraz 
(Gray et al., 2001) and herbicide linuron (Lambright et al., 2000; McIntyre et al., 2000; 
Vinggaard et al., 2005) (Figure 1.8). In utero exposure of some male terrestrial 
mammals (e.g. rat, dog, sheep and pig) to vinclozolin and p, p’-DDE induces reduced 
anitogenital distance (AGD), reduced weight of sex accessory glands, hypospadias, 
ectopic and undescended testes, vaginal pouch and retained nipples (Gray et al., 2001; 
Wolf et al., 1999; Kelce et al., 1995a, b). No knowledge of phenotypic effect has so far 
been reported in the females of all the laboratory animals exposed to procymidone, p,p’-
DDE and vinclozolin. Identified effects of developmental exposure to each of the three 
compounds include testicular cancer (Shakkebaek, 1972), erectile dysfunction and 
infertility in rats (Brien et al., 2000). Given that anti-androgenic response of vinclozolin 
is very weak relative to its metabolites (M1 and M2), the potency is comparatively low. 
Although, linuron and methoxychlor also exhibit AR antagonism in vivo and in vitro, 
and induce reproductive-based effects similar to vinclozolin, procymidone and p,p’-
DDE, the fact that their bioactive concentration are higher implies low potency.  
Most of these agricultural anti-androgens have been detected in the environment 
either in their original or metabolised form.  Due to their non-persistence in nature, 
residues of a wide range of pesticides have been discovered in water, air, soil and food 
samples. Organochlorine chemicals such as DDT, linuron, procymidone, metachlor, 
vinclozolin and methoxychlor are widely used on agricultural farmlands to control 
broad range of pests. Although DDT is either completely banned or restricted in some 
countries across the globe, its residues are still being recovered in previously exposed 
soil layers years afterward. For instance, DDT detected in Tianjin soil samples analysed 
in China occurred in the range of 628.1-2840.5ng/g decades after its application was 
banned (Gong et al., 2002). In Argentina where DDT usage has been restricted, traces of 
it at levels of 0.0204-2.123ppm have been reported in dairy by-products such as butter 
(Lenardon et al., 1994). Similar investigation in Spain has also confirmed the 
occurrence of DDT in trace quantity in pasteurised milk (Martinez et al., 1997). 
Investigation carried out in Ayeduasi, KNUST and K-Poly in Kumasi, Ghana has also 
reported the occurrence of DDT in yoghurt at concentrations of 8.96µg/kg, 4.09µg/kg 
and 7.52µg/kg respectively (Darko and Acquaah, 2008). In addition, studies further 
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indicate that traces of DDT were detected in fresh milk at a concentration of 12.53µg/kg 
in KNUST samples and in cheese sampled from Aboabo, Tafo and Asawasi at 
concentrations of 14.02µg/kg, 298.57µg/kg and 42.17µg/kg respectively (Darko and 
Acquaah, 2008). In an experimental study undertaken thirty-days after procymidone 
application to four supervised leek fields in China, an average range of 0.033-
0.17mg/kg and 0.020-1.75mg/kg of its residues, corresponding to 74.9-100% and 82.5-
92.5%, were detected in leeks and soil samples respectively (Chen et al., 2010). 
Procymidone residues have been discovered in wine grapes and vegetables harvested 
from exposed farmlands (Urruty et al., 1997; Rodriguez et al., 2002). Linuron is a 
herbicide that is used extensively for cultivating tuber and vegetative crops such as 
onions, carrots and potatoes (Sanchez-Camazano et al., 2000). About 70% of linuron 
was reported to leach into the soil when four natural soil samples taken from the 
Province of Salamanca, Spain were investigated (ibid.). There was a significant 
variation in the result outcome when the organic content of the soil samples was 
modified indicating that the level of linuron retention in the soil changes with different 
soil profiles (ibid.). Prochloraz is a fungicide for controlling eyespot disease and 
powdery mildew in cereals and fungal diseases in vegetables and fruits (Birchmore et 
al., 1977; Lafuente and Tadeo, 1985; Kapteyn et al., 1992). A multiresidue analysis 
carried out on pesticide-contaminated soil samples taken from Sao Paolo state, Brazil 
reported a recovery range of 54-73% of prochloraz between 55-73
0
C temperatures. 
During the analysis, recoveries of linuron and vinclozolin were also measured at the 
respective range of 55-70% and 69-73% under the same temperature conditions (Risatto 
et al., 2005). Prochloraz-formylurea and prochloraz-urea are two metabolites of 
prochloraz that have been detected at different concentrations of various subsoil layers 
(Hollrigl-Rosta et al., 1999).  The level of prochloraz degradation is a function of the 
texture, pH and the temperature of the soil (ibid.). 
Analytical studies of horticultural soil samples taken in five different locations 
in northern Portugal showed the occurrence of chlorpyrifos (a derivative of 
chlorpyrifos-methyl) in 33.8µg/kg respectively (Goncalves and Alpendurada, 2005). 
While chlorpyrifos-methyl has been shown to possess anti-androgenic activity, the 
biological activity of chlorpyrifos is yet to be known. In Saudi Arabia, residues of 
toxaphene were detected in subsoil samples of contaminated farmlands (30-60cm) at 
concentration between 0.006-0.162mg/kg (Al-Wabel et al., 2011). Another commonly 
known anti-androgenic organochlorine pesticide is methoxychlor. It is used in isolation 
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or in combination with other chemicals to control cereal and fruit pests especially 
during storage and planting seasons (ATSDR, 1994). It is also used on agricultural 
fields planted with vegetable, soyabeans and nuts to control insect pests (ibid.). Its mode 
of action is known to be similar to that of DDT. Traces of methoxychlor residue have 
been detected in food stuff, water and soil. Due to its less persistence, methoxychlor is 
rarely found in the environment but could be detected near the disposal, dispensal or the 
manufacturing premises. In soil, methoxychlor has an anaerobic half-life of 30 days and 
an aerobic half-life over 100 days (Muir and Yarechewski, 1984).  Fenitrothion is a 
non-persistent organophosphorus insecticide that has been identified to exhibit anti-
androgenic property. It is commonly used to control insects associated with cereals, 
vegetables, stored grains and cotton on agricultural fields (Tamura et al., 2001). It 
undergoes biodegradation under aerobic condition to produce toxic nitrophenolic 
metabolites in soil and water (Mikami et al., 1985). One major metabolite generated 
during its aerobic biodegradation,  which only occur via artificial means, is 3-methyl-4-
nitrophenol (MNP) (Keith and Telliard, 1979). Due to the possibility of producing 
myriads of toxic metabolites aerobically, extensive use of fenitrothion has become the 
likely channel that could constitute environmental health concerns in humans and 
wildlife (Tago et al., 2006).  The structures of these agricultural anti-androgenic 
compounds are provided in Figure 1.8. 
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Figure 1.8: A diagram showing examples of agricultural anti-androgens found in the 
environment. 
NH
O
OH
CH3
CH2
Cl
Cl
Vinclozolin M2 
N
O
O
O
CH3
CH2
Cl
Cl
Vinclozolin 
Cl
Cl
NH
O
O
CH3
CH2
O
OH
Vinclozolin M1 
ClCl
Cl Cl
N
+
O
-
O
CH3
O
P
S
O
O CH3
CH3
N
Cl
Cl
Cl
O P
O
O
S CH3
CH3
Cl
ClCl
O
N
O N
N
CH3
O
O
N
CH3
O CH3
Cl
Cl
N
Cl
Cl
O
O
CH3
CH3
ClCl
Cl
O O
CH3CH3
p,p-DDE 
Fenitrothion 
Chlorpyrifos-methyl 
Prochloraz 
Procymidone 
Linuron 
Methoxychlor 
42 
 
1.5.4.3 Clinical Anti-androgens 
In utero administration of DES to pregnant women, as estrogenic supplement, 
for three decades in the USA led to a wide range of phenotypic end-points that indicated 
compromise in health conditions. Cases of cryptorchidism, hypospadias, and diminished 
volume and quality of sperm in adult laboratory animals have been reported (Imperato-
McGinley et al., 1992; van der Schoot, 1992; Silversides et al., 1995; Sharpe et al., 
2000).  For the fact that an estrogen could induce all the effects highlighted above 
strongly suggests that it can exercise the ability to block the androgen receptor. 
Investigation later confirmed similar reproductive effects when anti-androgen exposure 
was carried out. This highlights the fact that while the mechanisms through which these 
compounds operate in any vertebrate system are dissimilar, yet the endpoints are same. 
DES can be reported, on that basis, to exhibit anti-androgenic activity. 
Hydroprogesterone and cyproterone acetate (CPA), its synthetic derivative, are reported 
to demonstrate both anti-androgenic and progestational activities (Huang et al., 1985; 
Brinkmann et al., 1983). In vivo exposure of CPA, progesterone and anti-progestin 
RU486 has been shown to induce nuclear transport, AR DNA binding and 
transcriptional activity due to competitive AR inhibition binding (Kemppainen et al., 
1992). Cyproterone acetate belongs to the dydrogesterone (17-OH progesterone) class 
of anti-androgenic progestin family (Sitruk-Ware, 2008). Cyproterone acetate exerts its 
anti-androgenic activity by either engaging in competitive inhibition with AR or by 
disrupting the conversion agent (enzyme) of testosterone to dihydrotestosterone (DHT) 
(Sitruk-Ware, 2008). Other clinical anti-androgens in regular use today consist of 
flutamide, finasteride, nilutamide, spironolactone, hydroxyflutamide, valproate, 
osaterone acetate, danazol and ketoconazole (Imperato-McGinley et al., 1992; Death et 
al., 2005; Gunes and Fetil, 2000; Minato et al., 2005; Terouanne et al., 2002; Korner et 
al., 2004; Xu et al., 2006; Schurmeyer and Nieschlag, 1984) (Figure 1.9). Flutamide, 
nilutamide and bicalutamide are another category of clinical anti-androgens which 
operate in similar manner as CPA. Despite their regular use, their concentrations in the 
environment are not reported.   
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Figure 1.9: Structures of some clinical anti-androgens 
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1.5.4.4 Industrial Anti-androgens 
Anti-androgenic effects of industrial chemicals are increasingly being reported. 
This surge is due, in part, to the growing production of nonsteroidal chemicals, many of 
which have not been characterised. Examples of chemicals identified with anti-
androgenic activity include a range of phthalates such as dibutyphthalate (DBP), 
diethylhexylphthalate (DEHP) and butylbenzylphthalate (BBP) (Wilson et al., 2004) 
and polybrominated diphenyl ethers (PBDEs) such as   DE-71 and DE-100 (Stoker et 
al., 2005). Phthalates are ubiquitous environmental contaminants many of which have 
been reported to possess anti-androgenic activity in vitro. Although, in vivo studies 
indicate that phthalates are non-bioaccummulative, in this instance the parent 
compounds are metabolised into active hydrolytic monoesters (or oxidative metabolites 
via enzymatic oxidation of the alkyl chain when high molecular weight phthalates are 
involved) which may induce abnormal reproductive disorders (Silva et al., 2003; Gray 
et al., 1999; McIntyre et al., 2001; Mylchreest et al., 1998; Mylchreest et al., 1999).  
Male offsprings of pregnant animals exposed to DBP and DEHP were reported to 
induce cryptorchidism, hypospadias and testicular weight loss (Mylchreest et al., 1998). 
Similarly, exposure of laboratory animals to PBDEs have produced abnormal 
reproductive health effects some of which are delayed puberty in both sexes of rodents, 
weight loss during pregnancy, decreased sperm concentration, alteration in the ovary 
cells, decreased testicular size, exhibition of gender-specific sexual-related behaviours 
and some birth defects (Akutsu et al., 2008; Chao et al., 2007; Lilienthal et al., 2006; 
Meeker et al., 2009; Schreder et al., 2006; Stoker et al., 2005; Yang et al., 2009). Other 
anti-androgenic industrial chemicals detected in the environment or identified through 
laboratory analysis include bisphenol A (Sohoni and Sumpter, 1998), bisphenol F 
(Satoh et al., 2004), TCDD, polychlorinated biphenyls (PCBs), ethane-1,2-dimethane 
sulphonate (EDS) (Wolf et al., 1999; Gray et al., 2001), some polyhalogenated aromatic 
hydrocarbons (Calle et al., 2002; Sharpe and Irvine, 2004) and polycyclic musks (e.g. 
tonalide, phantolide, celestolide) and UV filters (e.g. homosalate, 3-benzylidene 
camphor, benzophenone-3 and 4-methylbenzylidene camphor)  (Ma et al., 2003; 
Schreurs et al., 2005) (Figure 1.10).  
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Figure 1.10: Diagrams of some industrial anti-androgens identified in the environment. 
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1.6. Anti-androgens in Wastewater Effluents as Potential Causal Agents of 
Intersex in Fish Living in UK Rivers and Lagoons. 
Anthropogenic chemicals present in aquatic environments can interfere with the 
endocrine system of the living organisms dwelling in them to the extent of modulating 
biological responses that could result in irreversible physiological and reproductive 
abnormalities. In the late 1970s and early 1980s, anglers in the United Kingdom 
observed the preponderance of abnormal incidence of intersexuality (i.e. simultaneous 
occurrence of male and female gonads) in roach (Rutilus rutilus), a gonochoristic fish, 
caught in the River Lee downstream of a sewage treatment plant. Studies have also 
shown that it is possible for some fish species to develop intersexuality, among other 
reproductive abnormalities, when exposed to chemicals in wastewater effluents via 
water samples from aquatic environments (Jobling et al., 1998; Allen et al., 1999b; 
Harshbarger et al., 2000; Hashimoto et al., 2000; Vigano et al., 2001; van Aerle et al., 
2001; Sole et al., 2003). Some of such chemicals identified in wastewater effluents 
possess estrogenic properties and they include ethynylestradiol, an active compound in 
birth control pills, bisphenol-A, octylphenol, alkylphenol ethoxylates (APEs) and 
nonylphenol (Korner et al., 2000). The identities of many other compounds in 
wastewater effluents are still yet unknown (ibid.). It has been discovered that some 
estrogenic compounds can induce vitellogenin at low concentrations and intersexuality 
at high concentrations. Some studies have shown that exposure of young medaka to 
17β-estradiol at concentration range of 0.01-1.66µg/L for a month would lead to sex 
reversal while exposure of its eggs and fry hatchlings to a concentration as high as 
15µg/L of 17β-estradiol could result in the formation of ovo-testis (Nimrod and Benson, 
1998; Koger et al, 2000). Similarly, laboratory exposure of some juvenile fish species to 
androgens at a range of concentrations can result in the formation of vitellogenin just as 
its long-term exposure can also lead to the formation of intersex. Laboratory exposure 
of juvenile zebrafish at concentrations less than 1µg/L 17-methyltestosterone can lead to 
formation of intersexuality. The modality, by androgens, for inducing intersex in fish 
has been associated with its (androgens) aromatisation to estrogen in the course of 
which the concentration of estrogen in the fish builds up to a trigger threshold. For pulp 
and mill wastewater effluents, aromatisation of androgenic chemicals can lead to 
induction of vitellogenin in juvenile zebrafish, just as it can also induce intersex (Orn et 
al., 2006). It is not yet clear whether environmental estrogens are solely responsible for 
inducing intersex in fish. Laboratory studies have shown that anti-androgens can also 
47 
 
induce intersexuality as estrogens would (Urbatzka et al., 2007). Exposure of some fish 
species to anti-androgens (e.g.nonylphenol) could also lead to the formation of ovo-
testis. Exposure of Japanese medaka (Oryzias latipes) to nonylphenol can induce 
intersex (Gray et al., 2007). Although, nonylphenol has estrogenic effect, it has also 
been shown to possess anti-androgenic property which underscores the assertion that 
some estrogens are equally anti-androgens (Sohoni and Sumpter, 1998).  
 
1.7. Wastewater Treatment Plants as Potential Sources of Environmental Anti-
androgenic xenobiotics. 
Wastewater Treatment Plants (WwTPs) are collection and treatment centres for 
a wide range of environmental chemicals entering into the aquatic environments. 
Wastewater contributions from households, industries and commercial settlements are 
reported to contain high concentrations of chemicals which are hazardous to the well-
being of the living environmental organisms.  In order to prevent (or minimise) the 
potential risks that would be posed by their presence, wastewaters are made to undergo 
physical, chemical and biological treatment processes (Svenson et al., 2003). During 
these stepwise mechanical treatment processes (classified into primary, secondary and 
tertiary) (Figure 1.11), various chemicals present in the waste samples are either totally 
or partially removed (Svenson et al., 2003). The first process involves the use of coarse 
grits to remove objects which are greater than 3mm in diameter. Further removal of 
particulates is carried out with sand traps before running the filtrate into pre-settling 
basins where aeration is applied, and solid organic materials and nutrients are removed. 
Through the process of adsorption, a wide range of lipophilic compounds are also 
removed. This complete removal mechanism described above is referred to as primary 
treatment.   
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Figure 1.11: A diagram showing the primary, secondary and tertiary stages of 
wastewater treatment plants. 
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may proceed in more than one step. Using the activated sludge alone or in combination 
with trickling filters (or biobeds) and biological nitrogen removal means, bacteria, 
nitrogen and anoxic substances are removed. The tertiary stage requires the use of 
chemicals to remove phosphorus, particulates and other dissolved organic matter 
through the process known as coagulation or chemical precipitation. The coagulants are 
precipitated and discharged as sludge. The settling of the coagulants may be facilitated 
using polyelectrolytes which fused the small coagulant units into heavier ones. 
Commonly used precipitating chemicals include aluminium sulphate, lime and ferric 
chloride (Svenson et al., 2003). Sometimes a direct precipitation of these contaminants 
with chemicals may be undertaken after the first and second filtration (ibid.).  In which 
case, the total microbial removal may be partly compromised. During this removal 
process, the sludge (which represents the waste substances removed) is treated and may 
be used as agricultural fertiliser. Otherwise, the sludge may be digested either 
anaerobically or aerobically or converted to compost manure.  
Generally, a series of physical, chemical and biological activities are discovered 
to occur at the WwTPs during treatment processes through which chemicals and other 
unwanted components are removed. These, in summary, include flocculation (Kim et 
al., 2002; Ternes et al., 2002), sedimentation (Zhang and Emary, 1999; Strenn et al., 
2003), coagulation (Adams et al., 2002), precipitation (Strenn et al., 2003), 
biofilteration (Shon et al., 2006), sorption or adsorption into sludge (Petrović et al, 
2001), vaporisation or volatilisation (Meakins et al., 1994; Birkett and Lester, 2003), 
photolysis (Gray and Sedlak, 2003; Liu et al., 2003; Mansell et al., 2004), 
biotransformation or microbial metabolism (biodegradation, aerobic and anaerobic 
degradation) (Holbrook et al., 2002; Johnson and Sumpter, 2001; Semple et al., 1999) 
and chemical transformation (chemical hydrolysis by oxidation and reduction, 
enolisation and isomerisation) (Huang et al., 2001; Sedlak and Pinkson, 2001).  
Studies have shown overtime that the final effluents which are released into 
receiving rivers and lagoons contain a complex mixture of chemicals indicating that 
some compounds are not completely eliminated during the treatment process. Published 
studies indicate that a wide range of some compounds found in effluent wastewaters 
possess estrogenic, anti-estrogenic and androgenic activities. A few of such reports have 
also indicated the occurrence of compounds having anti-androgenic activities. The 
diversity of the wastewaters treated is better appreciated based on the nature of the 
community from where supplies originate. By the same relationship, the nature of 
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compounds present in wastewater effluents is largely dependent on the origin of their 
sources.  It is expected that a more industrialised community will produce wastewaters 
with higher industrial contribution than less industrial communities. However, due to 
the pathway of this research, focus will be directed to wastewaters with minimal 
industrial contribution and mainly domestic input.     
 
1.8 Bioassays for Screening Endocrine Disruption Chemicals in Environmental 
Samples. 
Bioassays are biomolecular preparations or mixture of cellular formulations that 
can be used to activate and evaluate effect-based measureable end-points. Through 
formation of a new biomolecule, activation or inhibition of chemical reactions, 
induction of immunological responses or any variable parameter, screening of bioactive 
chemicals in environmental samples are achieved. The relevance of these biological 
assays includes detection, measurement and evaluation of biological activity, potency 
and toxicity of chemical compounds being considered for pharmaceuticals, or those 
derived from effluent wastes, contaminated soil and sediments. Two main categories of 
bioassays predominantly used are in vitro and in vivo bioassays.  
 
1.8.1 In vivo Bioassays 
Although in vitro bioassays are the most frequently used means of screening the 
endocrine chemicals especially due to the relative ease of use, cost effectiveness, 
reproducibility, sensitivity and accuracy, in vivo bioassays is still considered as the best 
evaluation approach. Tests of chemicals for endocrine effects are carried out in the 
system of living animals where true reaction of such an animals to the activity can be 
effectively measured. Common in vivo assays used are Hershberger, three-spined 
stickleback kidney cell culture assay and Tier 1 screening assay (Gray, 1998; Jolly et 
al., 2006; Katsiadaki et al., 2002, 2006). Given that the volume of environmental 
samples prepared for analysis at any specific time could be enormous, it is practically 
uneconomical to adopt in vivo method. For that reason, discussion on bioassays will be 
limited to in vitro bioanalysis.   
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1.8.2 In vitro Bioassays   
In vitro bioassays are a broad range of rapid, cost-effective bioanalytical 
techniques developed based on high sensitivity, specificity and optimally throughput 
biological scheme and used to identify, quantify and screen for the biological effects of 
endocrine disruptors from various environmental samples (Fertuck, 2002; Zacharewski, 
1997). Three major in vitro bioassays are currently used to screen androgen and anti-
androgens. They include: receptor competitive binding assays (or transcription 
activation assays), cell proliferation Screen Assays and Reporter Gene Assays. Receptor 
binding bioassays are test standards developed to bind to a specific receptor sites of 
target compounds. The non-radiolabelled ligand (the test compound) engaged in 
competitive binding with the established radiolabelled ligand (hormone) for androgen 
receptor site (Lambright et al., 2000) situated on the cellular or nuclear region of the 
target cell or tissue during incubation (Lambright et al., 2000; Wong et al., 1995). The 
problem associated with this type of assay is its failure to distinguish between 
androgenic and anti-androgenic activity of test compounds which explains why it is 
poorly selective. Androgen cell proliferation screen assay explores the ability of 
endogenous androgen to stimulate cell proliferation and induce hypertrophy in male 
secondary sex organs (Sonnenschein and Soto, 1998).  The proliferation process is 
activated when cell lines interact with the test compounds. During the interaction, the 
test samples replace receptor binding on the labelled hormone conjugate leading to the 
occurrence of bioactivity. For anti-androgenic compounds, the cell proliferation process 
is inhibited (Sonnenschein and Soto, 1998). A wide range of cell lines is readily 
available for this type of assay, which includes mammalian cells. Examples of this assay 
are MCF-7 and A-SCREEN. The major drawback is the inter-laboratory (and intra-
laboratory) variability but can be employed productively, efficiently and effectively to 
distinguish androgenic and anti-androgenic activity due to its selectivity.   
Endocrine disruptors have also been successfully evaluated with receptor gene 
bioassays where yeast or cell lines are used to measure the degree of transcriptional 
activity generated in response to hormone stimulation. The yeast or cell lines which are 
developed from either mammalian cell lines (e.g. MCF-7, COS-1, CHO, AR-CALUX, 
HEH293) or yeast strains (e.g. Saccharomyces cerevisiae) are transfected with plasmids 
encoding the hormone receptor and the androgen-dependent receptor gene (Figure 
1.12). The receptor gene is coupled with a promoter (e.g. β-galactosidase or luciferase) 
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which consists of hormone response elements (HREs) via which the receptor activation 
process is facilitated (Sohoni and Sumpter, 1998; Roy et al., 2004).  
 
 
Figure 1.12: Diagram showing the (i) typical structural configuration of a genetically 
modified yeast strain in anti-androgen yeast screen (AYAS) assay, (ii) anti-androgenic 
binding pathways (1-3) and the (iii) activation of gene expression (4-5). The human 
androgen receptor (hAR) gene is incorporated into the yeast genome and expresses 
cytosolic hAR. In the presence of an androgen ligand such as DHT, it binds to an 
androgen receptor element (1) occurring within the promoter on the inserted plasmid. 
The anti-androgen complex (3) formed between the anti-androgen molecule and the 
human receptor gene (2) inhibits DHT, the natural steroid agonist, and the generation 
and expression of Lac-Z, (4) the reporter gene through which enzyme β–galactosidase is 
produced. Non-secretion of β–galactosidase into the medium containing the anti-
androgen will cause a chromogenic response from red to yellow colour to occur.   
 
 
Sample-receptor complex is produced from the active binding brought about by 
chemical interaction of the potential androgen sample and the receptor present on the 
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yeast strains.  The HRE of the reporter gene is activated when the sample-receptor 
complex binds to it following which the enzymes such as luciferace, β-galactosidase 
and chloramphenicol acetate transferase, which are suitably measured with luminometry 
or spectrophotometry, are produced (Sohoni and Sumpter, 1998; Roy et al., 2004). 
Generally, reporter gene bioassays are easy to culture and manipulate genetically. In 
addition, they possess the ability to metabolise the test samples. They produce non-
uniform permeability when yeast cell walls are exposed to test compounds which cause 
them to have different set of AR co-regulators better than the mammalian cells. They 
have been used for screening of androgens and lately anti-androgens (ibid.).  
   
1.9 Aims and Objectives. 
The aims of this research work are to investigate, identify and quantify 
anthropogenic chemicals that can induce androgen-receptor antagonism, and to measure 
the relative potency of these compounds in predominantly domestic wastewater 
influents and effluents sourced from Horsham Wastewater Treatment Plant, South East 
of England. This investigation encompasses the following objectives: 
1. To investigate the profiles of androgen-receptor antagonists in a domestic 
wastewater (from Horsham wastewater treatment works) using the in vitro 
androgen recombinant receptor transcription yeast screen (AYAS). 
2. To identify the structures of androgen receptor antagonist chemicals present in 
effluent and influent samples from Horsham wastewater treatment works using 
Toxicity and Identification Evaluation (TIE) techniques.   
3. To measure the relative potency of anti-androgens identified in the wastewater 
samples.  
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CHAPTER TWO
Preliminary Studies on Characterisation of Anti-androgenic Activity Present in
Wastewater from Sewage Treatment Works.
2.0 Introduction
Wastewater effluents are repositories of natural and synthetic chemicals as well
as metabolites that can modulate endocrine activities and cause endocrine-related
adverse health conditions. The review in Chapter One has shown that many natural and
man-made chemicals which are present in wastewater treatment plant (WwTP) effluents
can cause developmental and reproductive health abnormalities. Potential endocrine
disrupting compounds identified in the previous studies of wastewater effluents include
nonylphenol, phthalates, bisphenol A, alkylphenol polyethoxylates (Gimeno et al.,
1997) as well as steroids such as androstenedione (Thomas et al., 2002), 17β-estradiol,
17α-ethynylestradiol, estrone and estriol (Desbrow et al., 1998; Snyder et al., 1999).
However, the identity of many xenobiotics in WwTP effluents (Steven et al., 2003) as
well as those new chemicals emerging in the environment (as a result of a steady annual
rise in production and use of high volume consumer products) are yet unknown (Younes
et al., 1999). Numerous studies undertaken on EDCs in WwTP effluents had identified
compounds that mostly have estrogenic activities and, to a lesser extent, some anti-
estrogenic activities, but some studies have also identified steroidal androgens and also
some xenoestrogens, such as nonylphenols, which possess anti-androgen receptor
activity too (Sohoni and Sumpter, 1998).
It has been shown that exposure of some wildlife and humans to endocrine
disruptors can induce sex differentiation (Toppari et al., 1996; Vos et al., 2000; Chapter
One). Exposure studies of some fish species to samples of WwTP effluents, and
wastewater-receiving rivers, in United Kingdom have revealed cases of intersexuality
suspected to be induced by endocrine disrupting chemicals (Allen et al., 1999; Harries
et al., 1996; Jobling et al., 1998; Purdom et al., 1994). Male juvenile fish exposed to
natural and synthetic estrogens can also develop intersex (Metcalfe et al., 2001). There
is the possibility also that the presence of anti-androgenic chemicals in WwTP effluents
could contribute to the demasculinisation and the development of ovo-testis in male fish
exposed to WwTP effluents (Parks et al., 2000; Borch et al., 2004; Wilson et al., 2004).
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Kelce and Wilson (1997) reported that exposure of fetal male rats to anti-androgens can
disrupt male sex differentiation.  Anti-androgens are generally known to alter androgen
signalling through different modes of action which include blocking production,
transportation and metabolism of androgen hormones (Katsiadaki et al., 2006; see
Chapter One) as well as disrupting signalling of FSH and LH (Massaad et al., 2002). At
the receptor level, a wide range of chemical compounds such as flutamide, vinclozolin,
bisphenol-A, butyl benzyl benzoate (BBB), procymidon, linuron, o,p-DDE, p,p-DDE
and other environmental chemicals had been tested in vitro (and some in vivo) in the
laboratory and shown to have anti-androgenic activities (Cook et al., 1993; Gray et al.,
1994; Kelce et al., 1994; Kelce and Wilson, 1997; Monosson et al., 1999; Ostby et al.,
1999; Sohoni and Sumpter, 1998;Vinggaard et al., 1999). While some compounds can
act purely as anti-androgen agonist at the receptor level, some others can act as both
agonist and antagonist (Massaad et al., 2002). Some estrogenic receptor agonists, such
as bisphenol-A, butyl benzyl phthalates and o,p-DDE, also show anti-androgenic
characteristics (Sohoni and Sumpter, 1998).
Anti-androgens are generally considered to be less common in the environment.
Recent studies have detected anti-androgens in final effluents of WwTPs surveyed in
United Kingdom, many of which were investigated using in vitro yeast-based
recombinant assay (AYAS) (Johnson et al., 2007). Although a number of in vivo assays
are available to detect anti-androgenic activity (AA) of chemical compounds in
wastewater samples (see Chapter One), the use of such assays is uneconomical and
time-consuming given that a lot of test animals will be required to screen a massive
quantity of sample fractions. In the studies conducted by Johnson and co-workers
(2007) on effluent wastewater samples sourced from twenty-five WwTPs, a potency
range of anti-androgenic activity between 2.13 and 228µgFeq/L was reported after
analysis of April-May batch of samples. The July-August batch figures were higher
with potency ranging from 90.7 to 1230.8µgFeq/L. Similar studies carried out on water
samples of the river Lambro, a wastewater receiving river, show an anti-androgenic
potency between 81.43 and 844.22μgFeq/L (Urbatzka et al., 2007). Kirk (2002) also
reported anti-androgenic activity at a concentration range of 55-377μgFeq/L in tertiary
effluents using in vitro assays. Generally, in vitro yeast recombinant assays have been
successfully used to screen a wide range of receptor-based anti-androgenic compounds
and other endocrine disrupting chemicals in wastewater and other complex
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environmental samples. This is simply because it is economical, simple to set up, quick,
stable, easy to use and record (Tanaka et al., 2001).  For all these reasons, this assay was
considered suitable to screen for synthetic anti-androgens present in influent and
effluent samples of the domestic wastewaters on which this study will be based.
For this work, a combination of biological and chemical analytical techniques
are necessary to provide a complete evaluation approach effective to capture all human
androgenic receptor antagonist activity in the wastewater  samples. In this study also,
the influent and effluent samples were purified with hydrophilic-and-hydrophobic-
balanced cartridges based on a previously published method (Evans, 2008). The anti-
androgenic activity of the eluates was estimated with in vitro yeast-based assay
demonstrated to be effective in identifying anti-androgenic chemicals in a number of
chemical mixtures (Sohoni and Sumpter, 1998). In this study, however, this approach
was used to screen for a broad range of novel, target and non-target anti-androgenic
compounds in domestic wastewaters. The bioassay assessment technique was
complemented by instrumentation analysis to enhance the quality of information that
will be derived from this study. HPLC was used to fractionate the sample extracts and
the anti-androgenic activity of the fractions were analysed and estimated using in vitro
yeast-based TIE assay. This approach had been used previously to estimate activity of
effluents (Bailey et al., 1995) and to identify estrogenic compounds in effluent samples
(Desbrow et al., 1998).
The aims of this study in Chapter Two were:
1. To extract and quantify anti-androgenic activity present in the influent
and effluent of a WwTP receiving waste from a predominantly domestic wastewater
source.
2. To use HPLC methodology to compare the profiles of the anti-
androgenic chemicals present in the extracts of the WwTP influent and effluent samples
prepared from the first aim above.
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2.1 Materials and Methods
2.1.1 Materials
20cc (1g) OASIS® HLB (polydivinylbenzene-co-N-vinylpyrrolidine) cartridges
used for purification and concentration of the wastewater samples were purchased from
Waters, Milford, MA, USA. Glass distilled grades of hexane, ethyl acetate and HPLC
grade water are common laboratory reagents purchased from Rathburn Chemicals Ltd.,
Walkerburn, Scotland. Acetic acid (≥99% pure) is a regular laboratory reagent which
was purchased from Sigma-Aldrich, Steinheim, Germany. All amino acids (L-leucine,
L-histidine, L-adenine, L-arginine-hydrochloride, L-methionine, L-tyrosine, L-
isoleucine, L-lysine-hydrochloride, L-phenylalanine, L-glutamic acid, L-valine and L-
serine) used to make growth media were purchased from ICN, Aurora, Ohio, USA and
the other growth materials
(iron(III)tetrasulphate(vi),potassium(III)phosphate(vi)(monobasic),
magnesium(II)sulphate(vi)heptahydrate, flutamide, 5α-dihydrotestosterone) were
purchased from Sigma, Poole, Dorset, United Kingdom. Chlorophenol red-β-D-
galactopyranoside (CPRG) was purchased from Boehringer, Lewes, East Sussex,
United Kingdom. Deionised water was distilled from Elga UHQ Distiller System made
by Elga Systems, Buckinghamshire, United Kingdom. Microtitre plates, polystyrene
and polypropylene, were purchased from Nunclon Surface, Roskilde, Denmark and
Greiner Bio-One Ltd., Stonehouse, Gloucestershire, United Kingdom respectively. The
hAR-incorporated recombinant yeast cells were provided by courtesy of Professor
Sumpter, Brunel University, Uxbridge, United Kingdom.
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2.1.2 Methods
2.12.1 Scheme of Analytical Procedure for Profiling of Anti-Androgenic Chemicals
in Wastewater Treatment Plants Samples.
SPE
Methanol
Re-dissolution of
Sample
Ethyl Acetate Hexane
Fractionation
On HPLC
Toxicity and
Identification
Evaluation
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2.1.2.2 Collection of Wastewater Samples
Six Winchester bottles (2.5L capacity each) of wastewater samples were
collected with an aluminium bucket using a grab sampling technique. The wastewater
samples comprised three Winchesters of influent taken from the central inlet reservoir
and three Winchesters of effluent sourced at the exit point reservoir. Prior to sampling,
the aluminium bucket and the Winchester bottles were rinsed twice with 150mL of
methanol and 500mL of target samples sequentially. In order to minimise bacterial
degradation during sample transportation to the laboratory, 100mL of methanol was
added to every 2.5L of samples collected. Wastewater samples for this experiment were
collected on the 3rd of February, 2007 at Horsham Wastewater Treatment Works
(WwTW) located in West Sussex county of United Kingdom. Horsham Wastewater
Treatment Works are connected to five local districts serving a population of about one-
quarter of a million in addition to wastewater deliveries from other sources. The
wastewater received at Horsham WwTP consists of over 95% domestic contributions
delivered at an average flow rate of 16,500m3 per day.
2.2. Extraction, Purification and Storage of Samples
The wastewater samples were purified using solid phase extraction method used
by Evans (2008). In the method, 20cc (1g) OASIS HLB cartridges (Waters, Milford,
MA, USA) were plugged with glass cotton wool, mounted on the SPE vacuum manifold
(Sigma-Aldrich Company Ltd, Poole, Dorset, United Kingdom) and connected to a
vacuum pump via a conical waste flask. Glasswool was introduced to crudely filter
solid material in order to prevent the cartridges’ sorbent from being blocked by
particulates and suspended solids in the wastewaters. The cartridges were conditioned
with 5mL of hexane, 5mL of ethyl acetate, 10mL of methanol and 10mL of acetic acid
in water (10% v/v). The conditioning of the cartridges creates an optimal sorbent
environment such that the hydrophobic and lipophilic chains are exposed to solvent
thereby increasing their effective surface area for retention of target analytes and
eliminate impurities. For this experiment, fourteen such cartridges were prepared out of
which four cartridges were used to process the influent, another four for the effluent and
the remaining six were prepared for the control. A quadruplicate of each sample
(influent, effluent) was prepared by adding 5mL of acetic acid-water solution (1:99, v/v)
to each 500mL sample preparation. These sample preparations were loaded into the
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respective cartridges at flow-rates of 5 mL/min (influent) and 10 mL/min (effluent). The
loaded cartridges were rinsed with 10mL of aqueous methanol (methanol: water, 5:95,
v/v) to remove final traces of impurities. Elution of the loaded cartridges was carried
out with twice 5mL methanol, 5mL ethyl acetate and 5mL hexane respectively to
extract the broad polarity analytes that are sorbed by the cartridges. The first and the
second elutions were combined to make 10mL of each solvent extract. Each of the three
eluted extracts (methanol, ethyl acetate and hexane eluates) was evaporated to dryness
in a speed vacuum concentrator and resuspended in ethanol (300µL). An aliquot (10µL)
of the resuspended sample was assayed on in vitro yeast recombinant androgen receptor
assay in order to determine the total anti-androgenic activity. The remaining test
solution was stored in the freezer at -200C temperature for further analysis. In addition,
two sets of work-up controls (produced with three cartridges each) were made up. The
first set of work-up control cartridges were prepared as described above and were used
to analyse 500mL of HPLC grade water spiked with 5mL 1% acetic acid (acetic acid:
water, 1:99, v/v). The second set of work-up control cartridges were only prepared and
pre-conditioned as described for influent and effluent above. Whilst the first work-up
control was prepared to estimate the contributions of both the cartridges and water to the
overall anti-androgenic activity of the samples, the second is meant to evaluate the
contribution of cartridges only.
2.3 DNA Recombinant Yeast Transcription Screen Assay
In vitro yeast recombinant screens have been actively used to investigate and
detect agonistic and antagonistic activities of natural and synthetic estrogenic and
androgenic chemical compounds (Sohoni and Sumpter, 1998). In both cases, the
estrogenic and androgenic receptor ligands are quantitatively estimated. It is on this
premise that in vitro yeast assay has been employed to conduct investigation into the
likely behaviour of chemical compounds in living organisms. In the yeast, a human
androgen receptor gene which forms the androgen response elements is incorporated
into the nucleus of the yeast genome. On initiating binding with androgen-like
substances, the ligand-binding receptor in the yeast expresses Lac-Z (a reporter gene) on
the yeast plasmid which, in turn, induces the secretion of β–galactosidase. The degree of
conversion of the chromogenic chemical indicator, chlorophenol red-β-D-
galactopyranoside (CPRG), from yellow to red by the enzyme β-galactosidase is
proportional to the amount of androgen-like substance involved in the binding process.
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2.3.1 Cleaning and Sterilisation Protocols of Yeast Glassware
Apparatus for recombinant yeast assay must be kept clean and sterilised to
reduce the level of background noise which may occur due to apparatus contamination.
To achieve this, all glassware used for the yeast assay was soaked in a detergent for
about 12 hours before washing. After washing and thorough rinsing, they were drained
of water and furnaced at 5000 C for 2 hours and were allowed to cool down. Preparation
of yeast-related solutions (minimum medium, yeast culture, yeast growth medium and
microtitre plates) was carried out in the culture hood (Hera Safe, Heraeus GmbH,
Hanau, Germany). Together with other yeast assay materials (pipette tips, cotton wool
and aluminium foil), they were sterilised in an autoclave (Osprey 401, LTE Scientific
Ltd., Oldham, UK) at 1210 C for 30 minutes and were left to cool. Other materials that
were not directly used for the yeast assay was cleaned in absolute ethanol and allowed
to dry. Before use, the laminar flow cabinet (culture hood) was disinfected and sterilised
with industrial ethanol while the necks and caps of all reagent bottles were flame-
sterilised before and after pipetting from them.
2.3.2 Preparation Procedure of Minimum Media for Yeast Screen Assay
A 1 L of minimum medium was prepared by weighing the following reagents
into 900mL of ultra-pure water dispensed from Elga UHQ System (Elgar System,
Buckinghamshire, UK) into a baked conical flask (1L) placed on a magnetic stirrer
hotplate (Weiss Gallenkamp, England, UK) and set at 600C: 13.61g potassium
phosphate (monobasic), 1.98g ammonium(II) tetraoxosulphate(VI), 4.20g potassium
hydroxide pellets, 0.20g magnesium(II) tetraoxosulphate(VI)(heptahydrate),  50mg L-
leucine, 50mg L-histidine, 50mg L-adenine, 20mg L-arginine-hydrochloride, 20 mg L-
methionine, 30mg L-tyrosine, 30mg L-isoleucine, 30mg L-lysine-hydrochloride, 25mg
L-phenylalanine, 0.10g L-glutamic acid, 0.15g L-valine, 0.38g L-serine, 1mL iron(III)
tetraoxosulphate(VI) solution{40mg Fe2(SO4)3/50mL water}. 100mL of ultra-pure water
was added to make-up the solution after all the reagents had dissolved and the medium
was dispensed in 45mL aliquots into glass bottles for autoclaving. The autoclave was
operated for 30minutes at 1210C and the bottles were allowed to cool and were stored at
room temperature.
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2.3.3 Preparation of Yeast Culture and Yeast Growth Media for Yeast Assay
Yeast culture was prepared by the addition of the following to 45mL minimum
medium transferred  into an autoclaved conical flask: 5mL glucose solution, 1.25mL L-
aspartic acid solution, 0.5mL vitamin solution, 0.4mL L-threonine solution, 125μL
copper (II) sulphate(VI) solution. This solution was seeded with pre-vortexed 125μL
yeast stock (AYAS yeast cells in glycerol suspension) from a cryogenic vial stored in
the freezer at -200C. The conical flask was placed on an orbital shaker and incubated at
280C for 24hours. Yeast growth medium for AYAS yeast assay was prepared the same
way by adding all the items above (except for yeast where 0.7mL taken from the conical
flask on the orbital shaker), 0.5μL chlorophenol red-β-D-galactopyranoside (CPRG) and
15.68μL dihydrotestosterone (DHT, 3.2x10-9M). All these preparations were carried out
in a culture hood.
2.3.4 Preparation of AYAS Assay
Yeast growth medium prepared above (Section 2.3.3) contained DHT (an
androgen receptor agonist and a natural ligand) used as a positive control to detect
human androgen receptor (hAR) antagonism by producing 65% sub-maximal hAR
agonistic response (Sohoni and Sumpter, 1998). The influent and effluent extracts
stored in the freezer were defrosted and vortexed ready for use. A 20μL aliquot of the
standard (flutamide) and ethanol were pipetted correspondingly into the first and third
rows of the optically transparent flat-bottomed microtitre plates. Flutamide is chosen as
the standard for this analysis because it is a known anti-androgen that had been used in
previous in vitro yeast studies. For flutamide, the sequence of half-dilution proceeded
from the most concentrated left well to the less concentrated right. Given that ethanol
was used to resuspend the wastewater extracts for assay, the ethanol control was added
to the plate to monitor the background noise. The same volume of the test samples were
pipetted next by the same half-dilution concentration sequence for all test samples. The
plates were left in the laminar flow cabinet to allow all the solvents in the wells to dry
out. A 200μL of the aliquot yeast growth medium (Section 2.3.3) was dispensed into
each well using a multi-channel, syringe-incorporated pipette. The plates were sealed up
with a tape, mixed well with a shaker and incubated at 320C in a ventilated incubator
(LMS Systems, Sevenoaks, Kent, UK) for 24 hours and changed over to 240C ventilated
incubator (LMS Systems, Sevenoaks, Kent, UK) for another 24 hours. The sensitivity of
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the yeast assay was monitored both at absorbance of 540nm and 620nm after the second
24 hours of incubation with ELx800 BioTec spectrophotometer (BioTek Instruments,
Winooski, Vermont, USA). This ensures that the turbidity measurement is appropriately
corrected to reflect the true growth rate of the yeast. The calculation for this is expressed
mathematically thus:
Corrected Absorbance Measurement (CAM) value = [Sample ABS540nm-{Sample
ABS620nm-Ethanol BlankABS620nm}].
The flutamide concentration (the standard) decreases from the bottom of the
plateau to the top whereas the anti-androgenic activity increases in that order. As the
concentration of flutamide decreases and the DHT becomes accessible across the wells
there are high chances that the human androgen receptor in the yeast will bind to the
DHT and produce the β-galactosidase. This is revealed on the plate (Figure 2.1) as the
colour changes from yellow to orange to red across the wells in the first row. A deep red
colour in the assay indicated no anti-androgen activity due to production of β-
galactosidase whilst wells containing flutamide or samples with anti-androgens
appeared yellow-light orange indicating little or no production of β-galactosidase (see
Figure 2.1).
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Figure 2.1: The photograph of an AYAS assay plate after 48 hours of temperature-
regulated incubation. The light yellow and orange colours are indicators of positive
response on the yeast medium. The deep clear yellow coloration may be indicating a
response tending towards toxicity and could also be indicating cell lysis as the
concentration of the test compounds approaches lethal dose. The samples plated on the
assay are serially diluted two-fold in concentration from the left well (the most
concentrated) to the right (the least concentrated) in both the test samples (Rows D-H)
and flutamide standard (Row A) wells. The test samples which contain variable
concentrations of triclosan and dichlorophene (2.5mg/L, 5mg/L and 7.5mg/L of
triclosan are marked in rows D, F and H respectively and while 7.5mg/L and 15mg/L of
dichlorophene are marked in rows E and G respectively) indicate different degree of
responses on the yeast assay. Only Rows B and C, which are blank (media only) and
ethanol solvent with media respectively, consistently indicate no AA on the assay as
they are negative controls.
In accordance with Beer-Lambert law, the values of the absorbance generated
from the plate corresponds proportionately to the degree of colour intensity in the wells.
Inhibition on the assay was reflected by the yellow-light orange colour and corresponds
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to the concentration of the anti-androgenic activity produced in the wells of the assay.
The dose-response curve was plotted using the corrected values of absorbance to
produce a reverse sigmoid curve (Figure 2.2 and 2.3). The flutamide standard curve
(Figure 2.2) shows the normal positive response curve and graphical expression of the
spectrophotometrically generated data from the yeast assay. The test samples (Figure
2.3) show similar positive response curve whenever they are active although with
different shapes.
Figure 2.2: Flutamide standard curve showing the plot of corrected absorbance against
concentration with the region between the top and bottom plateaux exhibiting strong
anti-androgen activity. The EC50 of the Standard Curve is measured as 0.95mg/L and is
equivalent to 3.44x10-6M. The dose-response curve is plotted as the mean ± one
standard deviation (mean±SD) of the response to three flutamide replicates (n=3).
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Figure 2.3: The response curve showing the positive response of test samples on AYAS
assay. The sample measurement is taken in volume (µL) and the anti-androgenic
activity equivalent is determined with respect to the absorbance equivalent of the
standard flutamide concentration. The dose-response curve is plotted as the mean ± one
standard deviation (mean±SD) of the response to the test sample replicates (n=3).
2.3.5 Evaluation of Recombinant Androgen Receptor Antagonism
The plot of corrected absorbance against concentration for the standard produced
reversed sigmoid curves (Figure 2.2) with the top and bottom plateaux corresponding to
a maximum and minimum respectively. Similar curves could also be produced when
assays of samples containing appropriate dose of anti-androgens are analysed (Figures
2.3 and 2.4) by halving their successive concentrations. The AA is calculated by finding
the mid-point between the lowest (minima) and highest (maxima) active points on the
curve. The mid-point absorbance from the curve is used to derive a correspondent
absorbance on the standard flutamide curve which is extrapolated to produce the EC50
and also corresponds to the value of receptor antagonism of the samples. This is related
proportionately to the amount of the flutamide contained in the well and that of yeast
media added to each well. The overall mathematical evaluation produces a mid-point
absorbance and concentration, known as the EC50 values, used as the standard
measurement to quantify the AA of environmental samples (influent and effluent) under
similar laboratory conditions. For the anti-androgenic activity of the samples to be
accurately determined, their turbidity readings (taken at 620nm) are comparatively
analysed with that of the ethanol blank at the same wavelength. A test sample at any
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given concentration is considered active (as indicated by the 540nm values) when its
620nm values are correspondingly roughly equal or greater in magnitude than the mean
(-2SD) of the 620nm absorbance readings of ethanol control (see Section 4.1.2.2).
However, if the 620nm values of the samples fall significantly below the mean-2SD of
the 620nm absorbance values of ethanol control, then it will be regarded as toxic
irrespective of the 540nm values recorded. The degree of receptor antagonism was
evaluated and expressed graphically using the corrected absorbance values and the
corresponding concentrations of the test samples (Figure 2.2).
2.4 Fractionation of Influent and Effluent Replicates in HPLC
The control sample (in Section 2.2) and four aliquot samples comprising two
influent and two effluent replicates were fractionated by reversed phase High
Performance Liquid Chromatography (HPLC). The HPLC instrument (Waters 600E
Millennium 2000 Edition, MA, USA) consisted of a degasser, an automatic sample
injector, a pump, a Novak Pak column (4µm particle size 4.6x250mm) and a photodiode
array detector coupled together. The combined extracts from each effluent replicate
were vortexed and reduced to dryness and re-dissolved in 250µL of methanol-water
mixture (1:1 v/v). Similar procedure was repeated for the influent replicates. All the
samples were filtered with 0.2µm Whatman Anopore filters to remove the particulates.
Aliquot of the control, the effluent and the influent samples were fractionated separately
by injecting each in turn into the HPLC at room temperature. The HPLC was operated
at a flow-rate of 1mL/min in a linear water-acetonitrile gradient flow starting from 0
min (90:10), 10min (70:30), 65min (0:100) holding for 15min. The acetonitrile mobile
phase of the HPLC was prepared by acidifying acetonitrile with 0.16% glacial acetic
acid while the water mobile phase was made up by spiking the HPLC graded water with
0.16% and 4% of glacial acetic acid and acetonitrile respectively. The eighty HPLC
fractions of each sample were collected and reduced to dryness in a speed vacuum
concentrator. Each fraction was then re-suspended separately in 200µL of ethanol and
stored in the freezer at -200C for further analysis. Also, the residues in the filter sieve of
each sample replicate and the control were washed with 200µL each of ethyl acetate,
hexane and methanol into separate test tubes to check for any loss of anti-androgenic
activity.
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2.5 Determination of Anti-androgenic Activity of HPLC Fractions
A 200μL of the yeast growth medium (described in section 2.3.3) was dispensed
into the properly dried 96-well microtitre plates to which 30μL each of flutamide,
ethanol and the 80 fractions of an effluent replicate above (dried out and reconstituted in
ethanol) was previously added (Section 2.4).The fractions were dispensed into the wells
across the row such that 30μL aliquot of each fraction was replicated into two adjacent
wells. The plates were sealed with tape and carefully shaken on a plate shaker before
they were placed into 320C incubator for 24hours. The plates were transferred to 240C
incubator for another 24hours and read afterward on a plate reader at 540nm and 620nm
for colour development and turbidity respectively. The two absorbance readings were
transferred into an Excel program written to analyse the assay. The program works by
averaging each fraction duplicated in the successive wells of the plate and plots the
corrected mean absorbance against their retention time (which has automatically
becomes the fractions identity throughout this study). The total anti-androgenic activity
of the 80 fractions was estimated by determining the inhibition of the YAS assay in
response to 5α-dihydrotestosterone (DHT) standard. These values were quantified as
correspondent equivalence to flutamide concentration on a flutamide standard curve.
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2.6 Results
2.6.1: Determination of Background Noise Level, Limits of Detection and
Quantification in AYAS.
Pre-analytical treatments in the laboratory have become a known means by
which the accuracy of quantitative and qualitative analytical measurements can be
compromised. During experimental preparations in the laboratory, a wide range of
analytical signals or interferences are produced at the background of the target sample
which can influence the overall experimental results. Such analytical interferences
(which exist at the background of the samples) are known as background noise and, in
some instance where experimental controls are involved, as control blanks. For the
yeast experiment, the background noise and the control blank are constituted by the
yeast media in addition to other non-yeast work-ups (e.g. SPE apparatus) and the
solvents (e.g. acetic acid, methanol, ethyl acetate and hexane). The total anti-androgenic
activity of wastewater samples can be accurately estimated in AYAS when the
background noise from the yeast experimental work-up and the blank are known. The
analytical signals generated by the blank (or control work-up) of a yeast experiment
would record values corresponding to the lowest concentration of anti-androgenic
activity of wastewater samples. Therefore, for the assay to produce an analytical signal
or response which can be detected or quantified, the anti-androgenic activity of the
wastewater samples must produce an analytical signal which exceeds that produced by
the background noise. The background noise level of the yeast assay was estimated by
measuring the mean (± two times the standard deviation) of the ethanol control.
Similarly, the limit of detection (LOD) was determined by addition (or subtraction) of
three times the standard deviation of the mean of the ethanol control. For the limit of
quantification (LOQ), it was evaluated by adding (or subtracting) nine times the
standard deviation of the mean of the ethanol control.
2.6.2 Determination of Anti-androgenic Activity of WwTP Samples by
Recombinant Androgen Yeast (AYAS) Assay.
The AYAS assay has been successfully used to determine and estimate the anti-
androgenic activity of the wastewater extracts. The reverse sigmoid curve typical of
flutamide standard curve was also generated with increasing concentrations of the
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wastewater extracts. The EC50 for each sample was measured between the sub-minima
and sub-maxima at the lower and upper regions of the curves (Figure 2.4).
Figure 2.4: The response curve of effluent on the AYAS assay indicating positive
response and anti-androgenic activity. The anti-androgenic activity of the effluent is
measured in mgFeq/L and it corresponds to the mid-point of the linear response of the
curve. The dose-response curve is plotted as the mean ± one standard deviation
(mean±SD) of the response to effluent replicates (n=3).
As stated in Section 2.6.1, the anti-androgenic activity of samples cannot be
accurately determined until the contributions from the laboratory work ups are known.
The background studies to determine the contributions of SPE apparatus and the
solvents to the overall anti-androgenic activity were carried out. The three SPE solvent
extracts obtained from a set of solely preconditioned cartridge, and another set of
cartridges loaded with HPLC-grade water, were assayed after reconstitution in ethanol.
The results computed in Table 2.1 below were analysed and evaluated with respect to
the limit of detection (LOD).
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Table 2.1: Results of background anti-androgenic activity generated from laboratory
work-up controls as recorded by the three extraction solvents.
Sample* Mean AA
contribution of
Preconditioned
cartridges loaded
with HPLC-grade
water
Mean AA
contribution of
Preconditioned
cartridge only
Methanol (mgFeq/L) <LOD 0.007±5.774x10-5
Ethyl acetate (mgFeq/L) <LOD <LOD
Hexane (mgFeq/L) <LOD <LOD
*mgFeq/L is the anti-androgenic activity measurement unit as the anti-androgenic
activity contribution of the work-up is quantified in milligram (mg) of flutamide
equivalent per litre of sample.
The result (Table 2.1) has clearly shown that each eluting solvent recorded an
average anti-androgenic activity below the LOD (0.006mgFeq/L) except for methanol
extracts of pre-conditioned cartridges which showed slight background AA. The
occurrence of background AA in methanol (Table 2.1), though minimal, reinforces the
concern of possible build-up of AA which may arise from work-up during extraction.
This explains why cartridges loaded with samples are rinsed with methanolic solution
(methanol: water, 5:95, v/v) to remove the work-up anti-androgenic activity. In
addition, rinsing with methanolic solution helps to further reduce the AA contributed by
the contaminants/impurities in the raw samples.
The plate information about the test samples (effluent and influent) was
converted into statistically measureable data on the spectrophotometer. Their anti-
androgenic activity as measured on the AYAS is tabulated and evaluated in Table 2.2
and 2.3 respectively. Table 2.2 shows the anti-androgenic activity contributions from
polar, moderately polar and non-polar constituents of the influent samples as
represented by the methanol, ethyl acetate and hexane extracts respectively.
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Table 2.2: The amount of anti-androgenic activity present in all the three SPE extracts
of influent sample replicates. A 500mL of sample was extracted and analysed separately
as shown in the results of each of the four influent replicates (A, B, C and D).
Sample replicate* Methanol
(mgFeq/L)
Ethyl acetate
(mgFeq/L)
Hexane
(mgFeq/L)
Total
(mgFeq/L)
Influent A 0.190 1.176 1.800 3.166
Influent B 0.416 1.474 0.722 2.612
Influent C 1.200 0.746 0.500 2.446
Influent D 2.182 0.592 0.458 3.232
*mgFeq/L is the total anti-androgenic activity measurement unit which expresses anti-
androgenic activity in milligram (mg) of flutamide equivalent per litre of the sample.
The anti-androgenic activity recorded in each of the three solvent extracts (Table
2.2) ranged generally between 0.190 and 2.182mgFeq/L for influent samples. Similarly,
the effluent samples recorded anti-androgenic activity values that ranged from below
LOD to 0.452mgFeq/L (Table 2.3). It is interesting to note that the three solvent extracts
of both the effluent and influent replicates are active on AYAS but the anti-androgenic
activities of hexane extracts in effluent occur below the LOD. This would also suggest a
possible occurrence of active compounds with a wide range of polarity. The results
generally show variability in the total anti-androgenic activity between the four replicate
samples. The amount of anti-androgenic activity recorded in each of the three solvents
varies from one replicate to another. Due to inconsistency in the variation pattern, it is
extremely difficult to predict the spread of active compounds in the samples based on
their concentration in the three solvents. Although the variation in the anti-androgenic
activity of influent extracts is not unexpected considering that the analytes were grab
unfiltered wastewater samples, however, the level of such variability would still be
expected to be low. The reason for the variation is not known but the possible
explanations for this difference include blockage of the cartridges during loading,
incomplete dryness of cartridges due to uneven distribution of pressure around the
cartridges and variable solvent retention affinity.
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SPE has become a popularly used methodology for purifying and
preconcentrating crude samples. It is very effective when the crude samples (especially
in aqueous form) are filtered before purification and preconcentration. In cases where
crude samples were not filtered, repeatability of such SPE results are sometimes rarely
possible as the cartridges could become blocked during extraction. This may be mainly
responsible for the variation in the result. It is also possible, due to uneven distribution
of pressure around the cartridges, for the period (time-line) required to dry each of the
cartridges to vary. However, in this case a uniform drying period was maintained to
prevent oxidation and volatilization (that could facilitate losses), and perhaps working
under variable laboratory conditions may worsen the losses beside the fact that it will
make the results unreliable. Under the existing condition, there is a possible that some
cartridges may not be completely dry and the water which was retained in the cartridge’
sorbents becomes eluted with the extracts. As a result, the percentage of water in each
extract replicate would be different thus making the process of evaporating the samples
to dryness longer than would be expected. This could lead to sample losses as extract
replicates (especially that having the highest proportion of water) could lose more
volatile components due to longer drying duration. Hence the overall anti-androgenic
activity will be different in all the replicates. Another reason which is very rare is the
solvent retention affinity in the three cartridges. Given that the cartridges are made up of
the same material, this reason would not be tenable. However, in the circumstance of
variable pressure distribution around the various cartridges (explained as the probable
second reason above), it is very possible. It is worthy of note that the pressure applied to
the cartridges is proportional to the solvent eluted from the cartridges and, by
implication, inversely proportional to the solvent retained by the cartridges. This can
lead to variable sample retention by the cartridges.
Effluent samples were processed in quadruplicate akin to the influent samples.
Each sample replicate was extracted with the three solvents (methanol, ethyl acetate and
hexane) and were assayed. Their AA on the plates was analysed with a
spectrophotometer and presented in Table 2.3.
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Table 2.3: The amount of anti-androgenic activity present in all the three SPE extracts
of wastewater effluent replicates. A 500mL of effluent sample was extracted and
analysed separately as shown in the results of each of the four replicates.
Sample replicate* Methanol
(mgFeq/L)
Ethyl acetate
(mgFeq/L)
Hexane
(mgFeq/L)
Total
(mgFeq/L)
Effluent A 0.140 0.074 <LOD 0.214
Effluent B 0.254 0.014 <LOD 0.268
Effluent C 0.452 0.016 <LOD 0.468
Effluent D 0.212 0.084 <LOD 0.296
*mgFeq/L is the total anti-androgenic activity measurement unit which expresses anti-
androgenic activity in milligram (mg) of flutamide equivalent per litre of the sample.
The AA of the hexane extracts in all the effluent replicates are below the LOD
measured as 0.006mgFeq/L.
The anti-androgenic activity values recorded in each solvent extract creates a
pattern across all the four replicates. It can be seen that the level of AA in all the three
solvent extracts is highest in methanol and much lower in ethyl acetate and hexane
extracts respectively. In case of hexane, the anti-androgenic activity was below the
LOD. This implies that the percentage anti-androgenic activity contribution from
methanol extract alone ranged from 65.1 to 96.4%. Similarly, the anti-androgenic
activity of the ethyl acetate extracts account for between 3.4 and 28.3% of the total
activity per replicate. In contrast to the results of the influent (Table 2.2), the anti-
androgenic activities in these effluent extracts appear to contain more polar bioactive
compounds than non-polar judging from the results. Also, the level of anti-androgenic
activity in effluent samples were found to be significantly lower in contrast to what was
recorded in influent samples (Table 2.4). A drop of 90% in anti-androgenic activity was
recorded from influent to effluent samples and this, presumably, may be due to the
removal of contaminants after bacterial degradation, chemical biotransformation and
sedimentation processes during treatment at the wastewater works. Although there are
certain degrees of variability in both samples (Table 2.4), the effluent samples recorded
a statistical range that is comparatively better. However, one of the results (replicate C)
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appears to be an outlier as it records an AA value that is twice as much as that of
replicate A. The level of difference shown affects the mean, the standard deviation as
well as the RSD values. Although, the results of the influent samples also show some
extreme values which should adversely affect the mean, the standard deviation and the
RSD values, but because the values are well spread the effect has been mitigated.
Table 2.4: Summary of TAA present in influent and effluent samples as indicated by
the mean, standard deviation and relative standard deviation. The sum total of all the
anti-androgenic activity (mgFeq/L) recorded by each of the three solvent extracts is
represented in the replicates below.
Sample replicate A B C D Mean±Std RSD
Effluent* 0.214 0.268 0.468 0.296 0.312±0.110 0.35
Influent* 3.166 2.612 2.446 3.232 2.864±0.394 0.14
*mgFeq/L is the total anti-androgenic activity measurement unit which expresses anti-
androgenic activity in milligram (mg) of flutamide equivalent per litre of the sample.
Effluent replicate C (0.468mgFeq/L) is suspected to be an outlier and, as a result, the
data was subjected to Grubbs’ and Dixon’s tests at 5% significance level. The results
[(G=1.436; Critical value=1.481; P=0.05; N=4) and (Q=0.677; Critical value= 0.831;
P=0.05; N=4)] show that the data cannot be rejected as G and Q are less than the critical
values. Similarly, the influent data was tested with the two statistical measurements at
significant level of 5% and found that the results (G<critical value=1.481; Q<Critical
value=0.831; P=0.05; N=4) of all the suspected data are not outlier which means they
cannot be rejected.
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2.6.3 HPLC Fractionation of Control, Influent and Effluent Samples
200uL of effluent and 40uL of influent were injected into the High Performance
Liquid Chromatography. Below are the 254nm absorbance chromatograms of the
control work-up and wastewater samples.
The HPLC chromatogram of the control work-up shows only the solvent peaks
occurring between 1 and 2 minutes (Figure 2.5). No other significant peaks are detected
on the chromatogram.
Figure 2.5 HPLC Chromatogram of the control showing the background noise and the
solvent peaks monitored at 254nm UV absorbance.
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Figure 2.6 HPLC Chromatogram of influent sample showing the solvent peaks and the
cluster of peaks of unknown compounds monitored at 254nm UV absorbance.
The HPLC Chromatogram of the influent (Figure 2.6) reflects a different picture
to what is seen on the control chromatogram. Whereas the control chromatogram shows
only the solvent peaks, the chromatogram of the influent revealed a cluster of peaks of
several unknown compounds between the retention time of 5 and 50 minutes in addition
to the solvent peaks that occur between the retention time of 1 and 2 minutes. A similar
result is observed on the HPLC Chromatogram of the effluent (Figure 2.7) where the
solvent peaks emerged between 1 and 2 minutes but an additional cluster of peaks of
unknown compounds are observed between the retention time of 5 and 50 minutes.
Figure 2.7 HPLC Chromatogram of effluent sample showing the solvent peaks and
cluster of peaks of unknown compounds monitored at 254nm UV absorbance.
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2.6.4 Anti-androgenic Activity Profile of HPLC fraction by AYAS assay
The AA profiles of the influent, effluent and water (first work-up control)
fractions were prepared using the TIE approach. The AA (and the androgenic activity)
of the fractions (shown in Figure 2.8) are represented by 80 black vertical lines of
absorbance plotted against retention time in the range of 0-80minutes and each line
corresponds to the retention time of the fractions. For the fractions of the work-up
control, no significant anti-androgenic activity is recorded below the lower background
noise level (mean-2SD) indicated with the lower thin reference line (see Figure 2.8).
Although no significant trace of anti-androgenic activity is recorded in the control
fractions, there are some fractions with retention time of 25 and 30 that show apparently
weak androgenic activity (Figure 2.8). These fractions project above the upper
background noise level (mean+2SD) marked off at 2.556ABS.
Figure 2.8: Profile of total anti-androgenic activity of the work-up control extracted by
Oasis HLB cartridge and eluted with methanol, ethyl acetate and hexane. The mean
background level of ethanol media is indicated by the thick horizontal line on the profile
(absorbance unit 2.306) while the upper and lower background noise levels, marked off
with the faint horizontal lines, are plotted as mean (±2SD) at 2.556 and 2.056ABS
respectively.
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The profile of the influent A (Figure 2.9) shows the anti-androgenic activity of
the eighty HPLC fractions. To establish a significance response, only fractions with
values below the background noise level of the assay are recorded to contain anti-
androgenic activity. From the profile of influent A sample, sixteen fractions are
identified to contain anti-androgenic activity and fractions with 27, 28, 29 and 31
retention times show strong anti-androgenic activity.
Figure 2.9 Profile of total anti-androgenic activity of influent A sample replicate
extracted by Oasis HLB cartridge and eluted with methanol, ethyl acetate and hexane.
The mean background level of ethanol media is marked with a broad horizontal line at
absorbance unit of 2.50. The upper and the lower background noise levels are plotted as
(±2SD) of the mean, marked off respectively at absorbance (ABS) of 2.60 and 2.40 with
the thin horizontal lines.
The HPLC profile of anti-androgenic activity in the influent B replicate was
analysed under the same laboratory conditions and shows similar results to that of
influent A (Figure 2.10). Fractions that are anti-androgen-active in influent B occur at
the same retention times as influent A. In addition, fractions 24, 25 and 26 of influent B
are anti-androgenic too. In both influent samples, the major fractions identified as
potential anti-androgens occur at the moderately polar region of the profiles (i.e.
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fractions 25-29, 31). In addition in the influent samples, other less polar fraction (52)
also contains anti-androgenic activity.
Figure 2.10 Profile of total anti-androgenic activity of influent B sample replicate
extracted by Oasis HLB cartridge and eluted with methanol, ethyl acetate and hexane.
The mean level of ethanol media is marked with the broad line (absorbance unit 2.40)
whilst the upper and the lower levels of the background noise (mean±2SD) are marked
off with thin horizontal lines respectively at absorbance (ABS) of 2.55 and 2.25 as
shown.
The profiles of effluent A and B (Figures 2.11 and 2.12) show a combination of
androgenic and anti-androgenic activity.  In the effluent A profile, thirty-eight fractions
contain anti-androgens while twenty-five fractions of the effluent B are identified to
contain anti-androgenic activity. Precisely, twenty-one fraction pairs from both effluent
profiles with evidence of anti-androgenic activity are found to have the same retention
time and are common to both effluent replicates.
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Figure 2.11 Profile of total anti-androgenic activity of effluent A sample replicate
extracted by Oasis HLB cartridge and eluted with methanol, ethyl acetate and hexane.
The mean background level of ethanol media is marked with the broad horizontal line
(absorbance 2.30) and the upper and the lower background noise levels, plotted as
(±2SD) of the mean, are marked off respectively at 2.46 and 2.10 absorbance (ABS) as
shown with the thin horizontal lines.
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Figure 2.12: Profile of total anti-androgenic activity of effluent B sample replicate
extracted by Oasis HLB cartridge and eluted with methanol, ethyl acetate and hexane.
The mean background level of ethanol media is marked with the broad horizontal line
(absorbance unit 2.155) while the upper and the lower background noise levels, plotted
as (±2SD) of the mean are marked off respectively at absorbance (ABS) of 2.40 and
1.91 as shown by the thin horizontal lines on the profile.
The profiles of influent and effluent replicates show some dissimilarity. The
fractions containing anti-androgenic activity in the influent are more than those
identified in the effluent. This is not unexpected as some of the compounds could have
metabolised into non-bioactive form during the wastewater treatment. In addition the
effluent samples contain fractions at retention times of 25 and 30 mins which have
androgen activity (Figure 2.11 and 2.12). Possibly for three reasons, the potential
androgen fractions in the influent extracts are not detected. First, it may be due to the
research aim of this work which, in this case, is focussed purely on analysing anti-
androgenic activity. Second, there is a possibility that the androgenic activity present in
the active fractions in the influent extracts could be masked by the anti-androgenic
activity (Weiss et al., 2009; Conroy et al., 2007). For this to occur, the concentration of
anti-androgenic activity in the fraction must exceed that of androgens. Third, the
concentration of the fractions may be lower than the limit of detection in the influent
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extracts. The profiles of the two sample replicates of the influent and effluent extracts
reveal four anti-androgenic fractions common to all samples, namely: fractions 24, 26,
27 and 29.
2.6.5: Recovery of Samples after Fractionation
The recovery studies of the total anti-androgenic activity present in active post-
fractionated fractions was compared with the TAA of the pre-fractionated extracts. The
results are summarised in Table 2.5.
Table 2.5 Recovery of anti-androgenic activity in influent and effluent extracts
Sample Total Activity
(mgFeq/500mL)
TIE Recovery
from HPLC
(mgFeq/500mL)
Non-TIE
Recovery
(mgFeq/500mL)
% Total
Recovery
Effluent A 1.075x10-1 6.840x10-3 NGG 6.36
Effluent B 1.345x10-1 7.100x10-3 NGG 5.28
Influent A 1.538 1.840x10-2 INC INC
Influent B 1.331 1.620x10-2 0.848* 64.93
NGG: Negligible recovery value as only the injection vial glassware was extracted in
both effluents non-TIE recovery; INC: Inconclusive due to insufficient sample. *Non-
TIE recovery involving the additional solvent extraction of test-tubes and injection vial
glassware for the influent B.
After fractionation, the recovery of anti-androgenic activity of both the influent and
effluent samples was undertaken. In the studies conducted, however, the direct recovery
from TIE for both the influent and effluent samples is very poor. Recovery attempts via
extraction of the injection vial glassware produced poor results too. While recovery
from the effluent glassware is negligible that obtained from the influent replicates are
indeed less than 8%. Further recovery attempted when various test-tubes used for
sample retention and storage were extracted produced some interesting results. The
recovery study for influent B showed that over 57% of the sample anti-androgenic
activity was adsorbed to glassware indicating that much of the AA failed to dissolve in
the methanol-water solution used for fractionation. As a result, only a fraction of the
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influent anti-androgenic activity was available for fractionation in the HPLC. Test-tube
recovery results for effluent replicates and a replicate of influent are not available. For
that reason, it is inappropriate to conclude that the best recovery effort came from the
test-tube wash.
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2.7 Discussion
Wastewaters sourced from predominantly domestic environments are expected
to contain several chemical contaminants, some of which may act as anti-androgens in
the body of wildlife animals and humans. Consumer products for domestic and personal
applications such as cosmetics, pharmaceuticals, laundry and cleaning detergents, and
those for health and recreational, institutional, agricultural and industrial applications
constitute a potential channel by which harmful synthetic chemicals could be
unconsciously discarded into the environment. These compounds end up in Wastewater
Treatment Plants (WwTPs) either in their original or biologically altered forms.
Previously published steroid receptor bio-analytical studies reported the presence of
anti-androgenic activity of some chemical compounds in the influent and effluent
samples of some WwTPs (Lishman et al., 2006; Ternes et al., 2004). Similar studies
extended to wastewater samples from Horsham WwTP, which is primarily constituted
by wastewater collections from domestic sources, also revealed the presence of anti-
androgenic activity.
Horsham wastewater treatment proceeds in three stages: primary, secondary and
tertiary (Section 1.7; Chapter One). The wastewater influents undergo primary treatment
as it passes through the fine screening sand to remove particulates within the range of 3-
10 mm diameter at a reduced flow to allow the heavy grits to settle down. The emerging
water is conducted into a primary sedimentation tank where it remains for between 2-4
hours. In the primary tank, over 70% of the organic matters that are present in the
wastewater are removed as sludge. The secondary treatment involves biological filtering
and humus sedimentation. The biological filtering beds (trickling filters) contain a wide
variety of micro-organisms which include bacteria, protozoa, worms, algae and larvae
required for the decomposition of the organic matters. The water leaving these beds is
passed into the humus tank where humus particles are separated out. The treatment in
the biological filter beds and humus tank spans about 6 hours before it would be ready
for tertiary treatments. The tertiary treatment stage involves the interaction of ferric
chloride with the wastewater to remove phosphorus, dissolved organic matter and
particulates and the coagulants formed are treated as sludge. The final effluent is
discharged into River Arun. Removal of chemicals in wastewaters can potentially occur
in all the three basic treatment levels in the WwTPs. However, in many instances
significant chemical removal takes place at the primary and secondary treatment levels
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via biodegradation, volatilisation, sorption to sludge and particulates, biotransformation
and photolysis. The efficiency of WwTPs at removing these chemicals has been
associated with their technological framework, the nature of chemicals involved (log
Kow) and how often the treatment infrastructures are renewed and reviewed. Ternes et
al. (1999) showed that due to technology and facility differences at various municipal
Sewage Treatment Plants investigated in Germany, Canada and Brazil, the efficiency of
chemical removal of any Treatment Plant cannot be the same. Also, Svenson and Allard
(2004) reported removal of between 26 and 42% androgen receptor-active chemicals by
WwTPs where secondary treatment was by-passed. Similar account of chemical
reduction was reported by Kumar et al. (2008) on WwTP effluents in India. This agrees
with the findings in this work on Horsham WwTP which detected a substantial decrease
in anti-androgen activity during the wastewater treatment process.
In this study, the choice of extraction methods was critically evaluated
especially as there has been little information published on the anti-androgens in
wastewater samples. Evans (2008) reported that different cartridges with different
sorbent composition could retain anti-androgens differently. The choice of Oasis HLB
cartridge for this work was informed by comparative deductions from her report (ibid.)
which considered Oasis HLB favourable for anti-androgen extraction from wastewater
samples. Also, based on her recommendations, the samples were not filtered before SPE
so as to extract significant amount of targeted analytes from the samples. The three
solvents (methanol, ethyl acetate and hexane) considered for elution were chosen as
anti-androgens could range from polar to non-polar in nature (Evans, 2008). Another
significant step taken was the decision on the suitable choice of assay for this work.
Considering the eventual number of fractions that may likely be generated from the
analysis, the cost implication and limited time available to carry out the test, this work
was based on in vitro steroid receptor action using recombinant yeast assay (AYAS).
The preliminary findings of the anti-androgenic activities of Horsham WwTP
samples produced some interesting results. The two sets of the work-up controls
analysed produce responses on the AYAS. The first work-up control recorded the level
of AA in all the three eluting solvents (methanol, ethyl acetate, and hexane) below the
LOD (6µgFeq/L). Similarly, for the second, all the three solvents also recorded AA
below the LOD except for methanol that recorded AA at the level of LOD. Some
inferences can be drawn from these results. The fact that only the second work-up
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control recorded an elevated AA suggests that there are some AA contributions made by
pre-conditioned cartridges. If the first work-up control was only involved in the analysis
of acidified HPLC-grade water, it is possible that the water must have reduced the level
of AA interference in the preconditioned cartridges. It should also be remembered that
similar function must have been performed by methanol in the second work-up control
since it was the immediate solvent introduced into the cartridges after pre-conditioning.
It therefore suggests that the AA interference generated by the pre-conditioned
cartridges were removed by these (polar) solvents. Given that the suggestion of polar
solvent was based on the properties of both solvents involved in this analysis, further
investigation would be required to know if non-polar solvents could have performed the
same function in absence of polar solvents.
The summation of the anti-androgenic activity contained in each sample
replicate of the influent ranged between 2.446 and 3.232 mgFeq/L and their mean ± one
SD value was 2.864±0.394mgFeq/L. Their RSD value was 0.14. Similarly, the total
anti-androgenic activity of effluent replicates occurred in range of 0.215 and
0.469mgFeq/L while the mean± one SD and RSD were 0.313±0.109mgFeq/L and 0.35
respectively. The mean total anti-androgenic activity in the effluent extracts decreased
to 10.9% of that of the influent extracts. The amount of anti-androgenic activity
recorded in effluent samples analysed in this study is consistent with the upper range of
AA reported on the effluent samples analysed from twenty-five sewage treatment plants
across the United Kingdom (Johnson et al., 2007). Their findings showed that
wastewater effluents collected between April and May 2003 recorded anti-androgenic
activity potency range of 0.021-0.228mgFeq/L (ibid.). The July-August samples
recorded a much higher anti-androgenic activity potency range of 0.09-1.23mgFeq/L
(ibid.). In the analytical studies of the influent and effluent samples compared to this
work across the United Kingdom, there was a common pattern which stresses the
seeming variations in anti-androgenic activity from one treatment plant to the other
depending on the time in the year when the works were carried out (Johnson et al.,
2000; Kirk et al., 2002; Evans, 2008). These variations may be due to a series of factors
such as microbial activities, difference in influent sources, collections and composition,
duration of sample storage before analysis, temperature and climatic variations and
possibly difference in processing method.
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Two fractions containing androgen-like activity were noticed to be common on
the profiles of the effluent samples and the control. This seemingly androgenic activity
occurred on fractions 25 and 30 in the profiles of the target samples and the control.
Although, the androgenic activity was prominent on both fractions of the control, it was
absent in the profiles of the effluent and was poor in fraction 30 in the influent profiles.
Given that similar androgenic activity was also noticeable in the control, it is much
more likely that the contaminants responsible for this would have originated from the
laboratory work-up. However, further work is needed to identify the compound(s)
responsible for this androgen activity.
The percentage of anti-androgen activity recovered after HPLC fractionation is
very poor. The anti-androgenic activity recovered after fractionation for each of the two
effluent replicates is estimated to be <7% of the starting AA, and for the influent
replicates it is less than 2%. Considering that the TIE recovery is poor for all the
samples investigated, it is possible that most of the compounds in the original extracts
were insoluble in the injecting solution (methanol-water solution) used for HPLC
fractionation. Some compounds may also have adhered to the glass walls of the
extraction vessels which would only be removed by washing with additional solvents.
All the glass containers used in the extraction of influent wastewater samples were
subjected to additional solvent extraction with dichloromethane, and the extracts tested
in the AYAS assay. Although, the outcome of test-tube wash produced negligible AA
recovery in effluent replicates (as only the injection vial glass was extracted), a
significant recovery was achieved in influent B. Given that a single result (analysis) is
available for the influent, the success of the post-refractionation recovery technique
could not be accurately measured. These results indicate that the entire methodology
used for extraction and HPLC profiling should be reviewed in order to reduce losses of
anti-androgenic activity during work up.
It appears that most effluent anti-androgenic activities were lost in the course of
work-ups in the laboratory. Other possible mechanisms for loses to occur are through
repeated reduction of the extracts to dryness before re-dissolving in another solvent; it is
expected that for labile (volatile) anti-androgens, the process will not only facilitate
their exclusion from test samples it will also create erroneous mass balance. Other
probable mechanisms are photo-degradation, solvent incompatibility during re-
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suspension, biodegradation (even in storage system) and through fractionation on the
HPLC.
2.8 Conclusion
After thorough experimentation on the samples, it is obvious that domestic
wastewaters contain some chemicals that are anti-androgenic in nature as several
published works have pointed out. However, the nature of these chemicals is largely
unknown. The AYAS-based bioassay-directed technique facilitated the capturing of
likely unknown anti-androgens (and androgens) in the test samples which may be
represented by the active HPLC fractions detected in these samples. However, the
methodology of the analytical work needs to be revised so as to improve on the
efficiency of the recovery of anti-androgenic compounds.
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CHAPTER THREE
Development of Optimised Method for Profiling Xenobiotic Anti-
androgens in Effluent and Influent Samples of Horsham Domestic-
based Wastewaters.
3.1. Introduction
The preliminary investigation in Chapter Two revealed that the target
wastewaters contain over thirty-eight anti-androgenic fractions, many of which were
common to both the influent and effluent extracts. The occurrence of several active
fractions in the profile is an indication that wastewaters are complex heterogeneous
mixture of bioactive environmental chemicals whose concentration and identities are
currently unknown. It was discovered that only 5% of the total effluent anti-androgenic
activity (i.e. the sum anti-androgenic activity of effluent fractions) was recovered from
the HPLC fractionation. There was the possibility that a few of the androgenic fractions
observed in the HPLC profiles could have interfered with the estimation of total anti-
androgenic activity (TAA) in the wastewater extracts and could have also masked
detection of anti-androgenic fractions.   However, the recovery studies in Chapter Two
has clearly indicated that most of the losses of anti-androgenic activity occurred while
undertaking some laboratory work-up steps as additional solvent extraction of the
glassware resulted in recovery of significant anti-androgenic activity (AA). Urbatzka
and colleagues (2007) also reported that losses of chemicals can occur during
fractionation of a sample extract and speculated that such losses may be due to
additional work-up treatment to which the fractions had been subjected (ibid.). Other
likely causes of anti-androgenic activity losses include sample degradation and repeated
sample resuspension in solvents. To minimise these losses and optimise recovery, it is
necessary that a new methodology for analysing the wastewater samples must be
developed.
To develop a new methodology which will serve the general purpose of this
study, the various stages of the previous methodology (in Chapter Two) were reviewed
and improved. Different cartridges with a wide range of polarity were tested for the
ability to clean-up, pre-concentrate and elute standard anti-androgens. The various
sorbents contained in these cartridges were made with different materials which possess
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divergent ability to retain a wide range of compounds. Those selected for testing were
HLB OASIS, Strata-X, SDBL, Phenyl, CN, C18 and C8 and their effectiveness in
retaining a range of standard compounds were compared. Compounds that were
selected have a wide range of polarities (logKow: 3.10-7.44) and they include
dichlorophene, vinclozolin, p, p’-DDE, PCB-77 and PCB-138. The rationale for
selecting compounds with such a broad range of polarity was to produce a mixture
replica of environmental samples in the circumstance of which the true recovery
efficiency of the cartridges could be determined. These compounds selected are also
potential endocrine disruptors which are still being reported in environmental samples
today. The AYAS assay procedure was technically modified in order to minimise
background noise level and erroneous feedbacks from the samples.
In addition, a broad range of modifications was made to improve on some
essential steps in the previous SPE methodology. Ethyl acetate (dielectric constant of
6.0) was replaced with a more polar aprotic dichloromethane (dielectric constant of 9.1).
It was suspected that ethyl acetate was less effective at extracting or solubilising some
category of polar compounds present in the environmental samples under study. For
instance, dichloromethylanthracene (DCMA) is an environmental anti-androgen that is
regularly used for recovery studies in our laboratory. It is poorly soluble in ethyl acetate
but is soluble in dichloromethane (DCM).  Methanol and hexane were regarded as good
polar protic and non-polar solvents respectively and were therefore retained in the new
method development. Therefore the three eluting solvents selected in the new SPE
method are hexane, DCM and methanol.
In this Chapter, the yeast screen assay (AYAS) is used for screening steroid-like
anti-androgenic compounds that are present in the wastewater samples and to assess the
efficiency of the new methodology. The HPLC methodology is also used to simplify the
identification analysis of unknown compounds in the complex extracts while the GC-
MS is used to identify the unknown compounds in the fractionated extracts. This
approach is often known as bioassay-directed fractionation, or Toxicity identification
and Evaluation (TIE).
The aims of this research work include:
1. Developing an improved methodology for optimising recovery of steroid
receptor antagonists in wastewater samples (influent and effluent).
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2. Profiling the whole mixture of xenobiotic anti-androgens in these wastewater
samples using the TIE approach.
3. Identifying environmental anti-androgens in fractions of influent and effluent
extracts using GC-MS.
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3.2 Materials and Methods
3.2.1 Materials
The HLB OASIS, C18 and C8 cartridges were purchased from Waters
Corporation, Milford, MA, USA. Strata-X, SDBL, Phenyl and CN cartridges were
purchased from Phenomenex. Glass wool was purchased from Fishers Scientific, United
Kingdom. HPLC grade water, acetonitrile, heptane, methanol, ethyl acetate and hexane
were purchased from Rathburn, Scotland.  Dichlorophene (DCP), vinclozolin (Vz),
p,p’-dichloro-2,2-bis(p-chlorophenyl)ethylene (p.p’-DDE), ibuprofen, isopimaric acid,
17β-estradiol, estrone, estriol, 17α-ethynylestradiol, diclofenac and tris(2-
chloroethyl)phosphate (TCEP) were purchased from Sigma. 3, 3, 4, 4-
tetrachlorobiphenyl (PCB-77), 2, 2’, 3, 4, 4’, 5-hexachlorobiphenyl (PCB-138) and
chloroxylenol were purchased from Sigma-Aldrich, Steinhein, Germany. Acetic acid
(≥99% pure) was purchased from Sigma-Aldrich, Steinheim, Germany. Galaxolide was
a generous gift from the president of American Research Institute of Fragrance
Development (ARIFD). N,N-diethyl-methyl-toluamide (DEET), abietic acid and tris(1-
chloro-2-propyl)phosphate (TCPP) were purchased from Fluka. Bisphenol-A was
purchased from Aldrich. Triclosan, chlorophene, naproxen, TBEP (KP-140), 3,4-
dihydrobenzoic acid, pimaric acid, and 2,4,6-trimethylbenzoic acid were purchased
from Tokyo Chemical Industry (TCI), United Kingdom. All the yeast materials and
their purchase sources are stated in Chapter Two (Section 2.1).
3.2.2 Method Development and Validation.
Following poor recovery of anti-androgenic activity (AA) in Chapter Two, a
revised methodology to screen for, and optimise AA recovery of wastewater samples
was attempted. It involved testing recoveries of standards from different SPE cartridges,
modifying the AYAS assay and adapting it to evaluate steroid receptor antagonism in
polar (e.g. ethanol) and non-polar (e.g. dichloromethane) extracts.
Foremost, different cartridges, ranging from low to high polar affinity, were
tested with the purpose of selecting the most suitable one for wastewater extraction. As
stated in Section 3.1, the selected cartridges are HLB Oasis (divinyl-benzene-co-N-
vinylpyrrolidone), C18 (octadecyl-bonded silica), Strata-X (modified styrene
divinylbenzene), C8 (octyl-bonded silica), SDBL (styrene divinylbenzene), Ph (phenyl-
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bonded silica), and CN (cyanopropyl-bonded silica). For this experiment, each of the
cartridges listed above was made up in triplicate with each plugged with glass wool and
conditioned with 5mL hexane, 5mL methanol, 5mL dichloromethane and 10mL 1%
acetic acid solution(acetic acid: water, 1:99, v/v). A standard mixture was prepared with
equal concentration of DCP, p,p’-DDE, PCB-77 and PCB-138 out of which 4µg aliquot
(representing 1µg of each contributing compound) was added to 100mL of water for
analysis. To develop a work-up solution which will serve as the control for this study,
non-spiked HPLC grade water was used. The analysis was carried out in three
replicates. The properties of the test compounds selected for this analysis are tabulated
in Table 3.1. The sample preparations were loaded into the respective cartridges.
Table 3.1 Summary of standards used for method development with their CAS number,
logarithm octanol-water partition co-efficient (log Kow) and solubility in water.
Compound CAS Number Log Kow Solubility in water
at 200C (mg/L)
Dichlorophene 97-23-4 4.26 30
Vinclozolin 50471-44-8 3.10 3.4
p,p-DDE 72-55-9 6.51 0.12
PCB-77 32598-13-3 6.65 Nil
PCB-138 35065-28-2 7.44 1.0x10-2
CAS Number: Chemical Abstracts Service Number.
The cartridges were washed with 5mL 2.5% methanolic solution (methanol:
water, 2.5%: 97.5%, v/v) after sample loading and were left to dry on the manifold at
full vacuum (5.32 psi pressure) for one hour. Serially, the cartridges were eluted with
2x5mL methanol, 2x5mL dichloromethane (DCM) and 2x5mL hexane. Each load
container (beaker) was carefully washed with (every) 5mL of eluting solvent before it
was used to elute the standards. Each of the three solvent extracts collected from each
cartridge (i.e. eluates) was combined and reduced to dryness and then reconstituted in
100µL of acetonitrile. A 10µL of each replicate was injected to the HPLC-UV at
wavelength range of 210-400nm and was run at a gradient flow rate of 1mL/min starting
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from 50:50 water/acetonitrile to 100% acetonitrile for 5 minutes. The program was
maintained at 100% acetonitrile for 13 minutes. The mobile phase was made up of
water (HPLC grade), 5% acetonitrile and 0.2% acetic acid (A) while the acetonitrile
mobile phase consisted of acetonitrile and 0.2% acetic acid (B). As precautionary
measure taken to account for possible loss of test materials due to poor sample retention
on the cartridges and sample adsorption during loading, the load waste (which stands for
the discharge that filtered through the cartridges) and the cartridges-wash were collected
and were subjected to partition chromatography with DCM. The partition
chromatography extracts were analysed on the HPLC and evaluated. The recoveries of
test compounds undertaken via the HPLC were estimated by external calibration
method, and the calibration curves and their coefficient of determination (R2) for three
of the five test standards are shown in Appendix A. The coefficient of determination
(R2) is a statistical measurement that evaluates the closeness of agreement between the
peak area of a sample chromatogram and its concentration and measures how well the
regression line represents the plotted values. It also measures the proportion of total
variation associated with the data points which is accounted for by the regression line. It
can be statistically expressed as the square of correlation coefficient of the data points
and the regression model. Its values are expressed such that 0≤R2≤1. It is sometimes
regarded as a relative expression of the goodness of fit of linear plots but its failure to
explain the variation of the data points around the regression line is seen as a major
limitation (AMC, 1994). It is possible to have regression lines whose R2 values are close
to 1 where no single data point falls on the line. Inability to explain this data geometry
makes linear regression approach ineffective and inaccurate to evaluate the goodness of
fit of the regression line. Also, the linearity relationship may not exist when the data
values are below or above certain data range. For these reasons, the regression model
may not be suitable to predict the outcome of future experimental investigations.
3.3 Application of the New Method on Wastewater Effluent and Influent Samples.
Following poor sample recovery recorded in Chapter Two, fresh wastewater
samples comprising influents and effluents were collected on the 15th of September,
2008 and the new SPE methodology was applied for purification, pre-concentration,
elution and analysis. The results from this application were analysed in Section 3.6.
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3.3.1 Collection, Extraction and Purification of Wastewater Samples to Evaluate
the New Extraction Method.
The newly developed method was tested on a freshly collected wastewater
samples consisting separately of influent and effluent. 3 x 2 litres of each sample was
collected into six 2.5 litre-capacity methanol pre-rinsed Winchester bottles as described
in Section 2.1.2.2. A 100mL of methanol was added to each Winchester to minimise
bacterial degradation while being transported to the laboratory for processing. Each
sample (400mL of influent, 400mL of effluent) was prepared in five replicates and
loaded on glasswool-plugged HLB cartridges (200mg) fitted to vacuum manifold. After
loading, the cartridges were dried under vacuum at 5.32 psi for 1 hour before elution
was commenced. The analytes were eluted as described in Section 3.2.2. For each
replicate, the eluates were combined and were dried down in a speed vacuum
concentrator. The influent was redissolved in ethanol (200µL), vortexed, sonicated and
transferred into a new, labelled test-tube. This process was repeated with ethanol
(100µL) to fully extract the residual compounds in the sample. The extract was stored
away in -200C freezer for assay. The extraction procedure above was observed for all
other influent and effluent replicates. In all, three replicates of influent and effluent
samples (labelled X, Y and Z) were made up in contrast to four replicates (A, B, C and
D) which were prepared in Chapter Two as a lot of time is usually required for sample
purification. However, due to insufficient sample for further analysis, Effluent-X,
Effluent-Y and Effluent-Z were combined to make a single sample named Effluent-W.
3.3.2. Determination of Total Anti-androgenic Activity of Wastewater Samples
with Yeast Androgen Receptor Transcription Assay
The procedure employed to determine the total anti-androgenic activity of
ethanol extracts of the wastewater samples was similar to that described in Section 2.3.4
except for a modification. It was discovered that polystyrene plates are susceptible to
plastic degradation when they are exposed to some non-polar solvents (e.g. DCM). As a
result, they were replaced by polypropylene plates. Working with the polypropylene
plates, the anti-androgenic activity of non-polar soluble compounds which were not
soluble in polar solvents (e.g. ethanol) could be accurately evaluated.  The three extracts
produced by eluting each cartridge with methanol, DCM and hexane were combined
and evaporated to dryness in a speed vacuum concentrator following which they were
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resuspended in 100µL of ethanol. The procedure for plating, media preparation and
dispensing, incubation, plate reading and the result analysis is as explained in Sections
2.3.4 and 2.3.5.
3.3.3. Profiling of Sample Extracts Using Reversed Phase HPLC.
3.3.3.1 Test of Sample Solubility in HPLC Injection Solvent
The anti-androgenic activity of target analytes can sometimes be lost during
sample re-suspension especially when they are not completely soluble in the chosen
solvents. Tests to evaluate the level of solubility of test influent and effluent extracts
were undertaken using the AYAS techniques. Sample solubilisation was carried out in
acetonitrile-water solution in lieu of methanol-water used in Chapter Two. 112µL
aliquot of Influent-X was reduced to dryness in a speed vacuum concentrator and
reconstituted in 260µL acetonitrile-water solution (80:20, v/v) to make the
concentration of the extract non-toxic on AYAS. Similarly, 112µL of Influent-Y was
reconstituted in 260µL of acetonitrile-water solution and the 460µL aliquot of Effluent-
W was reconstituted in 260µL of acetonitrile-water. The anti-androgenic activity
recovery results are recorded in Table 3.4.
3.3.3.2 Fractionation of Sample Extracts on Reversed Phase HPLC
An aliquot of Effluent-W (described in Section 3.3.1), earlier reconstituted in
260 μL of acetonitrile-water solution (80:20, v/v), was dispensed into an Eppendorf tube
and was spun in a microcentrifuge at 13000 rotations per minutes for 30 minutes to
remove the particulates in the sample extract. The supernatant was transferred into a
HPLC vial and placed in an autosampler for injection. A small portion of the remaining
sample extract was assayed on AYAS to determine the total anti-androgenic activity of
the effluent extract at fractionation. Similar to the approach used in Chapter Two, a
reversed-phase HPLC system was connected to a photodiode detector (Waters UK Ltd,
Elstree, Hertfordshire, UK) and C18 Nova Pak column (4μL particle size 4.6 x
2500mm) and was set up with the solvent system comprising acidified HPLC grade
water (0.2% acetic acid) and acetonitrile hitherto degassed with an on-line degassing
system (Alltech Associates Applied Science, Lancashire, UK). The solvent system
(water: acetonitrile ratio) was operated on a gradient programme: 0 minute (90:10), 10
minutes (70:30), 65 minutes (0: 100) and 80 minutes (0: 100) with the fractionation
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occurring at room temperature in a regular flow of 1 mL/min. The gradient section of
this HPLC fractionation program was run for 65 minutes followed by 15 minutes
isocratic section (in 100% acetonitrile only). After ensuring a stable pressure, the
fractionation was started with the water control and was followed  by the standard
mixture which comprised β-estriol, 11-ketotestosterone (11-KT), 17β-estradiol (E2),
dichlorophene (DCP), technical nonylphenol (t-NP), PCB-77 and p, p’-DDE. 150μL of
the standard mixture, made with concentrations between 20 and 50ng of each standard
per microliter of acetonitrile-water solution, was injected into the HPLC using the
autosampler. After each injection and completion of each run, the autosampler was
cleaned five times with methanol (200µL on each occasion) and the system equilibrated
between 25-30 minutes. The same procedure was repeated for the analysis of 260µL of
effluent W and 150µL each of influent extracts X and Y.
3.4. Toxicity Identification and Evaluation Assay and Recovery Estimation of
HPLC Fractions
40µL aliquot replicate of each influent fraction was assayed as described in
Section 2.5 and the procedure was repeated on the effluent fractions. However, in this
Section, the aliquot replicates taken were assayed directly from the originating solution
without reconstitution in another solvent. The anti-androgenic activity of individual
fractions in the AYAS was measured using a spectrophotometer, and the data was
corrected for differences in turbidity and the anti-androgenic activity present in each
fraction was calculated as described in Section 2.5. In addition, the total pre- and post-
fractionated anti-androgenic activity of the influent and effluent extracts was also
determined using the AYAS (Section 2.3.5).
3.5. Gas Chromatography-Mass Spectroscopy (GC-MS) Analysis of HPLC
fractions with Anti-androgenic Activity
3.5.1 Selection of Fractions for GC-MS Analysis
The active fractions identified on the profiles were selected for GC-MS analysis.
The fraction selection was necessary in order to maximise the time required to complete
the analysis of the highly active fractions and the prospects of identifying the most
potent anti-androgens. The criteria for selecting the fractions were based on the level of
anti-androgenic activity of the fractions and on the possibility that some compounds
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which are present mainly in a fraction could also occur in the neighbouring fractions. In
addition, some selections were made based on the target analysis of some known
compounds commonly detected in wastewater samples. The fractions were selected
because their retention time tally with that of the target compounds using same HPLC
program. For such selection pathway, the anti-androgenic activity status of the fractions
would not matter much.
3.5.2 Silylation of Standards and Fractions for GC-MS Analyses.
A 400μL aliquot of anti-androgenic fractions confirmed in AYAS assay was
measured into a V-shaped derivatisation glass vial after which 50μL (50ng) each of
deuterated estrone and p, p’-DDE, both used as internal standards, were added. The
internal standards were used to monitor the analytical and instrumentation variability
given that their retention time and fragmentation pattern are known. The deuterated
estrone was also added to confirm the success of the derivatisation and to determine the
concentration of the GC-MS peaks produced (due to its relatively negligible volatility
and thermal stability during sample concentration). Similarly, the deuterated p, p’-DDE
was introduced to aid in evaluating the concentration of non-polar compounds where
derivatisation is either not successful or not required. The mixture in the derivatisation
tube was thoroughly vortexed and was evaporated to dryness using the speed vacuum
concentrator. Thereafter, 60μL of pyridine/ N, O-bis (trimethylsilyl)-trifluoroacetamide
(BSTFA) {1:3, (v/v)} was added and the sample was silylated to ether and/or ester
derivatives for 30 minutes in a heat block. Again, the derivatised sample was vortexed
and concentrated under nitrogen and transferred into GC-MS injection vials.  1μL of the
derivatised sample was injected into the GC-MS. Prior to the analysis of the derivatised
samples, pure silylating materials and derivatised internal standards were injected to
respectively check the sensitivity of the GC-MS and determine their retention time. The
GC-MS chromatograms of the fractions were analysed and the compounds were
identified using Xcalibur (Ver. 1.4SR1) and NIST library (Ver. 2.0).
3.5.3 GC-MS Analysis of Effluent and Influent Fractions
The GC-MS used for sample analysis comprised of a Trace Gas
Chromatography (Thermoquest, Texas, USA) and a Polaris-Q ion trap mass
spectrometer (Thermo, Texas, USA) connected together. Attached to the GC was a
fused silica capillary column (30m x 0.25mm x 0.25μm film thickness) where sample
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separation was executed. The sample was injected manually into the GC using a
microliter syringe (Hamilton Bonaduz AG, Switzerland) and was aided by a carrier gas
(Helium) at a constant flow rate of 1.5mL per minute.  The oven program was created
such that the oven temperature, which was initialised and held at 700C for 2min, was
raised steadily to 2640C at the rate of 80C/min. After being held at this temperature for
10 min, it increased until it reached a final temperature of 3000C at the rate of 100C/min
and was maintained for 5min. The mass spectrometer was operated in full scan to
capture mass range from 50 to 650u and analyse a wide range of ions generated by
standards, effluent and influent fractions. For the purpose of this analysis, corresponding
ions of the internal standards namely deuterated estrone, E1-d4 (m/z= 346) and p,p-
[13C]-DDE (m/z =258, 330) were also monitored.
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3.6 Results
3.6.1 Limits of Detection and Quantification in the AYAS and GC-MS
Determinations
Limits of detection and quantification are two statistical measurements used in
evaluating correctly the anti-androgens identified in wastewater samples. As expressed
in Section 2.6.1, LOD is measured as the difference between the mean and three times
the standard deviation of the control values whilst LOQ is evaluated as the difference
between the mean and nine times the standard deviation of the control values. The LOD
and LOQ were calculated for every yeast assay where quantification was necessary. The
background noise-to-signal level of each experimental measurement was undertaken in
AYAS with replicated ethanol blank, otherwise known as control. The measurement of
TAA of wastewater extracts undertaken in the entire yeast assay was evaluated whilst
taking into cognisance the response from the control. Similarly, the GC-MS
chromatograms of the samples were analysed using the chromatograms of the silylating
materials (regarded as the blank) and that of the standards as the foundation.  For both
the yeast assay and the GC-MS, the blanks were constructed to provide the needed
information about the background noise conditions existing in all the experiments.
Usually, they form the statistical foundation for defining the limit of detection (LOD)
and limit of quantification (LOQ) of analytes. The significance of demarcating actual
AA from those generated by experimental work-ups cannot be overemphasised. For
instance, during the comparison of chromatograms with that of the blank, the interfering
peaks occurring within the range of the analyte’s retention time were identified and
isolated. During quantification, the interfering peaks were factored into statistical
evaluations in order to get accurate results. For the calibration curve, the LOD and LOQ
are estimated based on the standard deviation (α) of the y-intercept and the slope (S) of
the regression lines of the curves (ICH, 1996). The value of α is estimated from the
relation: = ∑ where and are y-values produced
experimentally and those generated on the regression line respectively and n represents
the number of points used for generating the curve. The LOD and LOQ are calculated
from 3.3α/S and 10α/S respectively (Bartolomeo and Maisano, 2006).
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3.6.2 Recovery of Samples on Cartridges
From the previous work in Chapter Two, it appeared that wastewater effluents
and influents contain a wide range of anti-androgenic chemicals with differing
polarities. To effectively capture these classes of target analytes, high retention
cartridges are required. The recovery from different cartridges with variable sorbent
properties was investigated using the test standard mixture (Section 3.2.2) on HPLC.
High recovery (expressed as a % percentage of the total amount applied) from the HLB
SPE cartridge (which was also used in previous extraction in Chapter Two) was
demonstrated across all the test standards (Table 3.2). The results suggest that losses of
contaminants that may have similar chemical properties in the wastewater extracts are
likely to be very low. The calibration curves of recoveries of dichlorophene, vinclozolin
and p,p-DDE were plotted with their peak areas (as measured on the HPLC
chromatograms) against the corresponding concentrations and the results are shown in
Appendix A. The R2 values for the three test compounds are very high (>0.9998).
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Table 3.2: SPE recovery of test standards from seven different cartridges as analysed on
the HPLC. The recoveries are recorded in % mean±SD of the peak areas of the test
samples.
Cartridge Dichlorophene Vinclozolin p,p-DDE aPCB-77 aPCB-138
HLB 99.33±25 111.10±18 100.21±11 94.48±15 101.04±21
C18 63.80±2 79.01±13 53.77±10 - -
Strata-X 76.94±11 74.36±2 15.39±3 - -
C8 73.99±1 70.60±15 82.09±15 - -
SDBL 81.25±5 82.77±3 25.70±7 - -
Phenyl(Ph) 93.63±2 81.09±12 31.40±2 - -
Cyanide(CN) 88.37±3 91.90±1 33.28±1 - -
aPCBs were not tested on the cartridges marked with dash sign. Dichloromethane,
methanol and hexane were used as the eluting solvents for the test standards.
3.6.3 Total Anti-Androgenic Activity of Influent and Effluent Samples from the
New Methodology.
The anti-androgenic activity of the fresh wastewater samples was analysed using
the new methodology and the results are shown in Table 3.3.
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Table 3.3: Total anti-androgenic activity of influent and effluent sample replicates. The
samples were collected from Horsham Wastewater Treatment Plant in September 2008.
400mL each of influent samples (X, Y and Z) and 400mL each of effluent samples (X,
Y and Z) were extracted.
Samplea X Y Z Mean±SD %RSD
Influent 3.225 3.175 3.194 3.198±0.025 0.782
Effluent 0.222 0.210 0.226 0.219±0.008 3.796
aThe anti-androgenic activity of the sample replicates are measured in mgFeq/L of the
volume of wastewater extracted.
Generally, the anti-androgenic activity of the influent extracts range between
3.175 and 3.225mgFeq/L while that of the effluent extracts occur in the range of 0.210-
0.226mgFeq/L. The results of TAA (in Table 3.3) significantly demonstrate a high
degree of repeatability (or precision) expressed by a range of the following statistical
values {range (effluent: influent; 0.016/0.05), standard deviation (effluent: influent;
0.008/0.025) and %RSD (effluent: influent; 3.796%/0.782%)}. The results clearly show
that there is a significant improvement over that recorded in Chapter Two (Section
2.6.2). Partition chromatography analysis of loading waste (the solvent that emerged
from the cartridges during sample loading) produced a recovery below the LOD which
further suggest that HLB cartridges tested possess high sample retention efficiency.
3.6.4 Sample Solubility in Fractionating solvent
The measurement of sample solubility in acetonitrile-water (80:20, v/v)
undertaken in Section 3.5 as presented in Table 3.4 indicated that acetonitrile-water
solution is suitable as a resuspension solvent mixture for reversed-phase HPLC
fractionation. Evaluation of the total anti-androgenic activity of both test samples before
and after reconstitution in the injecting medium indicated that there was no loss
recorded in between the re-solubilisation process.
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Table 3.4: Test on re-constitution of influent ethanol extracts to acetonitrile-water
solution.
Influent] Total activity of re-solubilised ethanol
extract in acetonitrile-water*
Before (mgFeq/L) After(mgFeq/L)
X 0.121 0.121
Y 0.130 0.130
*Only two replicates were analysed due to insufficient sample for fractionation.
3.6.5 Activity Chromatograms of blank Control, Effluent and Influent Sample
Extracts
The chromatograms of the control and the standards generated during HPLC
fractionation (Figures 3.1 and 3.2) provide some useful information for effective
identification of potential environmental compounds that are present in the wastewater
samples being investigated. The prominent peak seen between 0 and 5 min of the
fractionation process represents the HPLC-UV peak of the acetonitrile-water, the
sample injection solvent for this experiment. The control chromatogram contained some
tiny peaks whose activities are below the LOD. In contrast, the chromatogram of the
standards contains several peaks which are distributed relative to the retention time of
the constituent compounds (Table 3.5).
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Table 3.5 Summary of reference standards injected into the HPLC before sample
fractionation to help establish elution pattern of synthetic compounds based on their
polarity.
Standard CAS Number Retention Time
(min)
LogKow
17β-estriol 50-27-1 17 2.81
11-kT 53187-98-7 20 2.00
17α-estradiol (E2) 50-28-2 27 4.01
Estrone (E1) 50-22-0 30 3.75
DCP 97-23-4 37 4.26
NP 104-40-5 52 4.48
p,p-DDE 72-55-9 61 6.51
PCB-77 32598-13-3 61 6.63
The chromatogram (Figure 3.1.) shows the polarity diversity of the standards (Table
3.5) injected into the HPLC during analysis. The injected standard mixture was run
using the same HPLC program (Section 3.3.3.2) and the peaks of the standards are
identified in the description of Figure 3.1.
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Figure 3.1: HPLC-UV chromatogram of selected standard mixture measured at a
wavelength of 254nm: (1) 20ng 17β-estriol (E3), (2) 30ng 17β-estradiol (E2), (3) 30ng
Estrone (E1) at 30min and 30ng chloroxylenol at 31min, (4) 40ng dichlorophene (DCP),
(5) 20ng nonylphenol (NP), and (6) co-eluting PCB-77 & p, p-DDE (50ng each). The
chromatogram asterisked in the diagram represents the solvent peak.
The chromatogram (Figure 3.2) reveals the level of contaminants present in the
samples being analysed which may contribute to the background noise interference. The
peak eluting between 0-5minutes on the left of the chromatogram represents the
refractive index of the injection solvent changing the UV response during analysis. On
this chromatogram, the background noise level is very minimal.
Figure 3.2: HPLC-UV chromatogram of control (methanol-water) at a wavelength
254nm showing the solvent peaks.
The HPLC-UV chromatogram (Figure 3.3) shows the clusters and peaks of
unknown compounds occurring in the extract of wastewater effluent. The
chromatogram which was monitored at wavelength of 254nm shows some of the
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chemical compounds in the wastewater samples that elute from the HPLC column. Most
of the chemicals detected at 254nm elute in the moderately polar section of the
chromatogram between 0-45minutes.
Figure 3.3: HPLC-UV chromatogram of effluent-W extract at a wavelength of 254nm
showing the solvent peak and clusters of other unknown compounds.
The influent-X and-Y chromatograms (Figures 3.4 and 3.5) reveal widespread of
chemicals across the three polarity divisions in the samples. Although the peaks are
distributed across the chromatogram, the density of the chemicals occurs at the polar
region. It can also be revealed that the chemical spread on the two chromatograms
correlates, indicating that they are replicates.
Figure 3.4: HPLC-UV chromatogram of influent-X at a wavelength of 254nm
consisting of peaks of unknown compounds.
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Figure 3.5: HPLC-UV chromatogram of influent-Y at a wavelength of 254nm replete
of peaks and clusters of unknown compounds.
3.6.6 Profile of Anti-Androgenic Activity in Influent and Effluent Extracts on
AYAS assay
The fractions of the samples generated by the HPLC fractionation process
produced a profile of anti-androgenic activity in the AYAS. This AA which are
presented in Figure 3.6 were validated and are marked off by the solid line which
represents the mean of the ethanol blank while the broken lines correspond to the upper
and lower background noise levels (mean±2SD) respectively.  Given that a reversed
phase HPLC fractionation approach and a water-acetonitrile gradient program were
used, the section of the profile ranging from time 0 to 29 corresponds to the strongly
polar section while those between the ranges of 30 to 47 and 48 to 80 correlate to the
moderately polar and non-polar sections respectively. As explained in Section 2.3.5, the
responses of the assay below the lower background noise (mean-2SD) value are
considered as fractions with potential anti-androgenic activity and are prioritised for
GC-MS analyses. However, it can be observed that some androgenic fractions (a black
vertical bar extending above the upper background noise level in the sample profile
(Figure 3.6B and C) are detected in both replicates (Y and X) of influent profiles but are
not apparent in the profile of the effluent sample or the control (Figures 3.6A and
3.6D). The spread of anti-androgen-active fractions of influent samples cut across all the
three divisions except that it mostly occurs in moderately polar and non-polar divisions.
No anti-androgenic activity is noticed on the control profile which indicates that the
contribution of anti-androgenic activity from the laboratory work-up is minimal (Figure
3.6). Also, a critical assessment of the sample profiles shows that a high proportion of
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anti-androgenic activity occurs in the strongly polar section of the effluent with patches
occurring in the moderately polar and non-polar regions. Initial data collected on
influents X and Y, which include their chromatograms (Figures 3.4 and 3.5) and AA
(Table 3.3), suggests that both samples are similar and are therefore expected to be
analytical replicate. However, the profile analysis of both samples indicates some
noticeable differences (Figure 3.6). Profile analysis (in Table 3.6) has shown that
twenty-nine anti-androgenic fractions are common to both influent profiles. The same
report (Table 3.6) also indicates that more than 40% of the anti-androgenic fractions are
different in both influents X and Y which put the ratio of similar and dissimilar anti-
androgenic fractions at 0.667. It is statistically evident that the two samples cannot be
similar. Although, cases of shift in retention time are sometimes responsible for the
variability of profiles especially when they are sample replicates, but such an argument
could not explain the structural difference noticed in the two profiles. Therefore, the
analysis carried out in Table 3.6 clearly shows that the profiles of both influent
replicates express variability which is a classical example of sample replicates that are
not analytical replicates. It must also be mentioned that effluent-X, effluent-Y and
effluent-Z were combined as effluent-W for fractionation due to insufficient sample
(Section 3.3.3.1). As a result, the profile could not be replicated. In general, eleven anti-
androgen-active fractions are found to be common to all the samples (Influent X,
Influent Y and Effluent W) and they include 26, 33, 34, 35, 37, 38, 41, 42, 48 and 53.
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Table 3.6: Profiles of influents X and Y showing active fractions (i) common to each
other and (ii) different from each other.
Sample Active fractions common to
both Influent-X and
Influent-Y replicates
Active fractions common to
both Influent-X and
Influent-Y replicates
Influent-X
6, 24, 25, (25)*, 26,33, 34,
35, 36, 37, 38, 40, 41, 42,
45, 48, 49, 50, 53, 58, 59,
60, 61, 62, 64, 65, 66, 67,
68
27, 31, 32, 63
Influent-Y
18, 19, 20, 21, 22, 23, 28,
29, 30, 39, 42, 44, 46, 47,
55, 56, 57
*The circled fraction which is asterisked in the middle lower column occurs in both
influent replicates and is presumed to possess androgenic activity.
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Figure 3.6: Profiles of the total activities of the control and effluent-W samples
(marked A and B respectively) extracted by Oasis HLB cartridges and eluted with
DCM, methanol and hexane. The mean background level of ethanol control is indicated
by the thick horizontal lines on the profile while the upper and lower background noise
levels are indicated by the broken horizontal lines defined by mean ethanol control
[±2SD].
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Figure 3.6. Profiles of the total anti-androgenic activity of influent X and influent Y
samples (marked C and D respectively) extracted by Oasis HLB cartridges and eluted
with DCM, methanol and hexane. The mean background level of ethanol control is
indicated by the thick horizontal lines on the profile while the upper and lower
background noise levels are indicated by the broken horizontal lines defined by mean
ethanol control [±2SD].
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3.6.7: Recovery of Anti-Androgenic Activity of Extracts after Fractionation
The recovery studies of the anti-androgenic activity of the extracts were undertaken
after fractionation and the results of the studies are reported in Table 3.7. The recovery
recorded by the two influent replicate is in the range of 78.63-97.32%. Recovery
evaluation of effluent activity, however, cannot be accurately estimated due to
availability of a single sample result. There is generally an improved recovery of TAA
from the extract results shown in Table 3.7 over that in Table 2.5 (Section 2.6.5 in
Chapter Two).
Table 3.7: Recovery of anti-androgenic activity before and after extract fractionation.
Sample Total anti-androgenic activity (mgFeq/L) % Recovery
Before fractionation After fractionation
Influent-Y 3.205 3.119 97.32
Influent-X 3.172 2.494 78.63
Effluent-W 0.178 0.147 82.58
3.6.8 Gas Chromatography-Mass Spectroscopy (GC-MS) Analysis
The fractions identified to be anti-androgenic on the TIE assay, together with
their neighbouring fractions, were silylated and analysed on GCMS following which the
potential compounds responsible for this anti-androgenic activity were identified and
analysed respectively using the NIST library and external calibration method. The NIST
library fits ≥85% was recorded for all the compounds identified.
3.6.8.1 Internal Standard Fragments Monitored on GC-MS
The internal standards produced fixed fragment(s) whose concentration was
used to estimate the quantity of each compound detected in sample fractions. For p, p’-
[13C]-DDE with multiple fragment ions, fragment ion 258 was chosen to quantify the
compounds. These monitored ions are tabulated in the Table 3.8 below.
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Table 3.8: The summary of the fragment ions of the standards monitored on the GCMS
Standard Retention Time
(RT)
Molecular Mass Monitored ion(s)
E1-d4 22.12 346 346
p,p-[13C]-DDE 22.38 330 258, 328, 330
It must be stated that during laboratory work-up, a negligible quantity of
samples and standards were lost especially by moderately polar and non-polar fractions
(Appendix B.5). In these fractions, E1-d4 standard was thermally stable over the period
the analytes were being derivatised and had produced a good recovery in both the
influent and effluent fractions. However, the recovery studies of these standards in
strongly polar fractions produced poor results (Appendix B). The observed reduction in
the concentration of the E1-d4 and the p, p'-[13C]-DDE in the sample during
derivatisation are suspected to be caused by prolonged process of evaporation-to-
dryness (liquid removal process) that occurred in the speed vacuum evaporator. The
strongly polar fractions contained water in the range of 75-100% which required a
longer time to dispose from the fractions. As a consequence, a considerable proportion
of the standards and the analytes were lost during evaporation-to-dryness and the
relationships between the absorbance, as well as the concentration of the standards and
the percentage water-acetonitrile mixture are shown in the linear graphs in Appendix B.
3.6.8.2 GC-MS Chromatogram of HPLC Fractions
A wide range of biologically active and non-active environmental xenobiotics
has been identified in the fractions of both the influent and effluent samples analysed.
The first compound identified from the huge number of fractions was dichlorophene.
Dichlorophene was detected in fractions 36, 37 and 38 of both influent and effluent
samples and its occurrence was further confirmed in fractions 34 and 35 of the effluent
sample. For a derivatised sample, dichlorophene occurred in the GC-MS chromatogram
with a molecular ion, M+ of 412 which corresponds to the substitution of the hydrogens
(in the –OH groups of the compound) as di-trimethylsilated derivative of dichlorophene
(Figure 3.7). The [M-35]+ occurred as the most relatively abundant fragment ion
(m/z=377) which corresponds to the loss of a chloride radical, Cl..  The spectra lines
were a good match to the NIST library with the percentage correlation standing at 90%.
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Dichlorophene is a chlorinated phenolic compound which has been widely used as
bacterioside and in pesticides and fungicides (Anderson, 1982; Takeuchi et al., 1985).
Figure 3.7: Schematic chromatograms comparing silylated dichlorophene compound
between the NIST library where it occurred as dichlorophene, bis-O-trimethylsilyl and
sample spectra lines.
Galaxolide, which has a molecular mass of 258, produced fragment ion peaks of
[M-15]+, [M-30]+ and [M-45]+ respectively. These correspond to fragment ion masses
of 243, 228 and 213 generated after consistent loss of a methyl group by the molecular
ion.  It was identified on the chromatogram at retention time 18.46 min for influent and
18.48 min and 19.23 min for effluent of fraction 58. Emergence of galaxolide at two
different retention times in the effluent suggests the possibility of its occurrence in
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isomeric form. The mass spectrum of the compound matched well with the NIST library
(Figure 3.8).
Figure 3.8: GC-MS chromatograms comparing galaxolide detected in sample extract
and that in the NIST library.
Galaxolide belongs to the family of polycyclic musks. It is an important components of
several personal care products especially cosmetics, detergents, perfumes, cleaning
materials, body and hair creams (Muller et al., 1996; Frater et al., 1999).
Triclosan is another environmental compound detected in fractions 45 and 46 of
both the influent and effluent samples (Figure 3.9). Triclosan, otherwise known as 5-
chloro-2-(2, 4-dichlorophenoxy)phenol, is a broad-based anti-bacterial agent widely
used as components of consumer and personal care products (Sabaliunas et al., 2003).
Some of these include cosmetic and skin care products (shampoos, toilet soaps,
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toothpastes, deoderants, skin creams and lotions).  Products such as footwear, plastic
wear and carpets are also composed of triclosan. Its regular application domestically
could trigger bioaccumulation in the body and compromise human health (Sabaliunas et
al., 2003; Lindstorm et al., 2002). Further studies are necessary to clarify its
implications with regards to suppression of immune function, carcinogenicity and
damage to the liver, kidney and lung.
Figure 3.9.A: GC-MS Chromatograms of isotopic triclosan expressing differences on
fragment ions 347 and 345 signals shown on A and B respectively.
Figure 3.9.B: GC-MS Chromatograms of isotopic triclosan expressing differences on
fragment ions 347 and 345 signals shown on A and B respectively.
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Figure 3.9.C: GC-MS chromatogram of laboratory standard of silylated triclosan used
in lieu of triclosan, bis-O-trimethylsilyl (NIST library) to compare sample
chromatograms. The silylated triclosan was not available on NIST library.
Triclosan is another chlorinated compound having three chlorine atoms present on the
molecular structure. The HPLC confirmatory test on triclosan proved significantly
consistent and correlated with its emergence in fraction 45. Triclosan has a molecular
ion M+ of 360/362. The fragmentation of m/z = 360/362 resulted in relatively abundant
fragment ions with masses 345/347 [M-CH3]+, 325/327 [M-Cl]+ and 200/202 [M-
C6H3Cl2O]+. It is possible for triclosan to exist as isotope in these fractions. On
fractions 45 and 46 (Figures 3.9.A and 3.9.B), spectra lines are correspondingly similar
except at 345 and 200. Fragments 345 are common to both fractions in approximately
equivalent magnitude of intensity or relative abundance. Similarly, fragment 200 and
207 occur in both fractions. While the signal of the former occurs at about the same
level of relative abundance in both fractions, that of the latter is more than triple in
relative abundance in fraction 45 compare to that in 46. Before a meaningful conclusion
could be drawn on its isotopic forms, it is necessary that further investigation be
conducted to establish the possibility. Although, NIST library for the silylated
compound was not available, the GC-MS chromatogram of the laboratory standard
(Figure 3.9.C) was used as a comparative reference.
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Another chemical compound found in the samples, which has flame retarding
properties, is the tris(1-chloro-2-propyl)phosphate (TCPP) (Figure 3.10). It is an
organophosphate ester used as flame retardant and plasticiser (Meyer and Bester, 2004).
When TCPP’s molecular ion (m/z = 326) fragments, four notable fragment ions are
generated in abundant proportion with spectra lines reflecting masses of 99, 125, 157,
175, 201, 215 and 276. The m/z values correspond to the following fragment ions in
sequential order of [H4PO4]+, [M-CH(CH2)5O3Cl2]+, [Cl2O(CH2)5]+,
[CH3(CH2)4O2Cl2]+, [CH(CH2)5O3Cl2]+, [CH(CH2)6O3Cl2]+ and [M-CH2Cl]+.
Figure 3.10: GC-MS and sample chromatograms of TCPP isomer I
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Two other isomers of TCPP were also detected in wastewater samples. These include
bis(1-Chloro-2-propyl)(3-chloro-1-propyl)phosphate (Laniewski et al., 1998) and bis(3-
Chloro-1-propyl)(1-chloro-2-propyl)phosphate (Figures 3.11 and 3.12).
Figure 3.11: Chromatograms of isomer II {bis(1-Chloro-2-propyl)(3-chloro-1-
propyl)phosphate}of TCPP detected in wastewater fractions.
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Figure 3.12: NIST library and sample chromatograms of isomer III {bis(3-Chloro-1-
propyl)(1-chloro-2-propyl)phosphate}of TCPP found in wastewater fractions analysed.
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The three congeneric compounds have more spectra lines that are common to them than
those in contrast.  The few identified compounds explained are common chemicals that
constitute the domestic-based products, which are regularly released into the
environment.
Figure 3.13: The GC-MS Chromatograph showing the three different isomers of TCPP
(I, II and III) in an effluent W fraction 34 in retention time 13.48min, 13.34min and
13.59 min respectively.
A comprehensive list of all environmental chemicals detected in the fractions
analysed are summarised in Table 3.9. Their corresponding chromatograms are
compiled in Appendix C.
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Table 3.9: Summary of environmental compounds detected in anti-androgenic fractions of both the effluent and influent samples
analysed on GC-MS.
Compound CAS
Number
Fraction Sample Retention
Time (RT)
(min)
Uses Reference
3-chlorobenzoic acid 114521-53-8 23 Effluent 12.11 Unknown -
3,4-dihydrobenzoic acid 99-50-3 24 Effluent 18.09 Unknown -
Tris(2-chloroethyl)phosphate (TCEP) 115-96-8 24 Effluent 17.27 Flame retardant Regnery et
al., 2010
2,4,6-Trimethylbenzoic acid 480-63-7 24 Effluent 13.58 Unknown -
1-Naphthalenecarboxylic acid 86-55-5 25 Effluent 17.58 Unknown -
Diethyltoluamide (DEET) 134-62-3 25 Effluent 14.72 Insect repellent Trenholm et
al., 2008
Bisphenol A 80-05-7 27 Influent 22.73 Plastic anti-
oxidant
Fromme et
al., 2002
Naproxen 22204-53-1 29 Influent 21.25 Anti-
inflammatory
Carballa et
al., 2004
Chloroxylenol 88-04-0 31 Effluent/Influent 12.32 Anti-bacterial Kaspryzyk-
Hordern et
al., 2008
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Table 3.9 continued: Summary of environmental compounds detected in anti-androgenic fractions of both the effluent and influent
samples analysed on GC-MS.
Compound CAS
Number
Fraction Sample Retention
Time (RT)
(min)
Uses Reference
Tris(1-chloro-2-propyl)phosphate 13674-84-5 33,34 Effluent/Influent 17.91 Flame retardant Meyer and
Bester,2004
Dichlorophene 97-23-4 34,35,36,37,38 Effluent/Influent 23.83 Pesticide Hill et
al.,2010
Diclofenac 15307-86-5 37 Effluent/Influent 23.67 Anti-inflammatory Carballa et
al., 2004
Ibuprofen 15687-27-1 37,38 Influent 15.35,15.38 Anti-inflammatory Carballa et
al., 2004
Chlorophene 120-32-1 40 Effluent/Influent 19.24 Biocide(germicide) Boyd et al.,
2003
Triclosan 3380-34-5 45,46 Effluent/influent 21.85 Anti-bacterial
agent
Sabaliunas
et al.,2003
Tris(2-butoxyethyl)phosphate 78-51-3 46 Effluent 24.74 Plasticiser, flame
retardant
Bester and
Schafer.,
2009
Galaxolide 1222-05-5 58 Effluent/Influent 18.48,18.46 Fragrance Carballa et
al., 2004
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Table 3.9 continued: Summary of environmental compounds detected in anti-androgenic fractions of both the effluent and influent
samples analysed on GC-MS.
Compound CAS
Number
Fraction Sample Retention
Time (RT)
(min)
Uses Reference
Abietic acid 514-10-3 58,59,60 Influent 24.83 Resin acid Wang et al.,
1995
Isopimaric acid 471-74-9 58.59 Influent 24.04 Resin acid Lacorte et
al.,2003
N-Butylbenzensulfonamide (NBBSA) 3622-84-2 32,33 Effluent/Influent 17.60 Plasticiser Pederson et
al., 2005
Pimaric acid 127-27-5 58,59 Influent 23.91 Resin acid Lacorte et al.,
2003
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In addition to the list of compounds tabulated, there are other two categories that would be
interesting to report. The first group consists of compounds that have been identified but
were not commercially available and, as a result, their mass spectra are not available to
compare analytically with that of the corresponding samples (Table 3.10).
Table 3.10: Compounds detected in wastewater samples and could not be tested due to
either non-availability commercially or inconclusive on-going analysis.
Compound Sample Fraction Retention
Time (min)
Status
1,1-biphenyl-4,4-dicarboxylate Effluent 19,20 26.52, 26.50 NA
6-hydroxy-α-methylnaphthalene
Acetate
Effluent 20 22.13 NA
3,4-dihydrophenylethane Influent 28 17.88 NA
Carbamazepine ether Effluent 22 23.39 NT
Carbamazepine Effluent 22 24.30 NT
1,4-benzenecarboxylic acid Effluent 24 17.66 NT
NA: Not available commercially for purchase; NT: Identified but not confirmed.
The second group concerns prominent chromatograms of unknown compounds that have
been discovered in active fractions of either the effluent or influent but could not be
identified. Some chromatograms of these unknown compounds can be found in Appendix
D.
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3.7 Discussion
3.7.1 Method Development.
The recovery studies undertaken (Table 3.7) have indicated that there is a
significant improvement to the overall recovery process.  It is difficult to pinpoint whether
the improvement to the recovery was brought about by substituting the HPLC injection
solvent or by any revised area of the methodology as the data to identify the cause are not
available. Also, it is not known if the scheme for this analysis (Section 3.2.2) had
significantly helped in reducing the possible channels for losing anti-androgenic activity
since stepwise data to justify it are not available. What is known was that the process of
sample resuspension occurred about five times throughout the laboratory activities. In
Chapter Two, however, sample resuspension exceeded six times during the determination
of total anti-androgenic activity alone due to sample toxicity. It is possible for the losses to
have occurred during this exercise but there is no statistical data to justify this observation.
In the new methodology, ethyl acetate (EtAc) was replaced with dichloromethane (DCM)
because it possesses higher dielectric constant (εᵣ=9.1) which makes it a better polar aprotic
solvent over EtAc. It is not known if the substitution has significantly impacted the process
of recovery as their contributions were not measured. For improved recovery of the target
analytes, sample recovery test was conducted on seven cartridges using test standards with
a range of polarities (LogKow: 3.10-7.44) and produced some remarkable results. Oasis®
HLB demonstrated the potential to produce optimal recovery among the cartridges tested as
the percentage recovery of test standards was between 94 and 100% (Table 3.2; Appendix
A). The results of the test standards justified the choice of Oasis® HLB for this wastewater
clean-up and analyte pre-concentration. Evans (2008) suggested the use of Oasis® HLB in
her previous work for wastewater clean-up process. Generally, polymeric sorbents (as
exemplified by Oasis® HLB) have multiple analyte retention potentials when compared to
silica-based extraction sorbents (Benijts et al., 2004). In addition, the microtitre polystyrene
plates used for the AYAS assay were substituted with deep well microtitre polypropylene
plates which allowed the use of the non-polar hexane solvent as well as DCM for
application of compounds which were not soluble in ethanol.
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3.7.2 Total Anti-androgenic Activity of Effluent Samples
The effluent extracts recorded total anti-androgenic activities with a mean of 0.219
mgFeq/L and a standard deviation of 0.008 as well as a standard error of mean of 0.005.
The results indicated good repeatability of the replicate grab samples. The TAA of the
effluent samples occurs within the range reported in other published works. Johnson et al.
(2007b) reported anti-androgenic activity in the range of concentration when effluent
samples collected and analysed in August 2003 were analysed. Evans (2008) recorded
approximately twice the concentration of the Horsham effluent reported in this study for
samples extracted in November 2005 (ibid.). Five UK WwTPs which were sampled and
investigated for anti-androgenic activity in 1999 produced a range of concentrations
between 0.055 and 3.770 mgFeq/L (Kirk, 2002).  A similar study carried out on forty-three
UK WwTP effluent samples reported TAA between zero and 1.231mgFeq/L (Johnson et
al., 2007b). The results of the influent samples collected in Chapter Two are comparatively
studied with that analysed in this section. While the samples analysed in Chapter Two were
collected in February, those analysed in this Chapter were sampled in September. By
implication, the equivalent quantity of samples analysed in this section are expected to
produce anti-androgenic activity higher in magnitude than those analysed in Chapter Two.
This is because samples collected and analysed in summer are expected to contain total
anti-androgenic activity more than their equivalent analysed in rainy season. However, the
fact that the samples in this Chapter were analysed 72 hours after collection has affected
that line of thinking. Given the level of bacterial degradation expected to occur in 72 hours
of storage, the amount of anti-androgenic activity recorded in this section is not unexpected
as the magnitude would reduce comparatively to that reported in Chapter Two. In addition,
the repeatability and precision shown by the results in this section are statistically better
than that expressed in Chapter Two.
3.7.3 Total Anti-androgenic Activity of Influent Samples
The influent samples collected from Horsham WwTP were also analysed using
AYAS. The average total anti-androgenic activity of influent samples of 3.198mgFeq/L
was measured in standard deviation of 0.025 and standard error of mean of 0.014. There are
few studies available about anti-androgenic activity of wastewater influent. Moreover,
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effluents are mainly the class of wastewaters that are usually released into the receiving
rivers after treatment. This may possibly explain why influent samples are less studied
compared to effluent samples. Nevertheless, studies conducted on influent samples are used
to predict and estimate the level of AA contained in the sewage in-flow and determine to
what extent the removal process has been successful. More importantly, the study will be
needed to predict the long-term account of bioaccumulation in aquatic environments. As
emphasised in Section 3.7.2, the level of anti-androgenic activity of influent samples in this
section is higher in magnitude compared to the equivalent analysed in Chapter Two as they
were collected in summer. The reason can be attributed to the fact that both samples were
collected and analysed at different seasons of the year (indicated in Section 3.7.3). The
results of influent samples in this section clearly show a degree of repeatability and
precision that are statistically better than those analysed in Chapter Two.
3.7.4 Toxicity Identification and Evaluation (TIE) of fractions
HPLC fractionation and profiling for anti-androgenic activity using the yeast screen
is a significant way of determining and characterising the nature of biological activity
exhibited by chemical compounds in environmental samples. It can also help in controlling
the potential errors which may be associated with the identification of chemical causative
agents of some biological effects.  The profiles of the control, influent and effluent have
offered useful information especially those related to the identification of active compounds
present in the analysed wastewater samples.  First, the shift in density of anti-androgenic
activity from mildly polar and non-polar in influent to polar fractions in effluent samples is
remarkable and may be explained in two possible ways: biodegradation and adsorption.
Most mildly polar and non-polar compounds are eliminated at the biological stage of
wastewater treatment process via biodegradation and chemical adsorption. During the
treatment process, less degradable polar compounds are rarely removed and were neither
adsorbed into the sediment bed (Li et al., 2000).  Most of these compounds are passed into
the receiving rivers. In addition, the polar section of the influent may have undergone
biodegradation including deconjugation of any glucuronide or sulphate conjugates. These
processes, in addition to previously described elimination means, may account for the
emergence of anti-androgenic activity in the polar region of the effluent samples.
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3.7.5 GC-MS Analysis of Compounds Detected in Wastewater Fractions.
The GC-MS chromatograms of the active influent and effluent fractions analysed
generated some interesting results. A variety of chemical compounds which were
discovered are largely components of home-use consumer products. These ranged from
pharmaceuticals, flame retardants, insect repellent, plastic anti-oxidants, plasticisers,
pesticides to wood resin acids. Several studies on wastewater effluents and influents have
reported the occurrence of this range of compounds. Pharmaceuticals such as ibuprofen,
naproxen and diclofenac have been detected in wastewaters in USA and Europe. These
three pharmaceutical compounds are widely used as analgesic and antiphlogistic (anti-
inflammatory) drugs in the management of inflammatory and arthritic conditions
(Blagbrough et al., 1992). Miao and co-workers (2002) reported the discovery of ibuprofen,
naproxen and diclofenac in Canadian wastewater samples taken from two treatment works.
In Germany, Ternes (1998) reported the recovery of some other pharmaceuticals in addition
to the three (ibuprofen, naproxen and diclofenac) in effluent discharges of Sewage
Treatment Plants.  Koutsouba and colleagues (2003) discovered diclofenac and ibuprofen in
Greece influent and effluent wastewater samples. Similar studies conducted in Spain
(Carballa et al., 2004), Austria (Clara et al., 2005), Finland (Vieno et al., 2005), Brazil
(Stumpf et al., 1999) and United States of America (Kolpin et al., 2004; Barnes et al., 2008;
Stackelberg et al., 2004) have also confirmed the recovery of these three compounds and
many other pharmaceutical products in their influent and effluent samples.
In addition to the pharmaceuticals, some pulp and paper mill resin acids comprising
of abietic acid, isopimaric acid and pimaric acid were identified in this study. Larcote and
co-workers (2003) reported the identification of this class of acids in pulp and paper mill
effluents as well as wastewater receiving rivers (see also Kalpin et al., 1997; Leppanen et
al., 1998). Significant amount of TCPP, Tris(2-butoxyethyl)phosphate (KP-140) and TCEP,
known as flame retardants and plasticisers, have also been detected in wastewater
discharges (Fries and Püttmann, 2003; Meyer and Bester, 2004; Martinez-Carballo et al.,
2007; Bester and Schafer, 2009). Like other flame retardants, they are composition of
foams used for furniture and bedding purposes. Likewise, chemical compositions of
cleaning facilities were discovered in wastewater samples and they include chloroxylenol,
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triclosan and chlorophene (Sabaliunas et al., 2003; Boyd et al., 2003; Kaspryzyk-Hordern et
al., 2008).  Other compounds reported in previous literature include dichlorophene,
bisphenol A and diethyltoluamide (DEET). The dichlorophene discovered is suspected to
emerge from agricultural input given that it is used as pesticide. Evans (2008) likewise
reported the occurrence of dichlorophene in the effluent fractions analysed. Bisphenol A is
an active component of plastics and plastic materials. Given that it is one of such high
production volume compounds, it is expected that the concentration in the environment will
be relatively substantial. DEET is a regularly used domestic chemical to reduce the menace
of insects. Their occurrence in the environment is highly expected.
The recovery studies also justified the development of the methodology as the
results indicated good recovery for both influent and effluent samples.
3.8 Conclusion
Horsham wastewater samples are complex heterogeneous mixture of a wide range
of discharges from household, agricultural settlements, hospitals and commercial
establishments. The results of this study revealed that Horsham Wastewater Treatment
Works are receiving largely from domestic sources. Although the broad spectrum of
compounds detected in these samples is a representative of several sources such as
household, industrial, agricultural and medicinal consumables, all the compounds identified
(except resin acids which originate form paper mill industry) are used in the domestic
environment. The results have also provided an evaluation of the WwTP’s efficiency at
removing these compounds. Contrasting the total anti-androgenic activity of both the
influent and effluent in this study, it could be reported that about 90% of the anti-
androgenic activity was eliminated after treatment. The TIE studies demonstrate the
presence of steroid receptor active chemicals as clearly expressed in the profiles of the
influent and effluent fractions. It is impossible for an in vitro bioassay to solely account for
all internal responses of any intact animal with respect to EDCs. For this reason, it will be
necessary for the biological activity of all the compounds detected to be characterised. In
addition, the quantity of the active compounds in wastewaters must be evaluated. Above
all, their contributions to the total anti-androgenic activity must also be determined in both
the fractions and generally in the whole samples.
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CHAPTER FOUR
Confirmatory Tests for Receptor-active Xenobiotic Anti-androgens in
Wastewater Influent and Effluent Samples
4.0 Introduction
Wastewaters contain numerous xenobiotics that possess androgen receptor
antagonist activity. Profile studies of wastewater fractions in Chapter Three showed the
occurrence of fractions with anti-androgenic activity from which over thirty xenobiotic
compounds have been identified. Wastewaters are known to originate from several
sources including hospital, domestic, industrial and agricultural sources. Many
compounds identified in Chapter Three have been traced to regular household products
such as pharmaceuticals, fragrances, flame retardants, plasticizers, insect repellent,
cosmetics and skin care, and other personal care products (Carballa et al., 2004;
Eriksson et al., 2002; Pederson et al., 2005) while few others can be linked to industrial
sources. The androgen receptor antagonist activity of most compounds identified in the
previous chapter is currently unknown; therefore, this study will focus on the
determination of their AA.
It is possible for some environmental compounds known to undergo receptor-
specific binding to interact with a wide range of other hormone receptors in vivo or in
vitro. Nonylphenol and bisphenol-A are estrogen agonists that could interact with
androgen and thyroid receptors to inhibit their binding abilities in vivo and in vitro.
Whereas nonylphenol antagonises the binding of triiodothyronine (T3) to transthyretin
in chicken and bullfrog, bisphenol-A successfully inhibits T3 binding to thyroid receptor
in mammal (Yamauchi et al., 2003; Moriyama et al., 2002). In addition, nonylphenol as
well as bisphenol-A could prevent androgen receptor binding and interaction to
coactivators (Lee et al., 2003). Gene expression could also be induced when bisphenol-
A interacts with progesterone receptors in rat uterus (Krishnan et al., 1993).  There is a
possibility that exposure to mixtures of receptor-active contaminants could result in
health diminishing effects in humans. For instance, the widespread increase of male
reproductive disorders in recent decades has been linked to the interactions of
environmental anti-androgens (and xenoestrogens) with wildlife and humans (Chen et
al., 2007). Laboratory studies have confirmed that exposure to bioactive xenobiotics
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such as 4-tert pentylphenol (TPP), dibutylphthalate (DBP) and diethylhexylphthalate
(DEHP) can result in disruption of sexual differentiation in rodents (Gimeno et al.,
1997; Mylchreest et al., 1998, 1999, 2000; Sharpe, 2006; Sultan et al., 2001a,b). In
humans, reproductive health defects that have been linked to chemical contamination
include reduced fertility and  reduced sperm count, motility and quality (Carlsen et al.,
1992; Swan et al., 1997; Andersen et al., 2000), increase in hypospadias, cryptorchidism
or undescended testis (Chilvers et al., 1984; Matlai and Beral, 1985; Toppari et al., 1996
and Paulozzi et al., 1997), increases in abnormal genitalia, testicular cancer (Adami et
al., 1994;  Forman and Moller, 1994), intersex (Reeder et al., 1998) and impaired
hormone production (Roy and Pereira, 2005).
A wide variety of bioactive chemicals identified as endocrine disruptors occur in
the environment as mixtures. While it is possible for bioactive chemicals to act mutually
exclusively of another, it is also possible for some to exhibit biological activity together
that could be additive, inhibitive or synergistic. The collective activity of bioactive
compounds in environmental samples is determined largely by the potency of the
contributing compounds and their concentrations as well as their overall chemical
interactions at the receptor level which will influence the final activity of the sample
mixture. When a compound demonstrated high level of activity at minimum
concentration in an isolated state or sample mixture it is considered more potent than
that which produced the same result at high concentration. To estimate the contribution
of each anti-androgenic compound in a complex environmental mixture, it is necessary
that its potency relative to a standard must be known. For that reason, this study will not
only identify potentially androgen receptor antagonists from the list of compounds
identified in Chapter Three but it will also estimate their potency relative to flutamide.
Screening such a wide array of compounds for anti-androgenic activity can effectively
be achieved with the in vitro yeast androgen screen assay (AYAS) which has been
proven successful and reliable in previous uses in this study. Much as AYAS has
demonstrated to be suitable for this screening exercise, care needs to be taken in
ensuring that a depression in the response of the assay is due to receptor antagonism and
not due to toxicity to the yeast or the galactosidase reporter gene product.
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The aims of this study are to:
1. Determine the receptor antagonist activity and potency of the
xenobiotics identified in the wastewater extracts in Chapter
Three.
2. Determine the degree of their anti-androgenic activity (potency)
relative to the standard anti-androgen flutamide.
3. Quantify the concentration of anti-androgenic compounds both in
the fractions and in the total wastewater samples.
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4.1 Materials and Methods
4.1.1 Materials
Galaxolide was a generous gift from the president, American Research Institute
of Fragrance Development (ARIFD). Naproxen, dichlorophene, chlorophene,
bisphenol-A, diclofenac, ibuprofen, abietic acid, isopimaric acid, pimaric acid, triclosan,
diethyltoluamide (DEET), 2,4,6-trimethylbenzoic acid, 1-naphthalene carboxylic acid,
3-chlorobenzoic acid, tris(2-butoxyethyl)phosphate (TBEP), tris(1-chloro-2-
propyl)phosphate (TCPP), tris(2-ethylchloro)phosphate (TCEP), N-
butylbenzenesulfonamide (NBBSA), chloroxylenol, deuterated estrone and deuterated
p,p-DDE were purchased from Tokyo Chemical Industry (TCI), UK, Sigma-Aldrich,
Fluka, Aldrich, Sigma and micronOrganics (see Section 3.2.1). All the materials used
for the yeast assay are outlined in Chapter Two, section 2.1.1.
4.1.2 Methods
4.1.2.1 Confirmation of Anti-androgenic Activity of Compounds Using Yeast
Screen Assay.
Yeast androgen screen (AYAS) assay for this experimental work (described in
Section 2.2.3.4, Chapter Two) was prepared and set-up such that the first three rows of
the plates were assayed with flutamide standard curve, the media blank and the ethanol
blank respectively. The other five rows were used to assay test samples. This plate
arrangement was replicated in two other separate plates in every test exercise
undertaken. The test compounds were prepared in ethanol in a range of concentrations
(1x10-10M to 1x10-5M) and were assayed in replicate to establish the degree of
repeatability of the screen. Each test concentration was replicated on different plates to
prevent interference through intra-well creeping. The absorbance values of the test
samples were taken with a spectrophotometer at 540nm to determine and measure the
anti-androgenic activity, and at 620nm to determine the turbidity of the yeast cells. The
results were analysed and are expressed as mean±SD and %RSD as described in Section
3.6.3.
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4.1.2.2 Identification of Turbidity of Endocrine Disrupting Chemical Compounds
on Yeast Androgen Receptor Transcription Screen
Xenobiotics demonstrate androgen receptor antagonism by inhibiting the true
response on yeast androgen transcription screen (AYAS). The true response on AYAS
corresponds to the linear expression of the androgen standard (DHT) on absorbance
2.45 (Figure 4.1). At the cellular level, interactions of the yeast cells in the AYAS with
anti-androgenic compounds could either bind the androgen receptor to inhibit the
expression of the androgen standard (DHT) or interfere with the usual cellular
functions. At concentrations below the lethal dose (LD), anti-androgens bind with the
androgen receptors which are incorporated on the yeast cytoplasm to produce a response
that is directly proportional to the concentration of the compounds applied.  The
responses generated by the yeast cells over a wide range of concentrations on the plate
are expressed as a reverse-sigmoid curve replica of the flutamide standard curve (Figure
4.1). The AA of these chemical compounds can be accurately estimated when the
turbidity measurement at 620nm (which expresses variation in the growth of the yeast
cells) is mathematically incorporated into the AA measurement undertaken at 540nm.
The turbidity removes the overestimation that is likely to occur during 540nm
measurement thus adjusting it to the appropriate value of AA (see Section 2.3.5).
However, when the yeast environment becomes unfavourably toxic, the anti-androgenic
activity cannot be accurately determined as the cellular configuration may be ruptured
thereby impeding the growth of the yeast cells in addition to disrupting the regular
biological activity carried out by the cells. Such unfavourable environment could be
created when the concentrations of the anti-androgens reach or exceed the LD. Sample
toxicity is estimated from the 620nm readings of the test compounds in relation to the
ethanol controls. If the 620 values of the sample fall below the mean±2SD of the
ethanol controls, then the sample is deemed to be toxic in the AYAS and an estimate of
anti-androgenic activity cannot be accurately made at that particular sample
concentration. An example of an absorbance-concentration curve of a sample showing
no toxicity and one showing clear toxicity in the AYAS are given in Figures 4.2A and
4.2B respectively. Under toxic condition, the difference between the 620nm readings of
both the test compound and the ethanol control can become relatively large (Figure
4.2B). In this study, it must be stated that any sample absorbance which falls within the
mean-2SD of the ethanol reading at 620nm is considered non-toxic.
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Figure 4.1: Schematic illustration of anti-androgenic activity-concentration relationship
of endocrine disrupting chemicals expressed on the yeast assay. The plots are expressed
in 540nm and 620nm absorbance. The curve section AC measures the effective
response (anti-androgenic activity) of the compounds on yeast. It represents 10-90% of
the dynamic signal range. Lines ED and BF correspond to the lowest and highest
concentration of the test compounds on the assay plate. The turbidity threshold,
measured in 620nm, refers to the background noise (mean-2SD) line and it demarcates
the region of activity (above the turbidity threshold line) and toxicity (below the
turbidity threshold line)
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Figure 4.2: Diagrams showing the two possibilities at turbidity threshold at absorbance
of 620nm. Figure 4.2A shows very close absorbance values of both the ethanol medium
and the sample (sample620nm). Figure 4.2B shows a wide deviation in absorbance
values between the ethanol medium and the sample values. Figure 4.2A indicates
turbidity of the sample is similar to that of the ethanol medium, whereas Figure 4.2B
indicates that the test compound is showing toxicity.
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4.1.2.3 Determination of In Vitro Biological Potency of Identified Anti-androgenic
Compounds.
AYAS was adapted for determining the potency of anti-androgenic xenobiotics
identified in Section 4.1.2.1. The plate was prepared similar to Section 4.1.2.3 such that
the flutamide standard curve, the medium blank and the ethanol blank occupied rows
one, two and three respectively. The test compounds obtained as pure standards were
prepared over a range of concentrations and were replicated into different plates to
eliminate interference which may be caused by inter-well creeping. The plates were
incubated and read using a spectrophotometer at 540 nm and 620 nm. The absorbances
of the standard and the test samples were incorporated on the Excel Program designed
to analyse the results. The EC50 concentration (mg/L) of the test compounds and the
standards was determined within the range of common mid-value (EC50) absorbance.
The EC50 values were calculated in terms of the standard equivalence using standard
non-linear regression analysis methods. The potency was evaluated based on the EC50
concentration (mg/L) of the test compounds and that of the standard.  Potency (P) of
any given anti-androgenic compound is calculated as
P = EC (Standard)EC (Anti − androgenic Compound)
The EC50 corresponds to the concentration of the standard or test compounds that will
produce 50% maximal effects on the sigmoid curve.
4.2 Calibration and Quantification of Anti-androgenic Concentration in the Target
Fractions of the Wastewater Samples.
The concentration of the identified anti-androgens in the fractions of wastewater
samples was determined using calibration curve method.  A range of stock solutions
containing the mixture of all the confirmed anti-androgenic compounds was made up.
The concentration of each contributing compound which ranged from 300pg to 1000ng,
was spiked with 300ng each of deuterated estrone (E1-d4) and p,p-DDE (internal
standards). After reconstitution in 60µL BSTFA/pyridine solution (3:1, v/v) as
described in Section 3.6.2, they were heated for 30 minutes in a heat block. 1µL of the
derivatised calibration samples was injected automatically into the GC-MS using the
program described in Section 3.6.3. The calibration curve was constructed by measuring
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the peak areas of each compound and the internal standards in the fractions using the
most abundant fragment ions (for compounds) and molecular ion (for E1-d4). The ratio
of the peak areas of the compound and the molecular ion of E1-d4 (m/z= 346) was
evaluated and used to produce the calibration curve with respect to the concentration of
the compound and the results are shown in Table 4.4.
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4.3 Results
4.3.1: AYAS Assay of Anti-androgenic Compounds Tested.
The AA of the compounds detected in sample fractions in Chapter Three was
determined using AYAS (described in Section 2.3.4) and the readings were analysed
using the Excel program designed for it. The positive response on the yeast assay
resulted in a reverse-sigmoid curve (Figure 4.1) and 620nm absorbance values within
the (mean-2SD) turbidity allowance. The cross-section of TCPP plates indicated a
transition from orange colour (anti-androgenic points on the curve) to red (non-anti-
androgenic points) at flutamide concentration explained in Section 4.1.2.2. However,
the plot of TCPP response is somewhat short of full sigmoid (Figure 4.3). At
concentration of greater than 400mg/L, TCPP is generally toxic.
Figure 4.3: The plot of absorbance against concentration (0.20-400mg/L) expressing
anti-androgenic response of TCPP on yeast anti-androgen screen (AYAS) assay. The
dose-response curve is plotted as the mean response of the TCPP replicates (n=3) and
the error bar is expressed as one standard deviation (±SD) of the response.
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Figure 4.4: Comparison between the 620nm absorbance values of the ethanol medium
and that of TCPP sample.
Although three isomers of TCPP were identified in the wastewater samples only
isomer I was commercially available for testing. The response curves (Figures 4.3 and
4.4) generated on the AYAS indicated that TCPP (isomer I) is anti-androgenic at the
level of the test concentration used. At a corresponding absorbance that produced a
flutamide concentration of 2.04mg/L at EC50, TCPP produced an EC50 concentration of
41.78 mg/L that results in a relative potency of 0.04.
Conversely, chloroxylenol produced a good response on the AYAS (Figure 4.5)
confirming that it possesses anti-androgenic activity at the test concentration. At
flutamide EC50 absorbance, flutamide and chloroxylenol produced EC50 of 2.12mg/L
and 10.62 mg/L respectively resulting in a relative potency of 0.20. Chloroxylenol
showed no indication of toxicity at a concentration range of 0.02-100mg/L. The 620nm
absorbance readings, presented graphically in Figure 4.6, show deviation that falls
within the (mean-2SD) absorbance of ethanol medium which is the turbidity allowance.
Triclosan is another compound whose response on the yeast assay produces a
good curve (Figure 4.7) and has been identified to have anti-androgenic activity at
concentration range of 0.02-20mg/L. The comparison between the 620nm absorbance
values of triclosan and ethanol medium (Figure 4.8) indicates that triclosan is turbid at
the test concentration. It produces a relative potency of 5.20 from concentrations of
0.41mg/L (flutamide) and 2.12mg/L (triclosan) at EC50 absorbance of flutamide.
Similarly, the assay of abietic acid produced a positive anti-androgenic response at a
concentration range of 1.25x10-3-5mg/L (Figure 4.9). The expression of toxicity was
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clearly demonstrated when the concentration of abietic acid was greater than 5mg/L
(Figure 4.10) and the yeast assay also showed some traces of cell lysis indicating the
extent of toxicity at such concentration.
Other compounds tested and found to express anti-androgenic activity on the AYAS are
reported in Figures 4.11 as well as Tables 4.1 and 4.2.
Figure 4.5: The plot of absorbance against concentration (0.05-100mg/L) expressing
anti-androgenic response of chloroxylenol on yeast anti-androgen screen (AYAS) assay.
The dose-response curve is plotted as the mean response of the chloroxylenol replicates
(n=3) and the error bar is expressed as one standard deviation (±SD) of the response.
Figure 4.6: Diagram of 620nm absorbance of chloroxylenol and ethanol medium.
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Figure 4.7: Graphical relationship between absorbance and concentration (0.02-
20mg/L) expressing anti-androgenic response of triclosan on yeast anti-androgen screen
(AYAS) assay. The dose-response curve is plotted as the mean response of the triclosan
replicates (n=3) and the error bar is expressed as one standard deviation (±SD) of the
response.
Figure 4.8: Response of triclosan and ethanol medium measured relative to sample
concentration on the AYAS at 620nm absorbance to evaluate the possible occurrence of
toxicity during the AA investigation.
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Figure 4.9: The plot of absorbance against concentration expressing anti-androgenic
response of abietic acid on yeast anti-androgen screen (AYAS) assay. The dose-
response curve is plotted as the mean response of the abietic acid replicates (n=3) and
the error bar is expressed as one standard deviation (±SD) of the response.
Figure 4.10: Comparison between the 620nm absorbance readings of abietic acid and
ethanol medium to determine possible occurrence of toxicity during the AA evaluation.
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4.3.2: Potency of the Anti-androgenic Compounds Detected with Respect to
Flutamide
The potency of anti-androgenic compounds is determined by measuring the
concentration that correlates with the EC50 absorbance of flutamide on the
concentration-absorbance scale. The repeatability of the assay is evaluated by taking the
mean of the results generated from the replicated assay. The summary of the relative
potency of all the anti-androgens as well as their chemical structures are provided in
Table 4.1 and Figure 4.11 respectively.
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Figure 4.11: Structures of compounds tested and found to exhibit androgen receptor
antagonistic activity in vitro.
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Table 4.1: Table of the relative potency and anti-androgenic activity of compounds
identified in WwTP samples.
Compound Mean EC50 of
Compound
(mgFeq/L)*
Mean
EC50 of
Flutamide
(mgFeq/L)
Potency
relative
to
flutamide
Mean±Std
EC50 of test
compound
(mgFeq/L)
%RSD EC50
of
measurement
in AYAS
Abietic acid 0.49 2.10 4.29 0.49±0.01 2.04
Bisphenol A 3.73 2.09 0.56 3.73±0.03 0.80
Chlorophene 0.16 2.12 13.3 0.16±0.02 12.5
Chloroxylenol 10.62 2.12 0.20 10.62±0.06 0.56
Dichlorophene 0.43 2.26 5.26 0.43±0.01 2.33
Galaxolide 32.29 2.26 0.07 32.29±0.01 0.03
Isopimaric acid 0.39 2.09 5.36 0.39±0.02 5.13
NBBSA 13.51 2.43 0.18 13.51±0.01 0.07
Pimaric acid 0.57 2.09 3.67 0.57±0.01 1.75
TBEP 34.89 2.10 0.06 34.89±0.03 0.09
TCPP 41.78 2.04 0.05 41.78±0.02 0.05
Triclosan 0.41 2.12 5.20 0.41±0.08 19.60
*The mean EC50 of the test compounds was measured with a minimum of three
experimental runs.
The potency of the compounds relative to flutamide ranged from 0.05 to 13.4. TCPP
possesses the least relative potency of 0.05. In all the compounds identified,
chlorophene is the most potent anti-androgen amongst the environmental compounds
analysed. The %RSD values range fairly between 0.03 and 12.50% except for that of
triclosan which was 19.60%.  The following compounds (Figure 4.12) were tested in
addition to those in Figure 4.11 but were discovered to be inactive.
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3,4-dihydrobenzoic acid 2,4,6-trimethylbenzoic acid 3-chlorobenzoic acid
Diethyltoluamide(DEET) Diclofenac Naproxen
Ibuprofen 1-Naphthanecarboxylic acid
Tris(2-chloromethyl)
phosphate (TCEP)
Figure 4.12: The structures of chemical compounds identified in wastewater samples
which are inactive on AYAS.
4.3.3: Calibration and Quantification of Anti-androgenic Compounds in GC-MS
The calibration was carried out using the internal standards (deuterated estrone,
E1-d4 and p, p-DDE-d4). The various identified compounds were injected as a mixture
at a wide range of concentrations spiked with the internal standards (30ng). For the
purpose of calibration and quantification, a fragment ion identified to possess the
highest intensity in the mass spectra was selected for each of the test compounds (Table
4.2).
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Table 4.2: Fragment ions used for the quantification of silylated derivatives of anti-
androgens and the labelled isotope of the internal standards on the GC-MS
chromatograms.
Compound Mass of fragment
ion used for
quantification
Molecular Mass of
non-silylated
compound
Molecular Mass of
silylated compound
Abietic acid 256* 302.45 374
Bisphenol A 357 228.29 372
Chlorophene 290 218.68 290
Chloroxylenol 213 156.61 228
Dichlorophene 377 269.12 412
Galaxolide 243 258.14 243
Isopimaric acid 256* 302.45 374
NBBSA 77 213.30 285.30
*Although the fragment ion 256 is common to abietic acid and isopimaric acid in
addition to having the same molecular mass, which makes the task of distinguishing one
from another difficult, they can be distinguished by the presence of other fragment ions
and their different retention times on the GC-MS.
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Table 4.2 continued: Fragment ions used for the quantification of silylated derivatives
of anti-androgens and the labelled isotope of the internal standards on the GC-MS
chromatograms.
Compound Mass of fragment
ion used for
quantification
Molecular Mass of
non-silylated
compound
Molecular Mass of
silylated compound
Pimaric acid 121 302.45 374
TBEP 57 398.47 398.47
TCPP 99 327.57 327
Triclosan 200 289.54 362
Estrone-d4 346 274.40 346
4.3.3.1: Quantification Parameters and Least-Square Linear Regression
Analysis.
The quantity of each anti-androgenic compound was estimated using internal
calibration. The peak area corresponding to the selected fragment ion of the required
compound was isolated on the chromatogram and related to the peak area of the internal
standard (estrone-d4) measured with the selected fragment ion.  This ratio of the
required compounds to the internal standard was evaluated at various concentration
measurements. The relationship drawn from these parameters was used to estimate the
quantity of each anti-androgen identified in this study (Section 4.3.3.2, Table 4.3).
Examples of such a plot are illustrated with chloroxylenol in Figures 4.13 and 4.14.
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Figure 4.13: The calibration curve of chloroxylenol plotted with linear concentration
range of 300-3000pg.
Figure 4.14: The calibration curve expressing linear relationship between
chloroxylenol/E1-d4 and corresponding chloroxylenol concentration range of 10-
1000ng.
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4.3.3.2:  Linearity of the Calibration Curves Used for Quantification of Anti-
androgens at Various Concentration Ranges.
The linearity of the calibration curves was estimated by taking into account the
various concentration points that form the linear dynamics of all the curves. The
calibration plots used for the quantification of the compounds were generated with no
fewer than six concentration points using the least square linear regression approach.
For the regression plot to be useful, it is necessary to establish whether there is a
relationship between the two variables employed to generate the curve. Otherwise, the
regression approach will not be appropriate for the analysis. The two statistical
parameters commonly used for estimating the suitability of any calibration plots are
coefficient of determination and p-values. They are determined using linear square
regression analysis and chi-square respectively. For example, the chloroxylenol
calibration plots (Figures 4.13 and 4.14) illustrate typical least-square linear regression
used for quantification. At 5% level of confidence, the linear plot points for the first
calibration curve indicate a goodness of fit as they fall within the normal distribution
(P>0.05; n=6). However, the first two points on the second calibration curve show a
slight variation from the range of the normal distribution.
Considering that several linear calibration graphs were prepared to quantify the
wide range of chromatograms associated with each compounds, it is therefore necessary
to select correctly. Generally, selection of calibration plots was made such that each
estimated peak area/E1-d4 in the fraction lies within the range of the calibration plot.
For the purpose of identifying the various calibration plots, a combination of alphabets
and a number codes (EL Reference codes) are assigned to each of the calibration plots
(see Tables 4.3 and 4.4). The low range calibration graphs were generated within the
range of picogram-microgram concentrations whilst the high range calibration graphs
were produced within the range of microgram-milligram concentrations of the
corresponding compounds.
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Table 4.3: Linearity of the calibration plots for quantifying anti-androgens analysed on
the GC-MS chromatograms.
Compound Linear range Equation of
Linearity(EL)
EL
Reference
Code
Coefficient of
Determination
(R2)
Abietic acid 300-2400pg Y=5E-05x-0.0013 AB1 0.986
1.2-25ng Y=0.116x-0.19 AB2 0.945
Bisphenol A NC NA NA
Chlorophene 1.2-25ng Y=0.125x-0.1878 CP1 0.951
Chloroxylenol 300-3000pg Y= 0.0002x-0.036 CX1 0.986
10-1000ng Y=0.0856x-2.5524 CX2 0.992
Dichlorophene 300-2500pg Y=2E-05x+0.0007 DC1 0.979
1.2-50ng Y=0.0464x-0.0743 DC2 0.992
Galaxolide 300-2500pg Y=1E-04x+0.008 GA1 0.997
1.2-50ng Y=0.1006x-0.015 GA2 0.997
1.2-150ng Y=0.1081x-0.0841 GA3 0.999
Isopimaric acid 300-2500pg Y=2E-05x+0.0029 SP1 0.993
1.2-50ng Y=0.0546x-0.078 SP2 0.984
NA: Not available as at the time of preparing this report; NC: Not computed due to non-
availability of calibration plot. The EL Reference Code quoted for each calibration plot
in the table indicates the calibration plot selected to correctly estimate the amount of the
compound present in that fraction.
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Table 4.3 continued: Linearity of the calibration plots for quantifying anti-androgens
analysed on the GC-MS chromatograms.
Compound Linear range Equation of
Linearity(EL)
EL Reference
Code
Coefficient of
Determination
(R2)
NBBSA 5.0-15ng Y=0.014x+0.0135 NB1 0.997
5-20pg Y=2E-04x-0.0177 NB2 0.989
Pimaric acid 2.4-25ng Y=0.0103x-0.0195 PM 0.965
TBEP 10-700pg Y=6E-05x+0.0014 TB1 0.998
0.3-2.0ng Y=4E-03x+1.762 TB2 0.906
TCPP 3-200ng Y=0.039x+0.0458 TC1 0.900
25-1000ng Y=0.004x+0.1269 TC2 0.981
Triclosan 300-2500pg Y=0.0001x-0.0049 TR1 0.988
25-1000ng Y=0.1525x+2.7794 TR2 0.985
1.2-25ng Y=0.2003x+0.2235 TR3 0.958
The EL Reference Code quoted for each calibration plot in the table indicates the
calibration plot selected to correctly estimate the amount of the compound present in
that fraction.
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4.3.3.3: Estimation of AA in Each Fraction Using the Calibration Plots
The amount of the compound (W) present in each proportion of the fraction
analysed was determined by substituting the peak area/E1-d4 (M) as the Y-value of the
appropriate linear graph (EL) expressed in the form of Y=mx+C. The X-value resulting
from the mathematical equation is equal to W where m and C are constants representing
the gradient and the intercept on the Y axis respectively. The detailed summary of anti-
androgenic compounds present in each proportion of influent and effluent fractions
analysed is prepared in Tables 4.4 and 4.5.
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Table 4.4: The concentration of each anti-androgenic compound (measured in
flutamide equivalent) present in a certain proportion of the influent fraction analysed.
They were estimated using their corresponding peak area/E1-d4.
Compound Fraction Peak area
/E1-d4
(M)
EL
Reference
Code
Amount of
Compound derived
from EL (ngFeq/L)
(W)
Abietic acid 58 2.509 AB2 23.267
59 3.004 AB2 27.535
60 0.244 AB1 4.906*
Bisphenol -A 27 10.773 - -
Chlorophene 40 0.920 CP1 8.862
Chloroxylenol 31 14.626 CX2 200.682
W is the amount of each compound present in the proportion of influent fraction
analysed. This is derived from the related linear calibration equation.*Indicates
compounds estimated using low range calibration plots.
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Table 4.4 continued: The concentration of each anti-androgenic compound (measured
in flutamide equivalent) present a proportion of the influent fraction analysed. They
were estimated using their corresponding peak area/E1-d4.
Compound Fraction Peak area
/E1-d4
(M)
EL
Reference
Code
Amount of compound
derived from EL (ngFeq/L)
(W)
Dichlorophene 34 - - -
35 - - -
36 0.032 DC1 1.565*
37 0.897 DC2 20.933
38 8.260x10-3 DC1 0.378*
Galaxolide 58 3.786 GA2 37.783
Isopimaric acid 58 1.682 SP2 32.234
59 0.420 SP2 9.121
NBBSA 32 13.406 NB1 956.607
33 3.873x10-1 NB2 2.025*
Pimaric acid 58 0.307 PM 31.893
59 0.031 PM 4.903
TBEP 46 2.566 TB2 201.041
TCPP 33 10.319 TC2 2548.025
34 0.198 TC2 17.775
Triclosan 45 0.192 TR1 1.969*
46 31.440 TR2 187.938
W is the amount of each compound present in the proportion of influent fraction
analysed. This is derived from the related linear calibration equation.*Indicates
compounds estimated using low range calibration plots.
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Table 4.5: The concentration of each anti-androgenic compound (measured in
flutamide equivalent) present in a proportion of the effluent fraction analysed. They
were estimated using their corresponding peak area/E1-d4.
Compound Fraction Peak area
/E1-d4
(M)
EL Reference
Code
Amount of compound
derived from EL
(ngFeq/L)(W)
Abietic acid 58 - - -
59 - - -
60 - - -
Bisphenol -A 27 0.016 - -
Chlorophene 40 2.305 CP1 19.942
Chloroxylenol 31 5.303 CX1 26.695*
Dichlorophene 34 4.29x10-3 DC1 0.180*
35 2.85x10-3 DC1 0.108*
36 9.16x10-3 DC1 0.423*
37 10.942 DC2 234.420
38 8.67x10-3 DC1 0.398*
Galaxolide 58 6.228 GA3 58.391
Isopimaric acid 58 - - -
59 - - -
NBBSA 32 10.784 NB1 769.321
33 7.39 NB1 526.893
W is the amount of each compound present in the proportion of effluent fraction
analysed. This is derived from the related linear calibration equation.*Indicates
compounds estimated using low range calibration plots.
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Table 4.5 continued: The concentration of each anti-androgenic compound (measured
in flutamide equivalent) present in a proportion of the effluent fraction analysed. They
were estimated using their corresponding peak area/E1-d4.
Compound Fraction Peak area
/E1-d4
(M)
EL
Reference
Code
Amount of compound derived
from EL (ngFeq/L) (W)
Pimaric acid 58 - PM -
59 - PM -
TBEP 46 8.416 TB2 1663.50
TCPP 33 11.816 TC2 2922.275
34 0.734 TC2 151.775
Triclosan 45 0.211 TR1 2.159*
46 3.235 TR3 15.035
W is the amount of each compound present in the proportion of influent fraction
analysed. This is derived from the related linear calibration equation.*Indicates
compounds estimated using low range calibration plots.
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4.3.3.4: Quantity and Contributions of Identified Compounds to Total Anti-
androgenic Activity of Wastewater Fractions
The amount of each compound estimated using the calibration graphs (Section
4.3.3.3) corresponds to the peaks of the chromatograms as well as the anti-androgenic
activity of the compounds present in the proportion of the fractions analysed.  Given
that a representative proportion of the samples was analysed and that such measure-
ments were estimated in flutamide equivalent, it will be appropriate to estimate the AA
of the compounds contained in the whole sample as well as express the outcome in a
universal measurement independent of flutamide. The process of estimating the amount
of AA can be achieved in two steps. First, the amount of AA present in 1mL of the frac-
tion in flutamide equivalent must be determined. Second, the amount of each compound
present in the whole sample in ng/L must also be estimated (Tables 4.6 and 4.7).
Chloroxylenol has been chosen to explain how the concentrations of compounds
which were originally estimated in flutamide equivalent are estimated in ng/L meas-
urement independent of flutamide. It can be recalled that the amount of chloroxylenol
contained in the fractions of wastewater fractions was estimated with the low and high
calibration graphs (CX1 and CX2) relative to flutamide (Figures 4.13 and 4.14). The
calibration graphs were generated with the best points of fitness which produced coeffi-
cient of determination above 0.95. Chloroxylenol was detected in influent and effluent
fractions 31 with peak area/E1-d4 of 14.626 and 5.303 respectively. To estimate the
amount of anti-androgenic activity (C) in 1mL of each fraction in flutamide equivalent,
the following equation is used,
C =
where W= the concentration of compound generated from the appropriate calibration
plot using the peak area/E1-d4; V= the volume (µL) taken for analysis from 1mL of
fraction produced during sample fractionation on the HPLC and 1000= the conversion
factor (from µL to mL). Therefore, for chloroxylenol having W of 200.682ngFeq/L in
influent (Table 4.4) and 26.695ngFeq/L in effluent (Table 4.5) and V of 500µL (for both
influent and effluent fractions), their C values will be 401.364ngFeq/L (Table 4.6) and
53.39ngFeq/L (Table 4.7) respectively. It is important to note that 77.75mL of influent
sample (as well as 1700.2mL of effluent sample) fractionated on the HPLC resulted in
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1mL of each fraction. Therefore, it can be inferred that each anti-androgenic compound
estimated in these fractions is equivalent to the TAA of the compound in 77.75mL of
influent sample (or 1700.2mL of effluent sample) analysed.
The next process is to express the amount of each compound present in each
fractions of the whole sample in ng/L given that they currently exist in flutamide equiv-
alent. By applying the equation of potency in Section 4.1.2.3 and the relative potencies
of the compounds, the values of the compounds (C), estimated in flutamide equivalent,
can be converted to ng/L. The amount of AA (ng/L) is expressed mathematically as
AA = 1000PCH
where P is the potency of the compound, C is the amount of the compound present in
1mL of the fraction and H is the volume-equivalent of either influent or effluent sam-
ples fractionated. The value of H for influent and effluent is 77.75mL and 1700.2mL
respectively. The quantification step (with the ratio ) has simultaneously factored
the amount of wastewater samples analysed into the results. Where a compound is pre-
sent in more than a fraction, the TAA of the compound is calculated by adding the AA
present in all the fractions. For chloroxylenol with relative potency of 0.20, the amount
detected in fraction 31 was estimated as 40.14ng in 77.75mL of influent and 5.34ng in
1700.20mL of effluent which correspond to 1032.45ng/L and 6.28ng/L of the samples.
In addition, their calibration plots are also provided in Appendix E. The percentage con-
tribution of each compound to the TAA of each fraction was also calculated by finding
the percentage of AA in the fraction (C) relative to the TAA of the fraction (see Appen-
dix F). This can be related mathematically thus:
% Contribution of the compound to TAA of the fraction= x100
As explained above, C is the amount of AA in 1mL of the fraction and it is expressed in
ngFeq/L. For chloroxylenol, its percentage contribution to the TAA of the influent and
effluent fractions is 80.27% and 1.72% respectively. The comprehensive summary of
the various masses of each anti-androgenic compound detected in wastewater samples is
presented in Tables 4.6 and 4.7.
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Table 4.6: The summary of estimated masses of each anti-androgenic compound detected in wastewater influent samples evaluated relative to its
potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound
derived from
EL
(ngFeq/L)
(W)
Volume
analysed
(VµL)
Concentration
in 1mL of
fraction(C)
(ngFeq/L)
Potency (P) Mass of
compound
(1000PC
/77.75)
(ng/L)
% Contribution of
anti-androgenic
activity in fraction
Abietic acid 58 23.267 400 58.168 4.29 3209.53 1.35
59 27.535 400 68.836 4.29 3798.16 0.96
60 4.906 400 12.265 4.29 676.74 0.33
Bisphenol A 27 NC 400 NC 0.56 NC NA
Chlorophene 40 8.862 400 22.156 13.30 3790.03 0.57
Chloroxylenol 31 200.682 500 401.364 0.20 1032.45 80.27
Dichlorophene 34 - 400 - 5.26 - -
35 - 400 - 5.26 - -
NC: Not calculated due to non-availability of the calibration plot; NA: Not available because NC was not known.
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Table 4.6 continued: The summary of estimated masses of each anti-androgenic compound detected in wastewater influent samples evaluated
relative to its potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound
derived from
EL (ngFeq/L)
(W)
Volume
analysed
(VµL)
Concentration
in 1mL of
fraction(C)
(ngFeq/L)
Potency (P) Mass of
compound
(1000PC
/77.75)
(ng/L)
% Contribution
of anti-
androgenic
activity in
fraction
Dichlorophene 36 1.565 400 3.913 5.26 264.69 0.00
37 20.933 400 52.333 5.26 3540.47 2.09
38 0.378 400 0.945 5.26 63.93 0.01
Galaxolide 58 37.783 400 94.458 0.07 85.04 2.20
Isopimaric acid 58 32.234 400 80.586 5.36 555.52 1.87
59 9.121 400 22.802 5.36 1571.96 0.32
NBBSA 32 956.607 500 1913.214 0.18 4429.31 95.66
33 2.025 400 5.063 0.18 11.720 0.07
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Table 4.6 continued: The summary of estimated masses of each anti-androgenic compound detected in wastewater influent samples evaluated
relative to its potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound
derived from
EL (ngFeq/L)
(W)
Volume
analysed
(VµL)
Concentration
in 1mL of
fraction(C)
(ngFeq/L)
Potency (P) Mass of
compound
(1000PC
/77.75)
(ng/L)
% Contribution
of anti-
androgenic
activity in
fraction
Pimaric acid 58 31.893 400 79.733 3.67 3763.60 6.77
59 4.932 400 12.330 3.67 582.03 1.85
TBEP 46 201.041 500 402.083 0.06 310.290 9.81
TCPP 33 2548.025 400 6370.063 0.05 4096.50 82.73
34 17.775 400 44.438 0.05 28.58 0.57
Triclosan 45 1.969 500 3.938 5.20 263.48 0.16
46 187.938 500 375.877 5.20 25139.02 9.17
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Table 4.7: The summary of estimated masses of each anti-androgenic compound detected in wastewater effluent samples evaluated relative to
flutamide concentration with peak area/E1-d4, relative potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound
derived from
EL (ngFeq/L)
(W)
Volume
analysed
(VµL)
Concentration
in 1mL of
fraction(C)
(ngFeq/L)
Potency (P) Mass of
compound
(1000PC
/1700.2)
(ng/L)
% Contribution
of anti-
androgenic
activity in
fraction
Abietic acid 58 - 400 - 4.29 - -
59 - 400 - 4.29 - -
60 - 400 - 4.29 - -
Bisphenol A 27 NC 400 NC 0.56 NC NA
Chlorophene 40 19.942 500 39.885 13.30 312.00 1.73
Chloroxylenol 31 26.695 500 53.386 0.20 6.28 1.72
Dichlorophene 34 0.179 400 0.449 5.26 1.39 0.01
35 0.107 400 0.268 5.26 0.83 0.01
NC: Not calculated due to non-availability of the calibration plot; NA: Not available because NC is not known.
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Table 4.7 continued: The summary of estimated masses of each anti-androgenic compound detected in wastewater effluent samples evaluated
relative to flutamide concentration with peak area/E1-d4, relative potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound
derived from
EL (ngFeq/L)
(W)
Volume
analysed
(VµL)
Concentration
in 1mL of
fraction(C)
(ngFeq/L)
Potency (P) Mass of
compound
(1000PC
/1700.2)
(ng/L)
% Contribution
of anti-
androgenic
activity in
fraction
Dichlorophene 36 0.423 400 1.057 5.26 3.27 0.04
37 237.420 500 474.841 5.26 1469.04 16.96
38 0.398 400 0.873 5.26 2.70 0.03
Galaxolide* 58 58.391 400 145.978 0.07 6.01 5.41
Isopimaric acid 58 - 400 - 5.36 - -
59 - 400 - 5.36 - -
NBBSA 32 769.321 500 1538.643 0.18 162.90 28.49
33 526.893 500 1053.786 0.18 111.56 12.55
*The other isomer detected in fraction 58 (retention time 19.20min) was not quantified for lack of information about its anti-androgenic activity
and potency. NC: Not calculated for non-availability of the calibration plot; NA: Not available because NC is not known.
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Table 4.7 continued: The summary of estimated masses of each anti-androgenic compound detected in wastewater effluent samples evaluated
relative to flutamide concentration with peak area/E1-d4, relative potency and percentage contribution to the total anti-androgenic activity.
Compound Fraction Amount of
compound de-
rived from EL
(ngFeq/L) (W)
Volume
analysed
(VµL)
Concentration
in 1mL of frac-
tion(C)
(ngFeq/L)
Potency (P) Mass of com-
pound
(1000PC
/1700.2)
(ng/L)
% Contribution
of anti-
androgenic ac-
tivity in frac-
tion
Pimaric acid 58 - 400 - 3.67 - -
59 - 400 - 3.67 - -
TBEP 46 1663.500 400 4158.750 0.06 146.76 86.64
TCPP 33 2922.275 500 5844.554 0.05 171.88 69.58
34 151.775 400 379.438 0.05 11.16 7.74
Triclosan 45 2.159 400 5.398 5.20 16.50 0.08
46 15.035 400 37.587 5.20 114.96 0.78
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4.3.3.5: Estimate of Anti-androgenic Activity Removed in Influent at the WwTP.
In the course of influent treatment at the WwTP, certain proportions of some
chemicals are being removed. The variation in this proportion (from one chemical
compound to another) is due largely to the differences in their physicochemical
properties. The following figures (Table 4.8) summarise the estimated anti-androgenic
activity of each compound in the fractions that were removed at the Treatment Works.
The analysis should be treated with caution as it is based on a single sample of an
influent profile and a single sample of an effluent profile. Nevertheless, it does give an
indication of the propensity for chemical removal during the treatment processes.
170
Table 4.8: Relative mass of compounds removed in Horsham Wastewater Works
Compound Amount in Influent
(ng/L)
Amount in effluent
(ng/L)
Estimated AA*
removed (ng/L)/(%)
Abietic acid 7684.44 - 7684.44(100)
Bisphenol A NC NC NA
Chlorophene 3790.03 312.00 3478.88(91.77)
Chloroxylenol 1032.45 6.28 1026.17(99.39)
Dichlorophene 3869.09 1477.61 2291.48(61.81)
Galaxolide 85.04 6.01 79.03(92.93)
Isopimaric acid 7127.47 - 7127.47(100)
NBBSA 4441.03 274.46 4166.57(93.82)
Pimaric acid 4342.18 - 4342.18(100)
TBEP 310.23 146.76 163.46(52.69)
TCPP 4125.08 183.04 3942.04(95.56)
Triclosan 25402.39 131.47 25270.93(99.48)
Total 62209.44 2537.63
NC: Not calibrated due to limited time; * The AA removal is estimated in ng/L while
the percentage removal is enclosed in the bracket; total anti-androgenic activity of the
whole influent and effluent fractions analysed is 3.11mgFeq/L and 0.15mgFeq/L
respectively.
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4.3.3.6 Contribution of the Identified Compounds to the Total Anti-androgenic
Activity of the Effluent and Influent Wastewater Samples.
Following the evaluation of the total anti-androgenic activity (TAA) in the
samples, the contributions of the various identified anti-androgens in the fractions to the
TAA of whole samples were estimated. The mass of each compound (C) in each
fraction was measured (see Tables 4.6 and 4.7) and where the compound occurs in more
than one fraction, the AAs were added up (∑C) (Table 4.9). The percentage contribution
made by each identified compound to the overall anti-androgenic activity was estimated
relative to the TAA of the wastewater effluent (150000ngFeq/L).  That is
% Contribution of a compound to the TAA of the sample=∑ x100, where M is the
TAA of influent sample (i.e. 3110000ngFeq/L) or effluent sample (which is
150000ngFeq/L) under consideration.
In this study, chlorophene and dichlorophene contributed a majority of the TAA
(representing 0.21% and 0.99% respectively) of the wastewater effluent. Analysis
further shows that NBBSA ranks third contributing 0.18% to the TAA of the
wastewater effluent. Each of TCPP, TBEP and triclosan contributes AA below 0.13% of
TAA while that of chloroxylenol occurs below the LOD of the overall effluent’s anti-
androgenic activity (see Table 4.9). It is significant to note that there is no record of AA
contribution from the resin acids (abietic acid, isopimaric and pimaric acid).
Collectively, the AA contributed by the identified compounds in Table 4.9 to the TAA
of wastewater effluent is 1.69%. This implies that 98.31% of the TAA in effluent
wastewater are yet to be accounted for.
Similarly, analysis to evaluate the various contributions of compounds to
the TAA of wastewater influent produced some interesting results (Table 4.10).
Contrary to the wastewater effluent results, the highest AA contribution to the overall
AA of the wastewater influent is produced by triclosan with 0.82%.  The resin acids
which include abietic acid, pimaric acid and isopimaric acid produced a combined AA
of 0.62%. Dichlorophene and chlorophene contribute 0.12% each to the TAA of the
wastewater influent while NBBSA added about 0.14% to the TAA. Each of the
remaining compounds except bisphenol-A was quantified and reported to express AA
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less than 0.13%.  The total AA contributions made by all the compounds to the TAA of
the wastewater influent is 2.00% indicating that over 98.00% are yet to be identified.
Table 4.9: Contribution of each identified compound to the total anti-androgenic
activity in wastewater effluent.
Compound Fraction(s)
where
compound
was detected
TAA of
compound in
effluent
fractions (∑C)
(ngFeq/L)
Compound
contribution to
TAA of
effluent
wastewater
(%).
Abietic acid - - -
Bisphenol A 27 NA NA
Chlorophene 40 312.00 0.21
Chloroxylenol 31 6.28 0.00
Dichlorophene 34, 35, 36,
37, 38
1477.61 0.99
Galaxolide 58 6.01 0.00
Isopimaric acid - - -
NBBSA 33 274.46 0.18
Pimaric acid - - -
TBEP 46 146.76 0.10
TCPP 33,34 183.04 0.12
Triclosan 45,46 131.47 0.09
Total= 1.69
NQ: Not quantified; NA: The data is not available due to NC that was not known; The
TAA of all the wastewater effluent fractions is 150000ngFeq/L
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Table 4.10: Contribution of each identified compound to the total anti-androgenic
activity of the wastewater influent.
Compound Fraction(s)
where com-
pound was
detected
TAA of compound
in influent fractions
(∑C)(ngFeq/L)
Compound con-
tribution to TAA
of effluent
wastewater (%).
Abietic acid 58,59,60 32967.77 0.25
Bisphenol-A 27 NA NA
Chlorophene 40 50418.17 0.12
Chloroxylenol 31 206.49 0.03
Dichlorophene 34,35,36,
37,38
19522.70 0.12
Galaxolide 58 5.95 0.00
Isopimaric acid 58, 59 38289.99 0.23
NBBSA 32,33 2906.91 0.14
Pimaric acid 58, 59 15867.39 0.14
TBEP 46 186.17 0.01
TCPP 33,34 206.26 0.13
Triclosan 45,46 132092.38 0.82
Total= 2.00
NQ: Not quantified; NA: The data is not available due to NC that was not known; The
TAA of all the wastewater influent fractions is 3110000ngFeq/L.
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4.4 Discussion
Xenobiotic anti-androgens are a recognised class of endocrine chemicals with
the potential to exert adverse effects on the reproductive biology of wildlife and
humans. Taking into account that different environmental chemicals have been
identified in different compositions of wastewaters and that comprehensive knowledge
of their anti-androgenic characteristics are still unavailable, determining the biological
status of the environmental compounds discovered in the analysed wastewater samples
is one way of resolving some of the many questions surrounding their endocrine
disrupting potentials. Urbatzka and co-workers (2007) identified nonylphenol, tert-
octylphenol, iprodione, p,p’-DDE, prochloraz, cyproterone acetate, fenthion,
pentachlorophenol, ketoconazole, fenitrothion, lindane, dieldrin, mirex, flutamide,
vinclozolin and metabolites (M1 and M2) and bisphenol-A in anti-androgenic fractions
of sediments and water samples taken from the river Lambro, a watercourse receiving
wastewaters from domestic, industrial and agricultural sources (see also Viagano et al.,
1999). These compounds are components of some unknown compounds responsible for
the total anti-androgenic activity of these samples. Exposure of experimental animals to
these chemicals has led to discovery of some abnormal reproductive effects.
Nonylphenol, which was detected by Urbatzka and colleagues (2007), has the potential
to inhibit sperm production, impair testicular development and the formation of ovo-
testis (intersex) in some male fish species (Jobling et al., 1996; Gray and Metcalfe,
1997; Panter et al., 1998).
Horsham wastewater samples analysed have been shown to contain over
95% of domestic waste contributions and have shown to be repositories of a wide range
of environmental chemicals (Chapter 3). In previous studies on Horsham wastewaters
within and without our laboratory, a wide range of androgen receptor antagonist activity
was reported in the range of 0.01-1.69mgFeq/L (Passmore, 2007; unpublished) and
66.7-76.2mgFeq/L (Johnson et al., 2007). The present investigation has identified the
musk fragrance galaxolide, organophosphates TCPP and TBEP, antibacterial
dichlorophene, triclosan and chloroxylenol, resin acids abietic acid, isopimaric acid and
pimaric acid, chlorophene, plasticizer n-butylbenzenesulfonamide (NBBSA) and
bisphenol A that is used in plastic industry for epoxy resin and polycarbonate
production.   It is important to say that galaxolide and bisphenol A had been hitherto
reported in some studies to possess anti-androgenic activity in vitro (Schreurs et al.,
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2005; Sohoni and Sumpter, 1998). Bisphenol-A was reported to possess same anti-
androgenic potency as flutamide in vitro (Sohoni and Sumpter, 1998). Galaxolide was
also reported to possess androgen receptor antagonism with potency five times less than
flutamide in vitro (Schreurs et al., 2005).
Galaxolide has recently been widely reported to occur at influent, primary,
secondary and effluent levels of wastewater treatment plants (Carballa et al., 2004).
Fragrance industries have experienced increased expansion following widespread use of
polycyclic musks and other nitro musks as fragrances in a spectrum of consumer
products globally. It is reported that over 5600 tons of polycyclic musks are produced
globally annually (Zhou et al., 2009). As a consequence, some representatives of this
polycyclic family have been found in the environment at relatively high concentrations.
The polycyclic musk galaxolide has been shown to bioaccumulate in the body of fish
and the human breast milk (Gatermann et al., 1999; Schreurs et al., 2005). Zhou and co-
workers (2009) reported a range of galaxolide concentration in three Beijing Sewage
Treatment Works with the influent samples recording 1649ng/L, 1251.40ng/L and
3003.80ng/L respectively. Their effluent concentrations also were measured in sequence
as 492.80ng/L, 729.90ng/L and 1258.3ng/L. Similar studies conducted on wastewater
treatment plants’ samples in Guandong, China reported influent and effluent
concentration of galaxolide in ranges of 11500-146000ng/L and 950-2050ng/L
respectively (Zeng et al., 2007). Lee and colleagues (2000) recorded a concentration
range of 830-1570ng/L when secondary clarifier effluent was analysed. The analysis of
five wastewater treatment plant samples in Canada put the average concentration of
galaxolide in the effluent as 2980ng/L (Lishman et al., 2006). The concentrations of
both influent and effluent samples in my study (expressed as 85.05ng/L in influent and
6.01ng/L in effluent) occur below the range of concentrations reported in all the studies
above. The reason for this is not known but may be due to the loss of anti-androgenic
activity during the work-up in the laboratory or due to 72-hour biodegradation during
storage. The reduction in the concentration of galaxolide compared to what are recorded
in literatures could also be due to high efficiency of removal in the WwTPs in United
Kingdom. For instance, the rough estimate in my analysis indicates that 92.93% of
galaxolide was removed at the WwTPs. Although there are no available data to suggest
so, it is possible that the level of galaxolide used in United Kingdom is very minimal as
compared to other classes of fragrances.
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Non-steroidal organophosphates are another category of environmental
xenobiotics detected in the analysed wastewater samples. They are used as chlorinated
organophosphate esters and in non-derivatised forms for a wide range of chemical
applications. Organophosphates are predominantly used as flame retardants (in plastics,
textiles and timber), plasticisers and lubricants. Some, especially the non-derivatised
forms, are used to control the sizes of pores occurring on building structures and
materials (Meyer and Bester, 2004). The quantity of organophosphates produced
annually in Western European countries runs into ten thousands of tons which makes
them rank among the high production volume (HPV) chemicals (ibid.). It is on the basis
of their widespread use that some members of this family are widely detected in
environmental samples across the world. Their presence in wastewater samples is not
unconnected with humans’ domestic usage from where they get to the wastewater
treatment plants via the central sewers. Although, organophosphates identified in
wastewaters in Europe and America include tris(2-chloroethyl)phosphate (TCEP),
tris(1-chloro-2-propyl)phosphate (TCPP), tris(butoxyethyl)phosphate (TBEP), tris-(1,3-
dichloroisopropyl)-phosphate (TDCP), iso-tributylphosphates (TiBP) and n-
tributylphosphates (TnBP) only the first three were detected in my wastewater samples
analysed (Meyer and Bester, 2004). The reason for non-detection of other
organophosphates is possibly because their concentrations in the analyte samples occur
below the LOD. The experimental findings (Tables 4.6 and 4.7) in the study clearly
showed a progression of the concentration of TCPP and TBEP from influent. In the
assay analysis, TCEP was discovered not to have anti-androgenic properties as it could
not elicit about 65% sub-maximal response in the assay but TCPP and TBEP were both
active as androgen-receptor antagonists. TCPP was quantified and reported to have
concentration of 4128.08ng/L in influent and 183.04ng/L in effluent. TBEP was present
in 310.23ng/L of influent and 146.76ng/L of effluent.  The quantity of TBEP was
measured in two samples sourced from different wastewater treatment plants in ranges
of 2300-6100ng/L and 2400-6100ng/L in influent and 290-790ng/L and 250-750ng/L in
effluent (Meyer and Bester, 2004). Of the two organophosphates identified as anti-
androgens in this study, only TCPP has been identified to have carcinogenic effect in
animals (ibid).
Another environmental chemical of interest which was detected in both samples
of wastewater analysed is dichlorophene. It functions as one of the commonly used
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antimicrobial agents in personal care products and cosmetics (Yamarik, 2004). Because
of its effectiveness in inhibiting aerobic metabolism, dichlorophene is used to treat some
cestode infection and fasciolopsiasis (Idris et al., 1980; Standen, 1963). It is also used to
control mould and algae growth to protect textile and horticulture materials (Brown et
al., 1986). It is applied to control moss in turf (ibid.). In humans and animals, it is used
to eradicate/treat tapeworm infection and fungal infection in athlete’s foot (Kintz et al.,
1997). The few recognised effects of dichlorophene on humans include wheezing (Watt,
1991) and dermatitis (Meynardier et al., 1992). In the influent fractions 37 and 38,
dichlorophene contributed anti-androgenic activity of 11.02% and 0.01% to the AA of
their respective fractions. Dichlorophene in effluent fractions 34, 35, 36, 37 and 38
equally contributed AA of 0.01%, 0.01%, 0.04%, 16.74% and 0.03% respectively to the
AA present in their fractions. On the whole, dichlorophene contributed 3869.09ng/L in
influent and 1477.61ng/L in effluent samples analysed. In similar work undertaken in
our laboratory, dichlorophene was reported to occur in detectable but not at measurable
level in effluent samples analysed (Hill et al., 2010).  Up till the time of reporting this
work, no single work has evaluated the anti-androgenic activity contribution of these
compounds to wastewater samples (influent and effluent).
Triclosan is one of the three widely used biocides which are detected in the
wastewater samples analysed. Triclosan is a known multi-purpose anti-microbial agent
contained in the compositions of skin care products and cosmetics, the commonly used
household products (carpet, sponges, socks and underwear), deoderants products and
oral care compositions (toothpastes). In recent times, triclosan has been incorporated in
some kitchen earthware products; also, it is the major anti-microbial present in liquid
soaps (Perencevich et al., 2001). In the medical environment, it is used as surgical
scrubs, hand washes and body washes to control the spread of Methicillin-resistant
Staphylococcus aureus (MRSA) bacteria strains (Tierno, 1999; Russell, 2004).
Triclosan, a trichlorinated bisphenyl, is a fairly non-volatile hydrophobic compound
which blocks the biosynthesis of lipid in bacteria and fungi by antagonising the enzyme
enoyl-acyl carrier protein reductase (Heath et al., 1999; McMurry et al., 1998). Even
though triclosan has been widely detected in environmental samples such as domestic
wastewaters, river sediments, sewage sludge and reclaimed water as well as fish bile,
human breast milks and the human plasma due to its lipophilicity (Adolfsson-Erici et
al., 2002; Allmyr et al., 2006; Houtman et al., 2004), the information about its endocrine
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toxicity is not available. At a concentration of 3.50x105ng/L, triclosan shows acute
toxicity to rainbow trout (Adolfsson-Erici et al., 2002; Lindstrom et al., 2002).
Although it is not considered to be acutely toxic in mammals, it can cause disturbances
to the metabolic system as well as hormone homeostasis (Hanioka et al., 1996; Schuur
et al., 1998; Wang et al., 2004; Jacobs et al., 2005). Administration of triclosan via
dental care products in humans could lead to accumulation of the compounds in tissues
especially when they gain access into the body through the mucosa (moist tissues lining
the gateway into the body such as nasal and buccal passages) and intestinal cavity (Lin,
2000; Sandborgh-Englund et al., 2006).  It is also possible for triclosan to
bioaccumulate in the body through the skin despite the level of metabolism that may
occur during the dermal absorption (Moss et al., 2000). Taking into account that
endocrine disruption studies of triclosan are limited, determination of its anti-
androgenic effects in animals would be extremely necessary.
Gatidou and colleagues (2007) reported that the anti-androgenic activity of
triclosan occurred in average concentration of 280ng/L, 430ng/L and 11840ng/g in
filtered municipal wastewater influent, effluent and sewage sludge respectively. In
addition, the hospital and university samples analysed recorded concentrations of
9070ng/L and 790ng/L respectively (ibid.). McAvoy and colleagues (2009) reported
field concentrations range of 3800-16600ng/L for influent and 200-2700ng/L for
effluent. In this study, the concentration of triclosan in influent and effluent samples
recorded is 25402.40ng/L and 131.470ng/L respectively. Two influent samples
collected from rural wastewater treatment plants in Australia recorded triclosan
concentrations as low as 805ng/L and 791ng/L (Ying and Kookana, 2007). Studies have
also reported the occurrence of triclosan in effluent between 40ng/L and 2700ng/L
(McAvoy et al., 2009; Reiss et al., 2002; Singer et al., 2002; Sabaliunas et al., 2003).
Chlorophene and chloroxylenol are two other antibacterial compounds
discovered in both influent and effluent fractions to be anti-androgenic. Chlorophene is
widely used as disinfectants for cleaning hospitals and homes (Zhang and Huang,
2003). The percentage chlorophene contribution to the total anti-androgenic activity of
the wastewater samples in my study is 0.12% (3790.03ng/L) for influent and 0.21%
(312ng/L) in effluent.  Chlorophene is the only anti-androgenic compound that recorded
relative potency of two digits (13.3 relative to flutamide) in this work. Chlorophene
concentration detected in influent and effluent samples taken from Cilfynydd
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Wastewater Treatment Plant measured in the region of 114 ng/L and 29ng/L
respectively (Kasprzyk-Hordern et al, 2008). Cilfynydd Wastewater Treatment Plant is
a treatment plant situated in southern Wales receiving predominantly domestic
wastewaters from a population of about 110,000. In another study involving five
sewage treatment works in Spain, the average concentration of chlorophene detected
was greater than 1000ng/L (Bueno et al., 2007). Similarly, chloroxylenol (also known
as para-chloro-meta-xylenol) is another chlorinated phenolic compound that is actively
used in disinfectants and antiseptics especially toilet cleansing. In addition, it has been
used as preservative in pharmaceuticals and cosmetic products. Loraine and Pettigrove
(2006) detected chloroxylenol in reclaimed wastewater as well as dry-season and wet-
season influent samples at an average concentration of 285ng/L, 3550ng/L and
1610ng/L respectively. In this study, 1032.45ng/L of chloroxylenol was discovered in
influent, 6.28ng/L was found in the effluent sample.
Resin acids are a group of diterpenoid carboxylic acids found in some
coniferous tree species. Resin acids can broadly be classified into abietanes and
pimaranes (Mohn, 1995). Abietanes can be distinguished from pimaranes by the
isopropyl group at C-13 as against vinyl and methyl groups at C-13 of the latter. Wang
and co-workers (1995) reported that lodgepole pine wood resin acids consist of abietic
acid, dehydroabietic acid, neoabietic acid, palustric acid, isopimaric acid, pimaric acid
and levopimaric acid. Sandaracopimaric acid is another pimarane discovered in wood
(Martin et al., 1999). Most of these wood acids and their metabolites are discovered in
wastewater samples. It is equally reported that wastewater receiving river sampled
downstream bleached kraft pulp and paper mill industry contains some of these resin
acids (Zender et al., 1994).  Although, only abietic acid, isopimaric acid and pimaric
acid were detected in my wastewater samples, other wood resin acids may be present in
negligible concentration (i.e. concentrations <LOD). In the influent fractions studied,
the percentage contribution of abietic acid, isopimaric acid and pimaric acid to the total
wastewater AA is 0.25%, 0.23% and 0.14% respectively.  Also, it must be stated that
the quantity of the individual resin acids detected in the effluent fractions was below the
limit of detection which has further been reflected by the effluent profile (Chapter
Three). Individual resin acids have shown acute toxicity in aquatic fish such as rainbow
trout and the acute lethal concentration occurred within the range of 4.00x105-
1.10x106ng/L (Chung et al., 1979; Leach and Chung, 1982).
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Another chemical compound detected in wastewater is a common plasticizer n-
butylbenzenesulfonamide (NBBSA).  It is used for manufacturing sulfonyl carbamate
herbicide, polyamide and copolyamide plastic industry (Lee et al., 1995; Huppert et al.,
1998). Although account of its aquatic toxicological effects is presently unavailable,
acute exposure of Wistar rats can induce chronic adverse effects in their motor activities
(Lee et al., 1995). In addition, laboratory studies have revealed that it could show acute
neurotoxocity by interfering with choline acetyltransferase in animals (Nerurkar et al.,
1993; Lee et al., 1995) and juvenile New Zealand white rabbits (Strong et al., 1991).
Presently, the production and use of NBBSA have been discontinued in Germany
(Huppert et al. 1998). A number of published works have revealed that NBBSA occurs
in a wide range of environmental samples such as seepage and leakage water from
landfills (4.20x105–7.10x105 ng/L), runoffs from agricultural field irrigated with treated
wastewater (350-6000ng/L) and wastewater influent samples (260-2600ng/L)
(Schwarzbauer et al., 2002; Paxeus and Schroder, 1996; Soliman, 2003; Paxeus, 1996;
Kasprzyk-Hordern and Dinsdale, 2008). In the samples analysed, a concentration of
4441.03ng/L was detected in influent samples while 274.46ng/L was found in effluent.
A study reported an NBBSA concentration range of 351-6000ng/L in effluent
wastewater (Pederson et al., 2005). Its occurrence in wastewater treatment works has
been linked to its composition in plastics used in domestic environment.
Bisphenol A (BPA) is a known environmental contaminant found in wastewater
effluents. It is used for producing polycarbonates (Krishnan et al., 1993) and epoxy
resins from which products such as inner coatings for canned food and drinks (Brotons
et al., 1995), baby-milk bottles and dental sealants (Olea et al., 1996), powder paints
and optical lenses (Steinmetz et al., 1998; Gatidou et al., 2007; Fromme et al., 2002) are
made. Epoxy resins are prepolymers with each molecule formed from two or more
epoxide groups. Thermoset plastic is formed when the resins react with curing agents.
Some of the properties of the cross-linked product (thermoset plastic) formed include
toughness, versatility, high chemical resistance and elastic strength (Vilchez et al.,
2001). The can inner linings react with the food in it and induce estrogenic effect (Kim
et al., 2001). It is also used as raw materials in plastic and polymer industry (Fukazawa
et al., 2001). In addition, it is a precursor/starting material in the production of
adhesives, automobile lenses, window glazing, building materials, compact disks,
thermal paper, paper coatings and as electrical encapsulation and electronic components
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(Fürhacker et al., 2000; Pulgar et al., 2000).  It may be discharged accidentally as
fugitive dust during processing, packaging and transportation in a closed system
(Staples et al., 2000). Bisphenol A has been quantified in various environmental
samples which include river sample (9-780ng/L), sediments (0.018-0.190mg/kg),
sewage sludge (0.004-1.363mg/kg) and wastewater samples (21-702ng/L) (Fromme et
al., 2002). Due to inconclusive experimental work as at the time of putting together this
report, the concentration of BPA in influent and effluent samples could not be
determined.
It must be stated that the calibration plots of some compounds showed poor
goodness of fit (or lack of fit) due to a wide range of reasons. It is possible for some
compounds which produce a linear calibration plot at low concentration range with
positive gradient also to generate a linear calibration plot at high concentration range
with negative gradient or vice versa. When such occurs, there is the likelihood that some
plot points would fall at random away from the projected line on the calibration graphs.
The calibration graphs derived under this condition cannot be expected to produce a
perfectly accurate estimate of such compound. Moreover, inappropriate choice of
internal standard could contribute adversely to the level of inaccuracy that may likely
arise from such estimation. Another reason for the poor goodness of fit is the sensitivity
of various columns deployed for the analyses of the compounds in wastewater fractions
and the standards. As would be expected, the level of analysis undertaken on the GC-
MS can reduce their sensitivity (due to bleeding) and hasten their rapid burn-out.
Variability in the column sensitivity (random error) could arise which will affect the
estimated results from the data generated.  In this study, various statistical
measurements of errors and level of confidence in these results were estimated. No
doubt, the various sources of variation explained in this discussion section will
contribute to the process that generates the calibration curves and the poor goodness of
fit. Beside these limitations, it is also necessary to emphasise that the least square
regression approach is not suitable to effectively and accurately determine the goodness
of fit and linearity of experimental data, especially using the R2. Whilst the values
generated as R2 in the regression line could sometimes be as high as 1, it is possible for
the fitted data to spread evenly around the regression line without any of the data points
falling on the regression line. The correlation coefficient, as well as the value of R2,
generated in such instance will be misleading. Although none of my regression models
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exhibits such data geometry, it will still be inappropriate to say that the measurement
errors arising from lack of fit of the data points to the regression lines have been
effectively accounted for by the regression models (AMC, 1994). It simply implies that
the regression model can be grossly inaccurate in predicting the future outcomes of the
two variables (dependent and independent). On the account of such development, there
is the possibility that the outcome of the measurements and estimations in this Chapter
will be affected either positively or negatively.
All the compounds identified in this study have contributed immensely to the
growing knowledge of steroid receptor antagonist compounds in wastewater samples
especially under in vitro conditions. However, their contributions to the overall anti-
androgenic activity in fractions of the wastewater extracts analysed was relatively little
(1.69-2.00%) compared to what are yet to be discovered. There are two possible reasons
that could be responsible for this result. It is possible that the compounds contributing to
the total anti-androgenic activity in each of these fractions is yet to be identified. It is
also possible for compounds already identified which were commercially unavailable
for testing to be partly responsible for the AA discrepancy. Another possible reason for
this could be additive or synergic effect (Graumann et al., 1999). It is plausible for
compounds which recorded anti-androgenic activity below the detection limit to add up
their effect (ibid.). It is possible that some highly potent androgen receptor antagonists
(e.g. dioxin congeners) were not detected in the GC-MS and therefore their
contributions were not included in the overall estimation of anti-androgenic activity in
the fractionated samples. It is also possible for the multiple contaminants with AA to act
as a mixture effect, either by concentration addition or by synergistic effect to enhance
the receptor AA of some fractions in the AYAS. In addition to the difficulty associated
with the identification of compounds occurring in low concentration, producing a model
for quantifying additive or synergic anti-androgenic effects of multiple compounds,
especially in instances where cumulative effects are being expressed at sub-LOD
concentrations, may be difficult. For that reason, most cumulative effects are either not
accounted for or inaccurately estimated. Furthermore, the fact that the majority of the
compounds identified came from the non-polar section and, to some extent, moderately
polar area of the profile suggests that most of the compounds yet to be identified (i.e.
about 98% unknown) may be localised in the polar section of the profile.
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4.5. Conclusion
A number of chemicals present in Horsham wastewaters have androgen receptor
inhibitory affinity. Although these chemicals emerged from different sources, and
possess different structural formula, they have demonstrated the potential of binding
antagonistically to androgen receptors using an in vitro AYAS assay. These results have
shown a level of human androgen receptor promiscuity, in that a wide range of
chemically active molecules can bind to the androgen receptor. In addition to screening
the anti-androgenic xenobiotics from the collections of environmental chemicals
detected, the AYAS assay was also used successfully to define the concentration range
for which a compound is said to be active and non-toxic at the same time. It was further
used to determine the potency of various xenobiotics tested for anti-androgenic activity
relative to the AA of flutamide. The quantity and the percentage contribution of each of
these anti-androgenic xenobiotics were evaluated in fractions and wastewater samples
collectively based on their relative potency. In conclusion, the various forms of
environmental anti-androgenic chemicals detected in Horsham wastewaters have been
found in other wastewater samples in United Kingdom, Europe and the Americas. What
appears significant in my study is that the in vitro anti-androgenic activity of most of the
identified compounds is being reported for the first time and clearly shows the complex
arrays of chemicals with potential endocrine disrupting activity present in wastewater
samples.
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CHAPTER FIVE
General Discussions and Conclusion
5.0 Introduction
This study has established that wastewater influents and effluents are
repositories of known and unknown environmental anti-androgens. It has also shown
that some chemicals associated with regular human consumption possess hormonal
properties and that continued interaction with such xenobiotics-indoor and outdoor-
could result in grave reproductive endpoints such as intersex, feminisation and
masculinisation. Given that the knowledge about the fate and biological activity of
emerging and new environmental chemicals is presently poor, it has also raised concern
that continued release of poorly treated environmental samples such as effluents, known
to contain unidentified offending chemicals, into various receiving environments may
pose severe health consequences. It has further reinforced the potential danger involved
in distributing recycled wastewaters for drinking and irrigation purposes across the
world when the current chemical removal technology seems ineffective for this purpose.
5.1. Recovery Methodology of Xenobiotic Anti-androgens on SPE and HPLC.
Comprehensive study of the receptor activity of xenobiotic anti-androgens
contained in the wastewater samples was undertaken with a SPE recovery methodology
and a modified HPLC fractionation program (in Section 2.2.4). The revised SPE
methodology produced over 96% recoveries of the test compounds which were selected
to cover a broad range of polarities. Although several cartridges with different sorbent
composition were tested, the HLB cartridge recoveries were generally satisfactory
(>94%) for all test compounds used. The TIE procedure was modified by replacing the
methanol-water solution with less polar acetonitrile-water solution as the sample
injecting solution into the HPLC. There was a general improvement to the recovery of
the total anti-androgenic activity (>78.6%) in the HPLC fractions of influent and
effluent extracts which emphasises the success of the new methodology.
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5.2. Xenobiotic Anti-androgens in Wastewater Treatment Works
This study has demonstrated that a wide range of offending chemicals which
have androgen receptor antagonistic affinity are not completely removed from
wastewater influents at the treatment works. Some studies on wastewater effluents have
also identified that endocrine disrupting chemicals which possess steroid receptor
affinity for estrogens, anti-estrogens and androgens were not removed during treatments
at sewage treatment works. Generally, the level of chemical removal from wastewater
influent varies from one treatment works to another. This is largely due to variability in
chemical elimination technology deployed from one treatment works to another
(Bandelj et al., 2006; Conroy et al., 2007; Johnson and Sumpter, 2001; Kim et al., 2006;
Ternes et al., 1999b). Also, this study has shown that removal of various contaminants
at the treatment works cannot proceed at the same proportion. This may be attributed to
the difference in physicochemical properties of the various compounds involved.
Elimination of toxic chemicals at the WwTP is generally known to proceed through
physical, chemical and biological processes. It must also be emphasised that removal
efficiencies of WwTPs are also dependent on the physicochemical properties of the
compounds and the treatment technology employed amongst other factors (such as
population of community served by the treatment works, the temperature of operation,
season and climatic variable e.g. rainfall and variation in the composition input from the
contributing sources) (Bound and Voulvoulis, 2005). The processes for removing some
proportion of non-polar organic and inorganic contaminants in these wastewater
samples are largely successful while also noting that most dissolved organic compounds
are not removed (Tabak et al., 1981; Alcock et al., 1999; Ternes et al., 1999a; Ternes et
al., 1999b; Drewes et al., 2002; Snyder et al., 2004; Joss et al., 2005). Also, after
undergoing oxidation or degradation at the works, some compounds would transform to
a receptor active moiety which could stubbornly persist and, to some extent, influence
the overall activity of the emerging effluents (Richardson et al., 2005). In this study, no
specific compound in that category has been identified, but that has not foreclosed the
non-existence of such compounds (given that some group of contaminants were
removed from the influent profile which culminated in the cluster of anti-androgenic
activity around the polar section of the effluent profile) (Chapter Three). This study has
further revealed that the anti-androgens in wastewaters are spread across a wide range
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of polarities. Incomplete removal of some chemicals and their metabolites can explain
why effluent samples emerging from treatment plants, as well as wastewater receiving
rivers, demonstrate toxicity. Actually, it will be inappropriate to conclude that trickling
filters used was successful in removing a wide range of environmental chemicals at the
Horsham treatment works. This is simply because the bulk of compounds identified so
far came from non-polar fractions only. As conspicuously seen, the most active
compounds occur in the polar section of the profiles many of which are yet to be
identified.
5.3. Profiles of Anti-androgens in Wastewater Treatment Works.
Wastewater profiles (influent and effluent) in Chapter Two and Three indicate
the occurrence of a wide range of receptor-active xenobiotic anti-androgens in the
WwTP samples. The fact that bioactive HPLC fractions are numerous in this study
suggests that xenobiotic compounds capable of demonstrating receptor antagonism after
binding are preponderant. Androgen activity, if at all it existed, is not conspicuous in the
profiles the reason for which may be attributed to the low occurrence concentration in
the samples analysed or masking by higher concentrations of anti-androgens in the same
fraction. There are some basic differences noticeable on the polar profiles of both inlet
(influent) and outlet (effluent) samples which have been attributed to the biological
activity at the wastewater works. Similar profile of bile harvested from effluent exposed
trout (from Horsham), investigated in our laboratory using the same protocol as in this
work, produced similar profile as the effluent samples in Chapter Three (Rostkowski et
al., 2011). This preliminary works with fish bile suggests that most xenobiotic anti-
androgens identified in effluent profile were bioconcentrated in fish.
5.4. Confirmation of Anti-androgenic Compounds in Wastewater Treatment
Works.
This study identified for the first time twelve xenobiotic anti-androgenic
compounds in wastewater samples (influent and effluent) which can interact with
steroid receptors. The category of xenobiotic compounds identified and confirmed to
occur in wastewater influent samples (and some in effluent samples) includes wood
resin acids (abietic acid, isopimaric and pimaric acids), antibacterial agents
(chlorophene, chloroxylenol, dichlorophene and triclosan), flame retardants (TCPP and
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TBEP), polycarbonate material (BPA), musk fragrance (galaxolide) and plasticiser
(NBBSA). With exception of galaxolide, triclosan, BPA, TCPP isomer and abietic acid
which have been identified as anti-androgens in previous studies (Chen et al., 2007;
Evans, 2008; Roh et al., 2010; Schreurs et al., 2005; Sohoni and Sumpter, 1998; Weiss
et al., 2011), all other compounds identified in this work are being reported to have
androgen receptor antagonist in vitro for the first time. Mostly, the identified
compounds (with exception of resin acids and NBBSA) could be traced to the
compositions of general consumer products. Given that Horsham wastewater influent
comprises over 95% contribution from domestic sources (Evans, 2008), it is likely that
these compounds emanated from domestic usage of consumer products. The findings in
this study corroborate the published discoveries which recognised that these arrays of
compounds can occur in domestic wastewater effluent (Rudel et al., 1998; Stasinakis et
al., 2008; Miege et al., 2009).
Bioaccumulation of most endocrine disrupting compounds in the tissues of
aquatic animals and humans can trigger dose-response effects at a certain threshold
concentration. At sub-lethal concentration, fish species exposed to bioactive chemicals
that are present in wastewater samples can develop biological effects, such as
intersexuality (Jobling et al., 1998). Although additive effects associated with
environmental samples can stand as the logical basis for explaining such behaviour, it is
also possible for highly potent bioactive compounds to induce such biological effects at
concentration below detection limit. It is difficult to estimate the implications of
environmental bioavailability of some anti-androgens in their metabolite state given that
their fate during transition may likely not be known. Several compounds can form
metabolites which are more potent than their parent compounds so also the
intermediates during transition which may even be much potent. For the fact that
chemical metabolism can also be induced in the animals’ system will partly widen the
diverse possibilities of chemical transformation in the environment. For that reason, it
will be difficult to explain which state of xenobiotic anti-androgen will be much potent
and whether the singular impact of a xenobiotic anti-androgen will account for the
intersex phenomenon and other interrelated reproductive effects.
Another important point that could be taken from this study is that chemicals
leaving the WwTPs may be relatively low in concentration in the receiving
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environment. The variability in the final environmental concentration as related to the
point source will be affected by seasonal activities (Loraine and Pettigrove, 2006). It is
discovered that concentration of effluent released into the receiving rivers will be
diluted during the rainy season and hence the concentration of the compounds in it
becomes low further. Conversely, concentration of possible pollutants in the same
effluent becomes relatively high when no rain falls indicating how seasonal climatic
effects can impact on the environmental level of some chemical toxicity and bioactivity.
Currently, the danger in distributing treated water for drinking and irrigation purposes is
as grave as converting the sludge from treated water as fertiliser given that much are
still needed to be done to improve on the treatment technologies presently in use. In
addition, the current chemical methodology for screening treated drinking water alone
cannot address the growing persistent cases of emerging contaminants. Biologically-
based risk assessment assays must be developed for evaluating chemical toxicological
end-points such as endocrinotoxicity, immunotoxicity, carcinogenicity and
neurotoxicity.  These all-purpose assays must be designed to accommodate
measurement of multiple chemical effects. This intended assay could also be used by
water industry for certifying the safety of water available for public consumption.
5.5. Further Work
Evaluation and screening of endocrine disrupters have been effectively achieved
through in vitro bioassay-directed mechanisms, many of which have proved very useful
in predicting molecular disturbances and endpoints. In the category of these belongs the
recombinant yeast transcription assay used in this study. Although AYAS has its short-
comings, it is significantly sensitive and effective for determining the status of an
environmental chemical in the midst of a complex mixture. However, it has been
discovered that no single assay, especially in vitro assay, can be sufficient alone to
determine the biochemical and molecular responses of genes to chemical
interference/intervention. It is in the light of this that an in vivo bioassay method would
be required to determine the full implications of this chemical binding on gene
expression. Three-spined stickleback assay has been used as effective genetic sex
biomarker for determining the effects of androgens and anti-androgens as endocrine
disrupting agents (Katsiadaki et al., 2002). Stickleback has the potentials of surviving
both in sea and freshwater environments. It can also exhibit distinctive reproductive
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behaviours (nest-building and courtship), one of which is the production of glue protein
(otherwise known as spiggin) used for quantifying the proportion of chemicals involved
in endocrine disruption. It has also been reported that the high egg survival rate coupled
with a very low fecundity are twin factors that have made it a better choice than other
fish (ibid.). Above all, it has a very short life span which is necessary for comprehensive
experimental studies. On that account, the in vivo stickleback androgen assay should be
used to test the anti-androgenic compounds identified from the in vitro studies.
Following the discovery that the presence of both estrogens and anti-androgens
has led to the formation of intersex in some fish species (Jobling et al., 2009), it is not
clear whether either of them can induce this effect independent of another. Due to lack
of clarity about separate individual chemical effect on this reproductive abnormality, the
mixture effects of the anti-androgenic compounds identified in this study should be
tested in order to understand the exact chemical conditions for which such biological
anomaly would occur.
Following limitation of in vitro analytical approach and the uneconomical use of
in vivo approach, for evaluating risk and toxicological effects of xenobiotics, a
microarray analysis is a novel pre-clinical methodology and a high throughput approach
for analysing simultaneous expression of virtually all known genes within a single
analytical run. The broad spectrum of existing in vivo bioassays and biomarkers which
are developed for evaluating chemical effects (through developmental and reproductive
end-points) in wildlife and laboratory animals are short in providing a measurement of
simultaneous multi-genetic end-points. Moreover, they are inadequate to predict long-
term toxicological risk assessment for clinical tests and trials. Microarray analysis tends
to provide a computational platform for toxicological measurements.
The result analysis in this study clearly indicated that about 2% androgen
receptor antagonists contributing to the TAA of wastewater samples were recovered.
The study further revealed that large proportion of AA yet to be recovered occurred in
the polar and semi-polar regions of the profiles. In order for the most potent compounds
responsible for androgen receptor antagonism in wastewater samples to be identified,
further analysis must be directed at identifying polar anti-androgens in wastewaters.
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5.6. Summary
This research work has accomplished all the objectives outlined in Chapter One.
The examination and analysis of influent and effluent profiles of steroid-receptor anti-
androgens, stated in objective 1, were carried out fully in Chapter Three (p.90) using the
newly developed method and partly in Chapter Two (p. 54). The structural
identification and measurement of steroid-like xenobiotic anti-androgens (Objective 2)
was accomplished partly in Chapter Three (p.90) and Four (p.133). The Objective 3
which entails determination of relative potency of the steroid-like xenobiotic anti-
androgens was fulfilled in Chapter Four (p. 133).
5.7. Conclusion
A wide range of home-use chemicals which possess binding ability to the extent
of modulating steroid-receptor antagonism are present in wastewater effluents and
influents as a result of human activities at both indoors and outdoors environments.
Given that domestic wastewaters are centrally collected for treatment at WwTPs, and
the discovery that anti-androgenic chemical removal at WwTPs are partial, the receiving
environments of effluents are contaminated on continuous basis. Due to their
physicochemical properties, they undergo biotransformation in the environment and
induce some biological effects in aquatic animals. The concept of recycling wastewaters
as an alternative source of drinking and irrigation water has to be re-evaluated following
partial removal of potential demasculinising chemicals at wastewater treatment works.
There is a need for developing and improving clean-up technologies that would
eliminate a wide range of biologically active environmental chemicals present in treated
wastewaters that may pose a threat to human and wildlife health.
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APPENDICES
APPENDIX A: Percentage recovery of test standards comprising dichlorophene
(DCP), vinclozolin (Vz) and p,p-DDE on different SPE cartridges and recovery plots of
some test compounds on HLB cartridges.
Appendix A.1: Showing % recovery of test standards with different SPE cartridges.
Appendix A.2: Recovery plot of dichlorophene (DCP) standard on HPLC.
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Appendix A.3: Recovery plot of vinclozolin standard on HPLC
Appendix A.4: Recovery plot of p,p-DDE standard on HPLC
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Appendix B: The projection of standard loss in acetonitrile-water solution when
evaporated using speed vacuum concentrator during sample derivatisation for GC-MS
analysis.
Appendix B.1: Recovery of standard in water-acetonitrile gradient injection
%
Water
Corresponding
Area Mass of E1-d4
100 0 1.50
75 147177 2.25
50 249063 3.00
25 358892 4.50
0 415221 6.00
Appendix B.2: Projection of standard loss during work-up as estimated on the HPLC
Appendix B.3: Estimation of sample concentration as influenced by polarity factor.
Appendix B.4: Mass of E1-d4 recovered when the solution ranged from 0-100%
acetonitrile (or 100-0% water).
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Appendix B.5: Projection of E1-d4 recovery on GC-MS as the percentage of water in
the sample fractions increases.
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Appendix C: NIST and sample chromatograms of compounds identified in effluent and
influent fractions. The chromatogram pair is labelled A and B.
Francis Effluent_all_Fraction 23 _run1_20th June 2009 #751-755 RT: 12.10-12.13 AV: 5 SB: 30 12.13-12.22, 11.89-12.08 NL: 2.25E4
T: + c Full ms [ 50.00-650.00]
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Francis Effluent_all_Fraction 24_run1_20th June 2009 #1352-1356 RT: 18.07-18.11 AV: 5 SB: 14 18.11-18.18, 18.02-18.07 NL: 1.12E4
T: + c Full ms [ 50.00-650.00]
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Francis Effluent_all_Fraction 24_run1_20th June 2009 #1268-1275 RT: 17.25-17.32 AV: 8 SB: 27 17.35-17.46, 17.11-17.24 NL: 3.11E4
T: + c Full ms [ 50.00-650.00]
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298.1267.1 364.1 419.1326.1 442.9 614.9514.1410.0 492.9 535.0 561.1 605.2 623.0
Peak of Tris(2-chloromethyl)phosphate (TCEP)
in effluent fraction 24 at 17.27min
(w9n08) Tri(2-chloroethyl) phosphate
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 2900
50
100
45
63
65
77
81
93
99
107
117 125
135
143
151
161 187
205
223
235
249
O P
O
O
O
Cl
Cl
Cl
3A
3B
258
Francis Effluent_all_Fraction 24_run1_20th June 2009 #890-902 RT: 13.52-13.64 AV: 13 SB: 156 13.63-14.22, 12.64-13.54 NL: 1.26E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
147.1
146.1
221.1
119.291.1
148.1 177.1 222.1
236.077.1 470.0265.065.1 161.2 178.2120.2 264.0 308.0291.1 474.0457.0385.9356.0 526.1413.1 556.0 587.2 617.0 647.0
Peak of 2,4,6-trimethylbenzoic acid
in effluent fraction 24 at 13.58min
(w9n08) Benzoic acid, 2,4,6-trimethyl-, trimethylsilyl ester
30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 2500
50
100
41 51 57 65
73
77
79 85
91
93
103
119
132
147
161 177 191 201 207
221
236
O
O
Si
4A
4B
259
Francis Effluent_all_Fraction 25_run1_20th June 2009 #1318-1323 RT: 17.56-17.61 AV: 6 SB: 66 17.61-17.86, 17.19-17.56 NL: 9.95E3
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
229.1
185.2
127.2
155.2
244.1
186.2126.2
174.2 217.2
123.2
128.277.1 245.1 360.1292.1114.2 326.1 450.053.1 427.1136.2 492.0197.2 578.3390.2 612.0503.0 531.0 646.8
Peak of 1-naphthalanecarboxylic acid, trimethylsilylester
in effluent fraction 25 at 17.58min
(w9n08) 1-Naphthalenecarboxylic acid, trimethylsilyl ester
30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 2600
50
100
35
45 51 59
63
65
73
77
80 87 92
101
105
114
127
141
155
169
185
200 211
229
244
Si
OO
5A
5B
260
Francis Effluent_all_Fraction 25_run1_20th June 2009 #1025-1041 RT: 14.67-14.82 AV: 17 SB: 184 14.84-15.50, 13.55-14.67 NL: 6.44E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
190.2
91.1 119.1
65.1
191.1
89.1
120.192.1 162.1 192.166.1 145.2 318.0244.1105.2 330.1 475.0459.0 540.0355.0 392.2 563.0259.1 501.1413.1 614.1576.1 628.2
Peak of diethyltoluamide (DEET) detected
in effluent 25 at 14.72min
(w9n08) Diethyltoluamide
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 2000
50
100
14 29 39 44 51 56 63
65
72 77 81
91
100 105
119
132 148 162 176
190
NO
6A
6B
261
Francis Influent-Y_Fraction 27_run1_16th June2009 #1816-1830 RT: 22.67-22.81 AV: 15 SB: 234 22.78-23.77, 21.34-22.68 NL: 2.13E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
357.2
358.2
73.1 359.2
191.1 207.1
373.1267.1151.275.1 251.2 341.291.2 165.2 323.267.1 491.1477.1 504.1376.1 445.1 595.0541.2 558.3426.1 642.2
Peak of derivatised bisphenol-A  also known as
{2,2-bis[(4-trimethylsiloxyl)phenyl]propane}
detected in Influent 27 at 22.73
(mainlib) 2,2-Bis[(4-trimethylsiloxy)phenyl]propane
20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 3800
50
100
29 45 53 60
73
82 91 99 115 135 151 171 191
207
222 233 251 269 281 299 311 323 341
357
372
O
Si
O
Si
7A
7B
262
Francis Influent-Y_Fraction 29_run1_16th June2009 #1672-1693 RT: 21.18-21.38 AV: 22 SB: 281 21.35-23.12, 20.16-21.19 NL: 3.14E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
243.1
185.2
302.0
141.2 170.2
244.273.1 287.1
115.1 153.2
186.2 303.1
227.2100.2 245.2217.2 304.170.1 379.174.1 279.2 369.1 394.2311.2 472.1 501.0452.2 583.2529.2 565.1 639.0623.0
Peak of derivatised Naproxen
detected in influent fraction 29 at 21.25min
(w9n08) 2-Naphthaleneacetic acid, 6-methoxy-α-methyl-, trimethylsilyl ester, (+)-
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 3100
50
100
15 27
45
59
73
89 102
115
127
141
153 170
185
198 212 227
243
255 272
287
302
SiO
O
O
8A
8B
263
Laboratory standard of derivatised chloroxylenol
Influent Fraction 31_run01-7th Feb 2010 #759-770 RT: 12.27-12.37 AV: 12 NL: 5.03E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
213.0
228.0
177.1
230.0
93.0
178.173.1 149.1119.1
95.1 231.065.0 163.1 183.0
441.0233.0 401.0281.0 327.1 341.0 579.6473.0 620.6560.0516.5 647.7
Peak of derivatised chloroxylenol in
Influent fraction 31 at 12.32min
calibration_standards_05October06 #755 RT: 12.22 AV: 1 SB: 105 12.26-12.70, 11.60-12.18 NL: 1.27E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
213.1
228.1
177.2
230.0
178.2
149.293.1 231.1119.2
139.275.1 401.095.1 159.2 183.1 402.065.1 233.0 336.2 441.0 488.9327.1 385.0 416.1281.1263.1 526.2357.0 564.4 612.9 629.9598.4
9A
9B
264
Francis_inf_rerun17june09_influent37 #1928-1936 RT: 23.63-23.71 AV: 9 SB: 8 23.70-23.73, 23.61-23.64 NL: 8.16E3
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nce
214.1
242.1
277.0
244.1
279.0 367.0
75.1
179.2
369.0151.273.1
180.2
352.1280.1245.1 370.0181.293.2 282.1149.1 310.2 451.1386.1 442.1 471.2 612.9519.0 597.1551.0 646.1
Peak of derivatised diclofenac in
Influent fraction 37 at 23.67min
(w9n08) Diclofenac, trimethylsilyl ester
20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 3800
50
100
27 39
45
51 63
73
89 103 126 136
151
164
179
186 201
214
242
250
277
308
352
367
Si
O
NH
OCl
Cl
10A
10B
265
Francis_inf_rerun17june09_influent37 #1093-1102 RT: 15.29-15.37 AV: 10 SB: 8 15.36-15.39, 15.25-15.28 NL: 2.10E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
160.1
73.1
117.1
263.1161.175.1
234.0
91.1
145.2
205.1 264.1 344.1265.1 334.1 352.2 541.1 561.2469.1395.1 623.9503.0438.1
Peak of derivatised ibuprofen in
Influent fraction 37 at 15.38min
(mainlib) Ibuprofen, trimethylsilyl ester
20 40 60 80 100 120 140 160 180 200 220 240 260 2800
50
100
27 43 57 65
73
91
117
131 145
160
191 205 220
234 263 278
SiO
O
NIST library  expressing peak of ibuprofen, trimethylsilyl
11A
11B
266
Laboratory standard of derivatised chlorophene
Francis Influent-Y_Fraction40_run1_28th May 2009 #1466-1482 RT: 19.16-19.32 AV: 17 SB: 161 19.31-20.01, 18.27-19.17 NL: 8.53E3
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
275.1
290.1
91.1
197.1
292.1
165.2 255.275.1
199.1
135.2
58.1 204.2152.2 181.2 239.1 293.192.1 215.1
111.2 461.1 489.0355.0294.2 509.2396.2 535.1 563.0429.0 595.0340.2 358.1 636.5
Peak of derivatised chlorophene in
Influent fraction 40 at 19.24min
calibration_standards_05October07 #1446 RT: 19.26 AV: 1 SB: 70 19.29-19.62, 18.84-19.22 NL: 2.78E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
10
20
30
40
50
60
70
80
90
100
Re
lat
ive
Ab
un
da
nc
e
275.1
290.0
91.1
197.1
292.0
255.2
75.1 165.2 199.1135.2
239.2152.273.1 293.0181.2 215.292.265.1 295.0 392.8 421.0 551.2354.1 536.0 570.8514.0441.1 618.2473.9 648.8
12A
12B
267
Francis Effluent_all_Fraction_46_run01_25thMay2009 #2003-2021 RT: 24.64-24.82 AV: 19 SB: 496 24.82-26.91, 21.82-24.66 NL: 4.02E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
125.1
85.2 199.199.1
55.1
73.2
155.1
153.1
187.2
127.1
227.1 255.1 299.2171.1
328.2
243.2 411.3329.2267.1 357.2300.2 412.4399.2 446.3 503.1459.2 563.1549.1 649.4595.1 615.1
Peak of TBEP (or KP-140) in effluent
fraction 46 at 24.73min
(w9n08) Ethanol, 2-butoxy-, phosphate (3:1) (CAS)
40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 4000
50
100
41
45 57
85
101
125
139
153
199
214
227
255
271
299
315 355 399
P
O
O
O
O
O
O
O
13A
13B
268
Francis Influent -Y_Fraction58_ run1_29th May 2009 #2080-2091 RT: 24.80-24.91 AV: 12 SB: 345 24.88-26.51, 23.11-24.77 NL: 3.35E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
256.2
241.2
185.2
331.1281.1
213.2
73.1
179.1 355.0
429.091.2 221.1 446.1284.1129.2 143.2 186.2 356.169.1 157.2 503.0447.1413.2199.2 295.0 504.0448.2401.1 491.0 536.1 549.1 638.9579.0 610.1
Peak of derivatised abietic acid  in
Influent fraction 58 at 24.85min
(w9n08) ABIETIC ACID 1TMS
70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 3900
50
100
73
91 105 131 143 172
185 213
241
256
359
374O O
Si
14A
14B
269
Francis Influent -Y_Fraction58_ run1_29th May 2009 #1996-2005 RT: 23.99-24.08 AV: 10 SB: 249 24.06-25.38, 22.93-23.99 NL: 4.29E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
und
an
ce
241.2
256.2
185.2
227.2 257.2214.2105.291.2 157.2145.2
295.0 359.2 369.067.1 296.1 371.0341.1 405.1 582.3465.1 550.0 624.0 646.9434.0 508.0
Peak of isopimaric acid TMS in influent
fraction 58 at 24.04min
(w9n08) Isopimaric acid TMS
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 3800
50
100
41 55
69
73
81
85
91 109 121
131 143
148 159 173
187 201
213
227
241
256
345
359
374
O
O
Si
15A
15B
270
Francis Influent -Y_Fraction58_ run1_29th May 2009 #1981-1991 RT: 23.85-23.94 AV: 11 SB: 218 23.94-25.10, 22.94-23.87 NL: 1.27E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
dan
ce
121.2
120.2
91.2
221.1 359.2
257.273.1
161.2 346.2133.1 241.257.1 345.1 475.1175.2 360.2
188.2 258.2 461.1 476.1 535.1280.2 375.2 402.1321.1 609.0581.2 624.1
Peak of pimaric acid TMS in
Influent fraction 58 at 23.91min
(w9n08) Pimaric acid TMS
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 3800
50
100
41
45
55
58
67
73
81 91
109
121
133
148 161 173 187 199 213 227
239
251
257
359
374
O
O
Si
16A
16B
271
Francis Effluent_all_Fraction 19_run2_19th June 2009 #2231-2243 RT: 26.45-26.57 AV: 13 SB: 213 26.58-27.74, 25.50-26.47 NL: 3.92E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
371.1
327.2
372.1
297.1
373.1328.273.1
386.0152.2 329.2179.2 255.2 298.2210.275.1 387.1299.2133.2 238.2181.2 294.2165.2 330.2 551.2499.290.263.1 514.2485.2460.2 589.3 633.2
Peak of 4,4-biphenyldicarboxylic acid bis(TMS)
ester in Effluent fraction 19 at 26.52min
(mainlib) 4,4'-Biphenyldicarboxylic acid, bis(trimethylsilyl) ester
70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 4000
50
100
73
76 90 104 127
141 152
164
178
193 210 254
297
327
371
386
O
O
Si
O
O
Si
17A
17B
272
Francis Effluent_all_Fraction 20_run1_19th June 2009 #1789-1800 RT: 22.06-22.17 AV: 12 SB: 115 22.17-22.75, 21.54-22.07 NL: 1.45E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
243.1
360.1
147.2 242.273.1 244.1
345.2
228.2154.2 227.2 361.1
316.1213.2 411.0185.2 362.1317.1245.1 535.074.1 412.1309.2 609.0 623.0489.0475.0401.1 553.153.1 113.2
Peak of 6-hydroxy-α-methylnaphthalene
Acetate in Effluent fraction 20 at 22.13min
(w9n08) 6-Hydroxy-α-methylnaphthaleneacetic acid, di-TMS
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 3700
50
100
45
59 69
73
101 115 127
154 165 185 199 213
228
243
255 272 287 301 316
345
360
O
Si
O
O
Si
18A
18B
273
Francis Influent-Y_Fraction28_run1_16th June2009 #1338-1352 RT: 17.83-17.96 AV: 15 SB: 180 17.93-18.64, 16.77-17.83 NL: 1.45E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
267.1
193.1
265.1 281.1
119.1
73.1 370.0191.1
207.191.1 355.0118.1 282.1177.2 371.1147.2 429.0117.1 209.1 395.250.9 307.2 341.0 449.1 595.1234.2 464.1 520.1 538.1 609.9 641.0566.4
Peak of 3,4-dihydrophenylethane in
Influent fraction 28 at 17.88min
(mainlib) Ethanol, (2-(3,4-dihydroxyphenyl)-, tris(trimethylsilyl)-
40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 3800
50
100
45
59
73
91 103 115 133 147 161
179
193
205 223 237 251
267
281 355
370
O
O
O S
i
Si
Si
19A
19B
274
Francis Effluent_all_Fraction 22_run1_20th June 2009 #1918-1927 RT: 23.37-23.46 AV: 10 SB: 198 23.43-24.17, 22.17-23.37 NL: 7.57E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
193.2
194.2192.2165.2
191.2
250.2 293.2164.2 203.2 337.1234.2 284.1139.289.1 381.163.1 438.3423.2 465.2 490.1 563.2503.1 613.2600.1 628.4
Peak of carbamazepine TMS in
Effluent fraction 22 at 23.39min
(w9n08) Carbamazepine tms
20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 3200
50
100
27 45 51 57 63
73
82 89 100 115 125 139 152
165
178
193
202 219 234 250 263 277
293
308
Si
HN
N
O
20A
20B
275
Francis Effluent_all_Fraction 22_run1_20th June 2009 #2005-2020 RT: 24.23-24.38 AV: 16 SB: 138 24.35-24.72, 23.23-24.21 NL: 3.24E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
193.2
192.2
236.1
165.2
191.2
194.2 270.1
164.2 275.2139.2 298.1255.2211.263.1 407.289.2 126.2 524.2423.2334.2 359.2 466.2 559.1510.2 578.2 642.3598.2
Peak of carbamazepine in
Effluent fraction 22 at 24.30min
(w9n08) Carbamazepine
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 2500
50
100
44 51 63 75 82 89 95 101 115 128 139 152
165
177
193
207 218
236
NH2O
N
21A
21B
276
Francis Effluent_all_Fraction 24_run1_20th June 2009 #1304-1323 RT: 17.60-17.79 AV: 20 SB: 217 17.74-19.25, 17.01-17.61 NL: 1.08E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
295.1
312.1
237.1
251.1194.2
209.1
147.1 221.1
252.1103.1 313.1148.275.1 314.1254.1120.283.1 268.152.0 334.1 407.0 484.1 517.1 579.1422.0361.1 529.1 625.0448.1 646.0
Peak of 1.4-benzendicarboxylic acid bis-TMS
(terephthalic acid bis-TMS) in Effluent fraction 24 at 17.66min
(w9n08) 1,4-Benzenedicarboxylic acid, bis(trimethylsilyl) ester
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 3200
50
100
15 26 45 59 65
73
76
89 96
103
118
135
149 163 178
193
207
221
231
251
264 279
295
310
O
O
Si O
O
Si
22A
22B
277
Appendix D: Chromatograms of some unknown compounds that occurred in effluent
and influent fractions in high concentrations.
Francis Effluent_all_Fraction 22_run2_20th June 2009 #633-652 RT: 10.90-11.08 AV: 20 SB: 415 11.07-12.76, 8.72-10.92 NL: 3.35E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
dan
ce
197.1
229.1
89.1
59.1
156.2 198.2 230.1 299.1173.2 267.1145.2 495.0233.1199.2143.272.1 102.2 496.0300.1201.2 263.1 471.1449.0387.2 564.7 580.9325.1 642.4413.0 549.2 623.1
Effluent fraction 22 at 10.99min
Francis Effluent_all_Fraction 22_run2_20th June 2009 #1248-1263 RT: 16.84-16.98 AV: 16 SB: 277 16.98-18.19, 15.36-16.82 NL: 1.53E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nce
229.1
213.1
259.1
185.173.1 201.1
75.1 230.0115.1
159.277.1 333.1139.1 275.0
295.0 341.099.269.1 369.0232.1 421.1 569.1463.1 549.1 615.0 643.0518.0494.9
Effluent fraction 22 at 16.89
1
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Francis Effluent_all_Fraction 22_run2_20th June 2009 #1551-1563 RT: 19.78-19.90 AV: 13 SB: 121 19.90-20.00, 18.74-19.79 NL: 2.87E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
dan
ce
91.1
119.2
173.2147.1
262.0172.1
73.1 221.1
247.1
179.1 276.169.1 145.2117.2 222.2 341.1205.1 429.0304.1 355.1 415.0 502.9461.1 533.1 595.0 607.3555.0 643.9
Effluent fraction 22 at 19.85min
Francis Effluent_all_Fraction 22_run2_20th June 2009 #1831-1849 RT: 22.51-22.69 AV: 19 SB: 276 22.66-23.54, 20.74-22.55 NL: 1.91E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
143.2
186.1
158.2
226.1
170.2
316.1
129.2 291.2
128.2
348.2 377.1
275.2
75.1 411.1
317.1 395.1201.273.1 115.2 349.2227.1103.2 339.2 412.167.1 376.181.2 413.1
453.2 623.1485.1 501.2 526.2 550.5 600.3 647.4
Effluent fraction 22 at 22.61min
3
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Francis Effluent_all_Fraction 22_run2_20th June 2009 #2082-2103 RT: 25.00-25.20 AV: 22 SB: 367 25.12-26.85, 23.08-25.00 NL: 4.71E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
202.2
131.2
160.2
187.2
159.173.1 245.1
147.2 203.2
91.1 261.0129.2 171.1 262.0115.2 227.2 329.1275.2 447.1 463.1372.199.2 307.153.1 403.1 535.1521.1 609.1559.2 644.0
Effluent fraction 22 at 25.07min
Francis Effluent_all_Fraction 22_run2_20th June 2009 #2276-2291 RT: 26.94-27.09 AV: 16 SB: 221 27.06-27.99, 25.65-26.93 NL: 4.94E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
73.1
143.2
91.1
229.2
171.1
275.2 377.1
172.1
189.1161.2
257.1
190.1105.2
131.2
276.2230.2
331.2284.2 378.1346.2
302.265.1
393.1303.2 465.1445.2 486.4 595.1 625.0506.3 529.1 574.2 638.2
Effluent fraction 22 at 27min
5
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Francis Effluent_all_Fraction 22_run2_20th June 2009 #2417-2435 RT: 28.37-28.55 AV: 19 SB: 258 28.51-29.42, 26.73-28.41 NL: 3.38E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
464.2
465.2
367.1249.2
466.2
582.2359.2250.2 368.2193.2 225.2 583.2381.2263.2 467.2159.2 285.2 341.1 492.295.2 331.2149.279.1 449.2 585.2433.2 567.2396.2 519.2 637.0
Unknown compound  found in
effluent fraction 22 at 28.47min
Francis Effluent_all_Fraction 21_run2_20th June 2009 #1798-1811 RT: 22.23-22.35 AV: 14 SB: 183 22.34-23.17, 21.28-22.23 NL: 2.07E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
143.1
144.1129.2
261.0128.2
73.1
75.1 205.1 245.1103.1 262.172.1 363.2 391.1145.2 169.2 317.1 407.1206.277.1 286.1 513.1 528.2479.2456.2 643.1579.0 594.1
Unknown compound in effluent fraction 21 at 22.29min
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Francis Effluent_all_Fraction 21_run2_20th June 2009 #2011-2024 RT: 24.33-24.46 AV: 14 SB: 144 24.45-25.47, 23.95-24.35 NL: 3.27E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
133.2
193.2
91.1
105.2
274.1124.2
150.2
175.2
256.1213.2
77.1
302.1228.250.9 275.2
321.2 433.3 468.3377.1 392.1 511.2337.2 583.2 638.1621.2554.2
Unknown compound in effluent fraction 21 at 24.41min
Francis Effluent_all_Fraction 21_run2_20th June 2009 #2263-2284 RT: 26.86-27.07 AV: 22 SB: 389 27.06-28.96, 24.91-26.92 NL: 2.19E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
73.1
91.1
143.2
171.2 229.2 377.1
203.2
172.1145.2 257.1131.2
189.1 275.2105.2
281.1
247.2
378.1369.1
331.2
65.1 359.2 379.1303.2 443.2 533.2459.2407.2 525.2 535.2 628.3577.2 591.4
Unknown compound in effluent fraction 21 at 26.98min
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Francis Effluent_all_Fraction 21_run2_20th June 2009 #2625-2654 RT: 30.54-30.84 AV: 30 SB: 307 30.81-31.58, 28.21-30.55 NL: 3.80E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nce
258.1
257.2
197.2
240.2199.2 259.2 348.1215.2
172.1143.2 330.1129.2 157.2 261.1 313.275.1 349.1 385.191.2 413.2 428.1 503.1277.2 593.1367.255.1 563.2475.2 518.2 634.2
Unknown compound in effluent fraction 21 at 30.69min
Francis Effluent_all_Fraction 21_run2_20th June 2009 #2713-2743 RT: 31.45-31.75 AV: 31 SB: 213 31.72-32.34, 29.90-31.45 NL: 9.50E3
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
400.1258.2171.1
257.2197.2
73.1 261.0
199.2
382.1
241.2
239.2
147.2
133.2 472.1212.2
310.2262.175.1 129.2 330.1 401.1293.2 331.2 428.1
333.2
503.1413.1338.1
91.2 117.2 518.1 593.1475.1339.2
367.2 519.155.1 490.1 594.2440.2 520.2 609.1575.2 648.2
Unknown compound in effluent
fraction21 at 31.60min
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Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2006-2022 RT: 24.36-24.52 AV: 17 NL: 1.48E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nc
e
172.1
73.1
133.2
265.2
262.0
147.1 175.1
129.2
91.1 245.1105.2
204.1
229.2 274.2
331.1 374.1275.2 299.2 449.155.1 346.1
325.1 375.1 450.1405.2
537.1422.1 467.1 611.1508.1 644.2598.1
Unknown compound in effluent
fraction 23 at 24.42min
Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2030-2042 RT: 24.60-24.72 AV: 13 SB: 111 24.69-25.10, 23.70-24.36 NL: 8.66E3
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nce
256.2228.2
374.1
346.1
172.1
133.2
238.2
275.2186.2
171.1
213.2
143.2
156.2
105.2
418.2347.2
331.2119.2 449.2
375.1
197.2 356.155.1
450.2285.2 419.2376.1 539.177.1 521.2391.2 431.1 481.1 540.2 564.2 613.2 634.1
Unknown compound in effluent
fraction 23 at 24.65min
13
14
284
Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2070-2080 RT: 25.00-25.09 AV: 11 SB: 132 25.11-25.53, 24.10-24.98 NL: 5.07E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
und
an
ce
202.1
131.2
160.2
187.2
159.1
73.1 245.1
203.2147.2
261.091.1 129.2 171.1 227.2 329.1262.0 447.1307.1 372.1 463.199.1 419.265.2 535.1 567.0520.2 610.0 622.2
Unknown compound in effluent
fraction 23 at 25.04min
Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2084-2094 RT: 25.13-25.23 AV: 11 SB: 166 25.22-25.69, 23.97-25.13 NL: 2.19E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nce
229.2 274.1
238.2
262.0129.2
73.1
275.2172.1
284.1171.1 213.2
356.1156.1 331.1201.2
184.2 449.1117.2 313.2143.275.1 387.2 421.285.255.1 374.1297.2 464.0402.297.2 535.1465.1 527.2 555.1 591.3 643.1610.4
Unknown compound in effluent
fraction 23 at 25.18min
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Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2109-2122 RT: 25.38-25.51 AV: 14 SB: 126 25.50-26.00, 24.65-25.38 NL: 5.01E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
229.2
374.0228.2
256.1
346.1
157.2
172.1 257.2213.2 284.173.1 185.2143.2
203.2133.2
375.1342.2 347.2
75.1 105.2 287.2 356.1331.2 449.2266.291.1
315.2 464.0376.155.1 421.1 467.1405.2 555.2507.2 596.3 640.9
Unknown compound in effluent
fraction 23 at 25.45min
Francis Effluent_all_Fraction 23 _run1_20th June 2009 #2140-2153 RT: 25.69-25.82 AV: 14 SB: 183 25.82-26.54, 24.59-25.67 NL: 4.07E4
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lati
ve
Ab
un
da
nc
e
201.2
187.2
226.2
227.2 261.0
171.1
73.1 262.0
255.2 329.1282.2 344.275.1 413.2372.1128.2 447.1301.2239.2157.2 462.1373.1 420.2121.2 353.2313.2103.2 376.261.1 465.1 493.2 524.3 553.2 626.7565.4
Unknown compound in effluent
fraction 23 at 25.74min
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Francis Effluent_all_Fraction 33_run01_20th Jan 2010 #347-360 RT: 8.39-8.52 AV: 14 SB: 138 8.50-9.13, 7.69-8.39 NL: 6.02E5
T: + c Full ms [ 50.00-650.00]
50 100 150 200 250 300 350 400 450 500 550 600 650
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
Ab
un
da
nce
212.2
73.1
216.1
115.1
163.2119.177.1 170.2 217.256.1 121.2 287.1262.0 305.1224.1 471.3424.1 599.3537.1 562.2506.1387.9362.9349.9 639.8
Peak of an unknown compound in Influent fraction 33 at 8.45min
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Appendix E: The calibration curves of identified compounds in wastewater samples.
These include abietic acid, chlorophene, chloroxylenol, dichlorophene, galaxolide,
isopimaric acid, N,N-butylbenzenesulfonamide (NBBSA), pimaric acid, TBEP, TCPP
and triclosan.
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Appendix F: The amount of AA in each fraction of effluent and influent samples
analysed.
Fraction AA of Effluent
Fraction(ngFeq/L)
AA of Influent
Fraction(ngFeq/L)
27 4100 2200
31 3100 500
32 5400 2000
33 8400 7700
34 4900 7800
35 3900 7600
36 3000 <LOD
37 2800 2500
38 2900 8600
40 2300 3900
45 6600 2400
46 4800 4100
58 2700 4300
59 1500 7200
60 1400 3700
